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Summary  
Patients with cancer, and their relatives, often have unmet information needs during 
the course of their illness. Within the NHS, there has been a shift from inpatient to 
outpatient cancer care, which has meant that patients are receiving less direct, regular 
supervision from their clinicians. The introduction of Smart technology has presented 
an opportunity to deliver interventions to patients, and their relatives, remotely. The 
aims of this thesis were to: (1) understand the needs and preferences of patients with 
cancer regarding an app to help them to meet their information needs in non-inpatient 
settings, and (2) to develop an app for patients, which may also be used by relatives, 
based on their identified needs and preferences.  
 
A qualitative study with patients and their relatives identified several barriers to 
information-gathering and understanding that occur during and between patient-
clinician consultations, which lead to unmet information needs. Patients and their 
relatives reported that an app intervention, which could help them to overcome these 
barriers and enable them to meet their information needs, would be useful. A 
qualitative study with cancer clinicians explored their opinions on the value of this type 
of app and clinicians appeared to be supportive of its development and use in 
consultations. The ‘Ask Us’ app was then designed and user-tested with patients in the 
community. Patients perceived the app to be a useful and acceptable intervention to 
help them to meet their information needs. A range of benefits were reported by 
patients and some barriers to app use were highlighted. Overall, the ‘Ask Us’ app 
appears to be a feasible intervention to support patients with cancer in the community.  
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Chapter 1 
Introduction 
 
It is estimated that one in two people in Great Britain will develop some form of cancer 
during their lifetime (Ahmad, Ormiston-Smith, & Sasieni, 2015). In 2014, 357,000 new 
cases of cancer were diagnosed in the UK and the incidence rate is increasing 
(Cancer Research UK, 2014). However, survival rates have doubled in the UK in the 
last 40 years and so for many, cancer has become a chronic condition with which they 
live for many years. Subsequently, there has been a shift from inpatient to outpatient 
and community cancer care (i.e. non-inpatient settings), where patients are required to 
manage their condition at home, away from regular supervision by clinicians. This 
change in care requires patients to take a more active role in their treatment and 
survivorship. Patients are often faced with an uncertain future, unfamiliar tests and 
procedures, treatment options, treatment-related side-effects and lifestyle changes. In 
order to take a more active role in their care, and to cope with and manage these 
changes to daily life, patients require relevant information (Hibbard & Gilbert, 2014; 
Jefford & Tattersall, 2002). Consequently, recent government initiatives and National 
Health Service (NHS) plans, such as the National Cancer Strategy and Cancer 
Delivery Plan, have highlighted information provision as one of their key priorities 
(Department of Health (DOH), 2011; 2013; Welsh Government, 2016). 
 
1.1 The importance of information for patients with cancer and variation in 
patients’ information needs 
A need can be described as, “a wish to receive support with an experienced problem” 
(Osse, Vernooij-Dassen, de Vree, Schadé & Grol, 2000, p.901), therefore an 
information need can be described as the more specific desire for informational 
support. The dominant view of what constitutes a need, in a culture geared towards 
increasing patient involvement, is that need is self-assessed by the patient themselves 
(Boberg et al., 2003; Tamburini et al., 2000). This is in comparison to a previous view, 
where a patient’s need was defined by a healthcare professional (Krishnasamy, Wilkie 
& Haviland, 2001; Walters, Iliffe, Tai & Orrell, 2000).  
 
Mills and Sullivan (1999) outlined six functions and benefits of information for patients 
with cancer following a review of the literature, which included gaining a sense of 
control, reduction of anxiety, increased adherence to treatment, more realistic 
expectations, increased feelings of safety, and promotion of self-care and participation. 
There is also evidence to suggest that information provision leads to health 
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improvements and improved health-related quality of life (Husson, Mols & van de Poll-
Franse, 2011). Studies across the UK, USA, North America and Australia have shown 
that most patients want as much information on their condition as possible, whether 
good or bad (Butow, Dunn, Tattersall & Jones, 1994; Jenkins, Fallowfield & Saul, 
2001). For example, a UK study of 2231 patients found that 87% of patients stated that 
they wanted detailed information on their cancer, with no difference in information 
needs between curative or palliative patients (Jenkins et al., 2001). Reviews of the 
literature suggest that patients generally want information on the extent of the disease, 
likelihood of cure and prognosis, available treatments, side-effects of treatment, self-
care and return to normal life (Bilodeau & Degner, 1996; Luker et al., 1995; Mills & 
Sullivan, 1999). Other, less urgent, information needs include the impact of cancer 
and/or treatment on social activities, family and friends, mental wellbeing and sexual 
activity, and the risk of family and friends getting cancer (Bilodeau & Degner, 1996; 
Luker et al., 1995). It is important to note that an information need is separate from 
other types of needs, such as emotional or practical needs. However, information 
related to emotional or practical issues can enable patients to meet their other needs.  
For example, access to information on services that provide psychological support 
enables patients to contact those services and meet their emotional needs. For the 
purpose of this thesis, the term ‘information need’ therefore refers to the need for any 
cancer-related information, such as information about the disease itself, treatment, 
emotional support services, practical support services and so on, which in turn, may 
help patients to meet a range of needs throughout their cancer. 
 
Cancer-related information seeking by patients and survivors has generally increased 
over time which likely reflects the increased access to information, however patients’ 
information-seeking has been shown to vary between and within patients (Leydon et 
al., 2000; Rutten et al., 2016). A number of demographic factors, such as age, gender, 
education and income, as well as the type of cancer, have been associated with 
variation in information needs and information-seeking (Morrison et al., 2012; Nagler et 
al., 2010; Rutten et al., 2016). Studies have previously suggested that patients who are 
younger, female, and have a higher education level and income, are more likely to 
have greater information needs and seek more information than patients who are 
older, male, less educated and of lower income (Morrison et al., 2012; Rutten et al., 
2016). Inequality in access to information resources, such as the Internet, perceived 
loyalty to clinicians and avoidant coping strategies in order to maintain hope have 
accounted for some of these findings (Leydon et al., 2000; Rutten et al., 2016). 
However, some recent studies suggest that the effects of demographic factors on 
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cancer patients’ information-seeking may be reducing, as the acceptance and use of 
newer information resources, such as the Internet, becomes more widespread 
throughout older generations and more accessible to patients of lower socioeconomic 
status (Katz, Roberge & Coulombe, 2014). Patients’ information needs also appear to 
vary throughout the cancer journey, however they are typically highest following 
diagnosis and then generally decrease over time (Rutten et al., 2005; 2016). Finally, 
information-seeking generally remains consistent throughout the cancer journey and 
into survivorship, regardless of time since diagnosis, which suggests that both cancer 
patients and survivors require long-term information support (Morrison et al., 2012; 
Rutten et al., 2016).  
 
1.2 Patients’ unmet information needs 
Unfortunately, research suggests that the information needs of cancer patients are not 
always met. Up to 93% of cancer patients across the US, Europe and the UK report 
having unmet information needs (Boberg et al., 2003; Cox, Jenkins, Catt, Langridge & 
Fallowfield, 2006; Faller et al., 2016; Harrison, Young, Price, Butow & Solomon, 2009). 
Similarly, the Wales Cancer Patient Experience Survey revealed that a significant 
number of patients across Wales declared unmet information needs (Quality Health, 
2014). Patients have generally reported a lack of basic information related to their type 
and stage of cancer, treatment, and other important information, such as the long-term 
consequences of treatment, available support services, necessary lifestyle changes 
and how to manage their finances. As well as limiting patients’ ability to participate in 
their care, unmet information needs are associated with a lower quality of life, 
increased anxiety and depression, and dissatisfaction with care (Faller et al., 2016; 
Husson et al., 2011).  
 
Research has highlighted several reasons for cancer patients’ unmet information 
needs. Firstly, previous studies have identified barriers to information exchange within 
patient-clinician consultations. Clinicians may underestimate patients’ information 
needs, overestimate the amount of information they give or patients may feel uncertain 
about what to ask, feel unable to ask questions, particularly patients with serious or 
life-threatening diseases, or forget to ask a particular question during consultations 
(Boberg et al., 2003; Jefford & Tattersall, 2002; Jenkins et al., 2001). Additionally, 
some patients forget or misunderstand the information they receive from the clinician 
or have difficulty assimilating the information due to anxiety or decreased cognitive 
performance caused by the disease or treatment (Hogbin & Fallowfield, 1989; Ley, 
1988; Jepson & Chaiken, 1990; Maguire & Faulkner, 1988). Secondly, many patients 
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find it difficult to identify reliable information resources and relevant information 
between consultations. Some patients struggle to find the information that they need 
on the Internet and may also be misled by inaccurate information from websites or 
misinterpret the information (Eysenbach, 2003; Kiley, 2002). Similarly, other common 
sources of information, such as family and friends, the media, and social media or chat 
forums, cannot be relied upon for accurate information (Rutten, Arora, Bakos, Aziz, & 
Rowland, 2005). 
 
1.3 Sources of information for patients 
Despite these issues in consultations, it is widely acknowledged that clinicians are 
patients’ most valued source of information (Mills & Sullivan, 1999; Rutten et al., 2016). 
However, patients commonly seek information from a variety of additional sources 
outside of the healthcare service, including the Internet, printed materials, the media, 
interpersonal sources (e.g. friends and family, support groups), and organisational and 
scientific sources (e.g. cancer charities, medical journals) (Rutten et al., 2005; 2016). A 
recent survey of breast cancer patients’ use of information sources in Ireland reported 
that the most common information resources included cancer clinicians (95%), leaflets 
(69%) and websites (59%), while other printed media (42%), books (41%) and medical 
journals (in print and online) (31%) were less popular (O’Brien et al., 2015). 
Additionally, although this study did not report the percentage of patients that used 
their Smartphones to search for illness-related information, 47% of patients perceived 
a Smartphone app to be a useful medium to learn from, or communicate with, their 
healthcare team.  
 
Comparison of several surveys demonstrate the increasing popularity of new web-
based information resources due to increased access to devices and availability of 
information websites and apps (Kempf et al., 2016; O’Brien et al., 2015; Rutten et al., 
2005; 2016). For example, a survey of cancer outpatients in France found that half of 
patients had used websites and a quarter had used apps to search for health 
information (Kempf et al., 2016). In contrast, the amount of patients that report using 
printed materials or the media as a first source of information on their condition has 
decreased (Rutten et al., 2016).  
 
The acceptance and use of new web-based technologies appear to be influenced by 
several demographic factors. Surveys of cancer patients across Europe, the US and 
Canada have shown that patients who are younger, urban-dwelling, more educated, 
and employed are significantly more likely to accept and perceive websites, apps and 
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text messaging as useful forms of education and communication with their clinicians 
compared to older, rural-dwelling, less educated and unemployed patients (Katz et al., 
2014; O’Brien et al., 2015; Rutten et al., 2016). Authors concluded that the acceptance 
of new technology as an information resource for patients with cancer is expanding as 
expected along generational trends and over time, use of these media as a resource of 
cancer-related information will increase. Given the benefits of information for patients 
with cancer, it is prudent to develop web-based information resources in order to cater 
for the increasing number of patients that prefer to access information in this way. 
 
Despite the increasing popularity of web-based technology, a review by Rutten and 
colleagues (2016) found that the percentage of patients reporting clinicians as their 
first source of information has increased over time, which suggests that although new 
web-based information resources are becoming more popular and are likely to replace 
traditional resources of information, clinicians are still patients’ first and preferred 
source of information. The continued reliance on clinicians for information may be an 
indicator of the complexity of the information environment and patients’ need for 
guidance in understanding the available information, particularly among those who are 
male, older, and socioeconomically disadvantaged, as these patients are especially 
likely to rely on clinicians as a key source of information (Rutten et al., 2016). It is 
therefore important to develop interventions to support information exchange and 
understanding in patient-clinician consultations.  
 
1.4 The information needs of patients’ families  
It is now acknowledged that a cancer diagnosis also has a significant negative impact 
on patients’ close family and friends, who experience similar levels of distress to 
patients following their diagnosis (Long et al., 2016; Revenson & Pranikoff, 2005). 
Reasons for the similar levels of distress include worrying about the patient’s future, 
feeling like ‘helpless observers’ and the burden of becoming an informal caregiver, due 
to the shift to outpatient cancer care (Davis-Ali, Chesler & Chesney, 1993; Lambert, 
Girgis, Lecathelinais & Stacey, 2013). As a result, the concept of cancer has evolved 
into that of a ‘family disease’ (Harrison, Haddad & Maguire, 1995). Family and friends 
of patients have become more physically and emotionally involved in patients’ care 
and are expected to perform duties, such as managing symptoms and treatment side-
effects, providing emotional and informational support, communicating with clinicians, 
organising finances and transport, alongside playing a key role in patients’ medical 
decision making (Long et al., 2016). Despite this increasing responsibility, most do not 
receive assistance and have a short time to gather the relevant information that they 
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need to care for the patient (Revenson & Pranikoff, 2005; Soothill et al., 2001). Similar 
to patients, previous reviews have indicated that relatives are dissatisfied with the 
information that they receive and require more information in order to cope with the 
impact of cancer, both on themselves and the patient (Deeken, Taylor, Mangan, 
Yabroff, & Ingham, 2003; Kitrungrote & Cohen, 2006). The demanding responsibilities 
and unmet information needs of a caregiver further contributes to the negative impact 
of cancer on their wellbeing and compromises their ability to provide effective care for 
the patient (Lambert et al., 2012; Long et al., 2016). It is therefore important to meet 
the information needs of patients’ relatives in order to maintain their wellbeing and 
optimise patients’ care. Recent cancer policies, government and health organisations 
now encourage the development of interventions that consider and support patients’ 
relatives, as well as the patient (DOH, 2011; 2013; Welsh Government, 2016). For 
these reasons, relatives of patients will be involved the development of an app for this 
PhD thesis.  
 
1.5 Information interventions for patients and their families 
Various types of interventions have been developed in an attempt to meet cancer 
patients’ information needs, including paper-based written information, audiotapes of 
consultations, telephone helplines, teaching and counselling services and multimedia 
resources, such as DVDs (Mills and Sullivan, 1999). Reviews of such interventions 
have generally reported a small but positive effect on at least one patient outcome, 
including increased knowledge of their condition, increased recall of the information 
provided, increased satisfaction with their care, improved symptom management or 
improved psychological well-being (Mills & Sullivan,1999; McPherson, Higginson & 
Hearn, 2001). However, many of these interventions are expensive to develop and run, 
and require staff for delivery. While paper-based printed information has generally 
been the most effective and efficient method of delivering information to patients, not 
all information has been found to be evidenced-based, easy to read or tailored to the 
patients’ individual needs. For example, one study of patients who had undergone a 
hysterectomy in the UK found that only 14% of written information provided was based 
on the patients’ needs, 26% of the leaflets were illegible, and 80% of hospitals did not 
follow printing guidelines, which meant the leaflets were difficult to read (Scriven & 
Tucker, 1997). Written information also needs to be pitched at the correct educational 
level to ensure full patient understanding (Foltz & Sullivan, 1996). Authors have 
suggested that information interventions should be used as a supplement to cement 
verbal information from clinicians, particularly due to the emotive nature of cancer 
(Cortis & Lacey, 1996; Hinds, Streater & Mood, 1995).   
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Consequently, many interventions have been developed to support cancer patients’ 
information-gathering in consultations, which include face-to-face or multimedia 
coaching, decision aids, audio recordings of consultations, and question prompt lists 
(QPL) (Brown, Butow, Dunn & Tattersall, 2001; Street, Voigt, Geyer, Manning & 
Swanson, 1995; Tattersall & Butow, 2002). The most cost-effective and useful 
intervention appears to be the QPL, where patients select questions they wish to ask 
their clinician from a pre-chosen list of relevant questions, which facilitates tailored 
information-gathering (Dimoska, Tattersall, Butow, Shepherd & Kinnersley, 2008). 
Reviews of the use of QPL for cancer consultations have suggested positive effects on 
patient-clinician communication, question-asking and recall of information (Brandes, 
Linn, Butow & Weert, 2015; Dimoska et al., 2008). However, these effects have been 
small and studies suggest that in order to have a larger effect, a QPL needs to be 
paired with a second intervention, such as coaching, prior to consultations, which 
increases the total cost of the intervention.  
 
Recently, more comprehensive, psycho-educational interventions have been 
developed for patients with cancer in response to a growing awareness of their unmet 
psychological needs, in addition to their informational needs (Faller et al., 2013). 
Psycho-educational interventions are typically multi-method interventions that often 
include education, coping skills training, stress management and psychological support 
(Fawzy & Fawzy, 1994). In comparison, information-only interventions are typically 
shorter in duration and lower in intensity (Faller et al., 2013). A large systematic review 
of RCTs of psycho-educational interventions reported small but significant positive 
effects on anxiety, depression and quality of life, with effects on quality of life shown to 
be sustained in the long term (Faller et al., 2013). Conversely, no effects on these 
outcomes were found for information-only interventions. This review suggests that 
intervention developers should seek to develop more comprehensive interventions that 
aim to support patients’ psychological needs, as well as their informational needs.   
 
Due to the cost of staff-delivered interventions, efforts have turned to the development 
of computer- and web-based psycho-educational interventions (also known as ‘e-
health’ interventions), which are low cost and wide-reach (Slev et al., 2016). A meta-
review of such interventions reported an increase in patients’ knowledge of their 
condition, as well as their ability to acquire and use information appropriately (Slev et 
al., 2016). Although more studies are needed to investigate the effects of these 
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interventions on health status, this review demonstrates the potential of technology to 
deliver comprehensive interventions to cancer patients remotely.  
 
Due to an awareness that cancer often affects both the patient and family caregiver, 
which are usually spouses, there has been an increasing number of dyadic 
interventions developed over the last decade which have aimed to support both 
patients and their caregivers by delivering interventions jointly (Northouse et al., 2010). 
Interventions have been in the form of psychoeducation, skills training or therapeutic 
counselling and have included content such as information on caring for the patient, 
maintaining relationships, caregiver self-care and addressing their informational and 
psychological needs (Lambert, Levesque & Girgis, 2016; Northouse, Katapodi, Song, 
Zhang & Mood, 2010). Modes of delivery for this type of intervention have included 
clinicians, self-directed, telephone and the Internet, however web-based interventions 
are becoming increasingly popular due to the lower cost, higher sustainability and ease 
of access compared to other types of interventions (Lambert et al., 2016; Northouse et 
al., 2010). Systematic reviews and meta-analyses of studies of dyadic interventions for 
patients with cancer and their caregivers have provided some evidence for small but 
beneficial effects on aspects of quality of life (e.g. physical, psychological and 
relationship well-being) for both the patient and caregiver (Badr & Krebs, 2013; 
Northouse et al., 2010). Reported benefits for caregivers of this type of intervention 
have included reduced burden, improved ability to cope, increased self-efficacy and 
increased quality of life (Northouse et al., 2010). For these reasons, it is prudent to 
consider the development of interventions that may be used by both patients and their 
families. However, it must be noted that many dyadic interventions have been patient-
focused. For example, many of the interventions reviewed by Northouse and 
colleagues (2010) primarily focused on patient care, whereas self-care for the 
caregiver tended to be a secondary focus. Furthermore, only two studies in this review 
conducted caregiver groups in which caregivers could interact openly with other 
caregivers without the presence of patients. It is therefore possible that the full effects 
of dyadic interventions on caregivers are unknown. Indeed, of the nine of 29 studies in 
this review that were of interventions for caregivers only, findings suggested that these 
interventions resulted in a more positive appraisal of caregiving benefit (Northouse et 
al., 2010). Authors suggested that these interventions may have been better able to 
focus on caregivers’ own needs and enabled them to reflect on their role as caregiver. 
These studies suggest that some studies of dyadic interventions may have limited 
exploration of the caregivers’ opinions in favour of the opinions of patients.  
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Furthermore, it is known that patients with cancer and their caregivers may participate 
in dyadic-level coping in an attempt to protect their relationship during times of stress 
(Hagedoorn et al., 2000). One such relationship-focused coping strategy is known as 
protective buffering, which has been defined as, “hiding one’s concerns, denying one’s 
worries, concealing discouraging information, preventing the patient from thinking 
about the cancer, and yielding in order to avoid disagreement” (Hagedoorn et al., 
2000, p. 275). Studies have suggested that dyads typically engage in protective 
buffering to avoid further burdening or worrying their partner or because they are 
uncertain about how best to support their partner (Kuijer et al., 2000). Dyadic 
interventions may therefore produce different effects on patients and their caregivers 
compared to individual interventions, particularly for the caregivers who participate in 
patient-focused interventions. It is therefore important to consider the effects of 
protective buffering on the part of the patient and caregiver when developing and 
evaluating a dyadic intervention.  
  
1.6 The introduction of Smart technology  
The introduction of Smart technology has provided a new platform to deliver 
interventions to patients remotely. Smart devices, such as Smartphones and tablet 
computers, are called so due to their advanced capabilities in comparison to older 
devices. For example, old generation mobile phones served the sole purpose of 
sending and receiving communications in the form of text messages and voice calls, 
whereas the new generation of mobile phones, that are made today, have dramatically 
enhanced power and capabilities, and an increasing list of software applications 
(known as ‘apps’). Smartphones are typically equipped with a touchscreen interface, 
customised apps, Internet access, digital cameras, music players, GPS systems and 
much more. Most mobile phones that are made and sold today can be described as 
Smartphones, as even the cheapest, less advanced mobile phones available (e.g. the 
Tesco Mobile IMO Dash mobile phone) offer the same types of functions as the most 
expensive and advanced Smartphones on the market (e.g. an Apple iPhone 7). 
Similarly, a tablet computer can be described as a wireless, portable personal 
computer with a touchscreen interface that is larger than a Smartphone but smaller 
than a notebook computer. Tablets are typically used for the same functions as 
Smartphones but do not have the capability to make conventional telephone calls 
(though calls may be made via apps that use the Internet, such as Viber).  
 
An app can be described as a software programme that runs on a technological 
device, such a computer. However, the term app has become specifically associated 
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with software that runs on a Smartphone or tablet. Apps make use of the capabilities of 
Smartphones and tablet computers, described above. Many companies have created 
apps so that it is easy for consumers to find and use their services. For example, it is 
now commonplace for people to use apps daily for communication with family and 
friends, banking, shopping, emailing, gaming or consulting the news and weather 
(Ofcom, 2016). Smart devices typically come with some basic apps installed and other 
apps are available to download via their respective app stores, either for free or for a 
small fee. Once downloaded to a device, an app is stored on the home screen and can 
be accessed quickly by tapping on the app icon.  
 
Approximately 93% of adults in the UK now personally own or use a mobile phone, of 
which 71% specify that they own a Smartphone (Ofcom, 2016). Additionally, around 
66% of adults report using their Smartphone to access the Internet (Ofcom, 2016). No 
other device has had such a commercial and societal impact as the Smartphone and 
the relentless innovation of such devices means that ownership and use are continuing 
to rise. Similarly, over two thirds of adults in the UK now own or have access to a tablet 
computer (Deloitte, 2016). Although ownership and use of Smartphones and tablets is 
continuously rising across all demographic groups, there are still some notable 
differences (Ofcom, 2016). Recent statistics showed that around twice as many 16-24 
and 25-34 year olds in the UK own a smartphone (90% and 91% respectively) 
compared to those aged over 55 (42%) (Ofcom, 2016). Additionally, those of the 
highest socioeconomic status were more likely to own a Smartphone than those of the 
lowest socioeconomic status (76% and 62%, respectively). Similar trends for tablet 
devices were reported. Contrary to popular belief, some studies suggest that minority 
ethnic populations are more likely than non-minority ethnic populations to use their 
Smartphones to access health information (Fox & Duggan, 2012; Smith, 2013). This 
may be due to the fact that these populations are less likely to have access to home 
computers and broadband, which means that Smartphone-based interventions could 
have greater reach than other web-based interventions (Smith, 2013). Similarly, 
acceptance and use of this technology by older adults, who may be less familiar with 
this technology than younger adults, is rapidly increasing (Zickuhr & Madden, 2012). 
Smart technology interventions have the potential to benefit healthcare due its wide 
reach to patients at the point of need and enabling access to tailored healthcare to 
those in resource-poor settings or those facing access barriers to traditional 
healthcare.  
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Similar statistics of Smart device ownership and use have been reported in cancer 
patient populations (Girault et al., 2015; O’Brien et al., 2015). One survey of patients 
with breast cancer reported that 97% of patients owned a mobile, of which 69% 
specified a Smartphone, and 83% reported using their mobile phone several times a 
day, in comparison to a computer by 52% (O’Brien et al., 2015). Over half of these 
patients used their phones for ‘Smart’ activities, such as accessing websites (53%), 
emailing (51%) or planning or scheduling (49%). An intervention delivered via an app 
therefore has the potential to reach a large number of patients with cancer remotely, at 
a lower cost compared to traditional healthcare interventions (Blake, 2008; Boulos et 
al., 2011). Subsequently, the UK government has encouraged the integration of new 
technology into traditional healthcare services (Liddell, Adshead & Burgess, 2008).  
 
1.6.1 The use of Smart technology for the management of chronic conditions 
Interventions that run on mobile devices, including Smart technology, have been 
developed to facilitate the self-management of many chronic conditions, including 
diabetes, heart disease and asthma (Cafazzo, Casselman, Hamming, Katzman, & 
Palmert, 2012; Klasnja & Pratt, 2012; Seto et al., 2012; Rhee, Allen, Mammen, & Swift, 
2014). Studies have found that they may improve patients’ biological markers of 
disease, quality of life, communication with clinicians and family, and adherence to 
medication, and achieve these positive patient outcomes whilst reducing health service 
costs (Charpentier et al., 2011; Gammon et al., 2005; Park Howie-Esquivel, Chung & 
Dracup, 2014; Seto et al., 2012). Following the early indicators of the effectiveness of 
this type of intervention for other chronic conditions, there has been development of 
mobile interventions to support patients with cancer. Existing reviews show that the 
majority of studies are of mobile interventions that support patients during the 
treatment phase of cancer, with fewer interventions developed to assist prevention, 
diagnosis, follow up and survivorship (Davoodi, Mohammadzadeh, & Safdari, 2016; 
Nasi, Cucciniello, & Guerrazzi, 2015; Odeh, Kayyali, Nabhani-Gebara & Philip, 2015). 
Previous searches of Apple and Android app stores in 2013 indicated that although 
there is a large number of publically available apps that provide information on cancer, 
only 55% of these apps provided scientifically validated data, and none appeared to 
have been systematically developed and evaluated (Bender, Yue, To, Deacken & 
Jadad, 2013; Nasi et al., 2015; Pandey, Hasan, Dubey & Sarangi, 2013). For these 
reasons, it was considered prudent to develop an app intervention to help patients with 
cancer to meet their information needs throughout their illness.  
 
1.7 Involving clinicians in the development of interventions for patients  
	 12	
Although the development of information and communication technologies has rapidly 
increased within the health service over recent years, they do not yet appear to have 
become established or commonplace within clinical practice (May, Mort, Williams, Mair 
& Gask, 2003). A main barrier to the successful implementation of such interventions 
appears to be a lack of involvement of clinicians in the development and testing stages 
(Mannan, Murphy & Jones, 2006). Studies that have involved clinicians have reported 
that clinicians found it difficult to incorporate such technology within their existing 
practices and other barriers included issues with the content and design of systems, 
training and confidentiality (Gibson, Aldiss, Taylor, Maguire & Kearney, 2009; Maguire, 
McCann, Miller, & Kearney, 2008). The perceptions of clinicians are essential to 
ensure the successful implementation of any new technological interventions that will 
be used by their patients in clinical practice, such as an app. Additionally, it is 
important that clinicians review and approve interventions to be used by patients, as 
patients trust the opinions their clinicians and are therefore likely to trust their 
endorsement of interventions. For these reasons, cancer clinicians will be involved in 
the development of an app for this PhD thesis.  
 
1.8 Frameworks to guide development and evaluation of an app intervention  
1.8.1 The Medical Research Council (MRC) framework 
The MRC framework is a general guide for the development and evaluation of complex 
interventions to improve health and will be used to guide intervention development for 
this thesis (Craig et al., 2008). This framework advocates a systematic, phased 
approach to intervention development and evaluation to ensure researchers fully 
understand, define and document the development process in order to successfully 
evaluate the intervention and enable replication, evidence synthesis and wider 
implementation. Four phases of development and evaluation are outlined, though 
these may not follow a linear sequence in practice (Figure 1).  
 
During the first phase, ‘development’, researchers are encouraged to identify the 
evidence base, relevant theories, model processes and outcomes of the intervention. 
The development phase of an app intervention for this thesis is reported from Chapters 
2 to 6, using primary and secondary data. The second phase, ‘feasibility and piloting’, 
encourages initial testing of the acceptability and feasibility of the intervention, prior to 
a full scale evaluation. A field testing study of the app intervention for this thesis is 
reported in Chapter 7. Although a feasibility study need not be a scale model of a 
future evaluation, this study was considered a field testing study and not a feasibility 
	 13	
study as the study did not aim to determine the required sample size for a full-scale 
evaluation. 
 
The third phase, ‘evaluation’, involves assessing the effectiveness and cost-
effectiveness of the intervention and developing an understanding of the change 
processes involved. Following evidence of an acceptable, feasible and effective 
intervention, the final phase of development, ‘implementation’, is carried out, which 
involves surveillance and monitoring of the intervention through long term follow up.  
 
 
Figure 1: Key elements of the MRC framework for development and evaluation of 
complex interventions [source: Craig et al., 2008].  
 
1.8.2 Frameworks for the development and evaluation of app interventions 
A scoping review of early-phase studies of app development for chronic conditions 
revealed that many studies have employed a user-centered, phased approach or 
philosophy, similar to the MRC framework (Craig et al., 2008), which includes the 
iterative involvement of patients in the development and user-testing stages, as well as 
consultation with clinicians, using qualitative research methods, such as interviews and 
focus groups (Cafazzo et al., 2012; Whittaker, Merry, Dorey & Maddison, 2012). 
Additionally, with the growing body of literature on digital health interventions, specific 
models and frameworks to guide development and evaluation of mobile interventions 
have been developed. These specific frameworks serve to increase rigor of such 
studies and facilitate the translation of literature into replicable and evidence-based 
mobile interventions that can be systematically evaluated, used and adapted to health 
care settings. It is important to use such frameworks to guide intervention development 
if studies are to contribute to the evidence base on which interventions (and 
components) are effective, for which population groups, and in which settings, to 
achieve desired outcomes.  
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The MRC framework (Craig et al., 2008) therefore provides a suitable overarching 
framework for the early-phase development of an app intervention for this thesis, 
whereas a framework that is specific to the development and evaluation of mobile 
interventions will be most useful following results of a field testing study, when more 
detailed information of the intervention has come to light, such as its potential 
outcomes. However, several specific models and frameworks for the design and 
development of app interventions were taken into consideration in this thesis, where 
appropriate. These include the ‘person-centred’ approach for digital health-related 
behaviour change (Yardley, Morrison, Bradbury & Muller, 2015), the Chronic Disease 
mHealth App Intervention Design Framework (Wilhide III, Peeples, & Kouyaté, 2016), 
the Technology Acceptance Model (TAM) (Davis, 1989; Venkatesh & Bala, 2008), the 
Health IT Usability Evaluation Model (Health-ITUEM) (Brown, Yen, Rojas & Schnall, 
2013) and the People At the Centre of Mobile Application Development (PACMAD) 
model (Harrison, Flood & Duce, 2013). The CONSORT-EHEALTH checklist, an 
adapted checklist to improve the reporting standards and level of detail provided 
specifically for randomised and non-randomised trials of web- and mobile-based 
interventions, was also used to guide the reporting of the studies in this thesis 
(Eysenbach, 2012). 
 
1.9 Aims and objectives of this thesis 
The primary aims of this thesis were: (1) to understand the needs and preferences of 
patients with cancer regarding an app to help them to meet their information needs in 
non-inpatient settings, and (2) to develop an app intervention for patients, based on 
identified needs and preferences, which may also be used by relatives. Based on 
existing literature, it was hypothesised that an app could help patients with cancer, and 
their relatives, to meet their information needs by facilitating information-gathering and 
understanding during and between consultations with clinicians.  
 
There were six objectives of this PhD:  
(1) Identify how mobile devices have previously been used to help patients with 
cancer to meet their information needs in non-inpatient settings. 
(2) Identify potentially relevant theory related to the impact of and self-
management of cancer. 
(3) Explore patients’ (and their relatives’) needs and preferences regarding an app 
to help them to meet their information needs and the reasons for these 
perceptions. 
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(4) Explore cancer clinicians’ opinions on the value of an app for patients with 
cancer and their relatives, their preferences for app features and reasons for 
these perceptions. 
(5) Design an app intervention based on the identified needs and preferences of 
patients and their relatives and opinions of clinicians. 
(6) Conduct a field test of the app with patients in the community to assess its 
acceptability and feasibility in practice.  
 
Each phase of work presented in this thesis was guided by two phases of the MRC 
framework (Craig et al., 2008). Phase one, which involved the development of the 
intervention, included a systematic review of the use of mobile devices to help patients 
with cancer to meet their information needs, a review of potentially relevant theories 
related to the impact and self-management of cancer, and a qualitative exploration of 
patients’ and their relatives’ information needs and experiences of information 
exchange in consultations, as well as their preferences regarding an app intervention. 
A qualitative exploration of cancer clinicians’ views on these topics was also 
conducted. An app was then created based on the findings of this body of work. Phase 
two consisted of user-testing an initial version of the app in a discussion group of 
patients, followed by final refinements of the app to produce a final version. A field 
testing study was then conducted with a sample of patients to test the acceptability and 
feasibility of the app in a real life setting. Figure 2 presents an outline of the work 
conducted for this thesis according to the phases of MRC framework and aims of the 
PhD.  
 
Figure 2: An outline of the work presented in this thesis, according the aims of the 
PhD and phases of the MRC framework.  
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1.10 Thesis structure 
 
Chapter 2  
Chapter 2 describes a systematic review of the literature which identified how mobile 
devices had previously been used to help patients with cancer to meet their 
information needs in non-inpatient settings. This review was conducted to establish the 
need for an app that enables patients to meet their information needs and the 
acceptability and feasibility of this type of intervention.  
 
Chapter 3 
Chapter 3 presents a review and critical appraisal of a selection of health behaviour 
models, theories and approaches that are relevant to the impact of cancer on patients 
and their self-management of the condition. This review was conducted to gain 
theoretical understandings of patients’ experiences of cancer, the type of app that 
might best support them and the changes that may be expected as a result of this type 
of intervention.  
 
Chapter 4 
Chapter 4 presents the findings from a qualitative interview study with cancer patients 
and their relatives. Interviews explored patients’ information needs and experiences of 
information exchange with clinicians in cancer consultations, and their needs and 
preferences regarding an app that aims to help them to meet their information needs.  
 
Chapter 5 
Chapter 5 presents findings from a qualitative interview study with cancer clinicians, 
including cancer nurse specialists, oncologists and surgeons. Interviews explored 
clinicians’ experiences of information exchange with patients in consultations and their 
opinions on the value of an app for patients with cancer. This study also explored 
clinicians’ preferences for app features.  
 
Chapter 6 
Chapter 6 describes the systematic process that was used to create an app 
intervention for patients with cancer, based on findings from Chapters 2-5 and 
consultation with a digital software team and clinical supervisors. This chapter also 
reports on ‘in-house’ testing of the app and user-testing with a group of patients. The 
final design and content of the app is presented.   
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Chapter 7 
Chapter 7 reports findings from a field testing study, which involved a sample of 
patients using the app in community settings, running up to and during a consultation 
with their clinicians. Qualitative interviews explored patients’ experiences of using, and 
opinions on, the app, including the acceptability and feasibility of the app, the 
usefulness of the app features, and the perceived benefits and disadvantages of, and 
barriers to, using the app in practice. This chapter also reports on the findings of 
software-logged app activity data.   
 
Chapter 8 
Chapter 8 summarises the key findings of this thesis, in relation to relevant literature, 
and highlights its novel contributions to existing knowledge. Methodological strengths 
and limitations of this thesis are discussed. Suggestions for further research are 
provided and the potential evaluation and implementation of the app are discussed.  
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Chapter 2 
The use of mobile devices to help patients with cancer to meet their information 
needs in non-inpatient settings: a systematic review 
 
2.1 Chapter overview  
This chapter presents a systematic review of literature that was conducted to identify 
how mobile devices, such as mobile phones and tablets, have previously been used to 
help patients with cancer to meet their information needs in non-inpatient settings. 
Non-inpatient settings include at home, in the community, outpatient settings and 
consultations. Several existing systematic and scoping reviews have previously 
explored the general use of mobile devices for patients with cancer (Bender et al., 
2013; Davis & Oakley-Girvan, 2015; Davoodi et al, 2016; Hesse, Beckjord, Rutten, 
Fagerlin, & Cameron, 2015; Nasi et al., 2015; Odeh, Kayyali, Nabhani-Gebara, & 
Philip, 2015; Pandey et al., 2013). Findings from these reviews showed that mobile 
interventions have been developed for a range of purposes, including for the 
prevention, detection, and management of cancer, however most interventions have 
aimed to support patients during the treatment phase of cancer, with fewer 
interventions developed to assist prevention, diagnosis, follow up and survivorship. 
There has not yet been a review that identifies how mobile interventions have been 
used to help patients with cancer to meet their information needs in non-inpatient 
settings.  
 
2.1.1 Aims of the present study  
The aim of the research described in this chapter is to conduct a novel systematic 
review to identify and critically evaluate literature that describes the use of mobile 
interventions to enable cancer patients to meet their information needs in non-inpatient 
settings, and to describe the effects and feasibility of this type of intervention. The 
findings of this review will be used to inform the development of an app intervention for 
patients with cancer.  
 
2.2. Systematic review methods 
A systematic review involves five stages in order to be deemed ‘systematic’, which 
include: (1) a fixed, clearly defined and prospectively developed research question, (2) 
identification of relevant studies, (3) a quality appraisal of included studies, (4) a 
summary of the evidence, and (5) interpretation of the findings (Khan, Kunz, Kleijnen, 
& Antes, 2003). All stages are required to be double checked by a second independent 
coder to reduce any potential bias during selection of the included studies, quality 
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appraisal and data analysis (Khan et al., 2003). Due to the efforts taken to reduce 
potential bias and the transparency of the methods used, systematic reviews are 
regarded as the highest level of evidence (Khan et al., 2003). It is this systematic 
approach that distinguishes this type of review from others, such as scoping reviews. 
Systematic review methodology was selected for the present review to provide a high 
strength summary of the evidence.   
 
2.3 Method 
This systematic review followed the PRISMA guidelines for the conduct of systematic 
reviews (Moher, Liberati, Tetzlaff, & Altman, 2009). The review was registered on the 
International Prospective Register of Systematic Reviews (PROSPERO) to prevent 
duplication (registration number: CRD42014010614). At all stages of the search, data 
extraction and quality appraisal, 10% of studies were double checked for consistency 
by another PhD student. All discrepancies were resolved through discussion. 
 
2.3.1 Search strategy 
A systematic search of titles and abstracts was conducted in MEDLINE (1946-2017), 
EMBASE (1947-2017) and PsychINFO (1806-2017) databases in January 2017. 
Advice was sought from a subject librarian on developing a suitable search strategy. 
Search terms focused on three concepts of the review question: ‘mobile devices’, 
‘information needs’ and ‘cancer’ (Appendix 1). Terms relating to the same concept 
were combined using the Boolean operator ‘OR’ and different concepts were combined 
using ‘AND’. Duplicates were electronically removed using the OVID de-duplicate 
function prior to review of abstracts. Titles and abstracts of citations were screened for 
appropriate studies. References of included articles were searched for further studies. 
The aim of this review was to assess data on the effects and feasibility of this type of 
intervention, provided by empirical studies. Prior to the search, it was therefore 
decided that grey literature would not be searched as these studies are not peer-
reviewed and are unlikely to contain empirical data.  
 
2.3.2 Inclusion criteria 
Identification of studies included a four stage process of identification, screening, 
eligibility and inclusion (Moher et al., 2009) (Figure 3). In order to be as inclusive as 
possible, there were no restrictions on study methodology or date of publication, 
however searches were limited to include only human studies and those written in 
English. Included studies were required to meet the following criteria: 
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i. Interventions delivered by a mobile or handheld device (e.g. mobile 
phone, personal digital assistant) 
ii. Primary participants are patients with cancer who are currently 
undergoing treatment 
iii. Interventions are for use in non-inpatient settings, or non-inpatient and 
inpatient settings  
iv. Interventions attempt to meet patients’ cancer-related information needs  
 
Only those participants who currently had cancer were included in this review 
as cancer survivors may have different information needs to those who are 
currently undergoing treatment for cancer. The aim of this thesis is to develop 
an app to support patients following a diagnosis of cancer, when their 
information needs are greatest and an intervention may have the greatest 
impact on their adjustment and self-management of their condition (Rutten et 
al., 2005). Additionally, this review will include interventions that are used to 
support patients in non-inpatient settings, as this is where patients are now 
primarily managed for the majority of their time during their illness and require 
additional support.  
 
2.3.3 Exclusion criteria 
Studies were excluded from the review based on the following criteria: 
i. Non-human studies 
ii. Studies not written in English 
iii. Studies not published in peer-reviewed journals 
iv. Studies not relevant to the research question 
v. Studies that do not provide sufficient information on the mobile 
intervention/disease type to be adequately reviewed 
vi. Studies that only provide a description of the intervention/creation of the 
intervention 
vii. Studies of only health professional/caregiver perceptions of a mobile 
intervention for patients with cancer  
viii. Studies of cancer survivors who have ceased treatment 
ix. Use of mobile intervention is in inpatient settings only 
x. Interventions are a method of data collection only and not interactive 
(e.g. used to collect questionnaire data) 
xi. Interventions do not focus on provision or exchange of information to 
support self-management (e.g. weight loss interventions)  
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xii. Studies conducted in lower income countries 
xiii. Not an original research study (e.g. review articles) 
xiv. Conference abstracts or articles 
 
Many studies were excluded for multiple reasons, however only one main reason was 
documented (Figure 3).  
 
2.3.4 Data extraction and synthesis 
Data were extracted onto a template under the following headings; research 
identification (authors, year of publication, country of study sample, study population), 
intervention (intervention type, mobile device type), research methods (study design, 
method, data analysis), outcome measures, principal findings, and quality appraisal. 
Due to a lack of suitable data, a meta-analysis was not conducted. A narrative 
synthesis was performed and organised by common themes found across studies 
(Popay et al., 2006). 
 
2.3.5 Quality appraisal 
Included studies were assessed for methodological quality using the Critical Appraisal Skills 
Programme (CASP) checklists for quantitative and qualitative research (CASP, 2014) 
(Appendix 2). The quality of each study was assessed according to each domain included 
in the checklists, including methodology, design, recruitment, data collection, data analysis, 
ethical issues, reporting of findings and contribution to research. The overall quality of the 
studies was categorised as good, medium or poor. This review will focus on the findings of 
studies that are appraised as ‘good’ or ‘medium’ quality, however studies that are appraised 
as ‘poor’ quality will also be referenced where appropriate.  
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Figure 3: PRISMA flowchart.  
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2.4 Results 
Searches during the identification stage generated 1,020 citations. A total of 54 articles were 
considered appropriate for eligibility screening and an additional 14 articles were identified 
through references. The full-texts of these 68 articles were screened using the secondary 
inclusion and exclusion criteria, which resulted in the exclusion of a further 45 articles.  
 
2.4.1 Description of studies 
A total of 20 studies were described by the 23 included articles (Table 1). Within these 20 studies, 
14 different interventions were identified. The Advanced Symptom Management System (ASyMS) 
was used in six studies (described by nine of the 22 articles) and the Cancer Care Home 
Telehealth intervention (CCHT) was used in two studies (described by two of the 22 articles). The 
remaining 12 articles described 12 separate intervention studies. Of the 23 articles, there were 13 
early-phase feasibility studies, one full RCT, three pilot RCTs, three process evaluations, one 
matched-case control study, a secondary qualitative analysis of data generated by a RCT 
included in this review and an analysis of software-logged data from a feasibility study included in 
this review. Sample sizes of patients ranged from n= 4-125, with 13 studies consisting of 25 
participants or less. Two studies were categorised as good quality, 12 were of medium quality 
and nine were of poor quality.   
 
2.4.2 Sample characteristics 
Patients with a wide range of cancer types were included in studies. A total of 17 studies were of 
adult patients and three studies were of adolescent patients. Ages of adult patients ranged 
between 24-87 years and ages of adolescent participants ranged from 8-18 years. Six studies 
reported the race and/or ethnicity of participants; in four studies, the vast majority of participants 
were white with a minority of black participants (three of which specified African American), one 
study reported a majority of Hispanic-White participants and the remaining study reported a 
majority of Chinese participants. Nineteen studies included non-inpatient participants only. Nine 
studies provided participants with a mobile device on entry to the study, a further four studies 
provided devices for participants but participants needed to have a telephone landline in order to 
participate, two studies required participants to own a mobile device and five studies failed to 
report whether participants were required to own a mobile device in order to participate in the 
study or whether a device was provided for the study period. It is also worth noting that one study 
that provided a mobile device for participants only included those who were ‘able and willing’ to 
use a mobile device and another study excluded participants if they had poor proficiency with the 
device.   
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2.4.3 Description of the interventions 
Ten interventions were run on mobile phones; nine of which used Smartphones. One intervention 
that required participants to use their own mobile phone for the study included both Smartphones 
and non-Smartphones (Yap et al., 2013). Four interventions were run on tablets and two were run 
on a Personal Digital Assistant (PDA; a palmtop computer that functions as a personal organiser 
but also provides access to the Internet). A further four interventions were run on ‘handheld 
devices’ which were attached to the participant’s telephone line. Studies that used a handheld 
device did not report the functions of this type of mobile device, however these devices are 
typically the most limited device type in terms of functions. Studies published from 2013 onwards 
used more advanced Smartphones and tablets that are commonly used today, such as iPhones 
and iPads.  
 
All interventions were for patients use only and did not aim to support relatives simultaneously. 
Two interventions primarily aimed to directly increase patients’ knowledge; one intervention 
provided information on patients’ upcoming surgical operation and one intervention educated 
patients on cancer-related pain-coping skills. One further intervention study primarily aimed to 
improve patients’ communication of symptoms to clinicians in consultations, thereby facilitating 
information exchange. The primary aim of the remaining seventeen intervention studies was to 
improve the monitoring and management of treatment-related symptoms. These interventions 
provided treatment-related self-care information following patients’ symptom reports and/or 
included a system where clinicians would be alerted to contact patients and exchange symptom-
related information in order to manage severe symptoms. One of these seventeen interventions 
also provided cognitive and behavioural skills training in non-pharmacological pain management 
strategies. Study periods ranged from five days to six months, however some study periods may 
have been longer due to the individual duration of participants’ treatment, which were not 
reported. 
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Table 1: Characteristics of included studies. 
Study Author Study population Intervention Methods 
Outcome 
measures Principal findings 
Quality 
score 
1 Kearney 
et al., 
2009 
112 adult 
patients. 
Breast, lung or 
colorectal 
cancer. Mean 
age 56 years. 
UK. No 
information on 
race/ethnicity.  
Mobile phone, 
symptom-
monitoring for 
four weeks of 
chemotherapy 
(12-16 weeks). 
Provision of 
device 
unknown. 
Quantitative, 
RCT. Logistic 
regression. 
Incidence, severity 
and distress of six 
chemotherapy-related 
symptoms (nausea, 
vomiting, fatigue, 
mucositis, hand/foot 
syndrome, diarrhoea). 
Significantly lower reports of fatigue 
(p=0.04) and higher reports of 
hand/foot syndrome (p=0.031) in 
intervention vs control group. Reports 
of severity (p=0.033) and distress 
(p=0.028) associated with hand/foot 
syndrome were also significantly 
higher in intervention vs control group. 
Medium 
 McCann 
et al., 
2009 
53 adult 
patients from 
the intervention 
arm of Kearney 
et al. (2009). 
Breast, lung or 
colorectal 
cancer. Mean 
age approx. 55 
years. UK. No 
information on 
race/ethnicity. 
“” Mixed methods, 
process 
evaluation.  
Semi-structured 
questionnaires, 
semi-structured 
interviews. 
Descriptive 
statistics, 
thematic content 
analysis. 
Patients’ perceptions 
of the intervention 
Patients had positive expectations 
and experiences of study 
participation. Some patients (n=13, 
36%) experienced some issues when 
sending symptom reports, however 
this was rare. Patients found the 
technology and intervention to be 
acceptable and were all felt 
comfortable using it. Most patients 
reported a perceived improvement in 
symptom management (n=33, 91%) 
and patients commented that it had 
improved communication with their 
clinicians. 
 
 Patients also perceived that the 
alerting facility gave them a sense of 
reassurance. 
 
Medium 
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 Forbat et 
al., 2009 
12 adult 
patients from 
intervention 
arm of Kearney 
et al. (2009). 
Colorectal and 
breast cancer. 
Mean age 50 
years, age 
range 38-66 
years. UK. No 
information on 
race/ethnicity. 
“” Qualitative, 
secondary 
analysis. Semi-
structured 
interviews. 
Foucauldian 
approach with 
focus on 
surveillance and 
power. 
Patients’ perceptions 
of the intervention  
Patients perceived that the system 
improved access to and increased 
communication with clinicians. 
Patients found the alerting facility 
reassuring and suggested the system 
empowered patients to become more 
active and created a sense of control.  
Medium 
2 Maguire 
et al., 
2005 
10 adult 
patients. 
Breast and 
lung cancer. 
Age range 44-
74 years. UK. 
No information 
on 
race/ethnicity. 
Mobile phone, 
symptom-
monitoring for 
two weeks. 
Provision of 
device 
unknown. 
Mixed methods, 
process 
evaluation (from 
pilot RCT). 
Semi-structured 
questionnaires, 
semi-structured 
interviews. 
Descriptive 
statistics, 
thematic content 
analysis. 
Patients’ perceptions 
of the intervention 
Patients had positive experiences of 
study participation. Most patients 
(n=3, 75%) felt comfortable using the 
intervention and no patients reported 
any technical issues. All patients (n=4, 
100%) perceived that the intervention 
improved their management of their 
symptoms and communication with 
their clinicians. Patients commented 
that they felt reassured due to being 
monitored by clinicians.  
Poor 
3 Kearney 
et al., 
2006 
15 adult 
patients. Lung 
and colorectal 
cancer. Age 
range 24-77 
years. UK. No 
information on 
race/ethnicity. 
Handheld 
device, 
symptom-
monitoring for 
two cycles of 
chemotherapy 
(approx. 6-8 
weeks). 
Access to 
home 
Mixed methods, 
feasibility study. 
Semi-structured 
questionnaires, 
semi-structured 
interviews, 
software log of 
activity (reported 
in McGee and 
Gray (2005)). 
Patients’ perceptions 
of the intervention 
Patients had positive experiences of 
study participation. All patients 
commented that they felt comfortable 
using the device. Most patients 
perceived an improvement in 
symptom monitoring and self-
management (n=10, 91%) and 
communication with their clinicians 
(n=8, 73%). Patients also commented 
that the intervention empowered them 
Medium 
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telephone line 
required.   
Descriptive 
statistics, 
thematic content 
analysis. 
to feel more confident in managing 
symptoms by improving their 
knowledge and confidence.  
 McGee 
et al., 
2005 
“” “” Software log of 
activity, 
descriptive 
statistics.  
Software-logged 
activity; modem 
events, questionnaire 
events, and 
information access 
events. 
All but one patient (n=17, 94%) had 
difficulty trying to connect and send 
session data to the server but 
attitudinal data did not reflect this. 
Symptom questionnaire use, access 
to self-care advice and use of 
information pages greatly varied. All 
but one patient accessed these 
facilities at some point during the trial. 
Medium 
4 Aldiss et 
al., 2011 
4 adolescent 
patients. Non-
Hodgkins 
lymphoma and 
osteosarcoma. 
Age range 13-
15 years. UK. 
No information 
on 
race/ethnicity.   
PDA, 
symptom-
monitoring for 
one cycle of 
chemotherapy 
(2 weeks). 
Mobile device 
provided.  
Mixed methods, 
pilot RCT. Semi-
structured 
questionnaires, 
interviews. 
Narrative 
summary of 
results due to 
small number of 
participants. 
Patients’ perceptions 
of the intervention 
Patients commented that 
communication had improved with 
their clinicians and that the self-care 
advice was acceptable. One patient 
felt the intervention was helpful in 
monitoring symptoms, however one 
patient suggested that a longer time 
period was needed to capture the 
real-time symptom experience.  
Poor 
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5 McCall et 
al., 2008 
21 adult 
patients 
receiving 
palliative care. 
Breast, 
prostate, oral, 
respiratory, 
GI/colorectal, 
gynaecology, 
myeloma, 
unknown 
primary 
cancers. Mean 
age 64 years, 
age range 40-
87 years. UK. 
No information 
on 
race/ethnicity. 
Mobile phone, 
symptom-
monitoring for 
30 days. 
Provision of 
device 
unknown.  
Mixed methods, 
feasibility study. 
Questionnaires, 
semi-structured 
interviews. 
Descriptive 
statistics, 
thematic 
analysis. 
Patients’ perceptions 
of the intervention 
Patients had positive experiences of 
study participation. All patients felt 
comfortable (n=6, 46%) or very 
comfortable (n=7, 54%) using the 
intervention, however some required 
assistance from family members due 
to poor physical state (n=5, 38%). 
Most patients (n=9, 69%) felt the 
intervention improved symptom 
monitoring and communication of 
symptoms to their clinicians. Patients 
commented that the self-care advice, 
graphs and information provided by 
the intervention was fairly useful.   
Poor 
6 Chumbler 
et al., 
2007a 
125 adult 
patients. Lung, 
head and neck, 
colorectal, 
other cancers. 
Mean age 63 
years. US. No 
information on 
race/ethnicity. 
Handheld 
device, 
symptom-
monitoring for 
six months. 
Access to 
home 
telephone line 
required.   
Quantitative, 
matched-case 
control study. 
Electronic 
medical records. 
Multivariate 
regression. 
Number of 
preventable service 
uses (unplanned 
clinical visits) and 
cancer-related service 
uses (expected 
clinical visits) over a 
six-month period 
There was significantly lower use of 
preventable services in the 
intervention vs control groups 
(p=0.01). There were also significantly 
higher rates for use of some 
expected, cancer-related services in 
the intervention vs control groups 
(p=0.01), except for clinic visits, where 
patients in the intervention group had 
significantly fewer expected clinic 
visits compared to controls (p=0.01).  
Medium 
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7 Chumbler 
et al., 
2007b 
48 adult 
patients. Lung, 
head and neck, 
colorectal, 
other cancers. 
Mean age 64 
years. US. 
91% White, 9% 
African 
American. 
Handheld 
device, 
symptom-
monitoring for 
six months. 
Access to 
home 
telephone line 
required.   
Quantitative, 
feasibility study. 
Questionnaires, 
medical records. 
Descriptive 
statistics, linear 
mixed 
regression. 
Patients’ cooperation 
with the intervention 
(adherence) and 
health-related quality 
of life during cancer 
treatment 
Mean cooperation rate was 84% 
(range 4-100%) and this remained 
high over the six month period.  No 
variables were significantly associated 
with patient cooperation. There was a 
significant 6.45-point increase in 
HRQOL score between baseline and 
end of treatment (95% CI, 65-11.88). 
Patients who reported 
nervousness/worry symptoms during 
treatment experienced an average of 
8.86 points significant increase in 
HRQOL (95% CI, 2.08-15.64).  
 
Good 
8 Post et 
al., 2013 
60 adult 
patients. 
Breast cancer. 
Mean age 51 
years. US. 
84% White, 
16% African 
American.  
PDA, symptom 
communication 
with clinicians, 
for 160 days 
(around 5 
months). 
Provision of 
device 
unknown.  
Mixed methods, 
pilot RCT. 
Questionnaires, 
focus groups, 
and interviews. 
Descriptive 
statistics, 
random-effects 
linear 
regression, 
qualitative 
analysis. 
 
Effects of the 
intervention on pain, 
fatigue and 
depression 
symptoms, patients’ 
and healthcare 
professionals’ 
perceptions of the 
intervention and 
patients’ HRQOL and 
communication self-
efficacy 
Intervention group reported 
significantly lower average pain 
severity over time compared to the 
control group (p=0.02). Patients and 
healthcare professionals reported 
positive experiences of the 
intervention. Mean pre-post 
decreases in HRQOL were generally 
higher among intervention group. Pre-
post changes in communication self-
efficacy were equivalent.   
Poor 
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9 Weaver 
et al., 
2007 
6 adult 
patients. Colon 
cancer. Age 
range 54-76 
years, median 
age 64 years. 
UK. No 
information on 
race/ethnicity. 
Mobile phone, 
symptom-
monitoring for 
two cycles of 
chemotherapy 
(approx. 6-8 
weeks). Mobile 
device 
provided.  
Mixed methods, 
feasibility study. 
Informal 
interviews. 
Descriptive 
statistics, 
narrative 
summary of 
results due to 
informal nature 
of interviews. 
Number of alerts 
generated and 
reasons for 
alerts/responses to 
alerts, patients’ 
perceptions of the 
intervention 
Data entry compliance was 98%. 
There were 91 alerts, 54 red and 37 
amber; 54% of the red alerts were 
data delay and transmission 
problems. All patients (n=6) had 
positive experiences of study 
participation and found the 
intervention simple to use. All patients 
commented that they felt reassured 
due to their symptoms being 
monitored and all felt involved and 
responsible for their care.   
Poor 
10 Yap et 
al., 2013 
68 adult 
patients. 
Breast, GI, 
head & neck, 
lung, 
lymphoma, 
ovarian, 
cervical, 
bladder 
cancers. 
Median age 50 
years. 
Singapore. 
68% Chinese, 
25% Malay, 
3% Indian, 2% 
other.  
Mobile phone, 
symptom-
monitoring for 
five days. 
Access to own 
mobile device 
required.   
Mixed methods, 
feasibility study. 
Semi-structured 
telephone 
questionnaire. 
Descriptive 
statistics, 
Pearson's chi-
squared and 
Fisher's exact 
tests, qualitative 
analysis. 
Study feasibility 
measured by patients’ 
adherence to the 
intervention, patient 
satisfaction and 
number of 
pharmacists’ 
interventions 
 
Patients found the intervention 
acceptable. A total of 44 patients 
(73%) were adherent over five days of 
monitoring. Adherence was 
significantly higher among 
smartphone users vs. basic phone 
users (p=0.001). Most patients (n=54, 
90%) of patients were comfortable 
with the duration of the intervention, 
especially smartphone users 
(p=0.017) and adherent patients 
(p=0.038), however 15% (n=9) found 
the intervention too difficult or 
complicated. Over half of patients 
(n=37, 62%) found the SMS advice 
useful, especially those with lower 
education (p=0.003) and chemo-naive 
patients (p=0.045). Most patients 
(n=43, 72%) agreed that the service 
made it easier to contact pharmacists.  
Medium  
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11 Head et 
al., 2011 
44 adult 
patients. Head 
and neck 
cancers. Mean 
age 59 years. 
US. 91% 
White, 9% 
African 
American.  
Handheld 
device, 
symptom-
monitoring for 
the duration of 
treatment, 
average 70 
days (around 
10 weeks). 
Access to 
home 
telephone line 
required.   
Mixed methods, 
process 
evaluation (from 
a RCT). 
Interviews, 
telephone 
questionnaires. 
Descriptive 
statistics, 
correlation 
analysis, 
descriptive 
qualitative 
analysis. 
Feasibility of the 
intervention, patient 
perceptions, 
satisfaction and 
acceptance, and long-
term impact of 
intervention 
Patients completed the intervention 
over 86% (average of 70 days) of the 
expected days of use with a median 
and modal percentage use of 94% 
and 100%, respectively. Most patients 
(n=37, 85%) had a positive 
experience using the device and 80% 
(n=35) were satisfied with the 
intervention. Patients commented that 
the intervention provided needed 
information and improved 
management of their condition. 
Significant positive correlations were 
found between percentage use of the 
intervention and the physical 
(p=0.048) and emotional (p=0.042) 
well-being scores during treatment. A 
long-term follow up survey showed 
that 65% (n=13) patients felt they had 
better care as a result of the 
intervention 
Medium 
12 Stinson 
et al., 
2013 
14 adolescent 
patients. ALL, 
AML, Ewing's 
sarcoma, non-
Hodgkin's 
lymphoma, 
osteosarcoma, 
rhabdomyo-
sarcoma, 
other. Mean 
age 13 years. 
Canada. No 
information on 
race/ethnicity. 
Mobile phone, 
pain-related 
symptom-
monitoring for 
two weeks. 
Mobile device 
provided.   
Mixed methods, 
feasibility study. 
Semi-structured 
questionnaires. 
Descriptive 
statistics, t tests. 
 
 
Feasibility and 
patients’ perceptions 
of the intervention 
Patients found the app to be 
acceptable. Almost all (n=12, 86%) 
liked the app and 11 (79%) patients 
found the app easy to use. All bar one 
patient (n=13, 93%) reported that the 
app did not interfere with their daily 
activities. The mean rate of adherence 
was 81% and there were no 
differences in adherence across the 
day, time of week or between week 
one and week two of the study period.  
 
Poor 
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13 Weaver 
et al., 
2014 
26 adult 
patients. 
Breast, 
colorectal 
cancers. Mean 
age 57 years. 
UK. No 
information on 
race/ethnicity. 
Mobile phone, 
symptom 
monitoring for 
approx. five 
cycles of 
chemotherapy. 
Mobile device 
provided 
(participants 
required to be 
able to use 
device). 
Mixed methods, 
feasibility study. 
Questionnaires, 
interviews. 
Descriptive 
statistics, 
thematic 
analysis.  
Toxicities and 
treatment., 
management of 
toxicities, summaries 
of advice generated 
by the app, number of 
alerts, perceptions of 
the intervention.  
Ten patients were advised to be 
admitted to hospital by the nurse to be 
treated for severe toxicities. A total of 
1,954 alerts were generated, a 
median of 103 alerts per patient, 
however only 25% of these were 
genuine toxicity alerts. Patients 
commented that real-time monitoring 
made them feel safe and were 
reassured by the fast response of the 
nurse. Patients also commented that 
their confidence to self-manage their 
toxicities had improved.  
Medium 
14 Somers 
et al., 
2015 
25 adult 
patients. 
Breast, lung, 
colorectal, 
prostate 
cancers. Mean 
age 53 years. 
US. 76% 
White, 24% 
Black.  
Tablet, pain 
coping skills. 
Four sessions 
(30-45 
minutes). 
Mobile device 
provided.   
Mixed methods, 
feasibility study. 
Questionnaires, 
qualitative data 
collection 
method not 
specified.  
Descriptive 
statistics, paired 
sample t-tests. 
Pain severity, 
physical functioning, 
physical symptoms, 
psychological 
distress, self-efficacy 
for pain management, 
pain catastrophizing.   
Patients rated the intervention as 
good or excellent (n=13, 62%), were 
very satisfied (n=14, 67%) or mostly 
satisfied (n=7, 33%) with the 
programme and all received the 
information and skills that they 
wanted. Most patients (n=19, 92.5%) 
said that it helped their pain 
management. Patients reported 
significantly decreased pain severity 
(p=0.009), physical symptoms 
(p=0.001), psychological distress 
(p<0.001) and pain catastrophising 
(p=0.005) following the intervention. 
The mean score on pain self-efficacy 
also increased but was not of 
statistical significance.  
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15 Sundberg 
et al.,  
2015 
9 adult 
patients. 
Prostate 
cancer. Mean 
age 69 years. 
Sweden. No 
information on 
race/ethnicity. 
Mobile phone, 
symptom 
monitoring for 
two weeks. 
Mobile device 
provided.  
Mixed methods, 
feasibility study. 
Focus group, 
interviews. 
Descriptive 
statistics, 
content analysis.  
Software logged data, 
patient perceptions of 
ease of use and 
feasibility  
A total of 59 symptom alerts were sent 
and patients commented that they 
found the alert system to be helpful. 
The self-care advice was accessed by 
most patients (n=8, 85%), and those 
who did found it useful. Only some 
patients commented that they 
accessed links for further information 
but all patients suggested the 
potential usefulness of this function. 
No technical problems were 
experienced during the study. All 
patients found the app easy to use 
and understand. Patients commented 
that symptom reporting via a mobile 
device was acceptable and they felt 
reassured.  
Medium 
16 Maguire 
et al., 
2015 
16 adult 
patients. Lung 
cancer. Mean 
age 64 years. 
UK. No 
information on 
race/ethnicity. 
Mobile phone, 
symptom 
monitoring for 
duration of 
radiotherapy 
treatment plus 
one month 
post-treatment. 
Provision of 
device 
unknown. 
Mixed-methods, 
feasibility study. 
Semi-structured 
questionnaires, 
semi-structured 
interviews. 
Descriptive 
statistics, t-tests, 
Mann-Whitney U 
tests, 1-way 
ANOVA tests, 
Kruskal-Wallis 
tests, Fisher 
Exact tests, 
Wilcoxon signed 
ranks tests, 
McNemar tests, 
thematic 
Perceptions of the 
feasibility and 
acceptability of the 
intervention, anxiety, 
self-care self-efficacy, 
well-being, quality of 
life, physical symptom 
distress.  
All or nearly all patients (n=10, 100%) 
reported that they never or very rarely 
experienced problems in using the 
mobile device. All (n=9, 100%) felt 
that the intervention helped to 
manage their symptoms and 
communicate with their doctors and 
nurses. Patients commented that they 
felt reassured by the monitoring of 
symptoms by healthcare professionals 
and felt that the intervention reduced 
their uncertainty on whether to contact 
their clinician if needed. No 
statistically significant improvements 
in patient anxiety, wellbeing, self-care, 
or self-efficacy were found.   
Good 
	 34	
analysis.  
17 Dawes et 
al., 2015  
20 adult 
patients, 18 of 
which had 
colorectal 
cancers. 
Median age 58 
years. US. No 
information on 
race/ethnicity. 
Tablet 
computer, 
symptom 
monitoring for 
6-24 days, 
depending on 
time between 
operation and 
clinic visit. 
Mobile device 
provided 
(participants 
excluded for 
poor 
proficiency).  
Mixed methods, 
feasibility study. 
Questionnaires. 
Descriptive 
statistics, 
qualitative data 
was 
summarized 
narratively.  
Compliance with data 
entry, symptom 
monitoring, patient 
perceptions of the 
intervention.  
Compliance with the intervention was 
63% (ranging from 26-100% over 166 
of the 265 monitored days). Post-
operative monitoring of patients 
appeared feasible and provided more 
detailed and complete information to 
the clinical team. Patients commented 
that the intervention was helpful, 
aided in their recovery and improved 
communication and the relationship 
with their clinicians.  
Poor 
18 Besse et 
al., 2016 
9 adult 
patients. GI, 
lung, 
pancreatic, 
urogenital 
cancers, 
osteosarcoma, 
unknown/other 
cancers. Mean 
age 58 years. 
Netherlands. 
Mobile phone, 
pain 
monitoring for 
four weeks. 
Access to own 
mobile device 
required.   
Quantitative, 
feasibility study. 
Questionnaires. 
Paired t-tests.  
Quality of life, 
satisfaction with the 
intervention, pain 
course and treatment 
adaptations.  
Patients were satisfied with the 
intervention and did not consider it too 
burdensome, time consuming or an 
intrusion of their privacy. Most 
patients (n=7, 78%) considered the 
telephone response and therapeutic 
advice given by the researcher if their 
pain was clinically significant as 
useful. Overall, pain scores decreased 
significantly (p=0.047) and quality of 
life increased but was not of statistical 
Medium 
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No information 
on 
race/ethnicity. 
significance.  
19 Fortier et 
al., 2016 
12 adolescent 
patients. 
Leukemia, 
tumours of the 
central nervous 
system.  Mean 
age 12 years.  
US. Hispanic-
White (75%).  
Tablet, pain 
monitoring for 
ten days. 
Mobile device 
provided.  
Quantitative, 
feasibility study. 
Questionnaires. 
Descriptive 
statistics, 
Wilcoxon signed 
rank tests.  
 
Patient perceptions of 
content and usability, 
general symptom 
assessment, pain 
assessment, pain-
related coping 
strategies. 
Patients were highly satisfied with the 
app and perceived it to be useful. Pain 
and appetite disturbances were the 
most frequently reported symptoms. 
Nine symptom rating entries from 
three patients triggered an alert to a 
healthcare professional, eight of which 
were due to pain. Patients who 
experienced pain reported that the 
pain-related skills training were useful, 
in particular the positive self-talk, belly 
breathing and distraction techniques. 
Poor 
20 Foley et 
al., 2016 
39 adult 
patients. 
Breast cancer. 
Median age in 
intervention 
group 54 
years. Ireland. 
No information 
on 
race/ethnicity. 
Tablet, 
information 
provision prior 
to surgery. 
One week. 
Mobile device 
provided.  
Quantitative, 
pilot RCT. 
Questionnaires. 
Mann-Whitney 
tests, Fischer’s 
Exact tests.  
Mental adjustment to 
cancer, anxiety, 
depression, familiarity 
with technology, 
satisfaction with 
information.  
Anxiety was significantly lower in the 
control group at 7 days post operation 
(p=0.029). There was a significant 
difference in the intervention group in 
1 of the 5 domains of mental 
adjustment to cancer, pre-operative 
fatalism, which is a mal-adaptive 
coping response (p=0.004). 
Information satisfaction was similar 
between groups and overall, both 
groups rated the information they 
received as either good or excellent.  
Medium 
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2.4.4 Themes 
Findings from the narrative synthesis were organised into two main themes: (1) acceptability of 
the interventions, which included the subthemes of perceived usefulness, perceived ease of use, 
and adherence to interventions, and (2) benefits of the interventions, which included the 
subthemes of symptom management, patient empowerment, reduced anxiety, patient-clinician 
communication and health-related quality of life.  
 
Theme 1: Acceptability   
Subtheme 1a: Perceived usefulness 
The mobile interventions were perceived as useful by the majority of patients, particularly the 
self-care advice provided in response to symptom entries (Besse et al., 2016; Forbat, 
Maguire, McCann, Illingworth, & Kearney, 2009; Fortier, Chung, Martinez, Gago-Masague & 
Sender, 2016; Head et al., 2011; Kearney et al., 2006; Maguire et al., 2005; 2015; McCall et 
al., 2008; McCann et al., 2009; Sundberg et al., 2015; Weaver et al., 2014; Yap et al., 2013). 
Qualitative interviews with patients who took part in a RCT reported that the information 
provided them with expectations for their treatment, reminded them to watch for symptoms 
and suggested helpful home remedies (Head et al., 2011). Qualitative interviews from 
another RCT showed that patients also felt positively about the real-time, fast response of 
the clinician-alerting facility (McCann et al., 2009). However, interviews from a feasibility 
study found that some patients felt that the depth of the information available was insufficient 
and repetitive (Kearney et al., 2006) and two feasibility studies revealed variation in use of 
the self-care advice/information pages (Maguire et al., 2015; McGee & Gray, 2005, 
Sundberg et al., 2015). Yap and colleagues (2013) reported that whilst over half of patients 
(62%) found a mobile phone, symptom-monitoring intervention useful, patients with lower 
education and chemotherapy-naïve patients rated the intervention significantly more useful 
than those with higher education (75% vs 35%) or those who had received chemotherapy 
before (82% vs 53%). 
 
Subtheme 1b: Perceived ease of use  
Almost all patients reported that they found the mobile interventions easy to use, regardless 
of age, type or stage of cancer and experience with technology (Besse et al., 2016; Head et 
al., 2011; Kearney et al., 2006; Maguire et al., 2005; 2015; McCall et al., 2008; Post et al., 
2013; Stinson et al., 2013; Sundberg et al., 2015; Weaver et al., 2007). For example, Head 
and colleagues (2011) reported that all 44 patients from the intervention arm of a RCT 
reported a handheld device to be very easy (85%) or easy (15%) to use and a feasibility 
study reported that although 66% of 18 patients had little prior computer experience, at post-
study all 11 patients who had received the intervention reported that they felt comfortable 
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using the handheld device (Kearney et al., 2006). Interviews and questionnaires findings 
from an RCT and feasibility study suggested that daily use of a mobile phone intervention did 
not impact on patients’ daily routines or privacy and was not perceived as burdensome or too 
time-consuming (Besse et al., 2016; McCann et al., 2009). The majority of patients 
experienced no or very few technical problems with their mobile devices, however those who 
did tended to encounter problems with Internet connection or practical problems with the 
device itself (Maguire et al., 2005; McCall et al., 2008; McCann et al., 2009; McGee & Gray., 
2005; Post et al., 2013; Weaver et al., 2007; 2014).  
 
Subtheme 1c: Adherence to mobile interventions 
Studies generally reported high adherence rates to the mobile interventions, regardless of 
the length of the study (Besse et al., 2016; Chumbler et al., 2007b; Dawes et al., 2015; Head 
et al., 2011; Post et al., 2013; Somers et al, 2015; Stinson et al., 2013; Weaver et al., 2007; 
2014; Yap et al., 2013). A pilot RCT of 44 patients reported that patients used a handheld 
device consistently for an average of 10 weeks (Head et al., 2011). For the longest study 
period included in this review, up to six months, Chumbler and colleagues (2007b) reported 
that the mean adherence of 48 patients to daily dialogues with a care coordinator was 84%, 
with a decrease in adherence as treatment progressed. One study suggested that 
adherence might be affected by the type of device used or experience with this type of 
technology (Yap et al., 2013). Yap and colleagues (2013) reported that adherence was 
significantly higher among Smartphone users compared to basic mobile phones users 
(87.2% vs 47.6%). The most common reasons reported for non-adherence to interventions 
were hospitalisation, forgetfulness and technical problems (Head et al., 2011; Post et al., 
2013).  
 
Theme 2: Benefits of the interventions 
Subtheme 2a: Symptom management 
The majority of patients perceived the mobile interventions to be helpful in monitoring their 
treatment-related symptoms. Additionally, studies highlighted that mobile interventions are 
able to capture patient information and outcomes that are not captured via conventional 
reporting, such as questionnaires (Dawes et al., 2015; Fortier et al., 2016; Kearney et al., 
2006; Maguire et al., 2005; McCall et al., 2008; Somers et al, 2015; Sundberg et al., 2015; 
Weaver et al, 2014). However, a RCT of 112 breast, lung and colorectal cancer patients 
showed mixed results (Kearney et al., 2009). Authors hypothesised that a real-time, 
symptom monitoring intervention would facilitate better measurement of six chemotherapy-
related symptoms, resulting in more timely interventions. Although two out of six monitored 
symptoms were significantly different between groups, there were significantly lower reports 
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of fatigue and significantly higher reports of hand/foot syndrome in the intervention vs. 
control group. There was some evidence to suggest that symptom-monitoring interventions 
have the potential to reduce the unnecessary use of healthcare services by improving 
symptom management (Besse et al., 2016; Chumbler et al., 2007a; Weaver et al., 2014). For 
example, a matched case-control study of 125 patients investigated the effects of a handheld 
device intervention by measuring patients’ unexpected and expected use of cancer-related 
services over six months (Chumbler et al., 2007a). Findings showed that the intervention 
group had significantly lower use of unexpected care services and significantly higher use of 
most expected care services, however contrastingly, patients in the intervention group had 
significantly fewer expected clinic visits compared to controls. Authors suggested this 
contrasting result is possibly due to patients resolving issues with the care coordinator prior 
to an expected clinic visit thereby reducing the need for the visit.  
 
The majority of symptom-monitoring intervention studies further reported that patients 
perceived that the interventions had led to improved symptom management (Besse et al., 
2016; Dawes et al., 2015; Head et al., 2011; Maguire et al., 2005; 2015; McCann et al., 
2009; Somers et al., 2015; Weaver et al., 2014). Head and colleagues (2011) found that 
52% of patients reported that they were much better and 44% somewhat better at managing 
their condition as a result of a handheld, symptom-monitoring intervention. A more recent 
feasibility study reported that the mean pain score of participants from the start to end of a 
feasibility study decreased non-significantly, but when measured using the European 
Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC 
QLQ-C30), the mean pain score decreased significantly from 56 to 35 (Besse et al., 2016). 
Furthermore, two studies reported that patients were admitted to hospital as a result of a 
real-time symptom monitoring intervention, which resulted in proactive management of those 
patients’ symptoms (Besse et al., 2016; Weaver et al., 2014).  
 
Subtheme 2b: Patient empowerment 
Some studies suggested that remote monitoring of symptoms empowered patients to 
participate in their care and better manage their condition due to increased knowledge of 
their condition and symptom management strategies provided by the mobile interventions 
(Dawes et al., 2015; Fortier et al., 2016; Head et al., 2011; Kearney et al., 2006, Weaver et 
al, 2015). In qualitative interviews with 11 lung and colorectal cancer patients, patients 
explained that this type of intervention had increased their understanding of their symptom-
related problems and consequently, their confidence in their abilities to manage symptoms 
(Kearney et al., 2006). Furthermore, Weaver and colleagues (2014) reported that patients 
felt more in control of their care and had increased confidence to self-manage their condition 
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at home as a result the intervention. Similarly, Somers and colleagues (2015) showed that 
95% of participants reported that the intervention helped them to understand the experience 
of pain and 90% of participants felt the intervention had taught them skills that improved their 
pain coping, however an observed increase in pain self-efficacy following the pain-related 
coping skills intervention was not significant.  
 
Subtheme 2c: Reduced anxiety 
The majority of studies reported that patients perceived clinicians’ surveillance of, and 
response to, their symptoms as reassuring, however there were some mixed findings for the 
effects of information on levels of anxiety (Foley et al., 2016; Forbat et al., 2009; Kearney et 
al., 2006; Maguire et al., 2005; 2015; McCall et al., 2008; McCann et al., 2009; Sundberg et 
al, 2015, Weaver et al., 2007; 2014). Qualitative interviews with 12 patients from a process 
evaluation of an RCT of a mobile phone, symptom-monitoring intervention reported that 
patients felt secure in the knowledge that clinicians were being alerted about their symptoms 
(McCann et al., 2009). Results from a secondary analysis of these interviews suggested that 
patients viewed their surveillance as liberating, freeing them of the worry of making a 
decision to contact clinicians themselves (Forbat et al., 2009). In contrast, a feasibility of a 
mobile symptom monitoring intervention reported no change in anxiety levels (Maguire et al., 
2015). Conversely, a pilot RCT study of a tablet-based information provision intervention 
found that there was a significant difference in pre-operative fatalism in the intervention 
group and anxiety was significantly lower in the control group at seven days post operation 
(Foley et al., 2016). This suggests that increasing patients’ knowledge on patients’ treatment 
could potentially increase rather than reduce their anxiety. However, authors reported that 
some women were anxious about using a tablet device with which they were unfamiliar and 
this may have increased their anxiety. Additionally, the follow up period was short at 7 days 
post-surgery.  
 
Subtheme 2d: Patient-clinician communication  
Many patients perceived that communication with clinicians had improved or their 
relationship had strengthened as a result of the interventions (Aldiss et al., 2011; Dawes et 
al., 2015; Forbat et al., 2009; Head et al., 2011; Maguire et al., 2005; 2015; Weaver et al., 
2007). A post-study questionnaire of 44 patients from a RCT of a handheld, symptom-
monitoring intervention found that 65% of patients were more satisfied with the 
communication with their clinicians (Head et al., 2011). In a secondary qualitative analysis of 
patient interviews from a RCT of a mobile phone, symptom-monitoring intervention, Forbat 
and colleagues (2009) reported that patients felt the intervention gave them easier access to 
cancer specialists, as well as increasing the amount of communication with clinicians. 
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Authors suggested that easier access to clinicians may change the dynamic of the traditional 
hierarchical models of healthcare to a more patient-centred model, as clinicians are more 
responsive to the patients’ reports and needs. Furthermore, two feasibility studies found that 
as the intervention prompted clinicians to contact the patients, patients’ uncertainty about 
contacting whether to contact their clinicians when needed was reduced and they felt less 
‘bothersome’ to their clinicians (Maguire et al., 2015; Weaver et al., 2007).  
 
Subtheme 2e: Heath-related quality of life (HRQOL)  
Studies reported mixed findings of the interventions on patients’ HRQOL (Besse et al., 2016; 
Chumbler et al., 2007b; Head et al., 2011; Maguire et al., 2015; Post et al., 2013). A RCT of 
44 patients using a handheld device during treatment periods, which required patients to 
report symptoms three to five times daily, reported that significant positive correlations were 
found between usage of the intervention and physical well-being and emotional well-being 
scores during treatment (Head et al., 2011). A feasibility study of 48 patients using a 
handheld device to answer daily symptom questions from a care coordinator found a 
clinically significant improvement of 6.3 points in patients’ HRQOL between baseline and six 
months (Chumbler et al., 2007b). This study suggested that a symptom-monitoring 
intervention could reassure patients who are anxious during treatment thereby maintaining 
their HRQOL. In contrast, although one feasibility study reported a non-significant increase in 
quality of life following a pain-monitoring intervention (Besse et al., 2016), one feasibility 
study reported no change in wellbeing (Maguire et al., 2015), however both studies suffered 
from small sample sizes. Negative findings were also reported by Post and colleagues 
(2013). Their pilot RCT study of 60 patients using a PDA device, where patients reported 
symptoms weekly during treatment periods and viewed videos on how to communicate their 
symptoms to their clinicians prior to their consultations, found that patients’ HRQOL were not 
significantly different between groups. Furthermore, the pre-post treatment decrease in 
HRQOL was generally greater among the intervention group. Authors suggested that this 
result might be due to the intervention drawing attention to the symptoms experienced by 
patients in the intervention group. However, due to the methodological differences between 
studies, such as study design, measurement of HRQOL and intervention intensity (e.g. 
intervention functions, interaction with patient and duration of intervention), meaningful 
comparison of these studies is not possible, though it is possible that intervention intensity is 
partly responsible for these mixed findings.  
 
2.5 Discussion  
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This is the first systematic review to identify and evaluate literature that describes the use of 
mobile interventions to enable cancer patients to meet their information needs in non-
inpatient settings, and to describe the effects and feasibility of this type of intervention. 
 
2.5.1 Summary of the evidence 
The primary aim of the majority of intervention studies included in this review was to improve 
the monitoring and management of patients’ treatment-related symptoms, which included the 
provision of self-care information and interactive information exchange with clinicians. 
Although these interventions attempted to educate patients in some way, the information and 
skills provided were solely related to their treatment. Two further intervention studies 
primarily aimed to increase patients’ treatment-related knowledge and one intervention study 
aimed to improve communication and exchange of information between patients and their 
clinicians. There were no interventions that primarily aimed to meet patients’ full range of 
information needs by increasing their general knowledge and understanding of their 
condition. Additionally, all interventions were for patient use only and did not aim to support 
relatives simultaneously. 
 
Based on studies included in this review that were appraised as medium or good quality,  
there was moderate evidence to suggest that this type of technology and intervention was 
acceptable to patients with cancer, regardless of age, experience with technology, cancer 
type or stage of cancer. Similarly, there was moderate evidence to suggest that patients 
perceived the mobile interventions to be useful, particularly the self-care advice and the fast 
response from clinicians, and one study suggested that patients with lower education or 
chemotherapy-naïve patients could benefit more from this type of intervention than their 
counterparts. Studies of medium and good quality also reported that patients found the 
mobile interventions easy to use and non-intrusive on their daily routine, with few technical 
problems encountered, and that adherence to interventions was generally high, however 
there was considerable variation in usage of the different intervention components within and 
between studies. Reported benefits of the interventions from medium to good quality studies 
included improved symptom monitoring and management, patient empowerment and 
improved clinician-patient communication, however mixed findings were reported for 
patients’ anxiety and HRQOL. Overall, findings between studies of good, medium and poor 
quality were largely consistent. 
 
2.5.2 Findings in the context of other literature  
A plethora of mobile interventions have been developed to support patients with range of 
chronic conditions remotely, such as diabetes, heart disease, asthma and mental illnesses, 
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the majority of which primarily aimed to improve patients’ self-management behaviours, such 
as adherence to treatment and monitoring of their condition (De Jongh, Gurol-Urganci, 
Vodopivec-Jamsek, Car & Atun, 2008; Klasnja & Pratt, 2012). The findings of the present 
review are consistent with previous literature that has found mobile technology to be an 
acceptable platform to deliver interventions to patients with other chronic conditions, 
regardless of the patients’ type of disease, age, gender and experience with technology 
(Cleland, Caldow & Ryan, 2007; De Jongh et al., 2008; Holtz, & Lauckner, 2012; Logan et 
al., 2007; Wang et al., 2014). Generally, the majority of patients included in good, medium 
and poor-quality studies of the present review found mobile interventions easy to use and 
engaging, regardless of the type of device used (e.g. mobile phone, PDA) or age of the 
patient. Furthermore, very few barriers were reported by patients; a minority experienced 
minor technical issues when connecting to the server to transfer information and some forgot 
or were unable to complete symptom diaries due to hospitalisation. The finding that few 
technical problems were experienced is in contrast to previous literature, where many 
patients have cited technical difficulties as a barrier to use and satisfaction with the 
intervention (Cleland et al., 2007; Harrison et al., 2014; Holtz, & Lauckner, 2012; Wenze, 
Armey & Miller, 2014). One review of mobile interventions for patients with diabetes reported 
that 67% of 21 studies reported technical issues (Holtz & Lauckner, 2012) and some patients 
have found these types of issues frustrating and dissatisfying (Cleland et al., 2007). The 
contrasting finding of the present review may be due to the fact that many interventions for 
other chronic conditions, such as diabetes and asthma, require additional technological 
devices to monitor symptoms, which would increase the likelihood of technical errors. In 
contrast, mobile interventions for patients with cancer included in the present review required 
a mobile device only.  
 
Adherence rates to mobile interventions included in good, medium and poor-quality studies 
included this review were generally high throughout the study periods, which were up to six 
months, however engagement appeared to decrease over the course of the intervention. 
These patterns mirror those of studies of mobile interventions for other chronic conditions, 
which included study periods of up to a year in duration (De Jongh et al., 2008; Logan et al., 
2007; Wenze et al., 2014). However, despite generally high rates of adherence for this type 
of intervention, there appeared to be considerable variation in the usage of the different 
intervention components within and between studies included in the present review. In 2008, 
Abraham and Michie developed a taxonomy of behaviour change techniques (BCT), which 
included standard definitions of the techniques included in behaviour change interventions. 
This taxonomy enabled intervention developers to use a common language with which to 
systematically categorise intervention content, particularly complex interventions with 
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multiple components. This process allows intervention developers to trial and measure the 
effects of individual components and compare different versions of interventions, in order to 
create the most optimal version through an iterative, on-going process (West, Aiken & Todd, 
1993). All studies in the present review failed to code intervention content using this 
taxonomy and so it was not possible to identify and attribute success to active components. 
As a result, it will be difficult for future researchers to replicate effective interventions and a 
challenge to identify the most effective BCTs for this type of intervention for patients with 
cancer. It is therefore important that future intervention developers code interventions in 
order to develop effective interventions for patients with cancer and enable a more 
systematic evaluation (Michie, van Stralen, & West, 2011).  
 
Patients appeared to recognise the benefits of real-time symptom monitoring interventions, 
such as increased knowledge and confidence to participate in self-care, which appeared to 
result in improved management of symptoms. Mobile technology enables patients to keep a 
real-time record of symptoms, which improves the accuracy of symptom appraisal and 
management and enables clinicians to better identify and understand patterns of symptoms 
(Baggott et al., 2012; Moskowitz & Young, 2006). The capability of this technology to capture 
patient-reported outcomes in real-time may be of clinical importance as it promotes timely 
intervention. This could reduce the amount of preventable hospitalisations, as suggested by 
three medium-quality studies included in this review. Previous studies of the effects of mobile 
symptom-monitoring or adherence interventions on symptoms of other chronic conditions 
have shown similar findings, including improved symptoms, such as an increased blood 
glucose control, and increased self-management behaviours, such as better adherence to 
treatment (Angeles, Howard, & Dolovich, 2011; Baron, McBain, & Newman, 2012; De Jongh 
et al., 2008; Holtz, & Lauckner, 2012). As a result, some patients with other chronic 
conditions have reported fewer clinic visits or hospital admissions following a use of mobile 
intervention (Angeles et al., 2011; De Jongh et al., 2008).  
 
Some medium-quality studies included in the present review suggested that mobile 
interventions have the potential to empower patients by equipping them with the knowledge 
and confidence they need in order to participate more effectively in their care. Similarly, 
although not directly measured, studies of mobile interventions for other chronic conditions 
have provided some evidence for increases in patient empowerment, due to observed 
increases in knowledge and self-management behaviours (Angeles et al., 2011; De Jongh et 
al., 2008; Holtz, & Lauckner, 2012; Wang et al., 2014).  
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In the present review, studies of good and medium quality reported that patients perceived 
clinicians’ monitoring of their symptoms to be reassuring. Similar findings have been 
reported in studies of symptom-monitoring interventions for other chronic conditions, where 
patients described feelings of security, felt that they had not been forgotten and were 
receiving good care outside of hospital and clinic (Wang et al., 2014). Additionally, studies of 
good and medium quality in the present review reported that symptom-monitoring and 
management interventions appeared to improve patient-clinician communication, due to 
increased and easier access to clinicians and the reduction of patients’ uncertainty of 
whether to contact them. Similarly, patients with other chronic conditions, such as asthma 
and diabetes, have also reported increased and improved communication with their 
clinicians as a result of mobile interventions (Cleland et al., 2007; Harrison et al., 2014). 
Mobile interventions offer an inexpensive way to bridge the gap between patients and 
clinicians and increase their contact at a time when patients require more support following a 
shift from inpatient to outpatient cancer care.  
 
Studies in the present review reported mixed findings on the impact of mobile interventions 
on patients’ HRQOL and anxiety, however few studies included in this review measured 
these outcomes. Studies of medium and good quality provided evidence to suggest that 
symptom-monitoring and management interventions could reassure patients and reduce 
their anxiety. For some patients, having more knowledge on their condition might reduce 
their anxiety due to preparedness for treatment-related side effects, resulting in a better 
experience and the development of realistic expectations of the future. Conversely, one 
study of medium quality in the present review provided evidence to suggest that information 
might increase some patients’ anxiety by drawing attention to their condition, unknown 
symptoms or the risks of treatment. Previous research from the nursing and palliative care 
field, as well as theories of coping with a chronic condition such as cancer, including the 
Common Sense Model (CSM) of self-regulation of health and illness (Leventhal, Nerenz & 
Steele,1984) and Moos and Schaefer’s model of a life crisis and framework of coping (1984), 
have distinguished between two types of coping, namely approach coping and avoidance 
coping. Approach coping involves actively confronting the diagnosis, gathering information 
and taking action, whereas avoidance coping involves minimising the importance of the 
diagnosis and includes strategies such as denial or wishful thinking in an attempt to maintain 
hope. Although approach coping is generally regarded as the most adaptive form, studies 
have found that the usefulness of coping strategies for cancer patients depend on the fit 
between the demands of their situation and selected coping strategy (Christensen et al., 
1994; Lerman et al., 1990; Park et al., 2001). For example, avoidant coping strategies 
strategies may be useful in certain situations for some cancer patients, such as during 
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chemotherapy where active coping strategies may draw attention to the negative 
consequences of treatment (Lerman et al., 1990). Furthermore, studies have shown that 
denial and wishful thinking may help an individual through various stages of the illness and 
treatment by allowing them time to process distressing information at a more manageable 
rate (Rabinowitz & Peirson 2006). The usefulness of mobile interventions that aim to help 
patients with cancer to meet their information needs will likely depend on an individuals’ 
unique situation and preferred coping style at particular points during their illness trajectory.  
 
The majority of studies in the present review failed to report the race and ethnicity of 
participants and all studies failed to consider the potential differences in cancer experience 
and information needs between groups and the possible implications of these differences for 
this type of intervention. On one hand, some studies have suggested the absence of a 
dramatic difference in information needs between minority and majority groups with cancer in 
the UK and US and many studies have reported that most patients across groups prefer to 
have information on their condition from their healthcare provider (Guidry, Aday, Zhang & 
Winn, 1998; Kumar et al., 2004; Rutten et al., 2005). For example, a study of 82 Asian and 
220 White British cancer patients in Leicestershire, which included Indian, British Asian, 
Bangladeshi and Pakistani patients, reported that a high percentage of Asian patients 
wanted to know the specific name of their cancer (93.8%), week-by-week progress (86.4%), 
the chance of cure (84.0%), all possible treatment options (87.7%) and all possible side 
effects (85.2%), which were comparable to findings of White British patients (Kumar et al., 
2004). Conversely, studies have reported that some patients of black and ethnic minority 
groups, such as African American and Chinese, have different experiences of cancer, 
different needs and use different information sources compared to majority groups (Elkan et 
al., 2007; Matthews, Sellergren, Manfredi & Williams, 2002; Randhawa & Owens, 2004; 
Talosig-Garcia & Davis, 2005; Wills & Wootton, 1999). For example, a qualitative study of 
African American patients with cancer reported a number of barriers to medical information 
seeking and treatment participation, such as fatalistic beliefs about cancer, historical mistrust 
of the medical community, religious beliefs that God would ultimately take care of them, 
concerns about burdening the family and embarrassment of the stigma associated with 
cancer in their culture (Matthews et al., 2002). Patients with these types of beliefs are 
unlikely to want extensive information on their condition and may perceive this type of 
intervention as threatening (Matthews et al., 2002). Patients in this study also valued lived 
experience of cancer and so relied heavily on family and friends for information on their 
condition. It is therefore important that future studies explore the use and impact of this type 
of intervention for patients from black and ethnic minority groups. 
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Finally, some studies of good and medium quality in the current review provided some 
evidence for increased HRQOL and other studies of good and medium quality suggested no 
effect. Few studies that have measured the impact of mobile devices on patients’ quality of 
life or emotional disturbances for other chronic conditions have also reported mixed findings 
(Kirwan, Vandelanotte, Fenning & Duncan, 2013; Kristjánsdóttir et al., 2013). However, 
some of these studies have highlighted the potential of Smartphones to specifically increase 
patients’ awareness of stress and emotional well-being, by recording moods during both 
health and illness, and deliver therapeutic interventions accordingly, which has led to 
reduced anxiety (Kristjánsdóttir et al., 2013; Morris et al., 2010). Mobile interventions offer a 
new opportunity to increase patients’ access to psychological support and deliver 
psychological interventions remotely at a time when patients are vulnerable.  
 
Although findings of this review are largely positive, it highlighted the fact that the majority of 
the interventions included involved a significant amount of monitoring and interaction from 
clinicians. Studies that have explored clinicians’ perceptions, some of which are included in 
this review, have reported mixed opinions on the acceptability and feasibility of symptom-
monitoring interventions (Kearney et al., 2006; Maguire et al., 2008; McCall et al., 2008). 
This type of intervention may place an additional burden on clinicians during a time when 
they are already stretched.  
 
2.5.3 Quality of studies  
The large number of early-phase studies in this field means that many studies included in the 
present review used an uncontrolled design. The current evidence for the effectiveness and 
feasibility of mobile interventions to support cancer patients is therefore limited. Although 
these studies highlighted the potential benefits of such interventions, RCTs are needed to 
support the findings of this review. Additionally, most included studies included in this review 
were critically appraised as poor or medium quality, which further limits the conclusions that 
can be drawn from these studies. Limitations of some studies included small sample sizes, 
samples limited to single cancer types, under-reporting of response rates and details of 
participants who were lost to follow up, and short study periods. Other limitations included 
the failure of studies to explore the opinions of patients with negative views and the cost of 
this type of intervention. Additionally, some studies only included participants who had 
access to their own device or were already able to competently use a mobile device. This 
inclusion criterion may have biased findings, as those who participated in these studies may 
have had more favourable perceptions of mobile interventions than those who were unable 
to participate. However, findings across studies of good, medium and poor quality were 
generally consistent and conclusions of this review were drawn only from good and medium 
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quality studies. Finally, many studies relied on self-reported data which may have been 
affected by recall or the Hawthorne effect (Merrett, 2006), where participants may have 
changed their behaviour due to knowingly being observed.  
 
2.5.4 Strengths and limitations of this review 
The AMSTAR checklist (A Measurement Tool to Assess Systematic Reviews; 
https://amstar.ca/Amstar_Checklist.php) was used to assess the quality of this systematic 
review. Strengths of this review include an ‘a priori’ design, study selection and data 
extraction was conducted by two independent reviewers, multiple databases and references 
of included studies were searched, study characteristics were reported, and the studies were 
critically appraised on their quality, which was taken into account when drawing conclusions. 
However, the present review has several limitations. A meta-analysis was not conducted as 
the included studies did not have suitable data to aggregate. A narrative synthesis was 
considered to be a suitable alternative method to explore the findings of these studies. Other 
limitations include poor indexing of studies, which may have limited the number of studies 
included in this review, and a high number of potential studies was found through searching 
the references of included studies. Finally, this review did not report on the perceptions and 
experiences of healthcare professionals that participated in some studies. 
 
2.5.5 Implications for policy and practice 
This review has several implications. Firstly, it established that a wide range of patients with 
cancer perceived mobile devices to be an acceptable medium to provide interventions 
remotely. Secondly, this type of intervention appears to have the potential to provide a range 
of benefits for patients, clinicians and the healthcare service. Specifically, findings of this 
review suggested that symptom-monitoring interventions that provide treatment-related 
information to patients have the potential to improve patients’ self-management of their 
condition and provide clinicians with a better understanding of patients’ symptom 
experiences, whilst improving the patient-clinician relationship. This may lead to earlier 
detection of treatment-related side-effects and timely intervention, which could reduce costs 
for the healthcare system. This type of intervention also has the potential to sustain or 
improve patients’ well-being during a time where they typically experience a decrease.  
 
Importantly, this review established that, to date, mobile interventions have only attempted to 
meet a single type of information need (e.g. treatment-related symptom information, coping 
skills), which has typically been achieved indirectly. There are currently no app interventions 
that primarily aim to meet patients’ full range of information needs in non-inpatient settings, 
an intervention which may be used by both patients and their relatives. Additionally, the 
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majority of interventions required monitoring and interaction with clinicians, which may place 
unrealistic demands on an already stretched healthcare service. Few mobile interventions 
have been developed to be used independently by patients in non-inpatient settings. 
Development of such an intervention would support the initiatives of UK governments and 
health organisations to empower patients to take a more active role in their care by 
increasing support for patients in non-inpatient settings and harnessing the power of 
technology in order to do so (DOH, 2011; 2013).  
 
2.5.6 Conclusion 
This is the first systematic review to identify how mobile devices have previously been used 
to help patients with cancer to meet their information needs in non-inpatient settings and 
evaluate the effects and feasibility of this type of intervention. The majority of mobile 
interventions developed for patients with cancer so far have been to enable clinicians’ 
surveillance of patients remotely in the form of symptom-monitoring interventions. Despite 
promising findings, this type of intervention seeks only to increase patients’ knowledge of 
their treatment side-effects. Currently, there no app interventions that primarily aim to meet 
patients’ full range of information needs in non-inpatient settings, which may be used 
independently of clinicians, and no app interventions have been developed for use by both 
patients and their relatives. Nevertheless, mobile devices appear to be an acceptable 
platform to deliver interventions remotely to patients with cancer. However, this review 
highlighted the early stage of the research that is being conducted in this area, which limits 
the conclusions that can be drawn. Following on from the early-phase feasibility studies, 
RCTs are needed to support the findings of this review, further determine the effectiveness 
of this type of intervention to improve patient outcomes and to support the transfer of 
interventions into standard practice.  
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Chapter 3 
Models, theories and approaches relevant to patients’ experiences of cancer and 
self-management of their condition 
 
3.1 Chapter overview  
This chapter describes and critically appraises a selection of health behaviour models, 
theories and approaches that are relevant to being diagnosed and living with cancer.  
The purpose of the chapter is to gain theoretical understandings of how the illness 
might impact patients, the issues they might face and the type of app that might best 
support them. Theories related to patients’ self-management of a chronic condition, 
and the reasons for selection of these theories, will be described and critically 
evaluated in the context of cancer. This chapter will help to inform the development of 
an app intervention for patients with cancer.  
 
3.2 Introduction 
As described in Chapter 1, the MRC framework for developing and evaluating complex 
interventions in healthcare highlights the importance of identifying relevant theories to 
gain a deeper understanding of the behaviour to be targeted by an intervention and the 
changes that may be expected (Craig et al., 2008). This first phase of the MRC 
framework provides insight into the processes that are likely to underlie the targeted 
behaviour prior to intervention development, which allows the intervention to be 
designed specifically to address these processes (Craig et al., 2008).  
 
Previous studies, as described in Chapter 1, have provided evidence of the unmet 
information needs of patients with cancer, and their relatives, and the negative impact 
of these unmet needs. A systematic review of mobile interventions for patients with 
cancer, presented in Chapter 2, highlighted the potential benefits of interventions that 
were delivered to patients remotely by Smart technology. It was therefore anticipated 
that an app would be developed to enable patients with cancer to meet their full range 
of information needs in non-inpatient settings. Prior to developing an intervention, it is 
important to explore the views and opinions of the intervention users to develop an 
understanding of their needs and the type of intervention that they anticipate to be 
most useful (Yardley et al., 2015). A review of relevant health behaviour models, 
theories and approaches related to the impact and self-management of a chronic 
condition was conducted in order to develop an understanding of the experiences of 
cancer patients and their relatives, the issues they might face and the type of app that 
might best support them. It was assumed that these theories might also be relevant for 
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relatives, as well as patients, due to their shared experienced of cancer (Harrison et 
al.,1995).  
 
Theories selected for inclusion in this chapter refer to the concepts of coping, 
adjustment and self-management. Coping has been defined as, ‘‘the thoughts and 
behaviors a person uses to regulate distress, manage the problem causing distress 
and maintain positive well-being’’ (Folkman & Greer, 2000, p. 11), and this concept 
overlaps with, and has often been hypothesised to predict, adjustment to illness 
(Brown, King, Butow, Dunn, & Coates, 2000; Sharpe, & Curran, 2006). Adjustment has 
similarly been described as a response to a change to circumstance, such as a cancer 
diagnosis, that allows an individual to become more suitably adapted to the change 
Brennan, 2001; Sharpe, & Curran, 2006). Earlier definitions tend to refer to a desirable 
outcome to signify adjustment, such as emotional equilibrium, quality of life, or social 
functioning (Brennan, 2001; Sharpe, & Curran, 2006). More recently, adjustment is 
viewed as a disease-specific and on-going process, which is separate to the desired 
outcome, and desired outcomes of adjustment should include aspects relevant to 
physical, social and psychological adjustment (Hoyt & Stanton, 2012). The concept of 
self-management has come to encompass the concepts of coping with cancer and 
adjustment, and is described as, “the individual's ability to manage the symptoms, 
treatment, physical and psychosocial consequences and lifestyle changes inherent in 
living with a chronic condition. Efficacious self-management encompasses the ability to 
monitor one's condition and to effect the cognitive, behavioural and emotional 
responses necessary to maintain a satisfactory quality of life. Thus, a dynamic and 
continuous process of self-regulation is established.” (Barlow, Wright, Sheasby, Turner 
& Hainsworth, 2002, p178).  
 
Definitions of coping, adjustment and self-management all share a focus on the need 
of an individual to return to and maintain a status quo, the importance of coping with 
and managing the physical, social and psychological effects of a chronic condition and 
an individual’s self-efficacy to successfully adopt and carry out suitable coping 
strategies and self-management behaviours (de Ridder, Geenen, Kuijer, & 
Middendorp, 2008). Additionally, when reviewing theories for inclusion in this chapter, 
it was apparent that similar elements permeate the models and theories related to 
coping with a chronic illness and patients’ self-management of the disease (e.g. 
appraisal, coping responses, self-management behaviours). The term self-
management will therefore be used as an over-arching term throughout this thesis to 
encompass patients’ coping with, and adjustment to cancer, and self-management of 
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the disease, however the terms will be referred to separately in this chapter, as 
originally referred by authors of the theories. It is also useful to note the difference 
between the terms ‘theory’ and ‘model’. A theory is described as explanatory and 
predictive, and is used to guide selection of appropriate research methods and predict 
behaviour to guide intervention development. A model is descriptive and often a 
simplified version of a theory that outlines simplified cause and effects of key aspects 
of behaviour (Gabrenya, 2003).  
 
A number of core models of health psychology, such as the Health Belief Model (HBM) 
(Becker, 1974) and Theory of Planned Behaviour (TPB) (Ajzen, 1991), are potentially 
relevant to the development of an app for cancer patients due to their focus on 
behaviour change, however these models typically require a high level of specificity in 
identifying the target behavior. At this point in app development, it is prudent to allow 
for the consideration of a broad domain of behaviours. Additionally, these models lack 
a prescribed role for an individual’s emotional response to an illness and have 
therefore failed to account for the complex set of processes involved in adjustment to 
cancer (Sharpe, & Curran, 2006). For these reasons, the HBM and TPB were not 
included for discussion in this chapter.  
 
3.2.1 Aims of this chapter  
The aim of this chapter is to review and critically evaluate health behaviour models, 
theories and approaches that might be relevant to the impact and self-management of 
a chronic condition, such as cancer. This chapter will discuss how each theory may be 
used to inform the development of an app intervention to help to meet patients’ 
information needs in non-inpatient settings.  
 
3.3. Models relevant to the impact and self-management of a chronic condition  
3.3.1 The Common Sense Model (CSM) of self-regulation of health and illness  
The CSM (Leventhal, Nerenz & Steele,1984) (Figure 4) attempts to explain how an 
illness is inferred, understood and acted upon and is a useful model to explain how 
patients might come to understand and cope with a diagnosis of cancer. The CSM 
posits that, following a diagnosis, individuals aim to develop an understanding of their 
condition based on the need to maintain equilibrium and return to a state of ‘normality’ 
(which in the case of cancer is cure or management of the disease). Leventhal and 
colleagues (1984) assume an individual to be a problem solver who is actively involved 
in the management of their health by responding to a health threat, such as cancer, 
with a dual, parallel process of cognitive processing (i.e. identifying, understanding and 
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responding to the health threat) and emotional processing (i.e. the emotional response 
to the health threat and coping strategies to manage emotions).  
 
There are three key constructs of the CSM, which include: (1) interpretation of the 
illness (making sense of the diagnosis), (2) the coping response to the illness (an 
attempt to regain a state of normality), and (3) appraisal of the coping response 
(assessment of the success of the coping strategies used). The CSM posits that 
following a cancer diagnosis, patients actively construct representations of the illness, 
termed ‘illness cognitions’, by using their existing knowledge of cancer and accessing 
their implicit beliefs. Illness cognitions provide a framework for understanding and 
coping with the illness and are constructed according to five dimensions: 
 
(1) Identity (the label given to the illness) 
(2) Consequences (possible short-term and long-term physical, emotional, social 
and economic effects of the illness) 
(3) Causes (perceptions of the cause of the illness) 
(4) Timeline (perceptions of the timeframe of the development and duration of the 
illness) 
(5) Curability/controllability (perceptions of whether the illness can be cured or 
managed) 
 
Illness cognitions enable the individual to give meaning to the illness and adopt 
suitable coping strategies, which are suggested to have the ability to influence health 
outcomes. If and when new information about the illness comes to light, the relevant 
illness cognitions can be amended. Simultaneously, the model posits that a health 
threat, such as a cancer diagnosis, will result in an emotional response from the 
individual, such as fear, anxiety and/or depression. 
 
This model refers to two broad coping ‘styles’: approach coping and avoidance coping 
(Roth & Cohen, 1986). Approach coping involves confronting the diagnosis, gathering 
information and taking action, and includes strategies such as taking medication, 
venting emotions and going to the doctor. Avoidance coping involves minimising the 
importance of the diagnosis and includes strategies such as denial or wishful thinking. 
Approach coping is generally regarded as the most adaptive form. Once the individual 
has adopted a coping style, the coping response is appraised. If appraised as 
unsuccessful, the coping response can be amended or individuals may revisit their 
initial illness cognitions. The feedback loop between the interpretation, coping and 
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appraisal stages is therefore self-regulatory. This model implies that maladaptive 
illness cognitions (i.e when an illness is represented as serious, chronic or 
uncontrollable) could be addressed and modified by interventions in order to achieve 
improved health outcomes. 
 
It is worth noting that the match between a person’s beliefs about their illness and 
reality is important in determining their adjustment to illness, which is known as the 
goodness-of-fit or reality-matching hypothesis (Christensen, Smith, Turner, & Cundick, 
1994; Park, Folkman, & Bostrom, 2001). If a person’s illness is uncontrollable, beliefs 
about controllability of the cure or the progression of the illness might be unhelpful. 
Instead, patients could use other coping strategies that distract from the illness and 
focus on aspects of their illness that they can control, such as monitoring and 
preventing treatment-related side-effects (Sharpe & Curran, 2006). 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: The common sense model of illness self-regulation (adapted from Ogden, 
2012, p221). 
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There is much support for the central constructs of the CSM. In studies of cancer 
patients, maladaptive illness cognitions have been associated with poorer self-efficacy 
to manage their condition and treatment-related problems (Foster, Cotterell, Breckons 
& Fenlon, 2012), poorer self-management behaviours, such as passive coping 
(Hopman & Rijken, 2015), and poorer health outcomes, such as lower quality of life, 
higher symptom burden, psychological distress and higher rates of mortality (Ashley, 
Marti, Jones, Velikova & Wright, 2015; Gray et al., 2014; Thong, Kaptein, Vissers, 
Vreugdenhil, & van de Poll-Franse, 2016). Similarly, studies of women with breast 
cancer have shown that those who respond with an avoidant coping style report 
increased distress compared to those who respond with approach coping (Low, 
Stanton, Thompson, Kwan & Ganz, 2006; Rozema, Völlink, & Lechner, 2009). The 
CSM proposes that information available to cancer patients plays a key role in the 
formation of illness cognitions about their condition and some studies have shown that 
patients’ information needs vary as a function of adjustment to cancer (Mulcare et al., 
2011). Many studies suggest that interventions that aim to restructure cancer patients’ 
maladaptive illness perceptions by enabling patients to obtain relevant and accurate 
information may help patients to gain a better understanding of their illness and 
consequently, achieve better adjustment to cancer in the long term (Fischer et al., 
2013; Hirsch et al., 2009; Husson et al., 2013).  
 
For the purpose of this thesis, the CSM provides insight into how patients with cancer 
might come to understand their illness, how it is interpreted and effects of this 
understanding on their experience of cancer (i.e. their adopted coping strategies). This 
model describes the type of information that cancer patients might need in order to 
develop an understanding of their illness, such as information on the identity of the 
disease, and its consequences, causes, timeline and curability/controllability. An app 
could help patients with cancer to achieve an accurate understanding of their illness by 
enabling them to gather this specific information and construct adaptive illness 
cognitions. In turn, this might promote adoption of suitable coping strategies and 
adjustment to the illness. An app could also promote adjustment to cancer by directly 
including app features which enable the adoption of an approach coping style.  
 
3.3.2 Moos and Schaefer’s (1984) crisis theory of coping with an illness 
Similar to the CSM, Moos and Schaefer (1984) developed a theory to understand the 
impact of a diagnosis of a serious illness, such as a cancer, which they described as a 
life ‘crisis’ due to its representation of a turning point in a person’s life (Figure 5). Moos 
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and Schaefer (1984) further distinguished between the types of coping strategies that 
may be adopted during illness and the strategies that individuals might find most 
useful. Their framework of coping therefore provides further insight into how patients 
with cancer might manage their illness.  
 
As in the CSM (Leventhal et al., 1984), individuals are regarded as self-regulators who 
attempt to return to a stable state. Following a diagnosis of a chronic illness, crisis 
theory describes how changes in the following domains may occur: identity (e.g. from 
breadwinner to patient), location (e.g. from work/home to hospitalisation), role (e.g. 
from independent to dependent), social support (e.g. isolation from friends due to the 
illness), and the future (e.g. from a planned future involving children or travel to an 
uncertain future). The ensuing coping process includes three processes, including: (1) 
cognitive appraisal, (2) carrying out adaptive tasks, and (3) adopting coping skills. 
Cognitive appraisal involves the individual assessing the seriousness and impact of the 
illness, much like Leventhal’s illness cognitions (Leventhal et al., 1984). Following 
appraisal, individuals may use a variety of seven adaptive tasks in order to cope with 
the illness. These are divided into three illness-related tasks: (1) dealing with pain and 
other symptoms, (2) dealing with the hospital environment and treatment, and (3) 
developing and maintaining relationships with clinicians, and four general tasks: (4) 
preserving an emotional balance, (5) preserving self-image and a sense of 
competence and mastery, and (6) sustaining relationships with family and friends, and 
(7) preparing for an uncertain future.  
 
Following use of these adaptive tasks, the framework of coping posits that individuals 
select from three types of coping strategies, which include: (1) appraisal coping, (2) 
problem-focused coping, and (3) emotion-focused coping. Appraisal coping involves 
attempts to achieve an understanding of the illness and includes three sets of skills: (1) 
logical analysis and mental preparation, which enables the individual to manage a 
situation by turning it into small manageable events, (2) cognitive redefinition, which 
involves the acceptance of the illness and its reality and redefining the situation in a 
positive way, and (3) cognitive avoidance and denial, which involves denying or 
minimising the seriousness of the illness. Alternatively, problem-focused coping 
involves facing the illness and performing constructive tasks to manage it,  which 
includes: (1) seeking information and support to build knowledge and achieve an 
understanding of the illness, (2) taking problem-solving action, which can involve 
learning procedures or behaviours in order to manage the illness (e.g. keeping a 
chemotherapy symptom diary), and (3) identifying alternative rewards, which involves 
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planning of events or goals that provide shorter-term satisfaction. Finally, emotion-
focused coping involves managing emotions evoked by the illness in order to maintain 
an emotional balance, and includes: (1) affective coping, which involves efforts to 
maintain hope when facing a serious illness, (2) emotional discharge, which involves 
venting negative emotions, and (3) resigned acceptance, which involves coming to 
terms with the outcomes of the illness. The types of tasks and coping skills an 
individual uses following a diagnosis is expected to affect health outcomes, such as 
psychological adjustment, well-being and quality of life. Finally, this framework 
distinguishes between two types of equilibrium: health adaptation and maladaptive 
equilibrium. Health adaptation is expected to lead to maturation and involves the use of 
adaptive tasks and constructive coping skills, with the desired outcome being coming 
to terms with reality. In contrast, maladaptive equilibrium is expected to lead to 
deterioration.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Moos and Schaefer’s model of a life crisis and framework of coping (taken 
from Moos, 2013, chapter 1, p20).  
 
There is much overlap between Moos and Schaefer’s (1984) description of coping and 
that described by the CSM (Leventhal et al., 1984). It is worth noting that as a result of 
this overlap, coping strategies that involve an individual's acceptance of the illness and 
active attempts to deal with the situation are generally referred to as ‘active’, ‘adaptive’, 
‘approach’, ‘problem-focused’ or ‘monitoring’ strategies within the literature, and coping 
strategies that involve trying to avoid dealing with the illness and distancing from the 
situation are referred to as ‘avoidant’, ‘maladaptive’ or ‘blunting’ strategies. 
 
Moos and Schaefer’s crisis theory (1984) and the framework of the coping have gained 
considerable support from the literature. Studies have shown that patients with cancer 
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use a variety of these coping strategies throughout their illness (Heim, Augustiny, 
Schaffner & Valach, 1993). Overall, studies have tended to report that active coping 
strategies are beneficial for cancer patients' clinical and psychological outcomes, 
whereas avoidant strategies are generally associated with negative effects. For 
example, active coping has been associated with higher quality of life, positive 
psychosocial adaptation to cancer, improved psychological well-being and positive 
health behaviours compared to avoidant coping (Heim, Valach & Schaffner, 1997; 
Kershaw, Northouse, Kritpracha, Schafenacker & Mood, 2004; Manne et al., 1994).  
However, despite these overall trends for either coping style, there is a body of 
literature that has shown that illness-related information is not necessarily helpful at all 
time points during their illness or for all patients and/or their carergivers.  
 
In support of the goodness-of-fit hypothesis described in section 3.3.1 (Christensen et 
al., 1994; Park et al., 2001), studies have found that the usefulness of coping 
strategies for cancer patients depends on the fit between the demands of their 
particular situation and selected coping style. For example, Lerman and colleagues 
(1990) found that although active coping strategies were more beneficial during 
hospitalisation, avoidant coping strategies, such as denial, were positively associated 
with better adaptation during chemotherapy treatment. Patients who used active 
coping strategies experienced more anxiety and nausea symptoms before and during 
chemotherapy, whereas those who used avoidant coping strategies experienced less 
anxiety and depression and less nausea during and following treatment. These 
findings suggest that avoidant coping strategies may be useful in certain situations for 
patients with cancer, where active coping strategies may draw attention to the 
situation. Other studies in this body of literature that have focused on two further 
coping styles, ‘monitoring’ and ‘blunting’, have shown that some patients with cancer 
might not benefit from obtaining illness-related information (Folkman & Lazarus, 1980; 
Lazarus & Folkman, 1984; Miller, 1996). ‘Monitoring’ is described as attention to, 
scanning for, and amplification of threatening cues and involves the extent to which 
individuals are alert for and sensitised to the negative, potentially painful, or dangerous 
aspects of information and experience (Miller, 1995, p168.). In contrast, ‘blunting’ is 
described as the avoidance of threatening cues and involves the extent to which 
individuals distract themselves from such information (Miller, 1995, p168). Research 
suggests that patients who adopt a monitoring coping style tend to actively seek out 
information about their condition and are highly sensitive to it, whereas those with a 
blunting coping style try to avoid or minimise threatening information (Miller 1979a; 
1979b). Studies have reported that patients tend to have better physical, psychological 
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and behavioural outcomes when the information they receive about their condition is 
tailored to their particular coping style (Miller, 1995). For patients who adopt a blunting 
coping style, mobile interventions that attempt to provide information to patients with 
cancer may result in increased anxiety.  
 
For the purpose of this thesis, Moos and Schaefer’s (1984) framework for coping 
provides further insight into the changes that might occur for patients following a 
diagnosis of cancer and the types of activities, tasks and issues that they are faced 
with. An app could help patients to complete some of these tasks, for example, by 
including an app feature that facilitates the development and maintenance of 
relationships with clinicians. This framework of coping further outlines the different 
types of coping strategies that could be incorporated into app features. For example, 
an app feature that includes links to credible information websites may facilitate 
information-gathering and therefore serve as a problem-focused coping strategy. 
Alternatively, an app feature that includes links to information on local cancer support 
groups may enable patients to attend these groups, share their stories and vent 
emotions, which would serve as an emotion-focused strategy (i.e. emotional 
discharge). 
 
3.3.3 Taylor’s (1983) theory of cognitive adaptation 
There is a general trend for patients with cancer to suffer with psychological distress 
throughout the course of their illness, with the highest distress typically reported prior 
to a first treatment and a gradual decrease thereafter (Munro & Potter, 1996; Stiegelis 
et al., 2003). In contrast, some studies have shown that many patients show a sense 
of psychological well-being that is comparable to healthy individuals (Andrykowski & 
Hunt, 1993; Breetvelt & Van Dam, 1991). Several theories have been used to interpret 
these findings, such as the response-shift theory (Sprangers & Schwartz, 1999) or 
Helson’s adaptation theory (Helson, 1964). Instead, Taylor’s theory of cognitive 
adaptation (Taylor, 1983; Taylor, Lichtman & Wood, 1984) was selected for discussion 
in this chapter, as it has been popular in explaining these findings due to its concepts 
of adaptive cognitions, such as self-esteem, control and optimism, which can be 
targeted by interventions (Stiegelis et al., 2003). 
 
Similar to the CSM (Leventhal et al., 1984) and crisis theory (Moos & Schaefer, 1984), 
the theory of cognitive adaptation regards the individual as self-regulatory. In contrast, 
it proposes that adjustment (i.e. cognitive adaptation) depends on the ability of an 
individual to develop, sustain and modify illusions throughout their illness, which are 
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described as positive interpretations of reality (e.g. interpreting the cause of cancer to 
be stress-related, when there may be little evidence for the real cause), in order to 
buffer against threats or setbacks. The desired outcome is therefore cognitive 
adaptation and not reality orientation, as suggested by the previous theories, as reality 
orientation may be detrimental to adjustment.  
 
Three processes are believed to be central to achieving cognitive adaptation and 
include: (1) a search for meaning, (2) a search for mastery, and (3) a process of self-
enhancement. A search for meaning involves searching for the causes, consequences 
and implications of the illness in order to understand and give the illness meaning, and 
to predict and control the environment. This concept is similar to Leventhal’s illness 
cognitions (Leventhal et al., 1984) and cognitive appraisal described by Moos and 
Schaefer (1984). A sense of mastery can be achieved by making efforts to control the 
disease (and believing the illness is controllable) by using psychological techniques, 
such as having a positive attitude or meditating, and behavioural techniques, such as 
changing diet, controlling side-effects of treatment or gathering information on the 
illness.  
 
This theory further suggests that individuals will attempt to rebuild their self-esteem 
that was lost or decreased following a diagnosis of a chronic illness through a process 
of self-enhancement. This process was described with social comparison theory 
(Festinger, 1954), which suggests that individuals compare themselves to those who 
are worse off in order to increase their self-esteem (e.g. a woman who undergoes a 
lumpectomy compares herself favourably to a woman who had a mastectomy). Finally, 
the theory of cognitive adaptation suggests that illusions are maintained throughout the 
course of the illness as individuals are able to amend the goals and focus of their 
illusions when they are challenged (e.g. a reoccurrence of cancer when the individual 
believed they could control whether the cancer would come back).  
 
Studies testing the theory of cognitive adaptation are limited, however the available 
evidence provides support (Aspinwall & Taylor, 1992; Helgeson, 1999). For example, 
Taylor and colleagues (1984) reported that patients with breast cancer who were able 
to find meaning in their illness felt a sense of control and restored their self-esteem, 
and consequently showed better adjustment compared to patients who did not hold 
these perceptions. In a longitudinal study of cancer patients and a reference group of 
health individuals, cancer patients reported greater levels of optimism and self-esteem 
compared to those without the disease and this was maintained for three months post-
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treatment (Stiegelis et al., 2003). Authors suggested that the fact that patients reported 
greater levels of optimism and self-esteem provides support for social comparison 
theory or evidence that patients are able to focus on positive aspects of their lives in 
order to protect their self-esteem and optimism for the future. It is possible that social 
comparison, or benefit-finding, counteracts distress during cancer (Affleck, Tennen, & 
Apter, 2001). Further studies in patients with a poorer prognosis also provide evidence 
that patients attempt to adapt cognitively (Taylor, 1983; Taylor & Armor, 1996).  
 
For the purpose of this thesis, the theory of cognitive adaptation offers insight into the 
processes and types of psychological and behavioural techniques that could be 
targeted to help to maintain cancer patients’ psychological well-being throughout their 
illness. Additional to app features that would enable patients to develop an 
understanding of their illness (i.e. a search for meaning), this theory suggests the 
consideration of app features that will help patients to foster a sense of control (i.e. 
mastery) and self-esteem. For example, an app feature that allows patients to record 
and monitor treatment-related symptoms, such as a diary, might enable patients to 
gain a sense of control through their illness, whereas an app feature that enables 
patients to meet other patients might facilitate opportunities for self-enhancement and 
increase self-esteem.   
 
3.3.4 Self-efficacy theory  
In the theories of coping with chronic conditions described so far, there is an inherent 
assumption that increasing an individual’s knowledge and understanding of their illness 
will lead to behaviour change, such as executing suitable coping strategies. However, 
previous research has long established that this relationship is complex and there are 
often disparities between an individual’s knowledge and their actual health-related 
behaviours (Gollwitzer & Sheeran, 2006; Schwarzer, 2008). For example, self-
management education interventions for patients with chronic conditions, such as 
diabetes, have been found to increase patients’ knowledge without altering their 
behaviours (Atak, Gurkan & Kose, 2008). This phenomenon has come to be known as 
the ‘knowledge-behaviour gap’ (Sligo & Jameson, 2000).  
 
Studies have shown that self-efficacy, described as an individual’s belief that they are 
capable of executing a specific behaviour that will lead to a desired outcome (Bandura, 
1996), mediates some of the relationship between knowledge and health behaviour 
change (Atak, Gurkan & Kose, 2008; Rimal, 2000). Furthermore, within the cancer 
literature, studies have established the association between higher self-efficacy and 
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positive adjustment to cancer, as well as an increase in self-care behaviours (Lev, 
1997; Lev, Paul & Owen, 1999). The concept of self-efficacy permeates the theories 
that have been described so far in this chapter, as patients select and execute what 
they perceive to be effective coping strategies in order to adjust to their illness. For 
these reasons, the concept of self-efficacy will be discussed in more detail using 
Bandura’s theory of self-efficacy (1996).  
 
Perceived self-efficacy is believed to be a central mechanism for behaviour change 
(Bandura, 1996). As well as having the relevant knowledge, this theory posits that an 
individual needs to believe that they are capable of executing and maintaining a 
behaviour (e.g. coping strategies, self-care behaviours) in order to devote the 
necessary effort for them to succeed. Perceptions of self-efficacy are thought to be 
based on four sources of information, which include: (1) personal experience of 
success, (2) vicarious experience of success, (3) verbal persuasion about their own 
capabilities and (4) emotional arousal. These sources of information are thought to be 
mediated by an individual’s cognitive appraisal. For example, success of a behaviour is 
more likely to increase self-efficacy if it appraised as due to skill rather than due to 
chance, whereas success that is hard to achieve may not alter one’s self-efficacy due 
to the implied low ability. Additionally, Bandura (1996) distinguished between self-
efficacy and outcome expectancies. Outcome expectancies are defined as an 
individual’s beliefs about whether the specific behaviour will lead to the desired 
outcome. An individual’s self-efficacy and outcome expectancies are thought to 
influence the maintenance of behaviours, and the amount of effort invested and 
persistence, when confronted with adverse experiences.  
 
In support of self-efficacy theory, studies have shown the association between a higher 
degree of self-efficacy with increased self-care behaviours and decreased physical and 
psychological symptoms in cancer patients (Lev, 1997). Interventions were therefore 
developed to increase cancer patients’ self-care self-efficacy and were based on the 
premise that patients must develop an understanding of the relationship between the 
behaviour and their desired outcome, and be provided with the knowledge of how to 
modify the behaviour and believe that they are capable of executing the behaviour 
(Bandura, 1996). Such interventions have been shown to successfully increase self-
care self-efficacy and behaviours for patients with cancer and other chronic illnesses, 
as well as increase quality of life and reduce symptom distress (Lev et al., 2001; Lorig, 
Sobel, Ritter, Laurent & Hobbs, 2001). For example, psycho-educational interventions 
that aim to increase cancer patients’ control over their psychological states by teaching 
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coping skills have been shown to increase patients’ execution of these skills and 
consequently, their quality of life (Cunningham, Lockwood & Cunningham, 1991; 
Cunningham & Tocco, 1989).  
 
For the purpose of this thesis, self-efficacy theory provides further insight into why 
patients might lose a sense of control over their lives following a cancer diagnosis and 
ways in which self-efficacy may be increased by an intervention to promote self-
management behaviour. An app intervention could be used to help increase patients’ 
perceived sense of control over their lives and self-care self-efficacy by including app 
features that target the described sources of self-efficacy outlined by Bandura (1996), 
such as a feature that enables patients to meet other patients who are self-managing 
their condition (i.e. vicarious experience).  
 
3.3.5 Health literacy 
As well as knowledge and confidence to execute self-management behaviours, 
patients with chronic conditions also require the relevant skill set to take an active role 
in their healthcare (Hibbard et al., 2004). The particular skills that patients need to 
navigate their health and healthcare came to be known as ‘health literacy’. Recent 
studies lend support to the 2004 Institute of Medicine (IOM) definition of health literacy 
as a skills-based construct: ‘the degree to which individuals have the capacity to 
obtain, process, and understand basic health information and services needed to make 
appropriate health decisions’, (Kindig, Panzer, & Nielsen-Bohlman, 2004, p.37).  
This body of literature has provided further insight into the underlying processes of, 
and barriers to, patients’ self-management of chronic conditions, such as cancer, and 
is another piece in the knowledge-behaviour gap puzzle.  
 
In support of the important role of health literacy in the self-management of chronic 
conditions, such as cancer, studies of patients with various chronic conditions have 
found low health literacy to be associated with patients’ low knowledge of their 
condition and poor self-management skills (Gazmararian, Williams, Peel & Baker, 
2003; Williams, Baker, Honig, Lee & Nowlan, 1998). For example, patients with low 
health literacy demonstrate an inability to read and understand instructions, which 
means that they have a limited ability to prepare for consultations and tests, and have 
poor understanding and recall of information from consultations (Poon et al., 2004; 
Wilson et al., 2010). Similarly, patients with low health literacy may fail to understand 
self-care advice, which means that they are more likely to be hospitalised or make 
medication errors (Williams et al., 1995). This body of literature has also highlighted 
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the most likely mechanism through which health literacy might impact health 
outcomes. Individuals with low health literacy find it more difficult to access and 
understand health information, which results in decreased knowledge of their health, 
reduced health prevention behaviours and poor adherence to medication (Bennett, 
Chen, Soroui & White, 2009; Von Wagner, Steptoe, Wolf & Wardle, 2009).  
 
The study of health literacy is particularly relevant in the context of cancer as newly 
diagnosed patients receive large amounts of information, which contain unfamiliar 
medical terms. Additionally, patients are often involved in choosing a treatment option 
along with their clinician and are required to adhere to a treatment regime, which 
requires an understanding of the treatment process and attendance of follow-up 
consultations with clinicians. Studies have suggested that health literacy plays an 
important role in the successful treatment and outcomes of cancer. For example, one 
prospective, population-based study of patients with cancer suggested that patients 
with higher health literacy were more likely to receive chemotherapy than their 
counterparts (Busch, Martin, DeWalt & Sandler, 2015). Furthermore, studies have 
shown that low health literacy has a direct impact on information-seeking; patients with 
low health literacy are less likely to seek printed information as they struggle to 
understand it and/or lack interest in reading (Von Wagner, Semmler, Good & Wardle, 
2009).  
 
Early health literacy interventions typically focused on simplifying medical language 
and improving readability of information resources in order to improve understanding of 
health information, however whilst showing some improvement, these interventions 
provided limited or mixed results (Davis et al., 1998; Gerber et al., 2005). Other 
interventions have focused on enhancing communication in the patient-clinician 
consultation, including presenting important information first, providing concise 
information whilst avoiding jargon, explaining medical terms, encouraging question-
asking and checking understanding, all of which have been shown to increase patient 
understanding and recall (Ley, 1989). However, due to the current demands placed on 
the health system, consultations are often rushed and clinicians may not be able to 
identify those with low health literacy and forget to present information in this way. 
Consequently, patients often have to rely on written information, which is unlikely to be 
understood by those with low health literacy (Manning & Dickens, 2006). 
 
More recently, interventions have focused on the relationship between cognition (i.e. 
processing speed, working memory and long-term memory) and health literacy due to 
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the association of the two on existing health literacy measures (Baker, Wolf, Feinglass, 
& Thompson, 2008) and the impact of cognitive ability on health outcomes (Insel, 
Morrow, Brewer, & Figueredo, 2006; Singh-Manoux, Ferrie, Lynch, & Marmot, 2005). A 
study of information recall for colorectal screening information found that although 
levels of health literacy were predictive of recall of information, cognitive ability 
accounted for much of the association, where those with poorer cognitive abilities 
recalled less information than their counterparts (Wilson et al., 2010). These findings 
have been supported by other similar studies, which have highlighted the potential 
usefulness of scientific learning principles when developing an intervention to help 
patients to meet their information needs, such as keeping the working memory 
demands low, sequencing and segmenting of the content, using a slow pace of 
learning and ‘chunking’ of information to improve recall and understanding (Kandula et 
al., 2009; Sobel et al., 2009). 
 
For the purpose of this thesis, the health literacy literature highlights the importance of 
developing patients’ skills to navigate their health and healthcare, such as enabling 
them to understanding cancer-related terminology, the written and verbal information 
that they are provided in consultations (or gather from other sources, such as the 
Internet) and the processes involved with their treatment. In terms of intervention 
development, recent studies encourage consideration of cognitive factors when 
designing interventions, in order to improve patients’ ability to obtain and understand 
health information and enable performance of self-management behaviours (Wilson et 
al., 2010). These studies also suggest that such educational tools are best used as 
supportive interventions for those with limited health literacy, perhaps in the presence 
of clinicians, rather than relying on the intervention alone to provide information for 
patients (Wilson et al., 2010).  
 
However, the concept of health literacy suffers from a limitation that has led to the 
development of the broader concept of ‘patient activation’ (Hibbard et al., 2004). 
Researchers argue that although a good predictor of health outcomes for patients, the 
concept of health literacy is a skills-based construct only and does not encompass the 
motivational aspect that is also crucial for behaviour change (Hibbard, Stockard, 
Mahoney & Tusler, 2004; Smith et al., 2013). Additionally, other measures of 
motivation, such as self-efficacy, tend to focus on specific behaviours, such as 
smoking (Smith et al., 2013).  
 
3.3.6 Patient activation 
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Developed by Hibbard and colleagues (Hibbard et al., 2004), patient activation is 
described as a behavioural concept that includes the core components that are 
necessary for execution of self-management behaviours, defined as, ‘an individual’s 
knowledge, skill and confidence for managing their health and healthcare’ (Hibbard & 
Mahoney, 2010, p.1). Importantly, this concept encompasses an individual’s 
motivation, as well as their knowledge, skills and beliefs about their ability to self-
manage their condition (i.e. self-efficacy), and the likelihood that they will put these 
beliefs into action. The Patient Activation Measure was developed in order to measure 
these constructs (Hibbard et al., 2004). 
 
Assuming that patients already have the skills to obtain the health information that they 
want (i.e. an adequate level of health literacy) but have low motivation, studies suggest 
that they may feel less able to self-manage their condition due to low confidence, have 
passive communication skills and less engagement in health behaviours (Hibbard & 
Cunningham, 2008; Hibbard & Mahoney, 2010). Patients with high levels of activation 
are expected to understand and feel capable of fulfilling their role in their care and as a 
result, are more likely to engage in preventive (e.g. screening, regular check ups), 
treatment (adherence to medications) and healthy behaviours (e.g. healthy diet, not 
smoking) (Hibbard & Greene, 2013). Patient activation has proven to be a changeable 
construct by tailored interventions and so a framework for understanding patients’ 
capabilities, beliefs and behaviours at different levels of activation was developed to 
guide intervention development. This framework enables developers to tailor 
interventions to an individual’s needs and levels of activation. Four levels of patient 
activation are described, ranging from low to high activation (Figure 6).  
 
 
 
 
 
 
 
 
 
 
Figure 6: The four levels of patient activation (from Hibbard & Gilburt, 2014, p9).  
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Patient activation has been found to be a better predictor of health outcomes 
compared to other predictors, such as demographic variables, including 
socioeconomic status, education, ethnicity, age and gender, which suggests that 
patient activation is not just a reflection of these factors (Smith et al., 2013). With 
regards to chronic illnesses, such as cancer, higher activation levels are associated 
with self-management behaviours, such as adherence to treatment, condition 
monitoring and obtaining regular care, which are evident across a diverse range of 
patients and conditions (Kansagara, Ramsay, Labby & Saha, 2012; Ryvicker, Peng, & 
Feldman, 2012). Consequently, studies have associated higher patient activation 
levels with better clinical outcomes (e.g. lower blood pressure and cholesterol), and 
decreased health service costs due to lower rates of health service use (e.g. 
hospitalisations, re-admissions following discharge, visits to accident and emergency 
departments) (Greene & Hibbard, 2012). Importantly, patient activation is associated 
with improved experiences of care. Highly activated patients appear to have the skills 
and confidence to create more productive interactions with their clinicians and are 
more adept at getting their clinicians to meet their needs (Alexander, Hearld, Mittler & 
Harvey, 2012; Hibbard & Gilburt, 2014). As a result, more activated patients report 
better quality communication with clinicians and more contact outside of consultations 
than less activated patients (Alexander et al., 2012).  
 
In contrast, those with low levels of activation typically misunderstand their role in their 
care, have little confidence in their abilities to contribute to their healthcare, possibly 
due to experience of failing to manage their health in the past, and so have become 
passive and would rather not think about their health (Hibbard & Mahoney, 2010). Less 
activated patients are also less likely to prepare questions for consultations, to ask if 
they don’t understand what the doctor has said and understand the treatment 
guidelines for their condition (Fowles, Terry, Xi, Hibbard, Bloom & Harvey, 2009; 
Rogvi, Tapager, Almdal, Schiøtz & Willaing, 2012).  
 
In order to engage the patients with low levels of activation, interventions must be 
tailored to their level of activation and patients should be encouraged to conduct a 
succession of smaller tasks to enable the individual to experience success, in order to 
increase their confidence and motivation, and progress to a higher level of activation. 
An example of such an intervention is where a specially trained medical assistant 
meets with less-activated patients prior to a consultation (Hibbard, Greene & Overton, 
2013). The assistant helps the patient to formulate questions for their clinician in order 
to organize their priorities and get the most from the consultation. Following the 
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appointment, the patient revisits the assistant to discuss the consultation, where the 
assistant ensures that the patient understands the information provided and the 
patients’ treatment plan is reviewed.  
 
For a range of chronic conditions, such as diabetes and hypertension, studies of 
tailored interventions have reported increases in levels of patient activation (Deen, Lu, 
Rothstein, Santana, & Gold, 2011; Parchman, Zeber & Palmer, 2010; Solomon, 
Wagner & Goes, 2012). These interventions have typically focused on fostering 
patients’ sense of responsibility for their health and the development of skills and 
confidence. Encouraging the use of strategies that stimulate autonomous motivation is 
also important so that patients begin to make choices for themselves and self-initiate 
the desired behaviours. Consequently, patients’ sense of control and responsibility for 
their health are expected to increase with their level of activation (Ryan & Deci, 2000). 
Although there is a vast amount of recent studies that specify a ‘patient activation’ 
intervention for a variety of chronic conditions, there appears to be limited new studies 
that specify this type of intervention in cancer care. However, one systematic review of 
this type of intervention for patients with cancer reported positive effects on symptom 
distress, uncertainty, communication and quality of life, with some potential evidence 
for survival, though studies in this review pre-dated or did not use the PAM measure 
and so do not specifically refer to ‘patient activation’ (McCorkle, et al., 2011).  
 
For the purpose of this thesis, this body of literature outlines the mechanisms by which 
interventions could improve cancer patients’ engagement in their care. With regards to 
the knowledge-behaviour gap, the concept of patient activation highlights the 
importance of considering both patients’ levels of knowledge and their illness-related 
skill set, as well as their confidence and motivation to engage in self-management 
behaviours, when developing behaviour change interventions to promote action-taking.   
This research further highlights the advantages of tailoring interventions to patients’ 
levels of activation, particularly for those with the lowest levels of activation, in order to 
facilitate engagement with the intervention and encourage progression to a higher level 
of activation and thus achieve better outcomes.   
 
3.4 Discussion  
This chapter aimed to select, describe and critically appraise a selection of models, 
theories and approaches that are particularly relevant to the impact and self-
management of cancer. The purpose of this exercise was to develop an understanding 
of patients’ experiences of cancer, the issues that they might face and the type of app 
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that might best support them, in order to inform the development of an app 
intervention.  
 
Discussion of the CSM (Leventhal et al., 1984), crisis theory (Moos & Schaefer, 1984) 
and the theory of cognitive adaptation (Taylor, 1983) highlighted parallels between 
central constructs, such as the Leventhal’s interpretation stage (Leventhal et al., 1984) 
with Moos and Schaefer’s cognitive appraisal (1984) and Taylor’s (1983) search for 
meaning, and the coping stages of each model and theory. Overall, these models and 
theories suggest that cancer is a traumatic experience which disrupts an individual’s 
‘normal’ life, leading to a perceived loss of control. Viewed as a problem-solver, the 
individual has a need to regain perceived sense of control over their lives in some way 
and re-establish normality. Individuals are hypothesised to achieve this by developing 
an understanding of their illness, and consequently, executing suitable coping 
strategies. Coping strategies may be adaptive or maladaptive, depending on the 
situation and strategy used. Taylor’s (1983) theory of cognitive adaptation further 
describes the impact of cancer on an individual’s sense of control and self-esteem and 
the types of behavioural and psychological strategies that could be used to maintain 
these throughout the course of the illness. Overall, these theories on coping with a 
chronic illness advocated prominent role for illness-related knowledge in the self-
management of, and adjustment to, a chronic illness, such as cancer. However, this 
chapter noted the disparities that are often found between an individual’s knowledge 
and their actual health-related behaviours in health research (Gollwitzer & Sheeran, 
2006; Schwarzer, 2008). Consequently, the roles of other constructs that are required 
for the execution of health behaviours were discussed, including self-efficacy and 
health literacy. Finally, this chapter introduced the concept of patient activation, which 
acknowledges that there are several important constructs that are required in order for 
patients to engage in self-management behaviours, including an individual’s 
knowledge, skills, confidence and motivation. Consideration of these theoretical 
frameworks and approaches leads to the conclusion that information-only 
interventions, which aim to help patients with cancer to meet their information needs, 
will not necessarily lead to behaviour change. Although this type of intervention might 
increase patients’ knowledge of their condition, other intervention components are 
likely required to enable patients to take a more active role in their health and 
healthcare.  
 
A further limitation of knowledge – and interventions that aim to help patients with 
cancer to meet their information needs – is that it may not necessarily be beneficial at 
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all time points throughout a cancer journey or for all types of patients and their 
caregivers. It is important that intervention developers, and cancer clinicians, are 
aware of this body of literature so as not to prescribe the use of information 
interventions for those patients who may actually suffer consequences, such as 
increased anxiety, as a result of this type of intervention.  
 
3.4.1 Implications of this review  
Together, the health behaviour models, theories and approaches described in this 
chapter suggest that an app could be used to enable patients to develop an adaptive 
representation of their illness (i.e. illness cognitions), and promote the adoption of 
adaptive coping strategies. Furthermore, an app could be used to develop patients’ 
cancer-related health literacy and subsequently, their knowledge, skills and confidence 
to participate in their care, which could increase patients’ levels of activation and lead 
to better health outcomes. It is hypothesised that these outcomes may be achieved by 
an app intervention that facilitates information-gathering and understanding of this type 
of information, and an app that incorporates features that develop patients’ skills and 
confidence to gather information. However, it is important that clinicians and 
intervention developers are aware that this type of intervention will not be suitable at all 
time points and for all patients with cancer and their caregivers.  
 
3.4.2 Conclusion  
This chapter reviewed and critically appraised a selection of health behaviour models, 
theories and approaches that are particularly relevant to the impact and self-
management of cancer, and described how each may be useful for the development of 
a novel app intervention to help patients with cancer to meet their information needs in 
non-inpatient settings. Each of the models, theories and approaches discussed in this 
chapter appear to account for a piece of the puzzle regarding the impact of cancer on 
patients and successful self-management of the disease, and so each will be 
considered when developing of an app intervention. Consideration of these theories 
during development, alongside consultation with patients and their relatives, could lead 
to the development of an app that has the potential to improve patients’ (and relatives’) 
self-management of their condition, including their psychological coping, performance 
of self-care behaviours and participation in their care. Following interviews with 
patients and their relatives regarding their needs and preferences for an app, this 
selection of models, theories and approaches will be used to interpret findings and 
guide development of selected app features.  
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Chapter 4 
The needs and preferences of patients with cancer regarding an app to help 
them to meet their information needs: a qualitative interview study with patients 
and their relatives 
 
4.1 Chapter overview 
This chapter reports a novel qualitative interview study that explored the views of 
patients and their relatives on their experiences of cancer, including their information 
needs and information exchange with clinicians in consultations, as well as their needs 
and preferences regarding an app intervention. This study was used to gain an 
understanding of the type of app that would be most useful and the potential uptake 
and possible outcomes of this type of intervention, including the benefits and 
disadvantages of, and barriers to, app use. Data from semi-structured interviews were 
analysed using thematic analysis. The implications of these findings for the creation of 
an app intervention are discussed.  
 
4.2 Introduction 
As described in Chapter 1, many patients with cancer and their relatives report having 
unmet cancer-related information needs (Faller et al., 2016; Kitrungrote & Cohen, 
2006). The introduction of Smart technology has provided a new opportunity to deliver 
interventions to patients and their relatives remotely. A systematic review of the 
literature conducted for this thesis, described in Chapter 2, identified the need for an 
app intervention to help patients, and their relatives, to meet their full range of 
information needs in non-inpatient settings. Prior to creating an intervention, the MRC 
framework (Craig et al., 2008) for the development of complex interventions in 
healthcare encourages researchers to identify the evidence base, relevant theories, 
model processes and outcomes. The evidence base and relevant theories for this type 
of intervention were described in Chapters 1- 3. Next, it is important to determine the 
views of users of the intervention in order to further establish the evidence base and 
identify the potential processes and outcomes of this type of intervention.  
 
Furthermore, frameworks and approaches that were created to guide the development 
and evaluation of digital health interventions highlight the importance of the 
psychosocial context (Glasgow, 2007; Yardley et al., 2015). For example, the ‘person-
based’ approach developed by Yardley and colleagues (2015) advocates a two-step 
developmental process, the first of which involves conducting iterative, in-depth 
qualitative research with a varied sample from the target user population at every 
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stage of intervention development, including planning, usability testing, feasibility 
testing and implementation stages. This provides a deep understanding of the views of 
various types of users to tailor the intervention accordingly and continually improve the 
intervention throughout these stages. Additionally, this information helps the 
researcher to anticipate the potential uptake of the intervention and its possible 
outcomes, including the potential benefits and disadvantages of, and barriers to the 
intervention. This process ultimately enables development of interventions that are 
more relevant and engaging for its users and helps to circumvent or minimise common 
issues in digital intervention research, such as low uptake and adherence (Kohl, 
Crutzen & de Vries, 2013). Following identification of the type of intervention required 
by users, the second step in the ‘person-based’ approach is to identify the objectives of 
the intervention and the key features (i.e. app features) which are required to achieve 
each objective.  
 
4.2.1 Aims of the present study 
To date, no study has sought to understand the needs and preferences of patients with 
cancer, and their relatives, regarding an app that aims to help them to meet their full 
range of cancer-related information needs in non-inpatient settings. The primary aim of 
this study was to explore the value of an app for patients with cancer and to establish 
the type of app required. This included exploration of their information needs and 
experiences of information exchange in consultations with clinicians, and their 
preferences for an app and its features. Specifically, the perceived acceptability of an 
app, desired app features and the potential benefits and disadvantages of, and barriers 
to, an app were explored, as well as the types of patient and the time at which they 
might find this intervention most useful. A secondary aim of this study was to explore 
the views of relatives in order to establish the value of an app which may be used by 
both the patient and their relatives.  
 
4.2.2 Qualitative methods 
Qualitative methods enable a more personal response from individuals compared to 
quantitative methods and so a qualitative method was chosen for this study to allow 
the candidate to gain a more in depth understanding of a phenomenon from the 
perspective of the individuals affected (Green & Thorogood, 2013). Qualitative 
methods, such as in-depth semi-structured interviewing, are also best suited when the 
subject matter is a sensitive topic, such as cancer (Smith, 2007). A sensitive topic can 
be defined as one having the potential to cause physical, emotional or psychological 
distress to participants or the researcher (Elmir, Schmied, Jackson & Wilkes, 2011).  
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Semi-structured interviews were chosen to allow participants the freedom to bring up 
other issues that they felt were relevant and allow the candidate the freedom to deviate 
from the topic guide to further explore any issues raised (King & Horrocks, 2010). 
Although interviews on sensitive topics have the potential to cause some discomfort, 
studies have shown that generally, interviewees perceive the interview process to be 
beneficial (East, Jackson, O’Brien, & Peters, 2010; Gysels, Shipman & Higginson, 
2008). Participants may feel empowered by having their stories and opinions listened 
to and feel a sense of purpose, and being valued, by contributing their experiences to 
research (East et al., 2010; Gysels et al., 2008). There is also evidence that many 
participants find sharing their thoughts to be therapeutic, as they undergo a reflective 
process of their experiences, which provides them with a sense of closure and relief 
(East et al., 2010; Elmir et al., 2011).  
 
Multi-perspective interviews, where several different groups of participants are 
interviewed on the same topics (i.e. patients, their relatives and clinicians) were 
chosen for this study in order to produce a richer understanding than single 
perspective interviews (Kendall et al., 2009). This research method allowed the 
candidate to explore the similarities and differences in participants’ perceptions, 
understand their relationships and generate a consensus of suggestions for app 
features (Kendall et al., 2009). As well as having their own unmet information needs, 
relatives were interviewed as they are often present during consultations and it was 
anticipated that some patients might be too elderly, unwell or may not wish to use an 
app, in which case their relative may wish to use the app on the patient’s behalf.  
 
Patients and relatives were offered the opportunity to be interviewed together if they 
wished to do so. This was done to aid recruitment of participants who would not be 
likely to take part in research alone. Joint interviews offer the benefit of participants 
building on each other’s answers, which may prompt them to explore topics that they 
may not have thought about themselves and describe their shared experiences 
(Gysels et al., 2008; Kendall et al., 2009). Other authors have considered how joint 
interviews can sometimes constrain the discussions, as it is difficult to get a full 
account from both participants on the same topic and some participants may withhold 
information that might cause distress for one another, known as ‘protective buffering’ 
(Hagedoorn et al., 2000; Kendall et al, 2009). These issues can lead to joint and 
separate interviews with patients and their caregivers providing different results. The 
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topics of the interview guide were carefully considered in order to minimise these 
potential issues (Kendall et al, 2009).  
 
Thematic analysis was selected to analyse interviews, as this method helps to provide 
insights by moving from a broad reading of the data to reporting patterns and themes, 
followed by their interpretation (Braun & Clarke, 2006). The thematic analysis 
conducted was not considered purely inductive, nor deductive. Instead, it can be 
considered a blend of both approaches. Inductive approaches are those that start from 
the data and search the data for patterns that suggest general laws, ultimately aiming 
for theory generation. In contrast, deductive approaches start with hypotheses that are 
derived from a theory which are then tested against a body of data that was gathered 
to test the hypotheses. However, many researchers argue that in practice, all research 
incorporates elements of both inductive and deductive logic. For example, Murphy and 
Dingwall (2003) argue that researchers are unable to analyse data with a completely 
blank slate as there are always theories and assumptions that shape the way in which 
we read and interpret the data. Similarly, they argue that theories and hypotheses do 
not come ready formed and researchers select particular theories to test and may have 
preconceived ideas about how to test them. The polarisation of inductive and 
deductive approaches is unhelpful and it is important to acknowledge that qualitative 
methodology can be a blend of both logics.   
 
4.3 Methods 
4.3.1 Participants 
Maximum variation sampling, a type of purposeful sampling strategy in which cases 
are selected on the basis of the study population characteristics and study objectives, 
was used to allow for divergent views to emerge (Patton, 2002). Patients were 
recruited from cancer clinics within University Hospital Wales (UHW) and Velindre 
hospital. Clinics at UHW provided access to more recently diagnosed patients who 
were waiting to have or had undergone surgical treatment, whereas clinics at Velindre 
hospital provided access to patients who were undergoing chemotherapy, 
radiotherapy, hormone therapy treatment or were in remission. Initially, patients were 
recruited from colorectal and urological cancer clinics at UHW and breast and 
gynaecological cancer clinics at Velindre hospital. These four cancer types were 
chosen in order to have a variety of some of the most common cancers in the 
participant sample (Welsh Cancer Intelligence Surveillance Unit (WCISU), 2015).  
A decision was made to include a varied sample of patients, including:  
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i. Patients undergoing surgery, radiotherapy, chemotherapy or hormone 
therapy for cancer 
ii. A range of cancer types: breast, gynaecological, colorectal and urological 
iii. Women and men 
iv. Patients older than 60 years and patients younger than 60 years 
 
Patients’ eligibility for the study was assessed by cancer nurse specialists (CNSs) at 
the clinics using the following inclusion and exclusion criteria:  
 
Inclusion criteria: 
i. Male or female 
ii. Aged 18 or above  
iii. Receiving neoadjuvant, adjuvant, radical or palliative treatments 
iv. At least 2 weeks after diagnosis (to allow patients time to come to terms with 
their diagnosis) 
v. Able to give informed consent 
 
Exclusion criteria: 
i. Patients who do not have an estimated life-expectancy of at least 12 months.  
ii. Patients who the clinician deems to be unsuitable for the research (for example 
in a current state of crisis or have their own significant health or social 
problems, unable to provide informed consent, or other reason for not being 
approached about the study). 
 
Although lung cancer is the third most common cancer in the UK, the majority of 
patients (72-76%) with this cancer are diagnosed at a late stage, either stage III or IV 
(National Cancer Intelligence Network (NCIN), 2016; Information Services Division 
(ISD) Scotland, 2016; Northern Ireland Cancer Registry (NICR), 2016). Diagnosis of 
lung cancer at these later stages is associated with poor survival rates. For example, it 
is estimated that less than 20% of patients diagnosed at stage IV will survive their 
cancer for a year or more (Cancer Research UK, 2017). Patients with lung cancer who 
are diagnosed at a late stage and have poorer prognoses may have different needs 
and preferences regarding an app, compared to patients with cancers who are 
diagnosed at earlier stages with better prognoses. The candidate and supervisory 
team also had concerns about the potential impact of study participation on those 
patients with lung cancer (and other cancers) who had poor prognoses and this issue 
was raised by, and discussed with, the NHS ethics committee. A decision was made to 
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avoid recruitment of patients with lung cancer for this study and at this early phase of 
development of the app. For the same reasons, recruitment of any patient with less 
than 12 months life expectancy was also avoided. The candidate and supervisory team 
acknowledged that this decision may be perceived as gatekeeping. However, it was 
anticipated that a wider range of patients, including those with rare cancers and/or 
poorer prognoses, could be recruited for future studies of the app at a later stage of 
development to explore the potential differences and similarities in need or preferences 
regarding an app, compared to other patients with cancer.  
 
4.3.2 Patient recruitment  
CNSs that took part in qualitative interviews (see Chapter 5) were asked to assess 
patients’ eligibility and recruit patients for the present study. Two CNSs from each of 
the breast, colorectal, gynaecological and urological cancer clinics agreed to help. The 
CNSs were provided with a total of 15 information packs per clinic to distribute to 
eligible patients, which contained an invitation letter printed on the relevant cancer 
clinic headed paper and signed by the lead clinician (Appendix 3), an information sheet 
(Appendix 4), reply form (Appendix 5) and pre-paid envelope addressed to the 
candidate at Cardiff University. Pre-paid envelopes and headed and signed invitation 
letters were used to increase response rates (Edwards et al, 2002). As relatives were 
being recruited through patients, an invitation letter (Appendix 6) and an information 
sheet addressed to relatives (Appendix 7) were included in patients’ information packs. 
The candidate kept in contact with the CNSs to track how many information packs 
were distributed to patients in order to determine the response rate.  
 
Recruitment using this method was slow, possibly because most patients were 
recruited from UHW clinics, where they had been diagnosed fairly recently and were 
perhaps emotionally unprepared to participate in research. The candidate’s clinical 
supervisor contacted the clinical trials unit (CTU) manager at Velindre hospital to help 
with recruitment. Patients having treatment at Velindre hospital have typically had 
more time to come to terms with their diagnosis, are likely to be familiar with their 
treatment regime and have more spare time, as their treatment often takes several 
hours, which means they may be more willing to participate in research. The CTU 
manager at Velindre was provided with information packs and asked to recruit patients 
with colorectal, gynaecological, and urological cancers (an adequate sample of 
patients with breast cancer had already been successfully recruited). The candidate 
kept in contact with the CTU manager to track how many information packs were 
distributed to patients. 
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4.3.3 Recruitment of relatives 
Information sheets given to interested patients asked if they had a relative or close 
friend who would participate in the study. Relatives (or friends) were asked to indicate 
their interest in the study by ticking a box on the patient’s reply form and include their 
contact details. Once received, the candidate contacted the patient to arrange an 
interview time that was suitable for both the patient and their relative. Relatives’ 
eligibility for the study was assessed using the following criteria: 
 
Inclusion criteria: 
i. Male or female 
ii. Aged 18 or above 
iii. Close family member (or friend) of a patient receiving neoadjuvant, adjuvant, 
radical or palliative treatments, as specified under patient sample inclusion 
criteria 
iv. Able to give informed consent 
 
Exclusion criteria: 
i. Relatives (or friends) of patients with an estimated life expectancy of less than 
12 months. 
ii. Relatives (or friends) of patients who the clinician deems to be unsuitable for 
the research (for example in a current state of crisis or have their own 
significant health or social problems, unable to provide informed consent, or 
other reason for not being approached about the study). 
 
4.3.4 Procedure 
The CNSs or CTU manager described the study to eligible patients and invited them to 
participate by providing them with an information pack. All written information was 
tested using a readability formula to ensure that it was easy to read 
(http://www.readabilityformulas.com/free-readability-formula-tests.php). Interested 
patients returned the reply form to the candidate in the prepaid envelope detailing their 
contact information. The candidate telephoned or emailed interested patients to 
answer any questions about the study and to arrange an interview in their own homes, 
at a time convenient for them. Participants were offered reimbursement of their travel 
expenses if they wished to have the interview at another location. At the time of the 
interview, patients and relatives were each provided with a consent form to sign and a 
further opportunity to ask questions about the study (Appendices 8-9). The candidate 
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explained that the interview was confidential and that only the candidate and lead 
supervisor would have access to the data. Participants were informed of how the data 
would be anonymised, stored securely and kept for 15 years at Cardiff University, after 
which it will be deleted. Demographic information was then collected from participants 
by questionnaire prior to the start of the interview (Appendices 10-11). Relatives were 
given the option of having an interview jointly with the patient or separately. Where a 
relative was present, the interview would be directed at the patient as the patients’ 
views were most important to the study, however the relative would be asked for their 
views and opinions where appropriate. Interviews were audio-recorded with permission 
and audio-files were sent electronically to a reputable company for transcription by 
uploading the files to a secure server used by the transcription company. Audio-
recordings were transcribed verbatim, which means that a full transcript of everything 
that was said in each interview was provided (including common terms, such as ‘ums’ 
and ‘ers’, and sometimes repetitive ‘I mean’, ‘sort of’, ‘you know’ etc). All contractions 
were typed as said (e.g. don’t and couldn’t) and ‘ums’ and ‘ers’ retained within the 
script. Any information that could identify participants in the interview was anonymised 
on the transcript. A confidentiality agreement was required from the transcription 
company to ensure that participant data and information was protected. Once the 
completed transcripts were provided to the candidate, the candidate listened to the 
audio-recordings whilst reading the transcripts to check for accuracy.  
 
4.3.5 Data management 
Transcripts and audio-recordings were securely stored on a Cardiff University 
password-protected server in accordance with the Data Protection Act 1998. This 
server is password-protected and confidential. All consent forms, transcripts and 
audio-recordings will be kept securely for 15 years according to Cardiff University 
research data policies. Following this time, all data will be destroyed.  
 
4.3.6 Interview topic guide 
A semi-structured interview topic guide was used (Appendix 12). Two separate 
interview schedules were originally created for patients and relatives, however as all 
participants chose to be interviewed together, the patient interview topic guide was 
used and relatives’ opinions were sought where appropriate. Studies included in and 
findings of the systematic review (i.e. to identify gaps in the evidence base), and other 
relevant literature on the use Smart technology to deliver interventions in healthcare, 
informed the development of the topic guide. The topic guide was reviewed by the 
candidate’s supervisors and amendments to the topic guide were made following 
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comments. The topic guide was then piloted on two post-graduate students at Cardiff 
University to ensure simple language was used and leading questions were not asked. 
The main topics covered at interview were: information needs, communication with 
clinicians in consultations, experience with Smart technology, perceived acceptability 
of an app for patients with cancer, desired app features, and the perceived benefits 
and disadvantages of, and barriers to, this type of intervention. At the beginning of the 
interviews, the candidate briefly explained the type of app that might be useful (i.e. one 
to help with their information needs) and described examples of types of app features 
in order for them to imagine what types of features are possible to include in an app. 
For participants who were unfamiliar with apps, the candidate briefly explained what an 
app is and showed them an example on a Smartphone.  
 
4.3.7 Analysis 
Patients were interviewed until data saturation was reached to ensure that adequate 
data were collected and the views of patients were represented. Data saturation was 
considered to have occurred when no new themes were identified for at least the final 
three interviews. Data were managed using the qualitative analysis software package 
NVivo (NVivo, 10). Interview transcripts were analysed using thematic analysis (Braun 
& Clarke, 2006). Each anonymised transcript was read several times for familiarity, 
actively searching for, and noting, meanings and patterns. Initial codes were generated 
from each data item and mind maps were created to identify the links between codes 
and possible overarching themes. Codes were then organised into meaningful 
subthemes and main overarching themes. Themes were reviewed and refined by 
reviewing each data item within a theme to ensure coherence. All themes were 
reviewed for validity in relation to the dataset as a whole, to ensure the final thematic 
framework accurately reflected the dataset. Finally, themes were defined and refined 
to reflect the essence of the theme. Five transcripts were independently analysed by 
the candidate’s supervisor, Dr Fiona Wood, who has extensive experience of 
qualitative research, in order to reduce the potential bias of subjectivity associated with 
coding and facilitate interpretation of findings. Discrepancies were resolved through 
discussion.  
 
4.3.8 Researcher values and relationship to participants 
It is important to reflect upon the personal values of the researcher, and the 
relationship between the researcher and the participant, when conducting qualitative 
research. The researcher requires an awareness of these how these might influence 
responses during an interview and interpretation of the findings. Firstly, I was aware 
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that I had not experienced living with cancer and so may not fully understand 
participants’ experiences or the psychosocial context. Secondly, during interviews, I 
was conscious of how I may be perceived by participants. Some participants may have 
perceived me to be of a higher social standing due to my role as a researcher from a 
reputable university and may have been conscious that I was in contact with some of 
their cancer clinicians. I was aware of how this might influence participants’ trust and 
openness during the interview and so made every effort to build rapport prior to the 
interview to make the participant feel comfortable. I assured participants that the 
interviews were confidential, that their views and opinions would not be discussed with 
their clinicians and any data published as a result of this study would be anonymised 
and could not be linked back to them in any way.  
 
4.3.9 Ethical Issues 
NHS ethical approval and R&D approval from each of the sites was granted 
(14/WA/0066, Appendices 13-15).  
 
4.4 Results 
Twenty three interviews were conducted with 32 participants in their own homes 
between November 2014 and February 2015. All relatives chose to be interviewed 
jointly with the patient. The average length of the interviews was 43 minutes (range 16-
75 minutes).  
 
4.4.1 Sample characteristics 
Patient participants 
A total of 130 information packs were distributed to eligible patients: 40 were 
distributed to urological cancer patients, 30 to colorectal cancer patients, 30 to 
gynaecological cancer patients and 30 to breast cancer patients. A total of 33 patients 
returned a reply form indicating interest in participating. Out of the 33 patients who 
responded and contacted, 23 participated and completed the study (overall response 
rate 17.7%). Four patients did not answer the telephone or respond to emails, four 
stated that they were not well enough to participate at the time, one patient was on 
holiday, and one patient declined to participate in the study. Characteristics of patient 
participants are presented in Table 2. The most common age category was 56-65 
years (n=8). There were 12 females (52%) and 11 males (48%). The most common 
cancer type was colorectal (n=10, 44%) and the rest of the sample was made of up 
gynaecological (n=5, 22%), breast (n=4, 17%), urological (n=3, 13%) and other (n=1, 
4%) cancers. The response rate of patients from each cancer type was 7.5% (3/40) for 
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urological cancer patients, 13.3% (4/30) for breast cancer patients, 16.6% (5/30) for 
gynaecological cancer patients and 33.3% (10/30) for colorectal cancer patients. 
Time since diagnosis ranged from 3-6 months to over 5 years and the most common 
time since diagnosis was 1-2 years (n=8). Level of education was collected as a proxy 
of socio-economic status. Nearly three-quarters of participants were educated to at 
least secondary level (n=17, 74%) and over a quarter were educated to degree level 
(n=6, 26%). All participants were white Caucasian. Seventeen out of 23 patients (74%) 
reported that they owned (or co-owned) a Smart device (Smartphone or tablet). 
Patients and relatives tended to own their own Smartphones and share a tablet device 
with their partner.  
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Table 2: Patient sample characteristics.  
ID Age Gender Cancer type Time since 
diagnosis 
Education level 
P1, Jim 66-75 M Urological 2-4 years GCSE/O levels 
P2, Vicky 18-25 F Gynaecological 3-6 months Diploma 
P3, John 66-75 M Colorectal 1-2 years None specified 
P4, Michael 66-75 M Colorectal 2-4 years Degree 
P5, Pam 56-65 F Breast 3-6 months Post-graduate degree 
P6, David 66-75 M Colorectal 3-6 months None specified 
P7, Julie 56-65 F Colorectal 2-4 years Degree 
P8, Mandy 56-65 F Gynaecological 5 years + Degree 
P9, Moira 85+ F Colorectal 1-2 years None specified 
P10, Sue  66-75 F Other 1-2 years None specified 
P11, Dawn 46-55 F Gynaecological 2-4 years GCSE/O levels 
P12, Kay 46-55 F Breast 1-2 years Missing data 
P13, Lynne 56-65 F Gynaecological 2-4 years Degree 
P14, George 66-75 M Colorectal 1-2 years Post-graduate degree 
P15, Albert 76-85 M Urological 1-2 years Diploma 
P16, Ralph 56-65 M Colorectal 6 months -1 year None specified 
P17, Jackie 46-55 M Colorectal 6 months -1 year Degree 
P18, Martin 56-65 M Colorectal 2-4 years GCSE/O levels 
P19, Paula 36-45 F Breast 1-2 years NVQ/HNC/HND 
P20, Beryl 56-65 F Gynaecological 1-2 years Degree 
P21, Nerys 66-75 F Breast 5 years + GCSE/ O levels 
P22, Clive 76-85 M Colorectal 2-4 years None specified 
P23, Paul 56-65 M Urological 3-6 months GCSE/O Levels 
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Relative participants 
Fourteen patients (42% of 33 patients) returned a reply form indicating a relative’s 
interest in participating in the study. Of those 14 nominated relatives, nine did not wish 
to participate in the study as they were nominated by patients that did not participate in 
the study. Five relatives agreed to participate in the study (response rate 36%). During 
the patient interviews, four extra relatives volunteered to participate in the study, 
resulting in a total of nine relative participants. Characteristics of participants are 
presented in Table 3. Two thirds of relatives were spouses or partners of the patients 
(n=6) and the majority were educated to at least secondary level (n=7). All participants 
were white Caucasian. All relatives reported that they owned (or co-owned) a Smart 
device.  
 
Table 3: Sample characteristics of relatives. 
 
ID 
 
Age 
 
Gender 
 
Relationship to patient 
 
Educational level 
R1, Sadie 66-75 F Wife of P1, Jim NVQ/HNC/HND 
R2, Geraint 18-25 M Boyfriend of P2, Vicky  Diploma 
R3, Helen 56-65 F Wife of P3, John GCSE/O levels 
R4, Stella 36-45 F Daughter of P4, Michael A levels 
R5, Susan 56-65 F Partner of P5, Pam Post-graduate degree 
R6, Lucille 46-55 F Daughter of P6, David GCSE/O levels 
R7, Sarah 36-45 F Daughter of P6, David NVQ/HNC/HND 
R8, Maude 56-65 F Wife of P6, David Other 
R9, Henry Missing data M Husband of P9, Moira None specified 
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4.4.2 Interview themes 
From the interviews, two key themes were identified: (1) information needs, and (2) 
opinions on an app for patients with cancer. Subthemes will be discussed in detail 
below. Figure 7 presents the full theme hierarchy in the format of a flowchart. Patient 
participants are identified with ‘P’ and relatives with ‘R’, followed by their identification 
numbers in Tables 2 and 3, respectively, and a pseudonym. The interviewer is 
identified with ‘I’. Where irrelevant, text was removed from quotes and denoted by {…}. 
Square brackets within the quotes represent inserted text to clarify the content. 
Exemplar transcripts are included in appendices 16 to 19. 
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Theme 1: Information needs Theme 2: Opinions on an app for patients with cancer 
Subtheme 1: Information-seeking 
as a coping mechanism 
Subtheme 2: Unmet information 
needs 
Subtheme 3: Barriers to 
information exchange in 
consultations 
Subtheme 4: Sources of cancer-
related information 
Subtheme 1: Anticipated 
acceptability Subtheme 1a: Anticipated uptake 
Subtheme 1b: Anticipated ease of 
use 
Subtheme 2: Suggested app 
features 
Subtheme 2a: Features that 
support patients’ self-
management of their condition 
Subtheme 2b: Features that 
facilitate information-exchange in 
consultations with clinicians 
Subtheme 2c: Features that 
increase access to patient support  
Subtheme 2d: Features that 
increase access to support for 
relatives  
Subtheme 3: Anticipated benefits 
of app use 
Subtheme 4: Potential 
disadvantages of app use 
Subtheme 5: Potential barriers to 
app use 
Figure 7: Flowchart of themes from interviews with patients and relatives. 
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Theme 1: Information needs 
This theme reflects the views of patients and their relatives on the use and importance 
of information during cancer and their experiences of cancer consultations. Key 
subthemes related to information needs were: information-seeking as a coping 
mechanism, unmet information needs, barriers to information exchange in 
consultations and sources of cancer-related information.  
 
Subtheme 1: Information-seeking as a coping mechanism 
Both patients and relatives described a cancer diagnosis as a shocking, upsetting and 
overwhelming experience. Cancer was talked about as a shared experience, 
particularly by patients and their spouses, who felt cancer impacted them equally.  
 
P13, Lynne (55-65 years, gynaecological cancer) - …Of course to be told 
you’ve got cancer you know, your whole world crashes around you. 
 
R5, Susan (56-65 years, partner of P5, Pam – …you lose total 
control of your whole lives you know it’s all about, you know hospital 
appointments, we’ve got a diary with hospital appointments you 
know, it’s....and the first couple of weeks it was just hospital 
appointments. 
 
R8, Maude (56-65 years, Wife of P6, David) – I mean the terrible 
thing that we went through was that ((David)) was diagnosed and it 
was a shock and it was, I mean it probably worried me I think more 
than ((David)). 
 
As a result, the majority of patients and their relatives reported that they had wanted in 
depth information on their condition following diagnosis and talked about their 
information-seeking and learning about their condition as if it was a coping mechanism. 
Having information enabled them to prepare themselves for treatment, relieved some 
of their anxiety and helped them to regain a sense of control over their lives (e.g. 
Appendix 16 (transcript for P5 Pam and R5 Susan), lines 673-815; Appendix 17 
(transcript for P3 John and R3 Helen), lines 189-194). 
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R5, Susan (56-65 years, partner of P5, Pam) - …Anything and everything we 
could get our hands on we read…we wanted to know the type, you know, we 
wanted to know what was going to happen, how you were going to do that. 
 
P20, Beryl (56-65 years, gynaecological cancer) - I suppose we want to know 
more, I suppose I’m a bit of a controlling person, I’ve always been a controlling 
person over my own life and know I still want to be that controlling person, so 
that’s why I want information …to try to, or to trick myself into thinking that I 
have some control.   
 
A minority of participants only wanted the minimum amount of information necessary, 
directly from their clinicians only, and explained that this was because they knew that 
this information was accurate. In contrast, the Internet was viewed by this group of 
participants as a source of unreliable and potentially threatening information, which 
increased their anxiety. 
 
P19, Paula (36-45 years, breast cancer) – I think I was very lucky because with 
the experts that I dealt with they only gave me the information I needed and 
nothing else, because if you do go to the Internet and you do search you get 
bombarded with too many bad scenarios that might not be your case, so from 
start I can tell you, from my diagnosis I’ve never, ever tried to investigate 
anything on the Internet at all. 
 
Subtheme 2: Unmet information needs 
Some patients and relatives did not appear to be satisfied with the information they had 
received during the illness and it was apparent that some patients were provided with 
more information from their clinicians than others (e.g. Appendix 16 (transcript for P5 
Pam and R5 Susan), lines 152-229, lines 398-408; Appendix 19 (transcript for P13 
Lynne), lines 267-291). Participants recalled a range of unmet information needs, 
including information on treatment-related side effects, cancer support services, 
lifestyle changes (e.g. diet, exercise and smoking), survival and recurrence rates, 
alternative therapies, managing finances, psychological support and logistical issues, 
such as parking at the hospital. One patient recalled that she had not had her surgery 
explained to her, which left her with many questions that she felt too embarrassed 
about to ask.  
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P22, Clive (76-85 years, colorectal cancer) -… I had to search [for information] I 
did, with a few friends asked friends, and they said well so and so had it have a 
chat with them, you know things like that, that’s the way I had to go around it 
 
P13, Lynne (56-65 years, gynaecological cancer) –…After my operation 
…nobody spoke to me at all, because um it’s a bit sort of I suppose it might 
sound a bit personal you know when you’ve had your womb removed it’s stupid 
((laughs)). Things like, cos I had everything removed, I know this is very 
specific to womb cancer, but womb, cervix and you think stupid things like well 
okay, so is there just a big hole there now? 
I - Yes, so you had questions?  
P13, Lynne – Yeah, but very sort of you know...not even specifically related to 
the disease, but what had happened to my body?  
I –…So no one spoke to you about that sort of thing?  
P13, Lynne – No, no one mentioned um sex, and you know, was it okay?  
 
Subtheme 3: Barriers to information exchange in consultations  
The unmet information needs of patients (and their relatives) appeared to be primarily 
due to barriers to communication of information in consultations, which are briefly 
described. Many patients reported that they found it difficult to concentrate in 
consultations due to anxiety and/or the effects of chemotherapy on their cognitive 
abilities (e.g. Appendix 16 (transcript for P5 Pam and R5 Susan), lines 1813-1826). 
Some patients were conscious of the amount of time that they spent with or contacting 
clinicians due to an awareness of their heavy workloads (e.g. Appendix 19 (transcript 
for P13 Lynne), lines 340-345) or reported that clinicians and nurses were hard to 
reach when they needed information (e.g. Appendix 18 (transcript for P19 Paula), lines 
541-546; Appendix 19 (transcript for P13 Lynne), lines 205-211 and 373-375).  
 
P20, Beryl (56-65 years, gynaecological cancer) - …You just completely forget 
what you’ve gone in [to the consultation] for, sometimes you forget what you’re 
saying half way through your saying it. If you’ve got treatment, it really affects 
your short-term memory. I can be halfway through a sentence and I don’t know 
the end of the sentence…it’s, it’s a real issue.  
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Some participants perceived a power imbalance, where they believed that their 
clinician was of superior authority. Furthermore, some patients reported that they did 
not understand some of the medical terminology used by clinicians in consultations or 
the cancer information resources that they were provided.  
 
P13, Lynne (56-65 years, gynaecological cancer) – … You know me being me I 
kept apologising and he [the clinician] said, “It’s alright, I understand, you 
know”, because you know there is the white coat syndrome as well isn’t there? 
Where you go in and everything in your mind goes blank  
I - What do you mean by the white coat syndrome?  
P13, Lynne – The whole thing of you know, as soon as you go into a medical 
professional setting, maybe more someone of my age who is used to, I mean 
I’m still surprised when a doctor comes up to me in hospital and says, “I’m Luke 
I’m one of the doctors”, I expect it to be, “I’m Dr so, and so”, ((laughs)) and 
there’s that sort of you know, it’s a doctor…! And I know it’s silly, but uh…and 
when I go to the GP, I take a list with me because you do, you’ve got that sort 
of, again, you’re afraid of wasting time, and you’ve got that oh it’s a doctor! 
 
P2, Vicky (18-25 years, gynaecological cancer) – Yeah they give us different 
leaflets, for different sorts of things you know  
I – Did you look at those, or did you...?  
P2, Vicky– No. I’ve read quite a few but there are words I don’t quite 
understand {…} 
I –Okay, so you said there’s quite a few words that you didn’t really 
understand? 
P2, Vicky– Yeah I don’t know what they mean to be honest  
R2, Geraint (18-25 years, boyfriend of P2, Vicky) - No, they’re doctors’ words 
and they…they’re not simple for a layman like myself. 
 
It appeared that these barriers meant patients sometimes forgot to ask or lacked 
confidence to ask questions and struggled to digest and recall information from 
consultations. 
 
Subtheme 4: Sources of cancer-related information 
Generally, it appeared that the cancer consultant was patients’ and relatives’ primary 
and most valued source of information, as this information was trusted and specific to 
their condition.  
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P2, Vicky, (18-25 years, gynaecological cancer) – Sometimes I try not to 
Google because like, it’s not all reliable. So when I want information, if 
anywhere, I ask my doctor.  
 
P13, Lynne (56-65 years, gynaecological cancer) – um well mainly from the 
doctor I’d get it [information]. I didn’t really, I would sort of look at websites, but I 
didn’t really trust you know? I wanted it from the mouths of the professionals 
 
Most patients and relatives also tended to gather information from other sources, most 
commonly from the Internet, though some found it difficult to identify relevant and 
reliable information online (e.g. Appendix 18 (transcript for P19 Paula), lines 16-22). 
Other sources included other cancer patients, cancer charities and family and friends, 
support groups and social media. No patients reported having previously used an app 
for cancer and only one relative reported using the NHS app to look up health 
information about her partner’s cancer (e.g. Appendix 17 (transcript for P3 John and 
R3 Helen), lines 842-860).  
 
I - …Is there any reason why you haven’t used the Internet?  
R2, Geraint (18-25 years, boyfriend of P2, Vicky) - Well we have looked a little 
bit in the beginning, but now we get information from the hospital. Everybody’s 
different, the treatment for everybody is different...and different chemo’s are for 
different treatments for particular people as well  
I – So you find that the information on the Internet is too general, the doctors 
can give more specific information? Is that correct? 
P2, Vicky - Yeah more specific. 
 
Theme 2: Opinions on an app for patients with cancer and their families  
This theme reflects the needs and preferences of patients and their relatives regarding 
an app and their views on the potential outcomes of this type of intervention. Key 
subthemes were: anticipated acceptability, suggested app features, anticipated 
benefits, potential disadvantages, and anticipated barriers.  
 
Subtheme 1: Anticipated acceptability  
Subtheme 1a: Anticipated uptake  
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The majority of patients and relatives anticipated that they would have used an app 
during cancer, if it was available, in order to learn more about the illness. Participants 
believed that other patients would also find this type of app to be useful.  
 
P11, Dawn (46-55 years, gynaecological cancer) - I find that what I wanted was 
to know as much as I could...I wanted to understand it [the cancer], so um, so 
I’d find it [the app] really useful. 
 
I – …And what about friends, friends and family of the patients?  
P5, Pam (56-65 years, breast cancer) – Yes I’m sure  
R5, Susan (56-65 years, partner of P5, Pam) – I would’ve been on it [the app] 
P5, Pam– Everybody wants to help  
R5, Susan – Absolutely 
 
Some participants anticipated that younger patients would be more experienced with 
Smart technology and therefore more likely to use an app compared to older patients, 
who may be more inclined to use traditional methods to source information, such as 
asking a friend or the doctor.  
 
I - So the type of app we’ve talked about, do you think that patients would want 
to use this app? 
P8, Mandy (56-65 years, gynaecological cancer) – I don’t know if older people 
would  
I – Okay and why do you think that?  
P8, Mandy – Um, I don’t think they use phones as much as, like your 
generation do, it’s like you have to be glued to them you can’t leave them...you 
gotta have them. I think I grew up looking up information, so I do see the 
Internet as a means of finding information but, I also like asking people things. 
But I think, because younger generations have grown up with phones and 
tablets and things then possibly you’ll make more use of them, whereas I think 
maybe older people might ask things first, be told about them and maybe have 
a look at them. 
 
Patients recalled how each phase of cancer prompted new questions for them and the 
need for new information. Participants therefore believed that an app would be useful 
for all types of cancer and all phases of the disease, including diagnosis, pre-
treatment, during treatment, post-treatment and remission. Patients expected an app to 
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be most useful following diagnosis, as they recalled having the greatest need for 
information at this point.  
 
I – …What about the different stages of cancer, do you think it would be useful 
for diagnosis, or treatment, or post treatment …or do you think it could be used 
throughout all of these stages?  
P12, Kay (46-55 years, breast cancer) – All of it I think, because obviously 
you’re diagnosed, “What happens next?” Like the treatments, “What happens 
next?” You know? 
 
P20, Beryl (56-65 years, gynaecological cancer) - …it was just, I’d say 
diagnosis was the big one, I needed loads and loads and loads of information 
then 
 
Subtheme 1b: Anticipated ease of use  
Most patients and relatives anticipated that they, and future patients, would find a 
cancer app easy to use, as the majority of the general population already use and are 
familiar with apps. Furthermore, participants believed that apps are intuitive to use.  
 
R2, Geraint (18-25 years, boyfriend of P2, Vicky) - Yeah I’d think it would be 
fairly easy, as long as the information is accessible and you haven’t got to go 
through like about 20 sub-headings to get the information that you need.  
 
P1, Jim (66-75 years, urological cancer) - Most apps I would suspect, they’re 
not too difficult to use, but whether they’re focused on what you’re looking 
for…but the use of the app, I suspect the average person these days, if they’re 
using other apps, will find out [how to use it].  
 
Some participants with no or limited experience with Smart technology suggested that 
they would need some initial training on how to use an app but anticipated that they 
would be able to learn how to use fairly easily.   
 
P15, Albert (76-85 years, urological cancer) – I might like a little training, 
perhaps one session but uh, because as I say, I’ve never used one I wouldn’t 
know how to start with it…I would soon pick it up I think.  
 
Subtheme 2: Suggested app features 
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Overall, suggestions for app features by patients and their relatives indicated that they 
primarily wanted an app that would help to increase their knowledge of the illness and 
meet their full range of information needs. Relatives reported that they wanted the 
same app features as the patient. Some participants found it difficult to think of app 
features and instead, listed the types of information that they had previously wanted. 
The most commonly suggested features were organised into the four themes: (1) 
Features that support patients’ self-management of their condition, (2) features that 
facilitate information exchange in consultations with clinicians, (3) features that 
increase access to patient support, and (4) features that increase access to support for 
relatives.  
 
Subtheme 2a: App features that support patients’ self-management of their condition  
Patients and relatives suggested features that would facilitate patients’ self-
management of cancer, such as self-care behaviours for symptoms and treatment-
related side effects. The majority of participants desired an informational feature that 
would contain the types of cancer-related information that they had wanted previously, 
as described in section ‘Subtheme 2: Unmet information needs’. Participants wanted 
information that was specific to their cancer and imagined this feature to be like an ‘Ask 
Jeeves’ website, where you would perhaps write a specific question in the app and 
immediately get the information you need (Appendix 17 (transcript for P3 John and R3 
Helen) lines 876-899).  
 
P11, Dawn (46-55 years, gynaecological cancer) – Well the sort of information 
that I wanted was um symptoms, um oh, what am I saying? Right someone’s 
got cancer, you’ve been told you’ve got colon cancer, like myself, um the sort of 
thing I wanted to find out was how curable is it? Um....treatments, I wanted to 
know what sort of treatment I was having. 
 
P10, Sue (66-75 years, other cancer) - I think the sort of information I got 
admittedly from that book which people might pick up um, the one thing with the 
chemotherapy, was probably the worst part of it was going to be the incredible 
tiredness, and I think things like that, the down side as well as the good side 
needs to be pointed out.  
 
Some participants suggested including links to credible cancer information websites as  
they reported that they found it difficult to navigate the Internet and identify reliable 
information, due to the large amount of websites and information available.  
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P14, George (66-75 years, colorectal cancer) – It [the app] could be used to 
direct them [patients] towards websites that contain that information, so you 
could use it as a roadmap, that I suspect could be useful. 
 
P17, Jackie (46-55 years, colorectal cancer) – … but to direct you to relevant 
things, rather than the masses of information out there which could contain all 
sorts of irrelevant things… {…} to point people in the right direction for the right 
answers, rather than give the answers… yeah signpost and direct people.  
 
Some participants suggested that a treatment-related symptom diary feature would be 
useful, as some of them benefited from keeping a paper diary. Participants described 
how it helped to predict how they would feel at certain times during their treatment and 
helped them to plan ahead to prevent or remedy symptoms, and organise their diet 
and social calendar. Participants also explained that they felt reassured by knowing 
when symptoms were likely to occur.  
 
P19, Paula (36-45 years, breast cancer) - …Uh like I told you when you start 
chemo, it’s really good for you to have a report, a detailed report of symptoms, 
how you feel. So throughout the cycles, not only for yourself to prepare yourself 
for what’s coming as well, for the nurses because they ask you, they ask you at 
every clinic, “How are you feeling?” “How did it go?” If you don’t write it down I 
can tell you, you will forget. If the app has um a way so that you could 
personalise your own link and then you can actually have a diary, so instead of 
writing, I got to the stage where I’d forgotten completely I thought oh I’ll 
remember, I’ll remember, well if you’ve got…because it’s much easier with 
technology so instead of writing… it’s much easier if you’ve got it there so when 
you do go to the nurse you can easily pop it up and say, “Look that day I went 
though that, this was a different symptom, or this one might’ve been a bit more 
graphic than the other time you know” that would be, that would be quite useful.  
 
Subtheme 2b: App features that facilitate information exchange in consultations with 
clinicians 
Patients and relatives suggested app features that would facilitate information 
exchange in consultations and their understanding of the information provided, in an 
attempt to overcome the barriers experienced in consultations (described in section 
4.4.2.1.3). Some patients recalled writing question prompt lists (QPL) for consultations 
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during their illness to remind them to ask questions (e.g. Appendix 19 (transcript for 
P13 Lynne), lines 465-472). Conversely, many patients that had not used a QPL 
reported that they had forgotten to ask questions. As a result, many participants 
suggested including a QPL feature and many anticipated that it would be the most 
useful feature for patients.  
 
P19, Paula (36-45 years, breast cancer) - I think if the app does that, you know 
gives you a list of questions that would be useful for you to ask so you can write 
them down… I think it’s extremely useful because at least you’ve got your mind 
set to ask the questions if you’ve got any… If I had any questions when I got 
home, I’d have to ring back and say, “Look I don’t understand this”, you know 
so I think if the app does that, that’s really good.  
 
P3, John (66-75 years, colorectal) - …When we saw the doctor he called us in 
on New Years day so I knew there was something wrong when he called us 
and then he said, “Anything you want to ask me?” Well of course you’re 
stunned and there is nothing you can think of to ask... it would be useful to have 
questions that you hadn’t thought of at the time.  
 
Participants suggested including a glossary feature that provides definitions of cancer 
terms to enable patients to understand the information that they are provided in 
consultations, as they recalled times when they did not understand the terminology 
used by clinicians or in information resources, such as leaflets.  
 
R6, Lucille (46-55 years, daughter of P6, David) - …They want a doctors’ 
dictionary on there [the app] ((laughs))… they said, when she give us the form 
she said, “There’s gonna be loads of things that you don’t understand because 
the words are about that long”, …it’s assuming you understand them isn’t it? 
 
P14, George ( 66-75 years, colorectal cancer) - I don’t class myself as to being 
of superior intellect, but I’m not a fool and um, I understand, but I suspect Mr 
Average might say to himself, “Well I don’t know what that means”. So the app 
would be useful for him, um....  
I – Well one of the things that we’re thinking about including is including a 
glossary of medical terms. Do you think that would be useful for patients?  
P14, George – To be honest with you yes, for the average person, uh and I 
think that would be useful and explain what that means to them, because I think 
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an awful lot of people would be to a degree, a little bit in awe of what the doctor 
is saying because they’re not trained as uh doctors they wouldn’t understand 
completely, and maybe there’s a slight reluctance to say to the doctor, “Well 
explain that more fully, be more open with me” because of that if you like, 
power differential, between the patient and the doctor, so having the ability to 
go to an app afterwards, provided you remember what all the big words were. 
 
Subtheme 2c: App features that increase access to patient support 
Patients and relatives suggested app features that would raise awareness of and 
increase patients’ access to other types of support, such as psychological and social 
support. Some participants suggested including links to local cancer support services, 
such as psychological support services and help with managing finances, and cancer 
charity websites that already contain some links to these services. It was hoped that 
this would raise awareness of and increase access to some of the services that 
participants found helpful during their illness (e.g. financial benefits advisor for patients 
who were unable to work).  
 
R2, Geraint (18-25 years, boyfriend of P2, Vicky) – …Yeah and then also they 
employ a McMillan advisor, she is fantastic, she helped us a lot  
I - Oh that’s good 
P2, Vicky (18-25 years, gynaecological cancer) – That’s one thing I reckon 
would be good to put on here is like numbers for people like, money wise, 
because we’ve struggled to find all the help…like what type of benefits to go on 
and even if you just put the McMillan Advisor’s number on it [the app].  
 
P8, Mandy (56-65 years, gynaecological cancer) –…I think there’s a lot of 
things the app could help to link up a bit. You know, there is a lot of stuff 
[cancer services] out there, putting it in one place would probably, I would’ve 
thought would be helpful, so that people haven’t got...I kind’ve stumbled across 
things by accident, like I didn’t realise that Macmillan did the complimentary 
therapy services thing, but there’s also links to sort of art therapy and all sorts 
of things that are there, and they’re there for families as well and I didn’t know 
they were there initially.  
 
Many participants recalled how they exchanged information with other cancer patients, 
both face-to-face at hospitals and online (e.g. information on remedies for treatment 
side effects), which they described as invaluable. Some patients therefore suggested 
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including a social feature or links to existing social forums or media, as they recalled 
the informational and emotional benefits of meeting other patients.  
 
P2, Vicky (18-25 years, gynaecological cancer) – …Because on the page on 
Facebook, there was a woman she just, her cancer came back and she was 
like, “What’s the chances of me even beating it this time, who beats cancer 
twice?” and a woman commented on it, ”I’ve beat cancer 3 times and I’m in 
remission”, and that woman, you could see like she was commenting on it 
saying, “Oh my God thank you, that’s made me feel so much better”, and any 
little help like that. Even with the groups on there, even if you’re not from their 
area, it doesn’t matter – they’re there for you. I think it’s really good with social 
media now and um maybe you could incorporate that into your app? 
I – Yeah, do you think that would be a good idea?  
R2, Geraint (18-25 years, boyfriend of P2, Vicky) – Yeah …certain social media 
sites and that sort of thing, like I know [hospital] has a Facebook page, and the 
ovarian page is where she’s with that sort of thing, like having that support base 
is better than like, I can support her as much as I can, but it’s nothing compared 
to someone who’s been through it, or going through it, you know they can talk 
about certain things that I can’t talk about with her because it doesn’t matter 
how hard I try, I can’t understand what she’s going through...  
 
R3, Helen (56-65 years, wide of P3, John) - We found that when we used to go 
down there (hospital), other patients with similar cancers or receiving 
chemotherapy and you talk and that always helped to find out their 
experiences, how they dealt with certain side effects and if that would be, if you 
could have that on an app I think it would be you know a help.  
 
Patients also suggested including links to information on online or local support groups 
to meet patients as they found it difficult to locate information on these services. 
 
I – So what sort of things would you like the app to do?  
P11, Dawn (46-55 years, gynaecological cancer) - Um, I think support side of it 
is very important, to give the information about support, um support groups, cos 
that’s what I couldn’t find, I couldn’t find any support groups. It was only about 
last year I found a support group near home. 
 
Subtheme 2d: App features that increase access to support for relatives  
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Some relatives, as well as patients, suggested some additional features that would be 
useful specifically for relatives. Some relatives explained that they had wanted 
someone to talk to during the patient’s illness for emotional support, such as another 
relative in a similar situation, who was outside of the family so as not to burden the 
patient.  
 
R8, Maude (56-65 years, Wife of P6, David) – I mean the terrible thing that we 
went through was that ((David)) was diagnosed and it was a shock and it was, I 
mean it probably worried me I think more than ((David)) I was you know, the 
fear of the future, I don’t know what other people think, but it certainly did worry 
me and in the beginning I thought, my mind was all over the place and then 
someone said, "Get in touch with these nurses", and I couldn’t do that because 
it’s [the cancer] not that bad...you know, I would’ve at that stage and they never 
said anything at the hospital "Would I like someone to talk to?"… I would’ve 
liked to have that, to have someone to talk to at that stage, and nothing was 
offered. 
 
Participants therefore suggested including an in-app feature that would enable 
relatives to talk with other relatives, or links to information on local support groups that 
they could attend (online or face-to-face). 
 
R3, Helen (56-65 years, wife of P3, John) - I tell you what I think would be 
helpful as well is if there was something on there for family, immediate partners 
where you could share experiences, or maybe chat to other people, because if 
you know what I mean. I’ve been strong for (P3, John) and doing everything for 
(P3, John) but then you get those moments when I’m on my own, and you do 
think down the wrong way and you get worried, and have concerns and then I 
don’t want to go to him with it.  
 
Patients and relatives also suggested including a feature that provides information on 
how relatives can best support the patient, in order to provide informed care. For 
example, one patient explained that a friend who had previously had cancer was able 
to help her in more useful ways due to her experience of the illness.  
 
P5, Pam (56-65 years, breast cancer) – All my friends have said, “What can I 
do to help you?” all of them, um they don’t know how to deal with me  
R5, Susan (56-65 years, partner of P5, Pam)– We just say “meet us for coffee”  
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P5, Pam - I think but if they...there’s a lovely website…um ‘not another bunch of 
flowers.com’. This woman, she’s had three breast surgery’s and uh she’s fed 
up of getting flowers, she wants useful gifts and I think that would be, if they 
[relatives and friends] had some ideas about how to alleviate... they might not 
feel so helpless, because they all want to do is help, don’t they?  
R5, Susan – …and don’t bring another bunch of flowers! 
P5, Pam – I mean a friend of mine with breast cancer sent me a bra, now she 
obviously knew exactly what I was going through, because my bras don’t fit.  
 
Subtheme 3: Anticipated benefits of app use 
Patients and relatives anticipated several potential benefits of an app that would help 
patients to meet their information needs. The most commonly anticipated benefit of this 
type of app was a more informed patient. As a result of increased access to reliable 
and relevant information, participants anticipated that future patients would have a 
better understanding of their condition and the information provided in consultations.  
 
P5, Pam (56-65 years, breast cancer) - …You go in with a bit more information, 
you feel more comfortable, you can ask them questions and the answer won’t 
confuse you because you know the rudiments of it like. 
 
R2, Geraint (18-25 years, boyfriend of P2, Vicky) - I think it will prompt a 
conversation between a nurse and a patient, it will give the patient questions, 
um you know which gives them more information and uh, I wouldn’t say it will 
level the playing field, cos I don’t think there is an app that can go into that 
much detail you know than a nurse’s expertise, but it will definitely give the 
patient a better idea of what is going on.  
 
A more informed patient was expected be able to identify treatment side effects and 
treat them accordingly, which may prevent complications and potentially improve their 
quality of life. For example, one patient and her partner reported that her lack of 
knowledge on the importance of monitoring her temperature during treatment almost 
lead to her hospitalisation.  
 
P5, Pam (56-65 years, breast cancer) - …On the Sunday night when I was 
feeling like death I took my temperature and it was 37.5 so I took it with another 
thermometer and it was 37.4, because 37.5 is the magic number [the threshold] 
I went to bed, in the morning I took my temperature and it was 37.9  
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R5, Susan (56-65 years, partner of P5, Pam) – …and I said, “It’s about time 
now you rang” 
P5, Pam –…but because I didn’t want to go in, ‘Its 37.4, I don’t want to go in”. If 
I had understood the very important aspect of that, I would have gone in to 
hospital that night. 
 
A more informed patient was also expected to have lower levels of anxiety throughout 
their illness due to having a better understanding and more realistic expectations of 
their prognosis and treatment. 
 
P7, Julie (56-65 years, colorectal cancer) - I think uh, give information on 
treatment, be specific about what’s involved with chemotherapy because 
people are afraid of chemotherapy and if it was explained to them beforehand 
they might not be as afraid. Explain about what happens with radiotherapy, as 
again, people are afraid of it.  
 
There was some evidence to suggest an app could help patients to increase their 
confidence in actively participating in their care and communicating with their clinicians. 
For example, one patient described that patients would be ‘armed’ with a question 
prompt list.  
 
I –What benefits do you think there might be for patients using this type of app?  
P20, Beryl (56-65 years, gynaecological cancer)– Well it might help them, it 
might help them get some confidence, within the system, because if they, you 
know if it opens up questions and answers session when they go [to clinic] it’s 
going to make them more confident next time isn’t it? It’s going to help 
encourage their relationship with their practitioners, so you know with their 
doctors, so.... 
I –…Do you think it would help or hinder communication with clinicians?  
P20, Beryl – Oh no I’m sure it would help… because it would open a dialogue 
{…} I think it does well for confidence and self-esteem and opening up 
relationships, which can only be a good thing I think 
 
R4, Stella (36-45 years, daughter of P4, Michael)- …I mean the thing is, it’s [the 
app] going to inform the patient far more um than, um so they’re going to be 
going to their appointments you know far more armed and prepared with 
questions.  
	 100	
 
Participants also highlighted the benefits of Smart technology. Accessing cancer-
related information and resources via an app was expected to be less burdensome 
compared to searching through the printed leaflets and booklets, which are provided at 
diagnosis. Additionally, participants highlighted that patients would be able to access 
an app independent of time and location.  
  
P2, Vicky (18-25 years, gynaecological cancer) -  You have these pile of 
booklets off them and when you see all that you’re like, “Oh have I really got to 
read all that?”, so if you’ve got an app there it’s easier then isn’t it. It’s like you 
haven’t got to carry everything around, and say you’re in an appointment, you 
can just pull the app up on your phone and just read up on it, rather than 
carrying all these massive books with you.  
 
Subtheme 4: Potential disadvantages of app use 
A minority of participants were concerned that some patients might become anxious if 
they misinterpret information on an app or are misinformed by inaccurate information.  
 
I - Do you see any problems at all with this app being used in practice?  
P14, George (66-75 years, colorectal cancer) – One point that might manifest 
itself would be Joe Bloggs getting the wrong end of the stick, when they’ve 
been diagnosed with a particular condition, their research make take them 
away from the condition to something else, and maybe anxiety could set in as a 
result of that, because they’ve over researched it perhaps and um, frighten 
themselves because they’ve got so much information about perhaps a 
condition which is similar to theirs, but not theirs and then they’ll put themselves 
in a place where they don’t want to be. That could be counterproductive health-
wise, if you like call it misinformation, because they’ve misinformed themselves, 
by using the app.  
 
Additionally, a small number of participants also worried that patients actively using an 
app in a consultation might distract them from the conversation with the clinician.  
 
P10, Sue (66-75 years, other cancer) - …In my case it [the app] would hinder 
communication...because you’re looking at this [the app] and you’re not looking 
at them [the clinician] and you’re just reading a list.  
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Subtheme 5: Anticipated barriers to app use  
The majority of patients and relatives reported that they did not foresee any barriers to 
an app for cancer patients working in practice. However, the most commonly 
anticipated barrier was patients’ age and experience with Smart technology. Some 
participants anticipated that many older patients would lack the knowledge and 
experience to be able to use an app, in comparison to younger patients, who typically 
use apps every day.  
 
P13, Lynne (56-65 years, gynaecological cancer) – …If you said to me there’s 
this app called such and such then I’d just go and look at it and find it out for 
myself, like my dad bless him who’s 82 and he plays around with his laptop um 
he wouldn’t know like to look at the little words and to click on them and things 
and explore an app you know? …When somebody of your generation finds it, 
oh that sounds patronising but imagine that um you know, there are some 
people they still don’t know what an app is. 
 
In support of these views, a minority of patients in the present study anticipated that 
they would be unlikely to use an app as they preferred traditional methods to gather 
information, such as asking a nurse or a friend.  
 
I - Do you think if you had a Smartphone or tablet that you would use, or try to 
learn to use the app?  
P10, Sue (66-75 years, other cancer) - Probably not, I would probably still ring 
the nurses.  
 
Access to Smart devices, in terms of cost or access to the Internet to be able to use an 
app, was also highlighted as a barrier by participants, though patients who do not own 
a Smart device were expected to have access to one via family or friends.  
 
P13, Lynne (56-65 years, gynaecological cancer) – ...the only barrier I can think 
of is that some people do not have any access to the Internet and I suppose 
that’s something that you just have to accept you know that’s not a reason for 
not producing something, but that’s the only barrier that I can see, in that 
people, there are people who don’t have internet access. 
 
Some participants anticipated that a minority of patients will only want minimal 
information on their condition in an attempt to minimise their anxiety, and so believed 
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that this group of patients would be less likely to use an app that primarily aims to meet 
patients’ information needs. These views are supported by comments from a minority 
of patients in the present study who appeared to have an avoidant coping approach.  
 
P5, Pam (56-65 years, breast cancer) - …I can’t have enough information, but I 
know from my experience people don’t want a lot of information  
R5, Susan (56-65 years, partner of P5, Pam) - Then they’re not going to use 
the app are they? They won’t, they’ll go...or they may open it and they may see 
a little bit and they’ll go, “Okay that’s as far as I want to go”.  
 
P17, Gerald (46-55 years, colorectal cancer) -…it [the app] may help some 
people… people who want to know the ins and outs of everything, but not 
somebody like me who doesn’t want to know the ins and outs of everything. 
 
A minority of participants were concerned about the accuracy of information sourced 
from an app, however they suggested that future patients would trust an app if it was 
endorsed by their clinicians or affiliated with a reputable cancer charity. Similarly, some 
patients who were less familiar with Smart technology were concerned about the 
confidentiality and security of any personal information required by an app.   
 
P19, Paula (36-45 years, breast cancer) – It all depends how the app runs, it all 
depends the basis, or what it’s based on, um for me when I think of the Internet 
as a reliable source, can I trust it or not? You know if it makes sense  
I – Okay, so how reliable the app is?  
P19, Paula – How reliable it is. For example, if you told me that the app had a 
support or background from the cancer research, I would be more than happy 
to you know to look up anything that I would read, or that I would obtain from 
the app was accurate and that I could rely on, for me that would be ‘the’ thing 
reliability, where it comes from, what’s the basis, can I trust it personally? 
 
P3, John (66-75 years, colorectal cancer) –…as long as it keeps confidentiality, 
which is I think absolutely imperative, I mean certain things slip past the old uh 
marker at times, um, yeah I think that’s generally that’s the most important thing 
confidentiality is not in any way breached, you know. 
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4.5 Discussion 
This is the first study to explore the needs and preferences of patients with cancer and 
their relatives regarding an app that aims to help them to meet their full range 
information needs in non-inpatient settings. The primary aim of this study was to 
explore the value of an app for patients and to establish the type of app required, as 
well as the acceptability of an app and its potential outcomes. A secondary aim of this 
study was to explore the views of relatives on an app which may be used by 
themselves, as well as the patient. Findings highlighted the importance of information 
for both patients and their relatives in order to cope with and effectively self-manage 
the illness. Barriers to information exchange and understanding in consultations, and 
identification of reliable information sources between consultations, appeared to largely 
contribute to unmet information needs for patients and their relatives. This was 
reflected in the type of app and features desired. Suggestions for app features 
indicated the need for an app that supports patients to retrieve the information that they 
need from their short time in consultations, facilitates understanding of this information, 
and collates the large amount of cancer-related information and support services that 
are available to helps patients and their relatives to navigate through them. Participants 
anticipated that this type of app would be useful for all types of cancers and phases of 
the disease, particularly following diagnosis. The potential benefits of this type of app 
identified by patients and their relatives appeared to outweigh the few potential 
disadvantages, and the potential barriers to app use are likely to be temporary or can 
be minimised with consideration of these findings during app development and 
implementation.   
 
The findings that a cancer diagnosis is a traumatic experience for both the patients and 
their relatives, and that information-gathering appeared to be used as a coping strategy 
to regain a sense of control, are consistent with findings of previous studies (Ranchor 
et al., 2010; Hinds et al., 1995). These findings suggest that an app intervention that 
facilitates information-gathering has the potential to promote better psychological 
adjustment for both patients and their relatives and are consistent with several 
overlapping theories related to coping with a chronic illness, such as the CSM 
(Leventhal et al., 1984), crisis theory (Moos & Schaefer, 1984), the theory of cognitive 
adaptation (Taylor, 1983) and self-efficacy theory (Bandura, 1996).  
 
Patients and their relatives recalled a range of unmet information needs, which 
appeared to be largely due to barriers to information exchange and understanding in 
consultations and barriers to finding reliable information sources outside of 
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consultations. These findings are consistent with previous studies on communication in 
medical consultations and patients’ preferences for information resources (Chapman, 
Abraham, Jenkins & Fallowfield, 2003; Shea–Budgell, Kostaras, Myhill & Hagen, 2014; 
Slort et al., 2011). The patient activation framework might be a useful framework to 
provide further insight into these issues (Hibbard et al., 2004). For example, many 
participants in the present study appeared to lack the skills (i.e. unable to identify 
reliable information on the Internet), knowledge (i.e. limited understanding of cancer 
upon first diagnosis, clinicians’ use of medical terminology in consultations) and 
confidence (i.e. lack of confidence to ask questions in consultations) to self-manage 
their condition. It was important to explore these issues in the present study as 
participants’ needs and preferences regarding an app were based on their 
experiences. Additionally, confirmation that these barriers still exist provides evidence 
to support the development of an app that enables them to overcome these barriers 
and meet their information needs in non-inpatient settings.  
 
Patients’ and relatives’ desire for an app that would help them to meet their information 
needs reflected their experiences of barriers to information-gathering and 
understanding during and between consultations. Firstly, participants suggested app 
features that would facilitate patients’ self-management of their condition in non-
inpatient settings (e.g. at home), such as an informational feature that would provide 
detailed information on their condition, such as their treatment and related side effects. 
This type of information is required for the performance of self-care behaviours, which 
in turn might prevent hospitalisations (Ream & Richardson, 1996). Participants also 
suggested including links to reliable cancer information websites to help them to 
navigate the Internet and source accurate information. As the Internet is now a 
common health information resource, studies have highlighted the importance of 
guiding patients and educating them on how to filter accurate health information online 
(Eysenbach, 2003; Gerber & Eiser, 2001). However, information needs can vary 
throughout a patient’s illness, as well as between patients with different types of 
cancers (e.g. common versus rare cancers) and between patients at different stages of 
cancers (e.g. stage I versus stage IV). Information needs may also vary between 
patients and their relatives. If an app was to include an information feature, it would 
therefore require the ability to be tailored to each individuals’ information needs in 
order to be able to offer something more than the most general, early advice. For 
example, a question prompt list feature would enable patients and their relatives to 
create their own tailored list of questions to help them to obtain information in 
consultations that meets their own individual information needs.  
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Secondly, patients and relatives suggested app features that would enable them to 
overcome the barriers to information exchange in consultations. For example, it was 
hoped that a QPL would prevent patients from forgetting to ask important questions. As 
described in Chapter 1, reviews of the use of paper-based QPLs for cancer 
consultations have suggested small but positive effects on communication, question 
asking and recall of information (Brandes et al., 2015; Dimoska et al., 2008). A 
glossary of cancer terms was also suggested by participants in the present study, in 
the hope of enabling patients to develop an understanding of cancer-related 
information provided in consultations or information resources, rather than relying on 
clinicians to explain terminology. In contrast, previous research has focused mainly on 
improving clinicians’ communication of information in lay terms in consultations (Ley, 
1989).  
 
Thirdly, patients and relatives highlighted other negative consequences of a cancer 
diagnosis, such as financial and psychological issues, and suggested that an app 
could be used to collate information on the available cancer services for patients to 
raise awareness of and signpost them to the relevant support when needed. Similarly, 
patients suggested including a feature than enables contact with other patients for 
emotional support. This finding is consistent with previous studies on the benefits of 
social support during cancer (Dukes Holland & Holahan, 2003) and theories related to 
coping with a chronic illness, such as the CSM (Leventhal et al., 1984), crisis theory 
(Moos &Schaefer, 1984) and the theory of cognitive adaptation (Taylor, 1983). These 
theories suggest that talking with other patients may act as an emotion-focused coping 
strategy, used to restore the patient’s emotional balance which is offset by the illness, 
or used as a mechanism to boost self-esteem. An app intervention that increases 
patients’ access to other types of support, such as emotional or social support, may 
further facilitate their adjustment to their illness.  
 
Relatives in the present study appeared to agree with and suggested the same types 
of app features as the patient, which may be due to their comparable information 
needs. However, all relatives participated in joint interviews with the patient and so it is 
possible that relatives perceived that they were there to validate the patients’ voice, 
which may have precluded their own unique experience and desires for app features 
(Kendall et al, 2009). Furthermore, relatives (and patients) may have chosen to not to 
disclose and discuss their own specific experiences and desires for app features if they 
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felt that this information might upset or burden the patient. Protective buffering may 
have led to artificial findings, where the experiences discussed and app features 
suggested where those that were felt to be appropriate in the presence of partners 
(Hagedoorn et al., 2000). Despite this possibility, there was some evidence to suggest 
that relatives (and patients) felt comfortable to discuss their own experience, as 
relatives told of their desire for emotional support from other relatives in a similar 
situation during the patients’ illness and for information on how they could provide 
more informed support for the patient. These findings are supported by a growing body 
of literature that shows the negative impact that a lack of information and support can 
have on the well-being of relatives and on the patient’s care (Hours, Rusenas, 
Simmonds, & Hueford, 1991; Soothill et al., 2003). Overall, patients and relatives 
suggested app features that can be thought of as a 'toolkit’ that would enable them to 
overcome the barriers to information-gathering and understanding that they have faced 
during and between consultations with clinicians.  
 
The majority of patients and relatives in the present study anticipated that an app 
would be an acceptable intervention, which they perceived could be useful for patients 
with all types of cancer, through all phases, particularly following diagnosis. This was 
due to their on-going need for new information as they progressed throughout their 
cancer and treatment. Based on patients’ and relatives’ perceptions in this study, it 
would be prudent to explore the usefulness of this type of app in a field testing study 
with a wider range of patients, including those with different types of cancers and at 
different stages of their illness. Exploring the use of an app with a range of patients 
might highlight whether certain populations might benefit more from this type of 
intervention (i.e. those recently diagnosed).   
 
Patients and relatives also expected that an app would be intuitive and easy to use. 
These findings are a positive preliminary indicator of the potential uptake of the app 
upon implementation and are consistent with patients’ expectations for other types of 
mobile interventions for other chronic conditions (Bostock et al., 2009; Pinnock, Slack, 
Pagliari, Price & Sheikh, 2006; Seto et al., 2010). However, the samples of this study 
included a majority of patients and relatives with higher levels of education compared 
to the general population. Studies have shown that those with lower levels of education 
(e.g. those educated to secondary school or college level) are less likely to engage 
with web-based activities for their health, such as downloading health information to a 
mobile device, communicating with a doctor via email or tracking personal health 
information online (Kontos et al., 2014). Participants included in this study may 
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therefore have had more favourable perceptions of an app that would enable them to 
perform web-based activities, compared to their less educated counterparts. This may 
have led to artificially inflated findings of the acceptability of this type of intervention.  
 
Some participants in the present study expected that older patients would be less likely 
to use an app compared to younger patients, and consistent with these expectations, a 
minority of older patients in the current study did not anticipate that they would use an 
app, instead preferring more traditional methods of information gathering. In contrast to 
these expectations, studies show that actually, many older patients are willing to learn 
to use a new technology if they think that it will benefit them (Joe, & Demiris, 2013; 
Parker, Jessel, Richardson, & Reid, 2013). Other perceived barriers to app use 
included access to Smart devices, the perceived reliability and security of information, 
and an avoidant coping approach. Access to Smart devices is likely to be temporary 
barrier as ownership of Smart devices is increasing rapidly in the UK across all 
demographic groups (Deloitte, 2016; Ofcom, 2016). Patients who do not currently own 
a Smart device will likely have access to one via family and friends. Affiliation with a 
reputable organisation and development of an app that does not require personal 
information will reduce concerns about reliability and security of information. A minority 
of patients in the present study appeared to have an avoidant coping style and 
therefore anticipated that they would not want to use an app to learn more about their 
illness. However, other useful features, such as links to information on psychological 
support, might still be of use for this group of patients.  
 
The most commonly anticipated benefit of this type of intervention was a more 
informed patient, which in turn, was expected to lead to a range of other benefits, such 
as increased quality of life, reduced anxiety and a sense of empowerment. Though 
anticipations of the outcomes of this type of intervention depended on the app features 
that were suggested, studies have provided evidence for these types of benefits as a 
result of improved communication with clinicians in consultations and increased access 
to information outside of consultations (Chumbler et al., 2007a; Street, Makoul, Arora & 
Epstein, 2009; Ussher, Kirsten, Butow & Sandoval, 2006). It is anticipated that relatives 
of patients might also experience some of these benefits by using the same app 
features, due to their comparable information needs with patients. As the majority of 
patients diagnosed with cancer are experiencing a disease for the first time, they are 
unlikely to have the knowledge or skills to actively participate in their care. Suggestions 
that this type of app might increase users’ knowledge of their condition, and 
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participation in consultations, might indicate that this type of app has the potential to 
increase patients’ levels of activation (Hibbard et al., 2004).  
 
Finally, two potential disadvantages of using this type of app were suggested, including 
increased patient anxiety and poorer communication with clinicians in consultations. 
The risks of these potential consequences may be minimised by including only 
reputable information resources and avoiding active engagement with the app during 
communication in consultations (i.e. use as a reference and not to type notes). Overall, 
the anticipated benefits of this type of intervention appeared to outweigh the potential 
disadvantages.  
 
Currently, there does not appear to be evidence of an existing, similar app intervention 
that has been successfully implemented into routine cancer practice. Participants in the 
present study did not report use or awareness of any cancer-specific apps during their 
illness. As described in Chapter 2, the development of Smart technology for use by 
patients in cancer care is in its infancy and so the majority of apps are in an early 
phase of development. Additionally, it is well known that a gap exists between the 
identification of beneficial research findings and the application in clinical practice in 
cancer care (Adesoye, Greenberg, & Neuman, 2016). Furthermore, as highlighted by 
patients and relatives in this study, the information and resources that patients receive 
upon diagnosis, and throughout their cancer, is not standardised and varies greatly 
between clinicians, clinics and hospitals. One way to implement this type of 
intervention into practice would be to make it available on the NHS digital apps library. 
This is a resource of evidence-based digital tools to help patients with a range of 
conditions to manage their health. Currently, the apps library contains only one app for 
cancer, called ‘OWise’, which enables patients to keep track of their treatment and 
wellbeing, including fatigue, appetite, pain and other issues to spot trends to help 
improve their care. Patients can also record conversations with their clinician to listen 
back to in your own time. However, the app is specified for patients with breast cancer 
only and would not be useful for patients with other types of cancers.  
 
In contrast, a handful of studies have explored the implementation of question prompt 
lists into clinical practice within the cancer setting (e.g. Dimoska et al., 2012; Glynn-
Jones et al., 2006). While these studies generally reported positive findings on the 
acceptability and feasibility of this type of intervention, they highlighted the challenges 
of implementing new interventions into practice. For example, one study aimed to 
distribute a question prompt list to 300 cancer patients in a UK oncology clinic over one 
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year (Glynne-Jones et al., 2006). A research nurse distributed the question prompt list 
to patients as they arrived for their consultation and patients were surveyed following 
the consultation. Despite efforts to ensure that all patients received the question 
prompt lists, only 85% (n=254) of patients received them. Additionally, some patients 
felt the doctor was busy and did not want to take up too much of their time by using the 
question prompt list. Nevertheless, 65% of patients (n=195) felt that the intervention 
was ‘very helpful’ and one-third of the patients were able to ask more questions about 
their disease as a result. A similar study was conducted across four cancer centres in 
Australia (Dimoska et al., 2012). This study also reported that only 64% of 606 patients 
received a question prompt list. Of those offered a question prompt list, 91% accepted 
and post-consultation, 89% reported reading the question prompt list and, of these, 
44% referred to the question prompt list during the consultation at least once. These 
findings highlighted the importance of implementation studies as the delivery and use 
of this intervention in practice was less than optimal.  
 
4.5.1 Study strengths and limitations 
The varied samples of patients and relatives are a strength of this study, however there 
are several limitations to consider. Firstly, the study had a low response rate for both 
patient and relatives and the samples included high numbers of Smart technology 
owners and a majority with higher educational levels. Additionally, information on the 
key characteristics of those who declined to participate was not collected and the 
different cancer sites had varying response rates. Specifically, the lowest response 
rate was from patients with urological cancer, which contrasts to patients with 
colorectal cancer, who had the highest response rate. The samples included in this 
study, particularly the patient group, may therefore not be representative of the general 
population. Due to these limitations, the sample may have included those with more 
favourable perceptions of an app than those who chose not to participate. For 
example, those who declined to participate may have not been familiar with Smart 
technology or liked the idea of an app for patients with cancer. Similarly, patients who 
do not own Smart technology were likely to be less familiar with it and may therefore 
have had more negative perceptions of this technology. Finally, the low response rate 
from patients with urological cancer, as well as a fairly low response rate from patients 
with breast and gynaecological cancers, might indicate differences in opinion of the 
acceptability and feasibility of an app between cancer sites. For example, patients with 
urological cancer, which includes kidney, bladder, prostate, testicular, and penile 
cancers, are more likely to be older male patients and studies have shown that this 
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population group are less likely to engage in health information-seeking and other 
related web-based activities (Kontos et al., 2014). It is therefore possible that these 
limitations artificially inflated the positive findings of this study. Participants included in 
this study may also have had different needs and preferences regarding an app 
compared to their counterparts.  
 
A further limitation of this study is that all participants were White Caucasian. While 
some studies suggest little evidence for a digital divide by race/ethnicity (Kontos et al., 
2014), some report that patients of black and ethnic minority groups, such as African 
American and Chinese, may have different experiences of cancer, and use different 
information sources, compared to majority groups, and may therefore have different 
needs and preferences regarding an app (Elkan et al., 2007; Matthews et al., 2002; 
Randhawa & Owens, 2004).  
 
The sample size of the relatives group was small and all relatives participated in joint 
interviews with the patients. Additionally, some relatives included in this study 
volunteered to participate at the time of the patient’s interview. It is therefore possible 
that relatives perceived that they felt they were present to validate the patients’ voice 
(Kendall et al., 2009). Joint interviews may have also prevented relatives (or patients) 
from discussing important issues that they might have talked about in a separate 
interview (i.e. protective buffering) (Hagedoorn et al., 2000). These limitations may 
have led relatives to agree with the views of the patient, however this risk was 
minimised as much as possible by careful development of the topic guide.  
 
Finally, providing examples of types of app features that participants might find useful 
prior to beginning the interview might have influenced responses due to social 
desirability. The risk of this bias was minimised as the prior to the interview, the 
candidate explained that all opinions were valued, both positive and negative, in order 
to develop an app that would be most useful for future patients and their families.  
 
4.5.2 Future research 
Future studies could investigate the views of certain minority populations of patients, 
such as those with negative perceptions of an app, those who do not own or have 
experience with Smart technology and those with lower levels of education or health 
literacy (Kontos Blake, Chou & Prestin, 2014; Neter & Brainin, 2012). This will help to 
determine the barriers to use of this type of intervention for these population groups 
and ways to overcome them, and identify possible strategies to increase engagement 
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of these patients and their families. Furthermore, the present study excluded those 
patients under 18 years of age. Interventions identified for adolescent patients by the 
systematic review in Chapter 2 were gamified apps. For this reason, it was 
hypothesised that this population may have different needs and/or preferences 
regarding an app for cancer. For the same reason, patients with less than 12 months to 
live were not included in this study. Further studies are required to explore the 
perceptions of these subgroups of patients. Further research is also needed with 
patients with urological, breast and gynaecological cancers, as these cancer sites had 
a lower response rate compared to patients with colorectal cancers in the present 
study. Finally, individual interviews with relatives of patients with cancer are required in 
order to support the findings of this study.   
 
4.5.3 Implications  
The findings of this study have several implications for the development of an app. 
Firstly, this study identified the psychosocial context of patients and their relatives 
which appeared to have shaped their needs and preferences regarding an app to meet 
their information needs. Specifically, findings confirmed that barriers to information 
exchange and understanding during consultations with clinicians, and identification of 
reliable information sources outside of consultations, still exist for patients with cancer 
and their families. This study also presented evidence to support the knowledge that 
information-gathering may used as an adaptive coping strategy. Together, these 
findings indicate the need for an app intervention to help patients and their relatives to 
overcome these barriers and enable them to meet their information needs. Secondly, 
this study presented novel findings on the needs and preferences of patients with 
cancer and their relatives regarding the development of an app. Preferences for app 
features can be used to develop intervention objectives and inform the selection of app 
features that are required to achieve these objectives (Yardley et al., 2015).  
 
Views of patients and their relatives on the usefulness and acceptability of this type of 
intervention for a wide range of patients may be interpreted as a positive preliminary 
indicator of the potential uptake of the app upon implementation (Craig et al., 2008; 
Yardley et al., 2015). However, these findings must be interpreted with caution due to 
the low response rate of the study. This study also identified the potential outcomes of 
this type of intervention, including the benefits and disadvantages of, and barriers to 
app use, which may be considered during app development in order to optimise its 
uptake, usability and usefulness (Craig et al., 2008; Yardley et al., 2015).  
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This study highlighted how several health behaviour models, theories and approaches 
related to the impact and self-management of a chronic illness were useful to explain 
some of the findings, including the CSM (Leventhal et al., 1984) crisis theory (Moos & 
Schaefer, 1984), theory of cognitive adaptation (Taylor, 1983) and the patient 
activation framework (Hibbard et al., 2004). These theories may be use to inform 
development of an app intervention and selection of app features. Finally, this study 
added to the preliminary body of work conducted for this thesis so far, which follows 
the MRC framework for the development of complex interventions (Craig et al., 2008). 
Specifically, findings of this study provided further insight into the theories that may be 
relevant for such an intervention, the processes that may underpin the intervention (i.e. 
the issues faced by patients and the app features suggested to overcome these) and 
potential outcomes of this type of intervention (i.e. the potential benefits and 
disadvantages).  
 
4.5.4 Conclusion 
This study was the first to explore the needs and preferences of patients with cancer, 
and their relatives, regarding an app that aims to help them to meet their information 
needs in non-inpatient settings. Patients and their relatives highlighted the importance 
of having information and its use as a coping strategy to regain a sense of control over 
their lives. However, barriers to information exchange and understanding during 
consultations with clinicians and identification of reliable information sources outside of 
consultations appeared to lead to unmet information needs. These findings led to 
discussions of the types of app features that patients and relatives would find useful. 
Specifically, an app that enabled patients and their relatives’ to develop an 
understanding of and subsequently self-manage the condition was required, including 
features to support information exchange and understanding in consultations and 
features to increase access to support for both patients and their relatives. Overall, 
patients and their relatives considered an app to be an acceptable medium to receive 
interventions to support them through cancer. However, the findings of this study must 
be interpreted with caution due to a low response rate and other limitations. 
Nevertheless, the potential outcomes of this type of intervention were highlighted and 
the benefits of an app appeared to outweigh the few possible disadvantages and 
barriers to app use.  
 
  
	 113	
Chapter 5 
The views and opinions of cancer clinicians regarding an app to help 
patients with cancer and their relatives to meet their information needs: a 
qualitative interview study 
 
5.1 Chapter overview 
This chapter reports a novel qualitative interview study that explored the views of 
cancer clinicians on the value of an app for patients and their relatives. This study was 
used to gain an understanding of the type of app that clinicians anticipate to be most 
useful for patients and their relatives, and the potential uptake and possible outcomes 
of this type of intervention, including the benefits and disadvantages of, and barriers to, 
app use. This study was used to identify whether clinicians would support the use of an 
app in cancer care and assess their training needs in relation to the app. Data from 
semi-structured interviews were analysed using thematic analysis. The implications of 
the findings for the creation of an app are discussed. 
 
5.2 Introduction 
As well as in depth exploration of the issues faced by the key users of an intervention, 
it is important to gain an understanding of the context in which an app intervention 
would be used and potential influences on the intervention (Murray et al., 2016, 
Yardley et al., 2015). Findings from Chapter 4 reported suggestions of features by 
patients and their relatives to include in an app that would help them to meet their 
information needs. These suggestions included features that would be used in 
consultations with their clinicians, such as a QPL. It is therefore important to explore 
clinicians’ perceptions of the acceptability of this type of app, as their support is key to 
the its successful implementation in consultations (Murray et al., 2016).  
 
Technology is fast becoming integrated into the healthcare service and there are many 
apps now available to assist clinicians with their clinical tasks, such as information 
gathering, clinical decision-making and medical education and training (Divall, 
Camosso-Stefinovic & Baker, 2013; Ozdalga, Ozdalga & Ahuja, 2012; Wallace, Clark 
& White, 2012). Studies have shown that the majority of clinicians have positive 
opinions on the use of such technology in healthcare, however some clinicians are still 
reluctant to use this technology in clinical practice (Bostock et al., 2009; Ozdalga et al., 
2012; Wallace et al., 2012). Unease about new technology in healthcare includes 
concerns about patient data protection, the impact of technology on the patient-
clinician relationship, and the integration of technology into clinical practice, as well as 
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the accuracy of intervention content (Moodley, Mangino & Goff, 2013; Mickan, Tilson, 
Atherton, Roberts & Heneghan, 2013). Early-phase studies of mobile interventions to 
support patients with cancer in non-inpatient settings, such as feasibility studies and 
pilot RCTs, have revealed mixed opinions from clinicians that use mobile technology in 
clinical practice (Kearney et al., 2006; Maguire et al., 2008; McCall et al., 2008). For 
example, a survey of 28 nurses involved with a mobile chemotherapy symptom-
monitoring intervention found that 67% perceived the intervention to be time-
consuming and 57% found it to be a challenging experience (Maguire et al., 2008). 
Additionally, post-study interviews revealed that nurses felt the intervention had 
impacted on their workload. However, despite this initial experience, the majority of 
nurses could see the potential benefits of such an intervention. Involving clinicians prior 
to the development of an app intervention for patients and their relatives provides an 
opportunity to identify and minimise the potential barriers to its implementation in a 
clinical context (Maguire et al., 2008; Murray et al. 2016). 
 
Clinicians also have a potential role in encouraging the uptake of an app for patients 
with cancer following a diagnosis, as patients value the opinions of their clinicians and 
trust them as a source of reliable information (Hall et al., 2002; Rutten et al., 2016). 
Furthermore, second to patients themselves, clinicians have an awareness of their 
patients’ needs and can provide further insight into the type of app and features that 
would most beneficial.  
 
5.2.1 Aims of the present study 
To date, no study has sought to understand the views of cancer clinicians regarding 
the development of a novel app intervention that aims to help patients with cancer and 
their relatives to meet their information needs in non-inpatient settings. This study 
aimed to explore clinicians’ views of information exchange in consultations and the 
type of app that they anticipate to be most useful for patients. Specifically, the 
perceived acceptability of an app, useful app features and the potential benefits and 
disadvantages of, and barriers to app use were explored, as well as the types of 
patient and the time at which they might find this intervention most useful. Views on 
whether clinicians would support the use of an app in cancer care and their 
perceptions of their training needs in relation to the app were also established.    
 
5.2.2 Qualitative methods 
Semi-structured interviews were used to explore the views of clinicians and thematic 
analysis was conducted to analyse interview findings. Reasons for choosing this 
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method and details of the analysis are similar to those discussed in Chapter 4, section 
4.2.2.  
 
5.3 Methods 
5.3.1 Participants 
Maximum variation sampling, a type of purposeful sampling strategy in which cases 
are selected on the basis of the study populations’ characteristics and on the study 
objectives, was used to allow for divergent views to emerge (Patton, 2002). Clinicians 
were recruited from colorectal and urological cancer clinics at UHW and breast and 
gynaecological cancer clinics at Velindre and the sample aimed to include consultant 
surgeons, consultant oncologists, cancer nurse specialists and trainee clinicians.  
 
5.3.2 Recruitment 
Lead clinicians were contacted by the candidate’s clinical supervisors to arrange for 
the candidate to attend multi-disciplinary team (MDT) meetings at each of the cancer 
clinics to present the study and invite clinicians to participate. Interested clinicians were 
encouraged to contact the research student via telephone or email. Following this, 
clinicians were provided with an information pack, including an invitation letter, 
information sheet, and reply form via email (Appendices 20-22). All interested clinicians 
chose to contact the candidate directly by email instead of returning a reply form. The 
candidate contacted interested clinicians to answer any questions about the study and 
arrange an interview at their clinic, at time convenient for them. It was not possible to 
attend an MDT meeting in all cancer clinics, in which case the lead clinician of the 
clinic was asked to email his/her colleagues to invite clinicians to participate in the 
study and to contact the candidate if interested. As a result of this recruitment method, 
it was not possible to determine the response rate.  
 
5.3.3 Procedure 
At the time of the interview, clinicians were provided with a consent form to sign and a 
further opportunity to ask questions about the study (Appendix 23). The candidate 
explained that the interview was confidential and that only the candidate and lead 
supervisor would have access to the data. Participants were informed of how the data 
would anonymised, stored securely and kept for 15 years at Cardiff University, after 
which, it will be deleted. Demographic data were then collected by questionnaire prior 
to the start of the interview (Appendix 24). The interviews were audio-recorded with 
permission. Audio-files were sent electronically to a reputable company for 
transcription by uploading the files to a secure server used by the transcription 
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company. Audio-recordings were transcribed verbatim, as described in Chapter 4. Any 
information that could identify participants in the interview transcripts was anonymised. 
A confidentiality agreement was required from the transcription company to ensure that 
participant data and information was protected. Once the completed transcripts were 
provided to the candidate, the candidate listened to the audio-recordings whilst reading 
the transcripts to check for accuracy. 
 
5.3.4 Data management 
Transcripts and audio-recordings were securely stored on a Cardiff University 
password-protected server in accordance with the Data Protection Act 1998. This 
server is password-protected and confidential. All consent forms, transcripts and audio-
recordings will be kept securely for 15 years according to Cardiff University research 
data policies. Following this time, all data will be destroyed.  
 
5.3.5 Interview topic guide 
A semi-structured interview topic guide was used (Appendix 25). Findings from 
interviews with patients and their relatives, and other relevant literature, informed the 
development of the topic guide. The topic guide was reviewed by the candidate’s 
supervisors and amendments to the topic guide were made following comments. The 
main topics covered at interview were information provision in consultations, clinician-
patient communication in consultations, experience with Smart technology, perceived 
acceptability of an app, perceived benefits and disadvantages of, and barriers to app 
use, useful app features for patients and their relatives and clinicians’ training needs in 
relation to the app. At the beginning of the interviews, the candidate briefly explained 
the type of app that might be useful (i.e. one to help with patients’ information needs) 
and described examples of types of app features to help clinicians to imagine what 
types of features would be possible to include an such an app. 
 
5.3.6 Analysis 
Participants were interviewed until data saturation was reached to ensure that 
adequate data were collected and the views of participants were represented. Data 
saturation was considered to have occurred when no new themes were identified for at 
least the final three interviews. Data were managed using the qualitative analysis 
software package NVivo (NVivo, 10). Interview transcripts were analysed using 
thematic analysis (Braun & Clarke, 2006), which has been described in Chapter 4, 
section 4.2.2. Four transcripts were independently analysed by the candidate’s 
supervisor, Dr Fiona Wood, who has extensive experience of qualitative research, to 
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reduce the potential bias of subjectivity associated with coding and facilitate 
interpretation of findings. Discrepancies were resolved through discussion.  
 
5.3.7 Ethical issues 
NHS ethical approval and R&D approval from each of the sites was granted 
(14/WA/0066, Appendices 13-15).  
 
5.4 Results 
Twenty interviews were conducted with 22 clinicians between June 2014 and 
November 2014. Four CNSs chose to be interviewed in pairs stating time constraints in 
clinic as their reason, however the remaining clinicians participated in individual 
interviews. The average length of the interviews was 27 minutes (range 20-39 
minutes).   
 
5.4.1 Sample characteristics 
Characteristics of participants are presented in Table 4. All participants reported that 
they owned a Smart device (Smartphone or tablet).  
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Table 4: Sample characteristics of clinicians. 
Participant 
ID Gender Occupation Cancer clinic 
C1 (Onc) Female Oncologist Gynaecology 
C2 (Onc) Male Oncologist Breast 
C3 (Onc) Female Oncologist Breast 
C4 (PCC) Female Palliative care consultant All types 
C5 (CNS) Female Cancer nurse specialist Breast 
C6 (TOnc) Male Trainee oncologist Gynaecology 
C7 (CNS) Female Cancer nurse specialist Gynaecology 
C8 (CNS) Female Cancer nurse specialist Gynaecology 
C9 (CNS) Female Cancer nurse specialist Colorectal 
C10 (CNS) Female Cancer nurse specialist Colorectal 
C11 (Sur) Male Surgeon Colorectal 
C12 (Onc) Male Oncologist Colorectal 
C13 (TSur) Female Trainee surgeon Colorectal 
C14 (Onc) Male Oncologist Gynaecology 
C15 (TSur) Male Trainee surgeon Urology 
C16 (Sur) Male Surgeon Colorectal 
C17 (TSur) Male Trainee surgeon Urology 
C18 (CNS) Female Cancer nurse specialist Urology 
C19 (Sur) Male Surgeon Urology 
C20 (CNS) Female Cancer nurse specialist Urology 
C21 (CNS) Female Cancer nurse specialist Urology 
C22 (TSur) Male Trainee surgeon Urology 
 
 
5.4.2 Interview themes 
From the interviews, three key themes were identified and included: (1) information 
exchange in consultations, (2) relatives’ information needs, and (3) opinions on an app 
for cancer patients and their relatives. Subthemes will be discussed in detail below. 
Participants are identified with ‘C’ followed by their identification numbers and 
abbreviations of occupations listed in Table 4 (e.g. C1(Onc) is Clinician 1, oncologist). 
The interviewer is identified by ‘I’. Where irrelevant, text was removed from quotes and 
denoted by {…}. Square brackets within the quotes represent inserted text to clarify the 
content.  Exemplar transcripts are included in appendices 26 to 29. 
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Theme 1: Information exchange in consultations 
This theme reflects the views of clinicians on their experiences of information 
exchange with patients in cancer consultations. Key subthemes included barriers to 
information exchange and varied information provision. 
 
Subtheme 1: Barriers to information exchange 
Participants reported several barriers to information exchange that they experience 
during consultations. Clinicians reported that anxiety as a result of the cancer 
diagnosis was the one of the most common barriers they experienced. Anxiety caused 
patients to struggle to concentrate, digest and recall the information provided and as 
well as forget to ask questions, particularly during the first few consultations after 
diagnosis. Additionally, clinicians reported many cases where patients appeared to 
have made themselves more anxious by searching for information on their condition on 
the Internet, where they had been misinformed.  
 
C15 (TSur) - Most of them [the patients] are really anxious actually that’s the, 
that’s the main problem. When they come in for the consultation... and many 
times it happens that whatever we say doesn’t register in the mind. Especially 
at the first consultation.  
 
C22 (TSur) -… you say something big like cancer and they start to drop off and 
don’t, don’t think of anything else, and I think that’s a major barrier …we always 
ask at the end of consultations, do you have any questions. Invariably, the 
answer’s no, or they’ll have one question. And I think when they leave the 
consultation and leave the room, they’ll think damn I should have asked that 
question… 
 
C16 (Sur) - I’ve had a few of the sort of more IT literate patients come 
extremely anxious into clinic saying I’ve read this forum where some patient 
was saying, “This is a disaster don’t let any surgeon do this operation”, and 
they’ve got completely the wrong information, they’ve been talking about 
completely the wrong operation and you know and you’re already starting on a 
really back foot with those patients. 
 
Another frequently reported barrier was an avoidant coping approach adopted by the 
patient. Clinicians reported that a minority of patients do not wish to have information 
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on their condition, and instead, prefer the minimum amount of information that they 
need to undergo treatment.  
 
C16 (Sur) - I think the, first and probably the most difficult one is the patient 
who doesn’t want to know, and you do get that not infrequently. And that’s a big 
problem because you get the patient who is happy to have an operation but 
doesn’t want to know about the operation and about the consequences of 
surgery and the potential complications of surgery, that’s a problem because 
you are obliged to discuss that with them.  
 
Many clinicians reported that some patients lack a basic understanding of cancer and 
its treatment, which limits the amount of information that they can provide to patients. 
Additionally, some clinicians reported that they, and other clinicians, do not always 
communicate information to patients in layman’s terms, which may limit patients’ 
understanding of the information provided. Clinicians also suspected that some 
patients may too embarrassed to tell them if they have not understood the information, 
which may lead to further unmet information needs. 
 
C22 (TSur) - I mean, I’m always conscious to keep it in as simple terms as 
possible, but you can go a little bit more into the technicalities with someone 
who knows about the subject. At the very other end of the spectrum, you have 
people who know nothing about the subject and, if that’s the case, then you 
want to just try and spell it out as simply as possible. But then you can’t get the 
details in there.  
 
C13 (TSur) - Something I try hard not to do but I have seen it as a trainee 
where consultants don’t necessarily use lay terminology… and even if you try 
hard not to slip up, I’ve done it myself, consciously trying to avoid it so I think 
that can be an issue.  
I - So patients’ technical understanding…  
C13 (TSur)- Yes so you use terms they are not understanding and they may 
not pick up on it or tell you, they are embarrassed and think they should know 
about it. 
 
Clinicians felt that the short amount of time allocated consultations limits opportunities 
to check patients’ concerns and understanding of the information and some felt it was 
not sufficient for patients to fully understand and memorise the information. Clinicians 
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also reported an awareness that some patients may be conscious of the time they 
spend in consultations due to clinicians’ busy schedules.  
 
C22 (TSur) - I think the main thing is you’ve got a very small window in your 
clinic, often a busy clinic to tell somebody some life changing news, so it’s 
difficult to convey, you know, you would like to spend as much time as you can 
with that patient, so they really understand what’s going on and what their 
options are and if they have questions at that time and things, but it’s difficult 
because of the time frame. 
 
C5 (CNS)– um, sometimes I think maybe the clinics are really busy so the 
patient perceives the doctor is very busy {…} they sense that sometimes, but 
certainly with all our consultants they do allow enough time for every patient, 
but you know in a busy clinic the patient’s are aware of other patients sat there. 
 
Subtheme 2: Varied information provision  
Clinicians reported that their awareness of these barriers to information exchange in 
consultations means that vary the amount and type of information that they provide to 
patients. Patients who are perceived to be less anxious and more knowledgeable tend 
to receive more information from clinicians than those who are perceived to be more 
anxious and less knowledgeable, as these patients are perceived to be less likely to 
cope with, understand and recall the information.  
 
C9 (CNS)-  … it depends on the individual really, the patient’s needs, some 
patients have got more than others, some patients can cope better than others 
and just assess it individually isn’t it, how shocked they are at the initial 
consultation. If they’re composed then we give them more information in the 
next outpatients, it’s all pretty by ear really. 
 
C18 (CNS) - Well in my view you have to try to establish a nice rapport, work 
out what they might be able to understand and how much they’d be able to 
understand in one sitting, that’s what I would say. Erm so you have to gauge 
the person and you have to ask them what they want to know and invite them 
to ask questions. 
 
In an attempt to increase patient understanding and recall of important information, 
clinicians reported that they only provide patients with the basic information and will 
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provide further information if the patient asks for it. Some clinicians described a staged 
approach of information-giving, where they tell the patient more information about their 
condition and treatment at each consultation to give them time to digest it.  
 
C16 (Sur) - I think there’s two boxes I’d say, I’d say there’s information about 
the cancer and the surgery which every patient needs to be told, I think you can 
put things in that, like you know {…} stage of cancer, erm prognosis to some 
extent, but then there’s a whole huge amount of information which you put in 
another box, for me anyway which is I can tell the patient this stuff if they want 
to know it. So I don’t see it as being compulsory to tell them stuff but depending 
on each consultation, depending what the patient’s cognitive ability is and 
whether they want to know this stuff or not there’s a huge amount of stuff which 
we can tell them if they want to know it. But I think there’s a core information 
which we have to tell the patient.  
 
 C19 (Sur) - …in the clinic, doctors have to think about that on the spot. So 
actually, “I think that’s a bit much, that’s enough now, I am going to step back a 
bit, and let’s look at it again once you’ve had time to have a think”. 
 
Written information and the format in which it is provided to patients also varied 
between clinicians, for example, some reported that they provide links to cancer 
information websites, whereas others reported that they provide information leaflets.  
 
C19 (Sur) - We might give them information booklets which describe ... 
Prostate Cancer UK website, is very good {…}. But in some appointments, er, 
we might, if we have got a reasonable screen, we might show them, “this is the 
Prostate Cancer UK website” {…}. But we don’t do that very often I don’t think, 
and obviously there are issues around availability of computer screens and 
showing patients, er, it’s not straightforward. 
 
Theme 2: Relatives’ information needs  
This theme reflects clinicians’ views of and concern for relatives of patients. Many 
clinicians reported that relatives of patients often ask their own questions in order to 
fulfil their own information needs. Clinicians reported that relatives often still want 
information in cases where the patient themselves does not wish to have extensive 
information on their condition.  
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C3 (Onc) - …Often it’s the relatives that come with the questions.  
 
C16 (Sur) - …Sometimes we get relatives phoning us up wanting to speak to us 
about, you know …from different areas of the family. 
 
C5 (CNS) –…Quite a lot of the time uh, the other family members will ask the 
questions that, that particular patient doesn’t. 
 
One clinician suggested that relatives of patients are often more anxious than the 
patient themselves, as they feel that they are unable to help the patient when they are 
unwell. 
 
C12 (Onc) - Um, relatives will often feel that, strangely enough, relatives often 
feel more stressed than some of the patients, because they feel useless, they 
feel they can’t do anything.  
 
Theme 3: Opinions on an app for cancer patients and their relatives 
This theme reflects clinicians’ views on the value of an app for patients and their 
relatives, and the type of app that they anticipate to be useful. Key subthemes were: 
anticipated acceptability, suggested app features, anticipated benefits, potential 
disadvantages, and anticipated barriers.  
 
Subtheme 1: Anticipated acceptability  
Subtheme1a: App use in consultations 
Most clinicians reported that they do not currently use Smart technology with their 
patients in consultations, however two clinicians had used apps to assist them in 
explaining a patient’s condition to them but had not jointly used it with a patient in a 
consultation. Most clinicians anticipated that it would be acceptable for patients to use 
an app for their cancer in consultations, as many patients already bring printed 
information or written question lists, and some use their Smartphones to make notes 
during consultations.  
 
C14 (Onc) - …There’s a few kind of apps erm that are useful, like a Figo app. 
I - What does that do? 
C14 (Onc) - Erm, it tells erm, it’s got all the different gynae cancers, what are 
the different stages and what the treatments erm… complications and stuff. 
I - And is that for clinicians? 
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C14 (Onc) - Erm, yeah more aimed at that.  
I - Do you ever use it with patients, do you ever sort of…? 
C14 (Onc) - Hmm, I haven’t done yet actually.  
 
C19 (Sur) - … I mean, patients bring bits of paper, articles, all sorts of things. I 
mean, I think the patient population is changing {…} …you know, it’s just a 
screen with information on it really isn't it? {…} So I think, you know, the 
delivery is not critical…in terms of what the response would be to them bringing 
it in and discussing it. {…} …the patients write things down quite a lot now. If 
they, I think if they did something on the app as opposed to the writing it down, I 
don’t think it makes any difference. 
 
C16 (Sur) - I mean often patients will bring out erm a notebook with questions 
they’ve written down at home so I can’t see how it’s different {…} it’s just a 
slightly technological way of doing the same thing. 
 
In contrast, two participants suggested that some older clinicians might perceive 
patients’ use of an app in consultations to be socially unacceptable and will ‘resist’ the 
use of this type of technology in consultations.  
 
C22 (TSur) – …Um there are still, I’m sure the old guard who will have to be 
moved out in the next ten years as well, and they might er, they might have a 
big resistance to it.  
 
Subtheme 1b: Anticipated uptake  
Clinicians anticipated that many patients with cancer, and their relatives, would want to 
use an app to help to meet their information needs, however many also expected that 
younger patients would more likely to use an app compared to older patients, as they 
are more familiar and experienced with Smart technology.  
 
C11 (Sur) - I mean, it’s difficult because a lot of these patients are elderly so, 
and I know a lot of elderly people do use tablets and Smartphones, but I don’t 
think it’s as prevalent as maybe in the younger age groups, so you know. I think 
certainly for some people it [the app] would be very useful {…}. You know, I 
think apart from, you know, the very elderly, I think most, a lot of people are 
starting to use the technology, you know, in their 70s and 80s, so I think it will 
apply to most groups. 
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Consequently, some clinicians anticipated than an app intervention would be 
particularly useful for cancers that more commonly affect younger patients, such as 
testicular or cervical cancer, though most anticipated that an app would be useful for all 
types of cancers.  
 
C19 (Sur)- …If you look at the, sort of, if you can imagine in your own mind the, 
sort of, age of the patients with different cancers. So testes cancer would be 
affecting quite a young male population, um, peak incidence in the late teens, 
early twenties. So that group would probably be quite familiar with 
Smartphones and apps. Er, many cancers, of course, affect the elderly 
population.  
 
Most clinicians anticipated that an app would be useful throughout all phases of the 
cancer journey (i.e. diagnosis, treatment, remission), as each phase brings new 
questions for patients. Some expected that an app that aims to help patients and 
relatives with their information needs would be most useful following diagnosis, as 
patients appear to have the largest need for information at this point.  
 
C12 (Onc) - I think it [the app] could be suitable for all, I don’t think there is any 
...routes {…} …I don’t think there are any groups that it shouldn’t be considered 
for. 
 
I - So you mentioned that an app might be most useful in the first month 
following diagnosis. Could you tell me why you think that might be the case?  
C22 (TSur) - Because I think in the first month, a majority of people who get a 
diagnosis, try and gather as much information as they can. The way they 
normally do that is with Google and with friends, both of which are pretty 
unreliable at best. Um you know, some people might be lucky and they come 
across the correct information, but some people might not and so I think it’s 
important that in that time period, they get the correct information {…}. Um I 
think, you know, once you are six months down the line, maybe you would have 
to have another app or you know, a year down the line, for the chronic 
proportion of their disease. Um but at that point generally, people know enough, 
they’ve gained enough information about their disease, that they aren’t looking 
for new stuff any more. 
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Alternatively, some clinicians expected that an app would be most useful for patients 
who are in remission and are being followed-up, as these patients often have 
questions about long-term side effects of their cancer or treatment and recovery but 
are not in regular contact with their clinicians.  
 
I - so you mentioned that, erm ... perhaps this app could be useful for sort of 
post treatment and follow up …can you just elaborate a bit on that?  
C14 (Onc) - Well like I said you can look out for possible problems, erm ... I 
think you know you can prompt who to call if you had a problem like that. {…} 
Erm … you could prompt, well I suppose it might get annoying but you could 
prompt the app to sort of check on you every morning, just to how are you 
feeling this, have you got any symptoms, but that could get annoying {...} but I 
suspect it’s a lot of being able to look at possible problems that a patient might 
be experiencing and then whether they should then, erm ... initiate something 
you know.  
 
Subtheme 1c: Clinicians’ training needs 
Clinicians did not anticipate that they would require extra training in how to deal with 
possible changes in communication with patients in consultations as a result of an app, 
as they already deal with more active patients who bring printed information or written 
question lists. Many clinicians reported that instead, they would like to know the 
content of the app.  
 
I - Do you feel that clinicians would require training in how to deal with more 
active patients as a result of this type of app? 
C14 (Onc) – Erm, I wouldn't have thought so, but they will need to know what is 
on the app and what’s on the … you probably will have to allow the clinician to 
look into what is actually in the app and how the app works so that they 
understand. 
 
Subtheme 2: Suggested app features 
Overall, clinicians’ suggestions for app features indicated that an app that would help 
patients, and their relatives, to meet their information needs was anticipated to be a 
useful intervention. Some clinicians found it difficult to think of potential app features 
and instead, listed the types of information that patients request in consultations (see 
below). The most commonly suggested app features were organised into four themes: 
(1) features that support patients’ self management of their condition, (2) features that 
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facilitate information exchange in consultations, (3) features that increase access to 
patient support, and (4) features that increase access to support for relatives.  
 
Subtheme 2a: App features that support patients’ self-management of their condition 
Clinicians suggested features that would facilitate patients’ general self-management 
of cancer, including information, organisation and communication features. Many 
clinicians described the types of information most commonly requested in consultations 
by patients. Clinicians suggested including information on the types of cancers and 
their investigations, treatment options, the potential side effects of treatment, 
symptoms caused by the cancer, recovery and potential long-term effects. Other 
suggested information included lifestyle (such as guidelines on diet, exercise and 
smoking), clinical trials, psychological support, cancer support services, genetic risk, 
transport to appointments, palliative care and cancer survival rates.  
 
I – I know there are loads of things that an app could do, but are there any 
features that you think might be useful? 
C21 (CNS) – Yeah erm, well definitely anatomy…things like why the 
investigations have been carried out, why we need to carry out extra tests, 
information about treatments, possible side effects and what psychological 
support is out there as well because I think that’s often missed really and, erm, 
and probably information on how to look after yourself as well you know. I mean 
smoking cessation, diet, stuff like that. Because a lot of patients ask that. 
 
Clinicians suggested including links to credible cancer information websites to signpost 
patients to reliable information, as they were aware that patients can often struggle to 
find reliable information outside of consultations, particularly on the Internet, where 
some patients had been misinformed.  
 
C5 (CNS) – …I think if the patients are getting good information, so you know if 
this app is directing them to the right sites and everything, so it’s specific to 
them, then lots of patients go on the Internet and Google breast cancer and you 
get millions of hits back and they don’t know what is good information and what 
is bad information, so I think if this [the app] is going to tailor, or point them in 
the right direction, the clinicians would be up for that totally.  
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C14 (Onc) - …So maybe if we had an admin signpost you are in the right place 
and perhaps even signpost you to the correct, erm … websites that you read 
through and information that would be really useful. 
 
Some clinicians felt that an app could help patients to organise their care, as they 
explained how patients are faced with many appointments, various tests and multiple 
treatment visits. Some clinicians suggested linking the app to the calendar feature on a 
Smart device to remind patients of upcoming appointments, as many forget to attend. 
Additionally, some clinicians suggested including a medication log for patients to 
record their medication, and some suggested a feature to remind patients to follow 
rehabilitation guidelines upon discharge.   
 
C13 (TSur) - …I mean I really like the idea of the prompts and the diary and 
reminders, I mean patients forget so maybe a day in advance to just remind 
them and then it reduces our DNAs [Did Not Attend]. Or a week before, “Have 
you asked your boss for that time off? Have you booked transport?” Or 
something like that. You get text messages from your bank appointments don’t 
you? Why not for your cancer appointments? And then if it’s changed [the 
appointment], so act maybe as a diary manager… they get a lot [of 
appointments] in a two-week period because they’ve got to be managed.  
 
C13 (TSur) - So what about a prompt that you get, I don’t know, 4 weeks, how 
you deal with cardiac rehabilitation. You know, “Have you done your three 
times a week walk round the block? If not why? Have you got any of the 
following symptoms? If you have speak to your GP”. You know and it sort of 
acts as a little pop up reminder, you can even have it so if it does actually pop 
up on your phone and sort of say, and you could set it so if you wanted to sort 
of achieve so much you could sit there with the patient say what I’d like you to 
do is this, and you set it with them, and then they’ve got a reminder. 
 
Clinicians suggested a feature that could store clinician contact details to enable 
patients and their relatives to contact their clinician quickly when they need to do so, as 
they explained that patients often forget their designated nurse or consultant or lose 
their contact details. Clinicians also suggested including the contact numbers of cancer 
charities as they provide many useful services for their patients, which many other 
patients are not aware of, and so could be used to provide extra support.   
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C13 (TSur) - The name of the clinicians that are looking after them, half the 
time they can't remember…contact details for their clinicians, that would be 
really useful. Summary of, you know, this is your diagnosis, this is your 
consultant, this is the number, the name of the nurse specialist, this is the name 
of the stoma nurse, these are their contact details, these are their email 
addresses, this is the secretary’s number. Everything they need there without 
having… because they come in with reams of paper scrawled and they can’t 
remember anything. 
 
C22 (TSur)- …Perhaps local phone numbers for specialist nurses or specialist 
departments…just having contact numbers so that if their relative becomes 
unwell or they have particular questions and need to get hold of someone 
urgently there’s a quick reference contact or phone number or email or 
something that they can have access to. 
 
C18 (CNS) - …Erm, relevant information on how to find help, you know how to 
get extra support like erm, like a forum …or group support …or MacMillan 
numbers, Tenovus numbers.  
 
Subtheme 2b: App features that facilitate information exchange in consultations 
Clinicians suggested app features that would facilitate information exchange in 
consultations and patients’ understanding of information, in an attempt to overcome 
some of the reported barriers in consultations (described in section 5.4.2.1.1). Many 
clinicians were aware that patients forget to ask questions in consultations and that this 
can lead to unmet information needs. Participants suggested including a question 
prompt list feature to remind patients to ask questions during consultations. 
 
C15 (TSur) - I mean many patients come and say to us, they’re once, first at 
the initial the shock, of the diagnosis, got cancer. So nothing, they can’t think 
about anything else. Um so if they can formulate some questions, they won’t 
forget to ask, and they can keep their Smartphone in front of the consultation, 
and keep ticking the boxes. That um, that’ll be useful actually for them, so they 
don’t forget anything.  
 
C6 (TOnc) - Erm, I mean you could have a subset of questions or you know like 
erm you know you could fill in a form and it goes to the nurses or something. 
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Many clinicians reported that they often use anatomical diagrams or images in 
consultations to help patients to understand the information they are given, such as 
diagrams showing the location of the cancer and how operations will be performed. 
Clinicians suggested a feature that includes anatomical diagrams and images that 
could be used by clinicians to facilitate the communication of information to patients in 
consultations.   
 
C14(Onc) - …Sometimes pictorially its better, erm ... I think with gynae as well 
is particularly difficult especially if you are dealing with different organs, which 
you may not be familiar with. So having pictures really helps. And, erm, trying to 
explain what we are trying to do in terms of the operation as well, sometimes 
having a diagram actually makes a difference. And there are some apps where 
you could then look at your staging pictorially, that might be helpful to include in 
an app. 
 
Subtheme 2c: App features that increase access to patient support  
Clinicians suggested including app features that would increase patients’ awareness of 
and access to patient support, as they explained that this information is provided 
secondary, if at all, to information on their type and treatment of cancer. Some 
clinicians reported that they sometimes fail to provide information on the psychological 
support available to patients, such as support groups, due to limited time in 
consultations. Clinicians also suggested a feature that enables patients to meet one 
another, particularly those with the same issues, either online via a blog or face to face 
via a support group.  
 
C17 (TSur) - I think your suggestion of links to other support groups is a very 
good one perhaps with, you know, sort of online links that would take you to the 
website for example. Um, local support groups as well as national groups. And, 
yeah, that’s probably it. I think more of the supportive side that perhaps we… 
we can’t really spend a huge amount of time on. Because I think we’re quite 
good at treating the disease and talking about the scientific part of the disease 
if the patients wish but it’s the, like the supportive aspect that we can’t provide 
enough time for that I think would be of greatest benefit to a patient. 
 
C14 (Onc) - Err, I don’t know if you could have, if you could use, it has like 
some sort of community so you know you can contact other people with the 
same problem. 
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Subtheme 2d: App features that increase access to support for relatives  
Clinicians anticipated that features that would be useful for the patient would also be 
useful for the patient, due to their comparable information needs, however clinicians 
suggested some additional features that would be useful for relatives. Due to the 
impact of a diagnosis on relatives, clinicians suggested including links to family support 
groups and reputable cancer charities that also provide psychological support for 
patients’ families and friends.  
 
I - Do you think there's any features that would be useful for the relatives or 
friends…?  
C19 (Sur) - I'm not sure there's anything over and above that would be unique 
for their purposes ...as opposed to over and above what would be helpful for 
the patient.  
 
C22 (TSur)- Um I guess in the same way that you have emotional support for 
the patients in so far as support groups and things, perhaps you could also get 
family support groups or carer support groups popping up on the app, so that 
would be quite useful. 
 
Clinicians also suggested including links to information for relatives on how they can 
best support the patient during their illness, including information on how to help with 
the patient’s diet, changing of a stoma bag or practical information, such as how to get 
to the hospital.  
 
C18 (CNS) -  I think support them [the patients], what they [relatives] could do to 
make their [patient’s] life easier... transport to hospitals and how they are going to 
get to appointments. Especially for chemotherapy if they go every day and then get 
there, helping and supported in that. What can they do to jolly them along, what 
can they do psychologically to help them through. There is a lot out there. And then 
the patients’ relatives feel they are doing something to help, so yes, just information 
about progress, how long it takes to get there, where do you park, how much is the 
car park, this sort of thing. 
 
Subtheme 3: Anticipated benefits of app use 
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Clinicians anticipated several potential benefits of an app that would help patients to 
meet their information needs. The most commonly anticipated benefit of an app was a 
more informed patient. Clinicians suggested that an app could provide patients with a 
better understanding of cancer prior to consultations, which would enable to have a 
more detailed discussion with them. Additionally, clinicians expected that a more 
informed patient might develop more questions to ask.  
 
C21 (CNS - I think it would have benefits in that the patient would be more 
prepared …and therefore understand more about their own disease erm before 
their consultations, which would help. Erm, there may be, it may be that they 
ask more questions as a result of it.  
 
C20 (CNS) - …You know if patients are coming in and they’ve looked at that, 
they know they know what the process is, they know what, you know potentially 
is available to them and it leads for a sort of much more informed discussion 
really.  
 
C7 (CNS) - But I suppose it enhances their, it enhances the information that 
they’ve got so it enables them maybe to ask the right questions.  
C8 (CNS) -Hmm.  
C7 (CNS) -To get more information that is useful.  
C8 (CNS) - Yeah. And maybe not leave a consultation without asking the 
questions isn’t it, you know because they know exactly what they should be 
asking. 
 
It was also anticipated that a QPL feature would encourage patients to think of 
questions that they may not have thought of. Some clinicians anticipated that this type 
of app could lead to more informed relatives.  
 
C21 (CNS) - I think erm it would really give them tips on how to prepare for a 
consultation…You know giving them ideas sort of what questions would be 
good to ask.  
 
I - What about for the family do you think there would be any benefits of this 
type of app for them? 
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C1 (Onc) – Well for the family I think the same thing, it gives them more 
information and it points them in the right direction if they’re trying to get more 
information. 
 
A minority of clinicians further anticipated that an increase in knowledge of their 
condition could provide patients with an increased sense of control over their lives and 
reduce their anxiety. A more informed patient was expected to have more realistic 
expectations throughout their illness, which would enable them to plan ahead and exert 
some degree of control over their condition.  
 
I - …What do you think the benefits would be in the long term for the patients?  
C1(Onc) – It just gives them more control, um I think when they have more 
control, feel more control that helps them because it’s their lack of control, their 
lack of being able to plan, their lack of, things just happening around them and 
at least if you know what’s happening, so many patients come in and say, 
“Even though you kind’ve given me bad news, I feel better leaving than I did 
coming because I know what’s happening and I know you’ve got a plan.”  
 
C17 (TSur) - I think it would, um, help them to learn more about it and not be 
alarmed by certain symptoms, um, to know what to look out for if their disease 
is progressing, if they develop new symptoms because a lot of people with 
cancer think that every little ache and pain is related to their disease and… and 
sometimes, you know, if… if they read about it perhaps or learned a bit more 
about it then they might not be too concerned at certain things. 
 
Clinicians also anticipated that this type of app could improve communication between 
patients and clinicians in consultations. Clinicians anticipated that a question prompt 
list feature would act as an agenda for the consultation, which would facilitate a more 
structured discussion and encourage patients to communicate their concerns. In turn, 
clinicians suggested that this might improve the efficiency of the consultation and 
increase clinicians’ confidence that they have met the patients’ information needs.   
 
I - What benefits do you think there might be for clinicians if patients are using 
this sort of app?  
C4 (PCC) – Well I think clearer communication actually you know, knowing 
you’re following the patient’s agenda and what their problems are enables you 
to you know, clarify things quicker and to answer questions better. 
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I - What kind of benefits do you think there might be for the clinicians if patients 
are using this app?  
C11 (Sur) - Er, as I say, hopefully it could form a very clear structure for a 
consultation em, which, you know, means it’s probably more time efficient. Em, 
you know, and again, consultations can be quite long sometimes, particularly 
when you’re trying to get the complex situation across, so I think, you know, 
there are benefits in terms of time. 
 
Clinicians also recognised the additional benefits of an intervention delivered via an 
app, such as access to information independent of time and location, which means 
patients can digest information in their own time, where they are comfortable. 
Clinicians anticipated that accessing information via an app less burdensome 
compared to searching through printed information leaflets, which can often be lost.  
 
I - Do you think patients would want to use this sort of thing?  
C18 (CNS) - I think they’d be open to the suggestion. Otherwise they have got 
reams and reams of paperwork. That’s the positive I can see from this. It’s not 
having reams of paperwork because it becomes overwhelming. They get too 
much information at the same time, and with an app I presume they can pick 
out the bits they want and only access what they are interested in rather than 
be bombarded with too much jargon and stuff. 
 
Subtheme 4: Potential disadvantages of app use 
A minority of clinicians were concerned that an app for patients could potentially 
increase their workload, and perhaps the length of consultations, by encouraging 
patients to contact clinicians (via a contacts feature) or encouraging them to ask 
questions in consultations (via a question prompt list feature). Despite the potential 
increase in consultation length, clinicians believed that the advantages of such an app 
would outweigh this potential disadvantage.  
 
C17 (TSur) - It probably would increase our workload…they’d have more 
questions, they’d probably want to spend more time with us as a result.  
 
C12 (Onc) – Um, they can potentially, obviously, slow down consultations, so 
then you make them longer. Er, we have to bear that in mind. But I think in the 
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end of you have a quality consultation, in the end it probably speeds things up 
overall. As well as improves the quality of that consultation. 
 
C21 (CNS) - …It may be that they ask more questions as a result of it so 
obviously there may be time... but overall I think you know that’s, that’s, the 
benefits outweigh the disadvantages there.  
 
A small number of clinicians were concerned that an app might hinder communication 
during consultations by distracting patients, who may then miss information. Some 
clinicians also suggested that an app might reduce patients’ non-verbal communication 
that enables clinicians to assess whether patients have understood the information.  
 
C12 (Onc) - I think there are certain patients who will want to scroll through the 
app consistently through the, um, through the consultation and you have got to 
be a little bit cautious of that. One, that they are actually paying attention to the 
answers you are giving, rather than just the app. 
 
I - Do you think clinicians would be happy for patients to use this app in a 
consultation?  
C15 (TSur) – If it doesn’t divert the consultation because they are constantly 
looking at the app, and they won’t be able to listen what we say, and they may 
even miss it. So I presume that’s the downside of it actually…I don’t, I 
personally don’t like um, somebody sitting in front of me and they’re just on the 
Smart phone ticking boxes, not listening to what I say, because a lot of it…face 
to face, eye contact on the person, and from the eye contact I can see whether 
the patient has understood it or not.  
 
Subtheme 5: Anticipated barriers to app use  
Clinicians anticipated several potential barriers to use of this type of app in practice. 
The main anticipated barrier was patients’ age and prior experience with Smart 
technology, where many clinicians believed that many older patients would lack the 
knowledge and experience with Smart technology to be able to use or want to use an 
app. Clinicians further explained that older patients might have problems with 
physically using an app due to poor eyesight and/or dexterity but this might be 
overcome by using a tablet device rather than a Smartphone, which has a larger 
screen. 
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C22 (TSur) - I think in general and it is a vast generalization, the cancer 
patients tend to be the older patients and the older patients tend not to be able, 
quite so versed, in using iPhones and apps and Smartphones and all that sort 
of stuff. So I think at the moment you might not get a great uptake. Give it ten 
years and I think yeah, I think everyone will be using it and the people who are 
in their sixties, seventies now who are then going on in to get cancer in their 
eighties and things… it’ll be very useful for.  
 
C13 (TSur) - Well the problems with the patients is as we’ve discussed before 
you’ve got the patients that really aren’t IT or technologically advanced enough 
to be able to use it, you do have the very practical problems with patients of this 
age group because their eyesight’s often poor, erm they can… their dexterity 
might not be that good…you know on an iPhone rather than an iPad.  
 
Despite these concerns, clinicians reported that there are many older patients who use 
Smart technology and anticipated this issue to be temporary. Clinicians suggested that 
relatives and friends could use the app on behalf of the patients that are unable or do 
not wish to use an app.  
 
C13 (TSur) - Not everyone is going to want to take it [the app] up, but it may be 
that it increases over the next 10 or 20 years as everybody understands it. {…} 
I mean I’d argue that if they [the patients] don’t then their relatives will. So I 
don’t think there’s a particular, and you would be amazed at the age who 
actually come in and use, you know their sitting there with their Kindles and 
their iPads and stuff. 
 
Another potential barrier identified by clinicians was access to Smart devices. Some 
clinicians were concerned that older patients might not own a Smart device and others 
highlighted that some patients might not be able to afford a device. Clinicians 
anticipated that the majority of patients will own a Smart device in the future and that 
those patients who do not currently own a Smart device are likely to have access to 
one via family or friends.  
 
C20 (CNS) - It would be sort of potentially a barrier you know for the older ones 
who may not have the equipment or want the equipment … but then again may 
have family members that would be willing. 
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C18 (CNS) -  You could be out in the clinic and people with their apps and then 
the man next door says I haven’t got one of those, where can I get one of 
those, it will cost you £300. So that will be a barrier, price. I don’t know, yes, but 
we are talking about future generations here really aren’t we, we are talking 10 
years in the future where people will all have one. So it is not such, so really it’s 
not a massive barrier because everybody will have one.  
 
Some clinicians were worried about the confidentiality of patients’ information on an 
app and suggested including password protection and/or limiting the amount of 
sensitive patient information stored on an app.  
 
C14 (Onc) - I think, erm, storage of information, erm sensitive information is the 
main issue I think. Erm, if they have a Smart Phone or, erm ... you know, erm ... 
a tablet that isn’t locked then potentially if you put sensitive information on it it 
could be easy to view, so you might need to put a password onto your app. 
 
Finally, some clinicians indicated that a minority of patients appear to have an avoidant 
coping approach and do not wish to have extensive information. As such, this type of 
patient was not anticipated to want to use this type of app.  
 
C5 (CNS) - One thing I guess I would say is that you’re always going to get the 
patient that will do everything, and you’re always going to get the patient that 
will do nothing {…} there are those patients that will use everything and 
everything that they can access they will do …and others won’t, you know? 
 
5.5 Discussion  
This is the first study to explore the views of cancer clinicians regarding the 
development of a novel app intervention that aims to help patients with cancer and 
their relatives to meet their full range of information needs in non-inpatient settings. 
The aim of this study was to understand the views of clinicians on the value of this type 
of intervention and to establish the type of app that clinicians anticipate to be most 
useful for patients. This study also aimed to explore the acceptability of an app for 
patients, and its potential outcomes, and identify whether clinicians would support the 
use of an app in clinical practice and their training needs in relation to the app. 
Findings identified several barriers to information exchange in consultations, and 
information-gathering outside of consultations, which appear to contribute to patients’ 
unmet information needs. These issues were reflected in the type of app and features 
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suggested by clinicians, which indicated the need for an app to enable patients, and 
their relatives, to meet their information needs by facilitating information-gathering and 
understanding during and between consultations. Clinicians anticipated that many 
patients and their relatives would want to use an app for cancer care, however they 
expected older patients to be less likely to use an app. An app was expected to be a 
useful intervention for all types of cancers and phases of the disease, particularly 
around diagnosis and remission, and for cancers that commonly affect younger 
patients. Clinicians appeared to be supportive of its use in consultations and did not 
perceive a need for specific training in relation to the app. The identified potential 
benefits of this type of app appeared to outweigh its few potential disadvantages, and 
anticipated barriers to its use in practice were considered temporary or minor issues 
which could be minimised by consideration of these findings during app development. 
The findings of this study largely mirror the views of patients and relatives described in 
Chapter 4.  
 
Findings of this study identified clinicians’ awareness of the barriers to information 
exchange with patients in consultations, including limitations of their own 
communication skills, such as the use of complicated medical terminology, and 
limitations on the patients’ behalf, such as anxiety. The views of clinicians on the 
barriers that exist within consultations were consistent with those of patients and 
relatives described in Chapter 4, and with previous studies of clinicians’ perceptions of 
issues in consultations (Légaré, Ratté, Gravel, & Graham, 2008; Slort et al., 2011). 
This study further identified that clinicians’ awareness of these barriers lead them to 
vary the information that they provide to patients, depending on their display of anxiety 
and level of understanding in the consultation, which is consistent with previous 
findings (Mills & Sullivan, 1999). These findings, and those from Chapter 4, indicate 
that patients might benefit from an app intervention that helps them to develop a basic 
understanding of cancer and the related terminology prior to consultations, which will 
enable them to understand more of the information that they are given by clinicians 
and guide clinicians to provide further information, if desired. Additionally, patients 
might benefit from an app that also enables them to become more active during 
consultations by prompting question-asking, to make their information needs clear to 
the clinician, instead of passively relying on the clinician to relay information. It is 
important for patients to voice their concerns and provide adequate information for their 
clinicians in order for clinicians to formulate the correct diagnoses and prescribe or 
amend treatment for patients (Waitzkin, 1985).  
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Clinicians’ awareness of the barriers to communicating and understanding information 
in cancer consultations, as well as knowledge of the difficulties that patients have when 
trying to find reliable information outside of consultations (i.e. on the Internet), were 
reflected in their suggestions for app features. Clinicians’ suggestions of app features 
were consistent with the four types of app features suggested by patients and relatives, 
however clinicians reported several additional app features, including a contacts 
feature and features to help patients to organise their care.  
 
Clinicians were aware of the impact of a cancer diagnosis on the relatives of patients 
and the lack of available support, and as a result, perceived that an app would be a 
valuable intervention to enable relatives to fulfil their own information needs. Like 
patients and their relatives, clinicians expected relatives to find use in the same app 
features as the patients, with some additional app features just for relatives, including 
links to family support groups and information on how to provide informed care for the 
patient.  
 
Only two clinicians reported that they had previously used an app to assist them with 
patients in consultations, however all clinicians owned a Smart device and were 
familiar with this technology. This finding is likely due to the lack of availability of 
patient-facing apps that are reliable and developed by researchers or health 
organisations (Bender et al., 2013; Pandey et al., 2013), as an increasing number of 
clinicians use apps for a wide variety of work-related tasks (Ozdalga et al., 2012). 
Importantly, clinicians appeared to be supportive of the development of an app to help 
patients and relatives to meet their information needs, which is likely due to their 
appreciation of the difficulties faced by clinicians and patients during and between 
consultations, as well as the negative psychological impact of cancer on patients and 
their families. Most clinicians in the current study anticipated that they would find it 
acceptable for patients to use an app for their cancer in consultations, as they told how 
patients already bring Smart devices or paper-based tools to consultations to facilitate 
the consultation process. Consequently, clinicians did not feel that they would require 
extra training to support an app for patients. Instead, clinicians suggested brief training 
on the content of the app to have an awareness of the information resources and tools 
being used by their patients. As clinicians are familiar with Smart technology, this 
training could be delivered via a brief, in-app tutorial. These findings are encouraging 
as the views and support of clinicians are key to the successful implementation of an 
app and its use by patients (Maguire et al, 2008; Murray et al., 2016). These findings 
are consistent with previous studies that reported clinicians’ positive perceptions and 
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expectations for other types of mobile interventions for other chronic conditions 
(Bostock et al., 2009; Pinnock et al., 2006; Seto et al., 2010).  
 
A novel finding of this study, in comparison to findings in Chapter 4, is that some 
clinicians anticipated that an app would be particularly useful for patients in remission. 
In support of this, research suggests that some patients who have completed their 
treatment still want information on their treatment, its long term side-effects, self-care 
and rehabilitation (Mistry, Wilson, Priestman, Damery & Haque, 2010; Rutten et al, 
2005). An app has the potential to bridge the gap for those patients who have recently 
ceased to have supervision from clinicians and regular appointments.  
 
Clinicians anticipated many patients would want to use an app to help to meet their 
information needs, however younger patients who are more familiar with Smart 
technology were expected to be more likely to use an app, compared to older patients. 
Clinicians appeared to be more concerned about the impact of this potential barrier on 
uptake of the app compared with patients and their relatives, which may be due to the 
fact that the majority of their cancer patients are of an older age. This led clinicians to 
anticipate that an app might be most useful for cancers that most commonly affect 
younger patients, such as testicular cancer. However, clinicians recognised that 
patients’ age and prior experience with Smart technology is only a temporary potential 
barrier.  
 
Other potential barriers to app use identified by clinicians included access to Smart 
technology and the security and confidentiality of patients’ information on an app, 
which were also concerns of patients and their relatives. Previous studies of clinicians’ 
anticipations of mobile interventions for a range of other chronic conditions have 
identified patients’ age, access to Smart technology, and confidentiality of information 
as concerns (Bostock et al., 2009; Pinnock et al., 2006; Seto et al., 2010). However, 
the ways in which these types of barriers may be circumvented, or minimised, have 
been outlined in Chapter 4.  
 
A number of clinicians in the present study identified a potential issue for the 
implementation of the app in consultations; some clinicians were concerned that an 
app might hinder communication during consultations by distracting patients, which in 
turn, might reduce the non-verbal cues that clinicians use to assess patients’ 
understanding and cause patients to miss important information. It was further 
anticipated that a number of older clinicians might also resist this change in 
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consultations. These findings are unsurprising as previous studies have reported that 
some clinicians perceive the use of a Smartphone in clinical settings to be 
unprofessional due to the association of mobile technology with social contact 
(Koehler, Vujovic & McMenamin, 2013; Koehler, Yao, Vujovic & McMenamin, 2012). 
Two theories of new technology adoption are useful to explain the findings of the 
present study. Firstly, the Technology Acceptance Model (TAM) (Davis, 1989; 
Venkatesh & Bala, 2008), arguably the most widely used model to explain the adoption 
of new technology in healthcare, suggests that if clinicians are exposed to an app and 
perceive it to be useful and easy to use, they are likely to accept its use by patients. 
Clinicians with negative perceptions of apps in the present study, and older clinicians, 
may be less familiar with this technology, hence their negative perceptions. Secondly, 
the diffusion of innovation theory (Rogers, 2003) describes the process that occurs as 
people adopt a new innovation, such as an idea, product, or practice and has been 
used widely in healthcare research (Putzer & Park, 2010). At its simplest, the theory 
describes the process of adoption using five categories of ‘adopters’. Firstly, there are 
an initial few, termed ‘innovators’ who are open to the new innovation and adopt its 
use. The innovators spread the word about the new innovation, which leads to more 
and more people, termed the ‘early innovators and the ‘early majority’, to adopt the 
innovation. The innovators, early adopters and early majority lead to the development 
of a ‘critical mass’; over time, they become the majority who have adopted the new 
innovation. The new innovation will then diffuse amongst the population until a 
saturation point is achieved, which involves the adoption of the innovation by the ‘late 
majority’ and finally, the ‘laggards’. Sometimes, a sixth group of ‘non-adopters’ is 
included in the model. The findings in the present study suggest that currently, there is 
a critical mass of clinicians who are open to the idea of the use of an app by patients in 
consultations. Over time, it is likely that those clinicians with concerns will become 
familiar with apps as they are used by patients and their colleagues, eventually leading 
them to perceive such technology as useful and easy to use, and become late 
adopters. Older clinicians are likely be the last group to accept the use of an app in 
consultations, i.e. the laggards (Putzer & Park, 2010).  
 
Models of the doctor-patient relationship, and the evolution of this relationship, may 
provide further insight into the anticipated resistance to change in consultations by 
some clinicians. A paternalistic model of the doctor-patient relationship dominated prior 
to the last two decades, which was characterised by ‘hard-line beneficence’ and 
imbalanced interaction (Hellin, 2002; Kaba & Sooriakumaran, 2007). This model of the 
relationship was analogous to the parent-infant relationship; the doctor’s role was to 
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act in the patient’s best medical interest, which involved making decisions that were 
silently complied with by the patient. A ‘good patient’ was regarded as one 
submissively accepted the passive role of the infant (Hellin, 2002). Over the last 20 
years, critics have challenged this model and proposed a more active role for the 
patient, reduced clinician dominance and mutual participation (Kaba & Sooriakumaran, 
2007). It is characterised by shared power and responsibility between the patient and 
clinicians, with recognition of the patients’ needs and preferences, and involves 
behaviours such as encouraging the patient to voice their opinions and concerns, 
listening, and offering or engaging in collaboration (Mead & Bower, 2000). This model 
is known as the patient-centred approach and has become the predominant model in 
medical practice today (Kaba & Sooriakumaran, 2007). The findings of the present 
study provided evidence of paternalistic care by some clinicians, who told how they 
make decisions about the level of information that they provide to the patients without 
explicitly informing and involving patients in this decision. Additionally, it is possible that 
older clinicians prefer a paternalistic approach for cancer care as they were trained in 
the era of paternalism. An app that empowers patients and activates them in 
consultations, for example, through use of a question prompt list, has the potential to 
facilitate a power shift and create a more patient-cantered consultation. Clinicians in 
favour of a paternalistic approach may therefore resist an app being used in their 
consultations in order to protect their preferred model of care.  
 
The most commonly anticipated benefit of an app that aims to enable patients to meet 
their information needs was a more informed patient, which is consistent with the 
expectations of patients and relatives. Clinicians further highlighted the benefits that 
they themselves might receive as a result of this type of intervention, including a more 
structured and therefore efficient consultation, and more confidence that they have 
dealt with patients’ concerns. Some previous studies of the use of paper-based QPL in 
cancer consultations have reported a decrease in consultation lengths, however the 
evidence is generally mixed (Brown, Butow, Dunn & Tattersall, 2001; Dimoska et al., 
2008).  
 
In contrast, some clinicians were concerned that this type of app would lead to an 
increased workload, if an app was to increase patient contact and question-asking. 
Some previous studies of clinicians’ perceptions of their involvement in mobile 
symptom-monitoring interventions for patients with cancer have reported issues such 
as an increased workload or technical issues to be problematic in clinical practice 
(Kearney et al., 2006; Maguire et al., 2008; McCall et al., 2008). However, these 
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interventions were used equally by the clinicians and patients, whereas a patient-facing 
app that is used independently of the clinician would limit the potential impact on 
clinicians’ workloads. Additionally, clinicians in the present study believed that the 
advantage of a better quality consultation might outweigh the potential increase in 
workload. Subsequently, studies of digital and paper-based interventions that are 
patient-facing and used during allocated consultation time have been found to be 
acceptable by clinicians (Dimoska et al., 2012; Politi, Adsul, Kuzemchak, Zeuner, & 
Frosch, 2015).  
 
5.5.1 Study strengths and limitations 
A strength of this study is that it recruited a varied sample of clinicians, including a 
variety of roles, settings, patient types, career lengths and genders. Although not 
recorded, the sample included a mix of ethnicities, however there is little evidence for a 
digital use divide by this characteristic (Kontos et al., 2014). Furthermore, the sample 
size was sufficient for this type of qualitative inquiry and data saturation was reached. 
However, this study has several limitations to consider. It was not possible to calculate 
the response rate for this study nor collect key characteristics of those who declined to 
participate. Additionally, all clinicians were Smart technology owners. The sample may 
therefore not be representative of the general population and may have included 
clinicians with more favourable perceptions of an app than those who chose not to 
participate. However, statistics suggest that ownership of Smart technology among 
clinicians is pervasive, where up to 90% of healthcare professionals own a Smart 
device, and new technologies will continue to be integrated into healthcare services 
(Chase, 2013; Wallace et al., 2012). It is therefore likely that the majority of clinicians 
will have favourable attitudes to the use of technology in healthcare. Joint interviews 
with four clinicians may have prevented these participants from discussing important 
issues that they might have talked about in a separate interview, however the majority 
of interviews were conducted individually at length. Finally, providing examples of 
types of app features that might be useful for patients prior to beginning the interview 
may have influenced responses due to social desirability. The risk of this bias was 
minimised as the prior to the interview, the candidate explained that all opinions were 
valued, both positive and negative, in order to develop an app that would be most 
useful for future patients and their families.  
 
5.5.2 Future research  
Future studies are encouraged to investigate the views of the minority of older 
clinicians who may find app use in consultations to be socially unacceptable, as 
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reported by clinicians in the present study. This will help to further determine the 
barriers to use of this type of intervention and explore ways to overcome them in order 
to increase the chances of successful implementation of this type of app in clinical 
practice.  
 
5.5.3 Implications 
The findings of this study have several implications for the development of an app for 
patients with cancer and their relatives. Firstly, this study provided further evidence of 
the psychosocial context that underpins the needs and preferences of patients and 
their relatives regarding an app, as clinicians corroborated the presence of barriers to 
information exchange and understanding during consultations, and difficulties that 
patients have when trying to find reliable information outside of consultations. 
Additionally, clinicians highlighted the importance of developing interventions that 
enable relatives to meet their own information needs in order to optimise the patients’ 
care.  
 
Secondly, exploration of the views of clinicians on the type of app that they anticipate 
to be useful for patients and relatives provides further justification for the development 
of an app that enables patients and relatives to meet their information needs by 
facilitating information exchange and understanding in consultations and identification 
of reliable information sources outside of consultations. Additionally, clinicians 
suggested further app features that were not suggested by patients and relatives. 
These additional suggestions can be considered during app development.     
 
Importantly, this study suggests that clinicians would be support of an app in practice, 
which provides further justification for its development. Findings identified further 
possible barriers to the uptake of the app, such as an increased workload for clinicians 
and older clinicians’ perceptions of the acceptability of app use in consultations. These 
potential barriers may be considered during app development in order to optimise its 
uptake, usability and usefulness (Craig et al., 2008; Yardley et al., 2015). 
 
Finally, this study adds to the preliminary body of work conducted for this thesis so far, 
which completes the first phase of intervention development outlined by MRC 
framework (Craig et al., 2008). Consideration of the findings of this body of work 
suggest that it is prudent to begin development of an app intervention that aims to 
meet the information needs of patients and their relatives, followed by exploratory 
research on the acceptability and feasibility of this type of intervention.   
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5.5.4 Conclusion 
This was the first study to explore the views of cancer clinicians regarding an app that 
aims to help patients with cancer and their relatives to meet their information needs in 
non-inpatient settings. Clinicians provided further insight into the psychosocial context 
that underpins needs and preferences of patients and their relatives for an app 
intervention. Findings indicated the need for an app that facilitates information 
exchange and understanding during consultations and identification of reliable 
information sources outside of consultations. Clinicians also highlighted the importance 
of developing interventions that support relatives, as well as patients, in order to 
optimise the patients’ care. Exploring the views of clinicians proved a useful exercise, 
as this led to the identification of further app features and potential outcomes that were 
not identified by patients and relatives in Chapter 4. Clinicians appear to be supportive 
of the development of an app and its use in consultations and did not perceive a need 
for specific training in relation to the app. Overall, the potential benefits of this type of 
intervention appeared to outweigh clinicians’ few minor concerns. 
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Chapter 6 
The design and user-testing of an app for patients with cancer and their relatives 
 
6.1 Chapter overview 
This chapter reports on the systematic process used to create an app for patients with 
cancer and their relatives. This was an iterative process consisting of several stages, 
including selection and development of app features and content, design of the app 
interface in consultation with a digital software company, and user-testing with a 
sample of patients and their relatives, which informed the final version of the app.  
 
6.2 Introduction 
As described in Chapter 1, the first phase of the MRC framework (Craig et al., 2008) 
for the development of complex interventions in healthcare encourages identification of 
the evidence base, relevant theories, model processes and outcomes of the 
intervention prior to development. Chapter 2 described a systematic review that 
reported preliminary evidence for the potential effectiveness of mobile interventions in 
supporting patients with cancer remotely. Additionally, this review identified a gap for 
an app intervention that aims to enable patients with cancer and their relatives to meet 
their information needs in non-inpatient settings. Chapter 3 reviewed relevant health 
behaviour models, theories and approaches related to the impact and self 
management of a chronic illness, such as cancer, in order to gain insight into the 
possible underlying processes and outcomes of such an intervention. Chapter 4 
described qualitative research that provided further evidence that indicated the need 
for an app intervention to enable patients and their relatives to meet their information 
needs. Qualitative research with patients and relatives also highlighted the possible 
processes (and features) through which this may be achieved and identified the 
potential outcomes of this type of intervention (i.e. the benefits and disadvantages). 
These findings were supported by further qualitative research with cancer clinicians 
(Chapter 5). Following completion of this initial body of work in line with the first phase 
of the MRC framework, it was decided an app intervention for patients and their 
relatives should be created.  
 
Next, the ‘person-based’ approach to development of digital interventions (Yardley et 
al., 2015) and other relevant frameworks, such as the Chronic Disease mHealth App 
Intervention Design Framework (Wilhide III et al., 2016), suggest determining the 
objectives of the intervention and the key features which are required to achieve each 
objective. Guidelines also suggest that the prototype intervention should be tested with 
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a sample of users to elicit their perceptions and reactions to intervention elements, 
including the content and design (Brown, Yen, Rojas & Schnall, 2013; Yardley et al., 
2015). User-testing of the intervention provides an opportunity to optimise the usability 
and acceptability of the intervention for future users prior to implementation (Yardley et 
al., 2015). A range of user-testing models and qualitative and quantitative research 
methods have been employed in previous research (Harrison et al., 2013; Zhang & 
Adipat, 2005). Studies have typically used think aloud techniques, where a sample of 
users are given a list of tasks to complete in front of the researcher while discussing 
their thoughts and opinions (Klasnja, Hartzler, Powell, Phan & Pratt, 2010; Mirkovic, 
Kaufman & Ruland, 2014; Yardley et al., 2015). This provides researchers with the 
opportunity to understand how users actually interact and use the intervention in 
practice.  
 
The Technology Acceptance Model (TAM) (Davis, 1989) (and its relevant extensions; 
Venkatesh & Bala, 2008) is another useful model to consider prior to developing an 
app intervention and testing its usability. The TAM was originally developed to predict 
the adoption and use of new information technology in the workplace and there has 
been much empirical support for the model (Adams, Nelson & Todd, 1992; Agarwal & 
Karahanna, 2000). More recently, the TAM has been used to predict individuals’ 
adoption and use of newer information technologies, including Smart devices (Kim, & 
Park, 2012). At its most basic level, the TAM posits that an individual’s behavioural 
intention to use a new information technology is determined by two beliefs, including its 
perceived usefulness and perceived ease of use (Davis, 1989). It is therefore important 
that these two concepts are prioritised during creation and testing of the app. With 
regards to an app for patients with cancer, perceived usefulness could be described as 
the extent to which a person believes that the app will help to meet their information 
needs and ease of use could be described as the extent to which a person believes 
that using an app will be free of effort (Ventakesh & Bala, 2008).  
 
The Health IT Usability Evaluation Model (Health-ITUEM) for evaluating mobile health 
technology (Brown et al., 2013) was informed by the TAM and other relevant 
frameworks (Folmer & Bosch, 2004; Shneiderman & Plaisant, 2010) and offers 
intervention developers a framework of concepts to consider when assessing the 
usability of a digital health intervention. A similar user-testing model, the People At the 
Centre of Mobile Application Development (PACMAD) model (Harrison et al, 2013), 
was also useful to consider prior to user-testing of the app.  
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6.2.1 Aims of this chapter  
This chapter reports on these next two steps in the systematic development of the app, 
including how the intervention objectives were determined from the synthesis of users’ 
(i.e. patients and their relatives) and key stakeholders’ (i.e. clinicians) perceptions and 
the process of user-testing to inform a final version of the app prior to field testing 
(described in Chapter 7). The aim of this chapter was to describe the systematic 
development of an app for patients with cancer, and their families, including: 1) The 
design of the app interface, 2) the selection of app features to include in an app and 
development of app feature content, and 3) the user-testing of the app with a sample of 
patients and their relatives.  
 
6.3 App design 
Digital Morphosis was selected to develop the app as they are a reputable, local 
software company and had experience of creating user-friendly apps. Additionally, they 
had previously worked with Tenovus Cancer Care and the Division of Population 
Medicine at Cardiff University. In order to create an app within the project budget, 
Digital Morphosis explained that the app would be created as a website to run on an 
app platform, as this would cost far less than creating a ‘real’ native app. A search of 
the Apple app store identified five apps that had similar features to the type of app 
desired by patients, described in Chapter 4. These five apps were shown to Digital 
Morphosis to provide the team with an idea of the types of apps that were currently 
available:  
 
• Breast Cancer: Beyond The Shock 
• Pain Diary: CatchMyPain 
• Pocket Cancer Care Guide 
• The Simplyhealth Back Care app 
• Macmillan’s ‘My Organiser’  
 
Design principles outlined in Apple’s ‘IOS human interface guidelines’ (Apple, inc., 
2010) were followed by Digital Morphosis during the app design and build. The 
guidelines facilitated the creation of a user-friendly and intuitive app, the navigation of 
which would be familiar to regular app users. It was important to create an app that 
was simple and easy to use for those patients who lack experience of using Smart 
technology. The app was created to run on any Smartphone and also run on tablet 
devices as they have a larger screen for users who have poorer physical health 
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(Charness & Boot, 2009). The candidate met with the digital team to discuss the initial 
findings from the qualitative interviews with patients, relatives and clinicians. Potential 
app layouts, colour schemes and fonts were discussed and decided upon in 
consultation with Digital Morphosis. It was decided that each app feature would have a 
separate tab on the home screen and an icon would be used to indicate the purpose of 
each feature. A Tenovus Cancer Care colour scheme of blue, orange and turquoise 
was chosen to indicate the affiliation of the app with a reputable Welsh cancer charity, 
which, it was hoped, would increase users’ engagement with and trust of the app. A 
contract was drawn up between Digital Morphosis and Cardiff University detailing 
issues such as Intellectual Property (IP) rights, confidentiality, fees and payment. The 
app and all IP are owned by Cardiff University, however the app includes a Digital 
Morphosis logo at the bottom of the home page to highlight the company’s 
involvement.  
 
Digital Morphosis created an initial version of the app which focused on design rather 
than content and the candidate then met with the digital team to review the app. The 
initial version of the app was satisfactory though some minor changes were requested. 
The content for the app was then sent to the digital team to input into the app. The 
name of the app was decided in consultation with the supervisory team, which was 
then approved by Tenovus Cancer Care. ‘Ask Us’ was chosen, as it highlights the 
question prompt list feature and encourages patients and relatives to ask their 
clinicians for information if they want more information. Additionally, this name is in line 
with other services provided to patients by Tenovus Cancer Care, such as their choir 
group, called ‘Sing with Us’, and their writing group, called ‘Write with Us’.  
 
A second version of the app that included the requested changes and app content then 
underwent ‘in-house’ testing by the candidate and supervisory team. ‘In-house’ testing 
is recommended in order to iron out any potential issues prior to user-testing with real 
users (Kirwan et al., 2013). The team were asked to use each app feature and report 
any suggestions for improvements or confusion and difficulties. Several minor changes 
were requested and were amended accordingly by the digital team.  
 
6.4 App feature selection and content 
6.4.1 Method 
Findings of interviews with patients, relatives and clinicians, described in Chapters 4 
and 5, were used to determine the most and least popular suggested app features. 
Suggested app features were evaluated using the APEASE criteria (Michie, Atkins, & 
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West, 2014), which involved reviewing each feature for its affordability, practicability, 
effectiveness/cost-effectiveness, acceptability, side-effects/safety and equity. Final 
selection of app features involved a discussion between the candidate and project 
supervisors based on how potential app features would help to achieve the objectives 
of the intervention (Yardley et al., 2015).  
 
6.4.2 Results 
Intervention objectives 
Synthesis of the findings of interviews with patients, their relatives, and clinicians 
indicated the need for an app intervention that enables patients with cancer and their 
relatives to meet their full range of information needs in non-inpatient settings. It was 
suggested by participants that this could be achieved by facilitating information 
exchange and understanding between and during consultations with clinicians. More 
specifically, patients, their relatives and clinicians desired an app that included four 
types of features:   
 
(1) Features that support patients’ self management of their condition 
(2) Features that facilitate information exchange in consultations  
(3) Features that increase access to patient support 
(4) Features that increase access to support for relatives 
 
It is important to create an app that is perceived as useful by patients and their 
relatives in order to increase the likelihood of adoption of the app (Davis, 1989; 
Venkatesh & Bala, 2008). An app feature to support each of these objectives was 
therefore included in the app. It was anticipated by the supervisory team that an app 
that included features to support each of the above intervention objectives could be 
useful for patients with different types of cancer, mirroring the views of patients, 
relatives and clinicians. For example, following a diagnosis of any type of cancer, it is 
likely that most patients will have to self-manage their condition during treatment, face 
barriers to information exchange and understanding during and between consultations, 
and may want to access further support for their condition, as told by patients, relatives 
and clinicians in qualitative interviews in Chapters 4 and 5. A decision was therefore 
made to create a non-specific cancer app that could help patients to overcome these 
generic issues. Where possible, app features would be designed so that they to be 
tailored to the individual and their specific condition.  
 
Theoretical underpinning  
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Qualitative interviews suggested that the common sense model (CSM) of self-
regulation of health and illness (Leventhal et al., 1984), crisis theory (Moos & Schaefer, 
1984) and the theory of cognitive adaptation (Taylor, 1983) may explain why many 
patients and their relatives (i.e. those with an active/monitoring coping style) appeared 
to use information-seeking as a coping mechanism. Furthermore, the framework of 
patient activation (Hibbard et al., 2004) provides insight into how meeting patients’ 
information needs might help them to develop the skill set and mind set needed to 
actively self-manage their condition. These theories, in combination with the qualitative 
data, were used as evidence to support the development of an app that aims to enable 
patients and their relatives to meet their information needs and develop their skills and 
motivation to better self-manage their condition.  
 
Summary of app feature suggestions from qualitative interviews 
Analysis from the qualitative interviews indicated that app features could be organised 
into four themes, as described in the ‘intervention objectives’ section. The most popular 
app feature suggestions are displayed in Table 5. Each theme is described below.   
 
Features that support patients’ self management of their condition: 
The majority of patients listed the types of information that they wanted during their 
illness in order to help them self-manage their condition, which were reiterated by 
clinicians. Patients and clinicians highlighted the difficulty in identifying reliable 
information on the Internet and suggested including links to signpost patients to 
credible cancer websites. Other suggestions to support patients’ self management of 
their condition included a symptom-monitoring feature to help patients record and 
monitor their symptoms during treatment, a contacts feature to store clinician and 
cancer charity contact details in order to increase access and encourage contact, and 
features to help patients organise their care, such as a reminder feature to prompt 
attendance of appointments.  
 
Features that facilitate information exchange in consultations: 
A question prompt list (QPL) feature was the most popular suggestion in this category. 
Many patients reported that they forgot or lacked confidence to ask questions in 
consultations and therefore suggested including a QPL feature to prompt question-
asking and facilitate communication with clinicians. Participants anticipated that this 
would be the most useful feature of all to help patients to meet their information needs. 
Participants also suggested features to facilitate patients’ understanding of information 
in consultations as some patients struggled to understand the terminology used by 
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clinicians. Patients and relatives suggested including a glossary of cancer terms and 
clinicians suggested including anatomical images to explain the location and nature of 
the cancer and/or treatment to the patient.  
 
Features that increase access to patient support: 
Features that enabled patients to talk with other similar patients was the most popular 
suggestion in this category. Patients reported the informational and emotional benefits 
of meeting other patients with cancer during their illness. Patients, their relatives and 
clinicians suggested including links to information on patient support groups and/or a 
feature to enable patients to connect with one another or links to online forms/social 
media platforms. Many patients also found cancer charities to be a useful source of 
information on the support services available to patients, such as psychological 
support and finances, and therefore suggested including links to cancer charity 
websites and links to local cancer support services to increase patients’ awareness of 
these services.  
 
Features that increase access to support for relatives: 
A feature that provides information on how the relatives can support the patient was 
the most popular suggestion in this category. Patients and relatives reported that 
relatives were unsure of how they could help the patient during their illness and 
therefore suggested including information on how to support them effectively. 
Participants also described the impact of a cancer diagnosis on relatives and therefore 
suggested features to increase access to support specifically for relatives, such as a 
feature to connect them with other relatives of cancer patients.  
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Table 5: Assessment of popular app features suggested by patients with cancer, their 
relatives and clinicians using the APEASE criteria (affordability, practicability, 
effectiveness/cost-effectiveness, acceptability, side-effects/safety and equity).  
App feature suggestions A P E A S E Outcome 
Features that support patients’ self-management of their condition 
Self-management related informational needs 
Informational feature 
providing information such 
as treatment side-effects, 
types of treatment and 
risks, and types of cancer 
and staging.  
√ X √ √ √ √ 
Building an in-app feature that 
contains all of this information 
was not practical due to the huge 
amount of information available. 
It would also be duplicating the 
efforts of reputable cancer 
charities, such as Macmillan, 
and health organisations such as 
the NHS. Alternatively, an app 
could include a feature that 
contains links to specific topics 
of information that already exist 
on credible cancer information 
websites.  
Signposting 
 
Links to credible cancer  
information websites 
 
√ √ √ √ √ √ Possible feature. 
Increasing access to clinicians 
 
Contacts feature to 
include clinician contacts 
details (and contact 
details of relevant health 
and cancer charity 
organisations)  
 
√ √ √ √ √ √ Possible feature. 
Symptom monitoring 
Treatment-related 
symptom diary √ X X √ √ X 
There is already a wealth of 
literature examining the 
effectiveness of this type of 
intervention for patients with 
cancer. Additionally, this feature 
would not directly help to meet 
the aim of the intervention which 
is to help patients to meet their 
full range of unmet information 
needs.  
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Organisation of care  
Reminder function for 
appointments, medication 
log, prompts for 
adherence to rehabilitation 
guidelines 
√ √ X √ √ √ 
Patients can already programme 
reminders and alerts using the 
‘Reminders’ feature on their 
Smart device. Additionally, this 
type of feature would not directly 
help to meet the aim of the 
intervention which is to meet 
patients’ information needs.  
Features to facilitate information exchange in consultation with clinicians 
Increasing communication of information needs 
 
Question prompt list 
 
√ √ √ √ √ √  Possible feature. 
Increasing patient understanding of information provided 
App feature to view 
anatomical 
images/diagrams 
√ X √ X X √ 
This type of feature might not be 
acceptable to all patients as 
images might cause distress. 
Additionally, the app aimed to be 
non cancer-specific.  
 
Glossary of cancer terms 
 
√ √ √ √ √ √ 
 
Possible feature. 
Features to increase access to patient support 
Signposting 
 
Links to cancer charity 
websites 
 
√ √ √ √ √ √ Possible feature. 
Links to local cancer 
services (e.g. 
psychological support, 
help with finances) 
√ X √ √ √ √ 
This feature was not practical as 
all local services would have to 
be included and this would 
decrease the ease of use of the 
app. Additionally, some support 
services are already signposted 
via cancer charity websites. 
Alternatively, an app could 
include a feature that contains 
links to existing, specific topics of 
information within cancer charity 
websites. 
Social support 
Feature to connect 
patients with one another 
or links to existing 
forums/social media 
X X X √ X √ 
An in-built app feature to connect 
patients online via a chat forum 
could potentially pose a risk to 
patients’ safety/well-being. This 
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type of feature would therefore 
have to be monitored to ensure 
patient safety, which is not 
practical. Alternatively, the app 
could include links to local 
patient support groups to enable 
patients to meet in person in a 
safe environment.   
 
Links to information on 
patient support groups 
(online or face to face) 
 
√ √ √ √ √ √ Possible feature. 
Features to increase access to support for relatives of patients 
Information needs 
Informational feature 
providing information on 
how relatives can help the 
patient effectively 
√ X √ √ √ √ 
Building an in-app feature that 
contains this information was 
not practical due to the large 
amount of information available. 
It would also be duplicating the 
efforts of reputable cancer 
charities, such as Macmillan, 
and health organisations such as 
the NHS. Instead, an app could 
include a feature that contains 
links to existing information for 
relatives on cancer charity 
websites. 
Increasing support for relatives 
Feature to connect 
relatives with other 
relatives of cancer 
patients  
X X X √ X √ 
An in-built app feature to connect 
relatives online could potentially 
pose a risk to their safety/well-
being. This type of feature would 
therefore have to be monitored 
to ensure safety, which is not 
practical. However, the app 
could include links to online of 
face-to-face support groups for 
relatives to enable relatives to 
meet in person in a safe 
environment.   
 
Links to information on 
support groups (online or 
face to face) 
 
√ √ √ √ √ √ Possible feature 
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Results of application of the APEASE criteria 
Assessment of the most popular app features suggestions with the APEASE criteria 
resulted in the following possible app features per theme:   
 
(1) Features that support patients’ self management of their condition: 
i. Links to credible cancer information websites 
ii. Links to specific topics of self management-related information within 
credible cancer information websites  
iii. Contacts feature to store clinician contact details (and contact details of 
relevant health and cancer charity organisations) 
 
(2) Features that facilitate information exchange in consultations:  
i. QPL 
ii. Glossary of cancer terms 
 
(3) Features that increase access to patient support: 
i. Links to patient support groups (online or face to face) 
ii. Links to reputable cancer charity websites 
iii. Links to specific topics of support-related information within reputable 
charity cancer websites  
 
(4) Features that increase access to support for relatives of patients: 
i. Links to information on how relatives can support the patient within 
reputable cancer charity websites. 
ii. Links to support groups for relatives (online or face to face)  
 
Selected app features 
The project team discussed these possible features and how to incorporate as many 
as possibly whilst maintaining ease of use. Four app features were selected, including: 
(1) a QPL, (2) a glossary of cancer terms, (3) a resources feature, and (4) a contacts 
feature. The selected app features, their aim in relation to the objectives of the 
intervention, reasons for their selection and a description of the development of their 
content are described below.   
 
Question prompt list feature: 
A QPL is a structured list of questions selected from a range of possible questions by 
the patient to increase patient participation by prompting question-asking, in order to 
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acquire the information that they need (Dimoska et al., 2012). The aim of this feature 
was to facilitate information exchange in patient-clinician consultations. It was 
anticipated that this feature would help patients to increase their knowledge and 
develop an accurate understanding of their condition by obtaining reliable and specific 
information from their cancer clinician. As described in Chapter 3, theories related to 
coping with cancer posit that accurate illness-related information helps patients to 
develop illness cognitions, which in turn, facilitates the adoption of adaptive coping 
strategies and promotes psychological adjustment (Leventhal et al., 1984, Moos & 
Schafer, 1984).  
 
Findings from qualitative interviews with patients with cancer, relatives and clinicians 
highlighted several barriers to information exchange and understanding in 
consultations, such as patients’ poor memory and concentration, lack of confidence to 
ask questions and a busy clinic environment, which meant that many patients did not 
always ask their clinician questions to obtain the information that they needed. Studies 
on the effects of paper-based QPLs have suggested that this type of intervention has 
the potential to circumvent these issues in cancer consultations (Brandes et a., 2015; 
Brown et al., 2001). A QPL aids patients’ memories and concentration by helping them 
to think about what questions they want to ask and reminding them to ask questions 
when in consultations. This feature will also have the benefit of allowing patients to add 
questions to their list as soon as they think of them, which will prevent them from 
forgetting which questions they wish to ask. Additionally, this feature could be useful 
for patients who lack the skills and confidence to ask questions in consultations (i.e. 
those with low health literacy) by helping them to prepare a question list and prompting 
them to participate in the consultation (Hibbard et al., 2004; Joseph-Williams, Edwards 
& Elwyn, 2014; Kinnersley et al., 2007). Indeed, studies suggest that an app might be 
best used as a supportive intervention in the presence of clinicians for those with 
limited health literacy, rather than relying on the using the app alone (Wilson et al., 
2010). 
 
Findings from qualitative interviews with patients with cancer and their relatives also 
suggested that clinicians are still patients’ most valued source of information, despite 
the increasing trend of seeking information on the Internet. It is therefore important to 
include a QPL as this feature will facilitate patients’ information gathering in 
consultations and enable patients to obtain information that is reliable and specific to 
their condition.  
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Content for the QPL feature was developed using findings from the qualitative 
interviews, the CSM of illness self-regulation of health and illness (Leventhal et al., 
1984) and existing paper- and app-based QPLs. This was followed by a review of the 
final included questions by clinical supervisors. General, and frequently asked, 
questions were chosen for this feature. As described in Chapter 3, the CSM model 
proposes that individuals actively construct representations of the illness, termed 
‘illness cognitions’ which have five dimensions, as described in Chapter 3, section 
3.3.1. Questions that addressed each of the five dimensions of illness cognitions were 
therefore devised for the QPL app feature in an attempt to enable patients to develop 
an accurate and adaptive understanding of their illness.  
 
Next, findings from interviews with patients, their relatives and clinicians on patients’ 
and relatives’ information needs were considered and questions that would help them 
to address these specific information needs were also included in the final QPL 
feature. Existing cancer-specific QPLs were then extracted from relevant literature and 
were searched for any additional, relevant questions (Dimoska et al., 2008). An app-
based QPL from Pocket Cancer Care Guide app was also searched for relevant 
questions. During this process of creating and collating potential questions for a QPL 
app feature, any questions deemed relevant and useful were added to a list of possible 
questions and duplicate questions were removed. Questions were then grouped into 
five categories: (1) after your cancer diagnosis, (2) treatment, (3) support, (4) family 
and friends, and (5) remission. This list of questions was sent to clinical supervisors 
(one consultant oncologist and one general practitioner) for review. Supervisors were 
asked to add any useful questions that were not already on the list and suggest the 
deletion of questions, if appropriate. The final list of questions consisted of the same 
five categories and a total of 62 questions. A function was then added to enable 
patients to add their own questions to their question list. Patients might use this 
function if the question they wish to ask is not already available within the categories 
Additionally, this functions allows patients with all types of cancer to tailor the app 
feature to their condition as they are able to add specific questions about their own 
cancer or treatment.   
 
Glossary of cancer terms: 
The aim of the glossary feature was to facilitate information exchange in patient-
clinician consultations and understanding of information sought during and between 
consultations. When diagnosed with cancer, patients are exposed to a new medical 
language about their illness. It is the role of their clinician to explain using terms that 
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the patient understands. Qualitative interviews confirmed that some patients do not 
understand medical terminology used by clinicians in consultations and other cancer 
information resources, and cancer terms are not always explained to patients. These 
findings are also supported by previous research (Lobb, Butow, Kenny & Tattersall, 
1999; Chapman et al., 2003). Additionally, patients may be embarrassed that they do 
not understand the terminology and are afraid of being ‘found out’ if they ask for 
explanations (Parikh, Parker, Nurss, Baker & Williams, 1996). If patients do not 
understand the information provided by their clinicians, they are likely to have a poor 
understanding of their condition, poor recall of information, decreased satisfaction with 
their care, and lower adherence to treatment (Ley, 1989; Siminoff, 1992). 
Consequently, clinical outcomes, such as survival time and quality of life, can be 
negatively affected (Siminoff, 1992). Taken together with the other issues in 
consultations described by patients, such as a power imbalance with clinicians, 
patients appeared to have low levels of activation (Hibbard et al., 2004). The patient 
activation framework (and field of health literacy) suggests that it is important that 
patients have the required knowledge, skills and confidence in order to increase their 
levels of activation. For these reasons, a glossary app feature was included in the app 
to help patients, and their relatives, to learn the meaning of cancer-related terms used 
in consultations and information resources. It was hoped that patients could build up 
their cancer-related vocabulary in their own time or chose to look up certain words as 
and when needed in order to facilitate patients’ understanding of cancer-related 
terminology in consultations and information resources. This in turn, might  
increase their confidence to participate in consultations. The QPL feature could then 
help to motivate and activate patients by prompting them to ask for information in 
consultations.   
 
Content was developed using existing glossaries from apps and websites (listed 
below). The initial list of terms comprised 495 terms, however this number was not 
feasible to include in the glossary. The following types of terms were excluded to 
reduce the initial list of terms:  
 
i. Specific drug names 
ii. Pre-diagnosis test procedures 
iii. Terms relating to specific cancer types 
iv. Vaccinations 
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The second draft of glossary terms was reviewed by the two clinical supervisors to 
ensure that all terms were useful for patients’ understanding of their condition and to 
ensure the readability of the definitions. No further terms were added to the list 
following clinical review, however some definitions were simplified. The final list 
included 179 terms related to the following topics: 
 
i. Types of treatment and related procedures/investigations 
ii. Non-specific cancer types/phases (e.g. advanced, malignant, hormone-
resistant) 
iii. Possible side-effects of cancer and treatment 
iv. Types of clinicians 
v. Anatomy and biology 
vi. Non-specific drug types (e.g. anti-emetic drugs) 
vii. Mental health 
viii. Lifestyle (e.g. balanced diet) 
ix. Clinical trials 
 
The final list of terms was organised alphabetically. Terms and definitions for the final 
glossary were extracted from the following resources and permission was obtained 
from Cancer Research UK as most of the definitions were extracted from their website:  
 
i. Pocket Care Cancer Guide app 
ii. Breast Cancer Glossary app 
iii. http://www.cancerresearchuk.org/about-cancer/utilities/glossary/ 
iv. http://www.cancer.org/cancer/cancerglossary/index 
v. https://www.cancer.gov/publications/dictionaries/cancer-terms 
vi. http://www.cancerindex.org/medterm/medtm3.htm 
vii. http://www.cancer.net/navigating-cancer-care/cancer-basics/cancer-terms-
cancer-basics 
 
Resources feature: 
The aims of the resources feature were to support patients’ self management of their 
condition, to increase access to patient support, and to increase access to support for 
relatives. The majority of patients and relatives requested an informational feature to 
access cancer-related information so that they could obtain information independently 
of their clinicians. However, it was decided that this type of feature would not be 
feasible, due to the huge amount of information available, nor practical, as it would be 
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duplicating efforts by reputable cancer charities and health organisations. Instead, the 
candidate decided to include an app feature that enabled patients to obtain information 
from consultations via a QPL feature, as described above, and a resources feature that 
enabled patients to obtain existing information outside of consultations. The resources 
feature included links to credible cancer information websites, such as health 
organisations (e.g. NHS) and cancer charities, and links to specific topics of 
information within these websites for faster access to information.  
 
Information-seeking was described as a coping mechanism by patients and their 
relatives, therefore a resources feature that enables patients to actively gather 
information via the Internet in non-inpatient settings, independently of clinicians, could 
promote better adjustment to the illness (Leventhal et al., 1984; Moos & Schaefer, 
1984; Taylor, 1983). In support of this, previous research on cancer patients’ Internet 
use for information-seeking suggests a positive impact on their sense of control and 
psychological well-being (Bass et al, 2006; Lee, Gray & Lewis, 2010).  
 
Additionally, patients, relatives and clinicians reported on the difficulty of finding reliable 
cancer-related information on the Internet and some reported that they had been 
misinformed by inaccurate or irrelevant information. A recent study suggested that up 
to 80% of cancer patients now search for information about cancer on the Internet and 
use of the Internet can affect patients’ clinical decisions (Castleton et al, 2011). The 
resources feature was included in order to help patients to navigate the Internet and 
filter out accurate information. Furthermore, access to accurate information is 
associated with improved clinical outcomes, increased adherence to treatment, better 
disease management and decreased anxiety (Galloway et al, 1997; Kessels, 2003; 
Mossman, Boudioni & Slevin, 1999). A further reason for including the resources 
feature was to enable patients’ and relatives to build a more in depth understanding of 
their condition outside of consultations, which might increase their levels of activation 
(Hibbard et al., 2004).  
 
Patients, relatives and clinicians also reported a lack of awareness of available support 
services and suggested including links to these services in order to raise patients’ 
awareness of them. Additionally, a recent systematic review of RCTs of psycho-
educational interventions, which are typically multi-method interventions that support 
both patients’ information and psychological needs, reported small but significant 
positive effects on anxiety, depression and quality of life (Faller et al., 2013). In 
contrast, information-only interventions failed to show effects on these outcomes. This 
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review therefore suggests that intervention developers should seek to develop more 
comprehensive interventions that aim to support both patients’ information and 
psychological needs. For these reasons, the resources feature also included links to 
information on patient and relative support services, such as support groups, help with 
finances and psychological support.   
 
A list of clinician-recommended websites was compiled from interviews with clinicians. 
Recommendations included reputable cancer charity websites, health organisation and 
general health information websites. Websites that were for specific cancer types were 
excluded. Administrators of the websites that were to be included in the app were 
contacted and permission was granted to include the website links. Links to the 
following websites were included in the resources feature:  
 
i. www.nhs.uk 
ii. www.tenovuscancercare.org.uk 
iii. www.macmillan.org.uk 
iv. www.cancerresearchuk.org 
v. www.mariecurie.org.uk 
vi. www.patient.info 
 
The most common topics of information needed by patients and relatives during their 
illness, as reported in Chapter 4, were searched for within the websites listed above.  
Where possible, links to these specific information topics (e.g. chemotherapy side 
effects) were included in the resources feature to enable patients, particularly those 
who are unfamiliar with Smart technology and websites, to easily locate and access 
the information they need. A ‘coping with cancer section’ included links to local patient 
support groups and information on psychological well-being to facilitate access to 
patient support. Similarly, a ‘support for family and friends’ section included links to 
information specifically for relatives on how to support the patient and links to support 
groups. Links to the following topics of information and support services were included:  
 
i. Chemotherapy side effects 
ii. Radiotherapy side effects 
iii. General anaesthetic side effects 
iv. Coping with cancer 
v. Support groups 
vi. Support for family and friends 
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vii. Maintaining a healthy lifestyle 
viii. Financial information 
ix. Information on clinical trials 
 
Contacts feature: 
The aims of the contacts feature were to support patients’ self-management of their 
condition and to increase access to patient support. During interviews with clinicians, a 
‘contacts’ feature was suggested in order to encourage patients and their relatives to 
save the contact details of their clinicians to facilitate easier access to clinicians, 
however few patients or relatives suggested this type of feature. This may be due to 
the fact that many patients are reluctant to contact their clinicians outside of 
consultations for fear of unnecessarily ‘bothering’ them (Maguire et al., 2015; Weaver 
et al., 2007). In support of this, interviews described in Chapter 4 described patients’ 
awareness of a pressured healthcare service. However, with the shift from inpatient to 
outpatient cancer care, patients spend most of their time at home self-managing their 
condition. It is therefore important that patients have access to, and feel able to, 
contact their clinicians in order to prevent hospitalisations or unnecessary anxiety 
(Besse et al., 2016; Maguire et al., 2015). During clinician interviews, there was also 
support for the inclusion of contact telephone numbers of cancer charities in an app in 
order to provide extra support for patients in cases of emergency. Research has 
suggested that patients use a range of information sources and cancer services to 
obtain different types of information on cancer, such as the Internet to obtain factual 
information, whereas emotional support was more likely to be sought via telephone 
helplines (Hardyman, Hardy, Brodie & Stephens, 2005). Including a range of services 
and sources of information in an app for patients would enable patients to benefit from 
each type, such as personal communication when using telephone helplines and 
anonymity when using the Internet. A contacts feature was therefore included in the 
app to enable patients to save clinician contact details and access the helplines for 
reputable cancer charities.   
 
The contacts feature was designed by Digital Morphosis. Up to five contacts can be 
input and saved into the contacts feature and each contact includes the name, 
telephone number and email address. The telephone helplines of the following 
organisations were listed (including two out of hours contacts for emergencies), with 
details of the telephone line operation times and costs:  
 
i. Tenovus Cancer Care 
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ii. Cancer Research UK 
iii. Macmillan 
iv. Marie Curie Cancer Care 
v. NHS Direct Wales (out of hours) 
vi. Samaritans (out of hours) 
 
Additional features:  
The ‘Ask Us’ cancer app also included useful technical features. As highlighted in the 
qualitative interviews, one of the main benefits of an app is the ability to use it 
independent of time and location. Although many community settings now offer free 
wifi, the location and connection are not always guaranteed. The QPL, glossary and 
contact features were designed to be used offline, without the use of Internet 
connection. This provides patients with the flexibility to use the app when on the move. 
However, the resources feature, which provides links to websites, does require Internet 
connection, although it is expected that patients would prefer to use this feature when 
at home, where they have time to read the information.  
 
The ability to use most of the features of the app offline is a unique advantage that sets 
it apart from similar tools that are available for patients with cancer. For example, 
existing glossaries of cancer terms that are available on cancer websites, such as 
Cancer Research UK, require the Internet to access them. Additionally, patients 
require the knowledge and experience to access the particular website via an Internet 
browser on a Smartphone (or tablet) and then locate the glossary within that website. 
This would be a difficult task for patients who lack experience with Smart technology. 
Instead, the ‘Ask Us’ cancer app glossary is located on the homepage of the app to 
enable fast and easy access for patients of all abilities. Similarly, the resources feature 
offers patients fast and easy access to topics of cancer information within existing 
websites, such as Macmillan. Some clinics or websites may offer patients paper-based 
QPLs to use and some patients have reported that they wrote questions for their 
consultation on a blank piece of paper. However, there is a risk of losing a paper-
based QPL and forgetting to take it to the consultation. As most people now carry 
Smartphones with them when in community settings, it makes sense to use an app-
based QPL that cannot be lost and or forgotten. Finally, the contact feature provides 
fast access to telephone numbers for emergency care or further cancer-related 
information and these numbers may be telephoned directly from the app. This saves 
patients the time of having to look up the organisations telephone number and typing it 
manually into their phones.  
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As described in section 6.3, there are a number of apps for patients with cancer that 
offer similar features as the ‘Ask Us’ cancer app, which were found through the Apple 
app store. However, as described in Chapter 1, previous searches of Apple and 
Android app stores in 2013 indicated that only 55% of the publically available apps 
which provided information on cancer provided scientifically validated data, and none 
appeared to have been systematically developed and evaluated (Bender, Yue, To, 
Deacken & Jadad, 2013; Nasi et al., 2015; Pandey, Hasan, Dubey & Sarangi, 2013). 
Additionally, the features included in the ‘Ask Us’ cancer app were suggested by 
patients, their relatives and clinicians and were further screened using the APEASE 
criteria, in consultation with researchers and clinicians. This rigorous process created a 
unique combination of app features and only included information and sources that 
were accurate and reputable. For example, the Pocket Cancer Care guide offers a 
QPL feature and a glossary feature, as well as a ‘care guide’ feature, however the 
glossary includes a huge list of cancer-specific terms which appears to decrease its 
ease of use. Additionally, this app does not include links to credible cancer information 
websites that were desired by many patients. Similarly, Macmillan’s ‘My Organiser’ app 
offers patients an appointment feature, medication log and a contacts feature. 
However, the appointment feature was not very popular amongst patients and their 
relatives in qualitative interviews described in Chapter 4, and Smartphones already 
have an inbuilt calendar feature that patients could use to record dates of 
consultations. Furthermore, although a medication log might be desired by some 
patients, it was not popular enough amongst patients in qualitative interviews for this 
thesis to be included in the app. Other features, such as the resources feature, were 
anticipated to be of more use. In summary, the ‘Ask Us’ cancer app provides patients 
with faster and easier access to a unique combination of useful cancer-related tools 
and services, that are available via one platform, by taking advantage of the benefits 
offered by Smart technology.  
 
6.5 User-testing discussion group  
6.5.1 Method 
A sample of patients and their relatives were invited to a discussion group to user-test 
the app and assess the design, its ease of use and content. Research has shown that 
user-testing with just five participants can reveal up to 85% of usability issues (Nielsen, 
1993; Nielsen & Landauer, 2000). A discussion group offers the benefit of prompting 
participants to think about issues that they may not have thought about individually and 
provides the opportunity to build upon one another’s opinions and the ability to reach a 
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consensus for suggested app modifications, much like a focus group (Kitzinger, 1995).  
As a result, a discussion group with around 5-6 participants was considered a suitable 
method to identify any issues with the app at this early stage in app development. The 
discussion group would not be audio-recorded as it would be a followed by an in-depth 
field testing study consisting of semi-structured interviews covering much of the same 
topics, such as perceived acceptability, usefulness and ease of use. The aim of the 
discussion group was to iron out any issues and optimise the app prior to field testing.    
 
Participants 
A small sample of patients and relatives that participated in qualitative interviews 
(Chapter 4) who consented to being contacted for further research were invited to 
participate in a user-testing session. Purposive sampling was used to recruit a varied 
sample of participants, including:  
 
i. Participants that had positive views of an app for patients 
ii. Participants that had negative views of an app for patients 
iii. Participants that were familiar with Smart technology and apps 
iv. Participants that were unfamiliar with Smart technology and apps 
v. Women and men 
vi. Participants above and below the age of 60 
 
Recruitment 
Selected participants were contacted by telephone or email to participate in the user-
testing session and were sent an information sheet about the session by email 
(Appendix 30). Participants were informed that they would receive a £20 Marks & 
Spencer voucher for their time and could be reimbursed for their travel expenses. The 
date and time selected by the majority of participants was then selected and 
participants were notified.  
 
Procedure 
The candidate began the discussion group by introducing herself and the participants 
to one another. The session was explained to participants and they were given an 
opportunity to ask questions. Written informed consent was given by each participant 
(Appendix 31). Demographic information was then collected by questionnaire 
(Appendix 32). A short PowerPoint presentation that included a brief overview of the 
PhD project and findings of the qualitative interviews with patients, their relatives, and 
clinicians was given, followed by a demonstration on how to use the app. Participants 
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were then provided with iPads and/or downloaded the app to use on their 
Smartphones and were asked to explore the app by using each of its features, reading 
the content, and completing the following tasks: 
 
(1) Question prompt list feature: create a question prompt list and add questions to 
the list.  
(2) Glossary feature: search for a term in the glossary.  
(3) Resources feature: select a link from the resources feature and obtain 
information.  
(4) Contacts feature: add a contact and save it.  
 
After 30 minutes, the candidate used a topic guide to facilitate a group discussion of 
participants’ views and opinions of the app. Throughout this discussion, participants 
kept the Smart devices so that they could continue to explore and refer to the app. 
Once the session had finished, the participants were debriefed about next steps for the 
app.   
 
Topic guide 
A semi-structured topic guide was used to facilitate the user-testing session (Appendix 
33). This allowed the candidate to cover certain topics of interest but also allowed 
participants the freedom to discuss other topics of importance (Harrell & Bradley, 
2009). Findings from previous chapters and usability testing models, including the 
Health-ITUEM (Brown et al., 2013) and the PACMAD model (Harrison et al., 2013) 
informed the development of the topic guide. These models encourage the 
consideration of concepts such as effectiveness (whether users can successfully 
complete a set task), learnability (whether users are able to use the app within less 
than five minutes), satisfaction (the perceived level of comfort and affect towards the 
app), and error prevention (how well a user can complete tasks without making errors 
or experiencing technical problems). The topics of the discussion group were grouped 
into three themes, including (1) the design (layout, colours, font, icons and placement 
of features), (2) navigation (the ease of which users navigate through the app), and (3) 
content (understanding of app content and perceived usefulness). 
 
Analysis 
The discussion group was recorded by the candidate by taking written notes. Any 
positive comments, confusion, difficulties and recommended modifications for the app 
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were noted. A consensus of themes and recommendations was created from the 
results.  
 
6.5.2. Results 
Sample characteristics 
Nine patients and three relatives were contacted to participate in the discussion group 
(Table 6). Four patients and one relative (daughter) agreed to participate and 
completed the discussion group (response rate 42%). Four out of five participants were 
educated to at least degree level. Of the seven participants who did not take part in the 
session, three participants were on holiday, two participants did not respond to the 
contact made, one participant did not wish to participate in further research, and one 
participant could not attend the date of the session.  
 
Table 6: Participant characteristics  
Participant 
type Age Gender Cancer type 
Time since 
diagnosis Education level 
Patient 66-75 M Colorectal 1-2 years Post-graduate degree 
Patient 66-75 M Colorectal 2-4 years Degree 
Patient 56-65 F Gynaecological 5 years+ Degree 
Patient 56-65 F Gynaecological 1-2 years Degree 
Relative 36-45 F N/A N/A A levels 
 
 
Themes 
Design 
Participants were satisfied with the overall design of the app and described it as 
‘laymen-friendly’. Participants were satisfied with the readability of the app and 
anticipated that it would be suitable for all patients. Most participants liked the colour 
scheme. One participant suggested increasing the size of the font and another two 
participants suggested changing the font to a more ‘friendly’ font such as Comic Sans 
to make it easier to read.  
 
Navigation  
The app appeared to be effective as all participants were able to successfully complete 
the tasks set. Participants appeared to use the app with ease on both a Smartphone 
and tablet device, which demonstrated the learnability of the app. There did not appear 
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to be any differences between usability of the app on each device. Participants were 
able to navigate easily between and within the app features, using both menus, and 
were able to use each feature successfully. Participants did not experience technical 
errors during the user-testing session, however some participants suggested 
modifications for some app features, which are described below.  
 
(1) QPL feature: Some participants reported that navigation through the QPL 
feature was not intuitive. Participants had to create a consultation list and title 
and then progress to the categories of questions where they could browse 
individual questions and add them to a list. Participants suggested that it would 
be more intuitive to have immediate access to the categories of questions and 
be prompted to create a consultation list only once they have selected 
questions that they would like to add.  
 
(2) Glossary feature: One participant noticed that once a term had been searched 
for and found in the glossary, it was not highlighted. This participant suggested 
including highlighting of the search term to increase ease of use.  
 
Content 
Participants were satisfied with the app features and their content and perceived all 
features to be useful for future patients. Participants particularly liked the QPL feature, 
anticipating that it would possibly be the most useful feature for patients. Participants 
commented that the questions within the QPL feature were comprehensive and 
covered all the concerns that they had during their earlier experience of cancer. 
Participants were satisfied with the terms and definitions in the glossary, however one 
participant wanted to add cancer-specific terms. Participants commented on the 
usefulness of the website links and were impressed with the amount of information 
available via the links, particularly the links for individual topics, such as chemotherapy. 
Two participants suggested adding links to local information, such as parking at the 
hospital and complimentary therapies available at Velindre NHS Trust. Participants 
were satisfied with the contacts feature and no suggestions for changes were made. 
Finally, all participants suggested that the app should be available in Welsh.  
 
Post user-testing app modifications 
The findings of the discussion group were reviewed by the candidate and supervisors 
and the following modifications were made:  
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(1) A function was added to the app that allowed users to change the font to 
two different sizes – normal and large, in increase its ease of use. 
 
(2) The layout of the QPL feature was amended to provide users with 
immediate access to question categories. Additionally, selected questions were 
added automatically to a consultation list called ‘Question list 1’.  
 
(3) The glossary feature was amended so that the definition of the main 
searched term now appears highlighted and at the top of the list of results.  
 
Screenshots of the final version of the app can be found in Appendix 34.  
 
6.6 Discussion  
The aim of this chapter was to describe the systematic development of a novel app 
intervention for patients with cancer and their relatives, including the design of the app 
interface, the selection of app features to include in an app and development of app 
feature content, and the user-testing of the app with a sample of patients and their 
relatives. Data from qualitative interviews with patients, their relatives and clinicians 
were used to decide what type of app patients and their families would find useful 
based on their needs within their psychosocial context. From these findings, objectives 
of an app intervention were developed. Findings from these qualitative interviews in 
combination with assessment of suggested app features using the APEASE criteria 
(Michie et al., 2014), review of relevant literature and consultation with the supervisory 
team, led to the systematic selection of four features to include in an app that would 
meet the objectives of the intervention. Selected features included a QPL, glossary of 
cancer terms, resources feature and contacts feature. The design of the app was 
created by Digital Morphosis and the candidate and supervisors guided its 
development through an iterative process. Development of the content of the app 
features was also an iterative process which was refined by the candidate and 
supervisory team. Content was created by using existing, credible information 
resources, where appropriate, such as health information and cancer charity websites. 
‘In-house’ testing of the app was conducted by the candidate and supervisory team, 
followed by a user-testing discussion group with a sample of patients and relatives. 
The design and testing of other app interventions for cancer patients and patients with 
other chronic conditions have followed a similar format of development prior to field 
testing studies (Aldiss et al., 2011; Cafazzo et al., 2012; Mirkovic et al., 2014; Stinson 
et al., 2013).  
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The discussion group found the app to be useful and easy to use and were satisfied 
with the overall design and content. As suggested by the Technology Acceptance 
Model (TAM) (Davis, 1989), an individual’s behavioural intention to use a new 
information technology is determined by its perceived usefulness and perceived ease 
of use. However, these findings must be interpreted with caution as the sample was 
highly educated. Education level, a proxy of socioeconomic status, has been shown by 
some studies to be predictive of the use of web-based technologies across the health 
care and health information-seeking domains (Kontos, Blake, Chou & Prestin, 2014; 
Neter & Brainin, 2012). For example, one study analysed data from the National 
Cancer Institute’s 2012 Health Information Trends Survey (HINTS) of 3959 adult 
Internet users and found that adults with lower levels of education had significantly 
lower odds of engaging in a range of health-related web-based activities, including 
searching for health-related information online, downloading health information to a 
mobile device, using email or the Internet to communicate with a doctor, tracking their 
personal health information online and using a website to help track diet, weight, and 
physical activity (Kontos et al., 2014). The divides among those less educated indicate 
possible issues of health literacy and eHealth literacy, which is described as the ability 
to seek, find, understand, and appraise health information from electronic sources and 
apply knowledge gained to addressing or solving a health problem (Neter & Brainin, 
2012; Norman & Skinner, 2006a; 2006b). It is possible that, with higher education 
levels, participants in the present user-testing discussion group were more engaged in 
their health and had higher levels of eHealth literacy. As a result, these participants 
may have found the ‘Ask Us’ cancer app easier to use and perceived it to be more 
useful compared to patients with lower levels of education. However, these studies 
have further identified that those with lower levels of education were more likely to use 
social media for their health compared to those with higher levels of education (Fox & 
Duggan, 2013; Kontos et al, 2014). Similarly, the Pew Internet & American Life 
Project’s 2013 Health Online study (Fox & Duggan, 2013) reported that non-Hispanic 
blacks (35%) and Hispanics (38%) were more likely to report using their mobile phone 
to access health information, compared to non-Hispanic Whites (27%). Individuals with 
lower education levels may therefore engage with the health care system in a different 
way, which may primarily be through the use of mobile phones and so an app for 
patients with cancer might be a way of reducing this digital divide. Nonetheless, further 
user-testing with a sample that is more representative of the population, including 
patients and relatives with lower levels of education, is needed in order to add weight 
to the present findings.   
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Suggested modifications from the user-testing session were discussed by the 
candidate and supervisory team and agreed changes were made to create the final 
version of the app. This was conducted in an attempt to optimise the usability and 
acceptability of the app prior to field testing (Yardley et al., 2015).  
 
6.6.1 Strengths and limitations 
The development of the ‘Ask Us’ cancer app was a systematic and thorough process. 
Selection of features for the app was determined by synthesis of qualitative of research 
conducted with key users (i.e. patients, relatives) and stakeholders (i.e. clinicians) of 
the intervention, review of relevant literature, application of the APEASE criteria and 
consultation with digital and supervisory teams. The app went through two rounds of 
user-testing, including in-house testing with the supervisory team and a sample of ‘real’ 
users, and user-testing was guided by existing usability models and frameworks 
(Brown et al., 2013; Harrison et al., 2013). However, there are several limitations to 
consider. Firstly, the sample size of the user-testing discussion group was small and 
four out of five participants were educated to degree level or higher, which may have 
artificially inflated findings on perceived ease of use and usefulness. Secondly, 
participants had also previously taken part in qualitative interviews for this thesis and 
so may have felt invested in this research. This sample may therefore have provided 
more favourable opinions of the app, compared to those who declined to participate or 
new participants who had not previously taken part in research for this thesis. 
However, efforts were made to include a varied sample of users for the discussion 
group, including those who displayed negative opinions and those who displayed 
positive opinions of an app during qualitative interviews. Additionally, participants were 
provided with a monetary incentive to participate so it possible that the participants’ 
views were influenced by a desire to be polite, as well as to be supportive of the 
candidates’ PhD and development of an app for future patients and their relatives (a 
form of social desirability bias). However, prior to start of the user-testing session, the 
candidate explained that both positive and negative opinions would help in the future 
development of the app. 
 
6.6.2 Implications 
This chapter outlines the systematic process involved in developing an app 
intervention to help patients with cancer to meet their information needs and will 
therefore be of use to intervention developers in the wider cancer intervention field. 
The findings from the user-testing study provide preliminary evidence for the uptake of 
an app for cancer patients, though these expectations are currently limited to those 
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with higher education levels and experience of Smart technology. Finally, the work 
outlined in this chapter enables progression to a field testing study, contributing to the 
second phase of the MRC framework, ‘feasibility and piloting’, which involves initial 
testing of the acceptability and feasibility of the intervention in real life settings. 
 
6.6.3 Conclusion  
This chapter describes the development and user-testing of a novel app intervention 
that aims to help patients and their relatives to meet their information needs in non-
inpatient settings. Four features were selected for inclusion in the ‘Ask Us’ cancer app, 
including a QPL, glossary of cancer terms, resources feature and contacts feature. An 
iterative process of in-house testing of the design and content of the app led to the 
creation of an initial prototype, which was then user-tested in a discussion group with 
patients and their relatives. The app was found to be useful and easy to use by the 
discussion group and patients and their relative were largely satisfied with the design 
and content of the app. However, further user-testing is required with less educated 
patients and relatives to support these findings. Minor improvements were made 
following the user-testing discussion group, which informed the final version of the app.  
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Chapter 7 
Exploring the acceptability and use of the ‘Ask Us’ cancer app in community 
settings: a field testing study 
 
7.1 Chapter overview 
This chapter reports a mixed methods field testing study that explored the views of 
patients with cancer on their experiences of using the ‘Ask Us’ cancer app. The 
purpose of this study was to assess the acceptability and feasibility of the app in a real 
life setting and understand whether it would be useful to patients in practice. A 
secondary purpose was to guide further development of the app content, where 
needed. This study also reports on app activity data that was collected during the study 
to identify patterns of app use and compare with qualitative findings. The implications 
of these findings for the future development of the app are discussed.  
 
7.2 Introduction 
The second phase of the MRC framework (Craig et al., 2008) for the development of 
complex interventions in healthcare, ‘feasibility and piloting’, encourages initial testing 
of the acceptability and feasibility of the intervention, prior to a full scale evaluation. A 
field testing study serves as an opportunity to explore the potential outcomes of an 
intervention and identify any problems that may occur in the context in which it will be 
used. For example, the ‘Ask Us’ app includes a QPL feature that is intended for use 
during a consultation with clinicians and so it is important to explore the use of the app 
in this context and identify possible barriers to successful implementation (Murray et 
al., 2016, Yardley et al., 2015). Furthermore, it enables examination of uncertainties 
that may have been identified during the development process (e.g. whether potential 
barriers to the uptake of the app identified in Chapters 4 and 5 occur in practice). 
Finally, following modification of the intervention after user-testing, the ‘person-based’ 
approach (Yardley et al., 2015) to intervention development encourages a mixed-
methods evaluation to check that the modifications have been successful in achieving 
an acceptable and easy to use intervention. A mixed-methods evaluation, such as 
qualitative interviews and recording of app activity data, is useful for a field testing 
study as this approach enables validation of users’ explicit perceptions (McGee & 
Gray, 2005). The ‘person-based’ approach highlights the importance of gaining an in-
depth understanding of how users may view and engage with the intervention in 
practice and which elements of the intervention may be useful or even rejected, in 
order to make the intervention more attractive to users and more feasible prior to 
implementation (Yardley et al., 2015).  
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7.2.1 Aims of the present study 
The aim of the present field-testing study was to assess the acceptability and feasibility 
of the ‘Ask Us’ cancer app. This study explored the views and opinions of patients with 
cancer after using the app prior to, and during, a consultation with their clinician. 
Specifically, the acceptability of this type of intervention, patients’ use of the app, the 
most and least useful features, and the benefits and disadvantages of, and barriers to, 
the app were explored. As the app may also be used by relatives, patients were asked 
about the opinions of their relatives on the app. A secondary aim was to guide further 
development of the app content, where needed. App activity was recorded and used to 
provide further insight into patients’ use of app features and to compare with patients’ 
perceptions.  
 
7.2.2 Qualitative methods 
Qualitative methods were chosen to gain in-depth understanding of patients’ 
perspectives and experiences of using an app for cancer care (Green & Thorogood, 
2013). As described in Chapter 4, qualitative methods, such as semi-structured 
interviews, are best suited when the subject matter is a sensitive topic, such as cancer, 
but also when the purpose is exploratory (Smith, 2007). Further reasons for selecting 
qualitative semi-structured interviews, such as the freedom of participants to bring up 
other issues that they felt were relevant, have been discussed in Chapter 4, section 
4.2.2. Thematic analysis was selected to analyse interviews as this method helps to 
move from a broad reading of the data to reporting of patterns and themes, followed by 
their interpretation (Braun & Clarke, 2006). Further description of this approach has 
been discussed in Chapter 4, section 4.2.2.  
 
7.2.3 Software-logged app activity data 
Patients’ use of the app, illustrated by app activity data, was also recorded and 
available for analysis. This provides insight into how patients engage with the app and 
further information on which elements of the app features are preferred.  
Collection and analysis of this data also provides an opportunity to validate patients’ 
perceptions or highlight potential discrepancies between the data sets (McGee & Gray, 
2005).  
 
7.3 Methods 
7.3.1 Participants 
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Maximum variation sampling, a type of purposeful sampling strategy in which cases 
are selected on the basis of the study populations’ characteristics and study objectives, 
was used to allow for divergent views to emerge (Patton, 2002). Participants were 
recruited from Velindre Hospital where patients typically undergo chemotherapy, 
radiotherapy, hormone therapy treatment or are in remission. Following discussions 
with supervisors, it was decided that a sample of approximately ten patients would be 
sufficient for this field testing study. Initially, patients were recruited from the clinical 
trials unit (CTU) as this provides access to a large number of patients who are often 
familiar with research and this method was most successful when recruiting patients 
for the qualitative interviews with patients described in Chapter 4. Recruitment of 
patients from breast, gynaecology, colorectal and urological cancer clinics at Velindre 
Hospital was also conducted where necessary, in order to meet the recruitment target. 
These four cancer types were chosen in order to have a variety of some of the most 
common cancers in the participant sample (WCISU, 2015) and to provide continuity 
with sampling methods used in Chapters 4 and 6 of this thesis. Within those cancer 
types, an attempt was made to include a varied sample of patients with cancer, 
including: 
 
i. Patients undergoing surgery, radiotherapy, chemotherapy or hormone therapy 
for cancer 
ii. A range of cancer types: breast, gynaecological, colorectal and urological 
iii. Women and men 
iv. Patients older than 60 years and patients younger than 60 years 
 
Patients’ eligibility for the study was assessed by the CTU manager or lead clinicians 
from the cancer clinics using the following inclusion and exclusion criteria:  
 
Inclusion criteria:  
i. Male or female 
ii. Aged 18 or above  
iii. Receiving neoadjuvant, adjuvant, radical or palliative treatments 
iv. At least 2 weeks from diagnosis (in order to give patients time to come to term 
with their diagnosis) 
v. Able to give informed consent 
 
Exclusion criteria: 
i. Patients who do not have an estimated life-expectancy of at least 12 months  
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ii. Patients who the clinician deems to be unsuitable for the research (for example 
in a current state of crisis or have their own significant health or social 
problems, unable to provide informed consent, or other reason for not being 
approached about the study). 
 
7.3.2 Patient recruitment 
The CTU manager from Velindre Hospital who helped to recruit patients for qualitative 
interviews described in Chapter 4 was contacted and invited to help with recruitment of 
patients for the present study. Initially, 25 study information packs were distributed to 
eligible patients in the CTU, of which 15 were given during consultations, and 10 were 
posted to patients who had upcoming clinic appointments. Information packs contained 
an invitation letter printed on the relevant cancer clinic headed paper and signed by the 
lead clinician (Appendix 35), an information sheet (Appendix 36), reply form (Appendix 
37) and pre-paid envelope. Pre-paid envelopes and headed and signed invitation 
letters were used to increase response rates (Edwards et al., 2002). All written 
information was tested using a readability formula to ensure that it was easy to read 
(http://www.readabilityformulas.com/free-readability-formula-tests.php). Response to 
this method of recruitment was lower than anticipated but could be explained by poor 
health of patients on clinical trials. A further 33 study packs were provided to lead 
clinicians at breast, gynaecology, colorectal and urological cancer clinics in order to 
recruit additional patients. The candidate kept in contact with the CTU manager and 
the clinicians to track how many information packs were distributed to patients, in order 
to determine the response rate.  
 
7.3.3 Procedure 
Interested patients were encouraged to return a reply form to the candidate in the 
prepaid envelope detailing their contact information. The candidate telephoned or 
emailed the patients to answer any questions about the study and arranged to meet 
them, at their homes or in clinic, to download the app to their Smart device and provide 
a brief training session on how to use the app, which involved demonstrating each 
feature once. Participants were asked to sign a consent form prior to the research 
student downloading the app onto their Smart device to consent to app activity being 
recorded and stored by Google Analytics (Appendix 38) and were given an opportunity 
to ask questions about the study. Demographic information was then collected by 
questionnaire (Appendix 39). Participants provided the date of their next consultation 
with their clinician and agreed to use the app prior to this date and during the 
consultation. The candidate then arranged an interview with each participant following 
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their consultation, in their own homes, at a time convenient for them. Participants were 
offered reimbursement of their travel expenses if they wished to have the interview at 
another location. Informed written consent for the interview was given immediately 
prior to the interview (Appendix 40) and participants were provided with a further 
opportunity to ask questions about the study. The candidate explained that the 
interview was confidential and that only the candidate and lead supervisor would have 
access to the data. Participants were informed of how the data would anonymised, 
stored securely and kept for 15 years at Cardiff University, after which, it will be 
deleted. The interviews were audio-recorded with permission. Audio-files were sent 
electronically to a reputable company for transcription by uploading the files to a 
secure server used by the transcription company. Audio-recordings were transcribed 
verbatim, as described in Chapter 4. Any information that could identify participants in 
the interview transcripts was anonymised. A confidentiality agreement was required 
from the transcription company to ensure that participant data and information was 
protected. Once the completed transcripts were provided to the candidate, the 
candidate listened to the audio-recordings whilst reading the transcripts to check for 
accuracy. 
 
7.3.4 Data management 
Transcripts and audio-recordings were securely stored on a Cardiff University 
password-protected server in accordance with the Data Protection Act 1998. This 
server is password-protected and confidential. All consent forms, transcripts and audio-
recordings will be kept securely for 15 years according to Cardiff University research 
data policies. Following this time, all data will be destroyed.  
 
7.3.5 Interview topic guide 
A semi-structured interview topic guide was used (Appendix 41). Findings from 
Chapters 2, 4, 5 and 6 informed the development of the topic guide. The topic guide 
was reviewed by the candidate’s supervisors and amendments to the topic guide were 
made following comments. The topic guide was then piloted on two post-graduate 
students at Cardiff University to ensure simple language was used and leading 
questions were not asked. The main topics covered at interview were: 
 
i. Usefulness of the training session 
ii. Acceptability of the app  
iii. Actual use of the app (times, frequency, location) 
iv. Most and least useful app features 
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v. Benefits of and barriers to app use 
vi. Communication in consultations 
vii. App development 
 
7.3.6 App activity data 
Google Analytics software was used to record and store app activity data 
(https://www.google.co.uk/analytics/). The following app activity was recorded: 
 
i. Total number of app sessions (number of times participants access the app)  
ii. Average duration of an app session (time engaged with the app) 
iii. App feature page views (number of times each feature was accessed) 
iv. App feature events (use of each app feature), including: 
a. Number and type of questions added to consultation lists in the question 
list feature 
b. Visits to home pages of cancer information websites and specific topics 
of information within websites in the resources feature 
c. Searches conducted using the search bar for cancer-related terms in 
the glossary 
d. Storing of contacts details of clinicians in the contacts feature 
 
7.3.7 Analysis 
Qualitative data were managed using the qualitative analysis software package NVivo 
(NVivo, 10). Interview transcripts were analysed using thematic analysis (Braun & 
Clarke, 2006), as described in Chapter 4, section 4.3.6. Two transcripts were 
independently analysed by the candidate’s supervisor, Dr Fiona Wood, who has 
extensive experience of qualitative research, to reduce the potential bias of subjectivity 
associated with coding and facilitate interpretation of findings. Discrepancies were 
resolved through discussion. App activity data was analysed using descriptive statistics 
as the small sample size precluded any meaningful statistical analyses.  
 
7.3.8  Researcher values and relationship to participants 
The potential influence of personal values of the researcher and the relationship 
between the research and the participant on data collection and interpretations of 
findings for this study have been previously discussed in Chapter 4, section 4.3.7.  
Additionally, it was important make clear to participants that the app did not intend to 
replace their regular care in any way. Participants were informed that if they had any 
concerns regarding their health during the study that they should contact their clinician 
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immediately and not wait for their upcoming consultation. This information was stated 
in a disclaimer on the first page of the app, to which patents had to agree.  
 
7.3.9 Ethical issues 
NHS ethical approval and R&D approval from Velindre NHS Trust was granted for this 
study (15/WA/0161, Appendices 42-43). 
 
7.4 Results 
Interviews were conducted with eight participants in their own homes between May 
and October 2016. The average length of the interviews was 18 minutes (range 12-23 
minutes).   
 
7.4.1 Sample characteristics 
A total of 58 study information packs were distributed to eligible patients, of which nine 
patients returned a reply form indicating interest in participating in the study. All nine 
patients agreed to participate (response rate 15.5%), however only eight completed the 
study. One participant was not able to be reached to conduct the interview following 
their consultation. Participant characteristics are presented in Table 7. Five participants 
were ages 56 or over and half were female. The sample was made up of patients with 
urological (n=3), colorectal (n=2), breast (n=2) and gynaecological (n=1) cancers and 
all participants were undergoing treatment for their cancer. Time since diagnosis 
ranged from 1-3 months to over 5 years and five participants were a year or less since 
diagnosis. All participants were educated to at least secondary level, with three 
participants educated to degree level or more. Six participants downloaded the app to 
a Smartphone and two downloaded the app to a tablet device. The amount of time that 
participants were able to use the app (from initial download of the app to their device to 
interview following the consultation) ranged from 4 days to 11 weeks, as this depended 
on whether they had a suitable upcoming consultation. 
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Table 7:  Participant characteristics. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ID Age Sex Cancer   type 
Time since 
diagnosis Education App use Device 
P1, Lucy 26-35 F Gynae 1-3 months Diploma 1 week Smartphone 
P2, Keith 56-65 M Urological 
 
6 months-1 
year 
A Levels 4 days Tablet 
P3, Rachel 36-45 F Breast 1-2 years Degree 8 weeks Smartphone 
P4, Mark 56-65 M Urological 5 years+  GCSE/O Levels 8 weeks Smartphone 
P5, Josie 66-75 F Colorectal 1-2 years A Levels 2 weeks Tablet 
P6, Karen 36-45 F Breast 3-6 months  Post-grad degree 1 week Smartphone 
P7, Albert 66-75 M Colorectal 3-6 months  GCSE/O Levels 5 weeks Smartphone 
P8, Thomas 66-75 M Urological 3-6 months  NVQ/HNC/HND 11 weeks Smartphone 
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7.4.2 Interview themes 
From the interviews, three key themes were identified: (1) acceptability of the app, (2) 
participants’ use of the app, and (3) the benefits of, and barriers to, app use. 
Subthemes will be discussed in detail below. Patient participants are identified with ‘P’, 
followed by their identification numbers listed in Table 7 and a pseudonym. The 
interviewer is identified with ‘I’. Where irrelevant, text was removed from quotes and 
denoted by {…}. Square brackets within the quotes represent inserted text to clarify the 
content.  
 
Theme 1: Acceptability of the app  
Subtheme 1a: Ease of use  
Participants were satisfied with the design of the app, including its layout, colour and 
font and perceived it to be was a user-friendly design. Most reported that they felt 
comfortable using the app following the brief training session. Participants who used 
the app on a Smartphone and those who used it on a tablet device reported that they 
found the app easy to navigate and were able to use the features with ease. As a 
result of the simple design, most participants anticipated that patients would find the 
app easy to use, including those who lack experience with apps, such as older 
patients. 
 
P2, Keith (56-65 years, urological cancer) – Erm, design wise it’s fine, it does 
what it needs to do. It’s user friendly so there was nothing in there that would 
make it difficult to … to use. {…} It’s very very user friendly and very very easy 
to navigate even for somebody that’s not that well up with modern technology. I 
think once its explained to them and once they are shown how to go through it, 
I think it will be very easy to follow. 
 
P4, Mark (56-65 years, urological cancer) - As I say it’s, it’s, this is the basic 
app, but it’s very good as I say for people who are not quite as tech savvy as 
you might be and the buttons are there. {…} I mean it was very easy to use and 
… you know, it was quick. 
 
Subtheme 1b: Technical problems 
All but one participant reported that they did not experience any technical problems 
with the app. One participant explained that when he added questions to a consultation 
list the questions would disappear, however no other participant reported this issue.  
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I – Did you have any technical problems at all? 
P3, Rachel (36-45 years, breast cancer)- No, no problems at all, no.  
 
I - Did you have any technical problems? So first of all we couldn’t find the app 
could we?  
P7, Albert (66-75 years, colorectal cancer) - No we could not.  
I - What about after that, did you have any problems?  
P7, Albert - Well when it come on mine [Smartphone] it was alright and I did 
load the question onto it but I can’t seem to find it now, do they drop off or …?  
I - Oh we’ll have a look at it now.  
P7, Albert - Okay, I can’t find it on there. I did put a question on there but … 
I - But you couldn’t find the question list?  
P7, Albert - I couldn’t find, I couldn’t find the question, I know the question I was 
going to ask but I can’t, I couldn’t find it again.  
 
Subtheme 1c: Relatives’ views on the app  
Some patients reported that their partners had had a look at the app but hadn’t use it 
with them, either because the patient was busy or had not used it much themselves. 
One patient reported that her daughter thought the app was ‘good’ and easy to use.    
 
P6, Karen (36-45, breast cancer) – Erm I think [husband] had a quick look at t 
just visually but didn’t use it.  
I – Okay. Did he have any comments at all? 
P6, Karen – Erm no, I don’t think so. 
 
I – Did any of you relatives or friends have a look at the app? Did any of them 
use it with you? 
P5, Josie (66-75, colorectal cancer) – My, my daughter. 
I - Okay, and what did she think of it? 
P5, Josie - She thought it was really good.  
I  - Oh that’s good. Did she find it easy to use? 
P5, Josie – Yes she is computer literature, so she found it very easy and she 
said how straightforward it was too.  
 
Subtheme 1d: Suggestions for improvement 
With regards to existing app features, one participant suggested expanding the 
glossary to include cancer specific terms and one suggested creating a separate 
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feature for relatives to make it easier to access. Some participants reported that 
initially, they found it confusing that there was no ‘Back’ button to exit the app features 
and instead had to scroll down to the bottom of the page and click ‘Done’.  
 
I - Okay so overall how did you find the app, how did you get on with it? 
P6, Karen (36-45, breast cancer) - Okay, erm I thought it was fine, I mean it 
was pretty easy to navigate I think once I got the hang of sort of putting 
questions in and how to sort of go back yeah.  
I - Yeah, what do you mean when you say you had to go back?  
P6, Karen - So erm, so when I was putting questions in, because on this you’ve 
got sort of a ‘Back’ key there which takes you out of the app rather than 
pressing the ‘Done’, I’d forgotten there was a ‘Done’ button.  
I - Right okay yeah.  
P6, Karen- Yeah so once I got that sorted it was fine.  
 
Some participants suggested additional app features that they thought would be useful 
for future patients, including a feature to write notes from consultations, a feature to 
organise and prompt attendance at clinic appointments, a treatment-related symptom 
diary feature, a feature to send a question list to their clinician prior to a consultation 
and a feature signposting to meditation resources. 
 
I - …What about any other features you might have thought of while you were 
using the app? 
P4, Mark (56-65 years, urological) - Erm … the only other thing would be like a 
diary section perhaps… just to keep track of, erm ... symptoms and 
appointments, erm ... you know just like a simple calendar. You know, I have 
one on my phone anyway but it gets overtaken with social events and things 
like that, so maybe having a specific hospital one.  
 
Theme 2: Participants’ use of the app 
Subtheme 2a: Frequency, time and location of app use  
Participants reported that they tended to use the app at any time when they wanted 
information but mostly prior to their consultations with clinicians. Participants reported 
that they mostly used the app at home but also when out in the community or at cancer 
clinic if they needed information or wanted to note down a question for a consultation. 
 
I - So how often did you use the app?  
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P4, Mark (56-65 years, urological) - Erm ... certainly a few days before I would 
have my clinical appointments. So about every three weeks to write down 
questions, but like I say I did use it to contact MacMillan and that was just 
sporadically you know whenever I felt the need to know something, yeah 
certainly every three weeks just before I am due in for a chemo.  
I - And when did you use it? Was there any typical time of day or… 
P4, Mark - Usually in the evening yeah, when our kids are in bed and I sat 
down to think about what I wanted to ask the oncologist I was using the the app 
then.  
 
Subtheme 2b: App use during consultations 
Three participants reported that they used the app during a consultation with their 
clinician to ask questions about their condition, two used the app immediately prior to a 
consultation to remind themselves of their questions, one planned to use it prior to her 
consultation but forgot to charge her phone so was unable to use it, one was unable to 
use it to prepare for a consultation as he felt he didn’t have questions to ask but also 
had experienced a technical issue with the QPL feature and suggested that if he did 
have questions, he would write them down. One participant did not use the app to 
prepare for his consultations due to lack of experience with Smart technology and 
preference for traditional methods (i.e. pen and paper). Of those participants who used 
the app during a consultation, all reported that they felt comfortable with the 
experience, though one participant also felt that it was ‘weird’ and not the norm.  
 
I - So you, you used the app in the consultation and you said the nurse 
responded well to it and that was okay? 
P6, Karen (36-45, breast cancer) - Yeah, that’s fine yeah, yeah.  
I - Erm were you comfortable using it in the consultation?  
P6, Karen - Erm yeah, I mean I did feel a bit weird taking my phone out and 
going, “Oh I'm just going to use this”, erm but I don’t think it was a massive 
issue. 
 
P7, Albert (66-75 years, colorectal cancer - I know in my own mind what 
questions I wanted to ask…. You know I'm quite intelligent… you know I'm 
quite intelligent and erm if I need to ask a question I generally write them down, 
if there's numerous questions you want to ask you sort of write them down, but I 
didn’t erm because there was not many questions I wanted to ask. 
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Participants who used the app in a consultation with their clinician reported that they 
did not find it to be distracting and suggested that their clinician responded positively to 
the experience, with some commenting that they thought the app was a good idea.  
 
I - And did you find it distracting using the app in the consultation? 
P4, Mark (56-65 years, urological) – No, its just two buttons and you are in 
really isn’t it, so it didn’t bother me. I think times have changed and they 
actually say how well organised I am so it’s just …another addition to being 
organised. Having everything to hand, and to make her [clinician] job easier 
rather then hassling her two days later saying, “I forgot to ask you this” … I 
have got it all there, on the question list. 
 
I - And how did the doctor react to you taking the app into the consultation? 
P2, Keith (56-65 years, urological cancer) - Very positively.  
I - Oh that’s good, erm ... did he mention anything at all, did you find they were 
more helpful or less helpful? 
P2, Keith -  Erm…no I mean they thought it was a very good idea. 
I – Yeah… 
P2, Keith – But they were more concerned with, erm…actual treatment 
than…anything else because obviously that’s what they are there for.   
 
Subtheme 2c: Most and least popular app features 
In general, participants perceived the app to be useful and found at least some of the 
app features to be useful for themselves. As a result, participants did not feel that any 
features should be removed from the app. Most participants reported that they found 
the QPL feature to be the most useful of all the features, followed by the resources and 
glossary features. It was suggested that this was because participants have regular 
consultations with clinicians and have questions to ask at each stage throughout their 
cancer journey. The majority of participants reported that they used the QPL feature to 
prepare for consultations and although they felt that the categories of questions were 
comprehensive, they liked that they could also add their own questions.  
 
I - What are the most useful features on the app?  
P4, Mark (56-65 years, urological) – Erm, the question lists for me.  
I - And why was that?  
P4, Mark - Well because we have clinics every three weeks so every.. you 
know before chemo you have … you go into the nurses on the Tuesday, so I 
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have always got questions to ask. So I did, erm … I used some of the loaded 
questions and added a few of my own, so I did use that. 
 
I - What were the most useful features for you on the app, I mean you 
mentioned the links and the question prompt list… 
P2, Keith (56-65 years, urological cancer) - Probably the questions because 
…you have these things [questions] and you might write them down on a piece 
of paper and then you will forget the piece of paper or you just want to get the 
questions, the fact you have got them all there in front of you [on an app] … 
then you can just open up that [app] page and you can go through them with 
the doctor or the nurse or whoever that might be … I think that’s a very good 
feature, and the fact … also the fact that you can add in your own questions … 
you know you are not confined to the questions that are there … the fact that 
you can add your own in is a good feature. 
 
Participants reported that they found the resources feature to be informative and the 
links to specific topics of information to be particularly useful, as this made it easier to 
navigate the cancer information websites and find the specific information they wanted. 
Two participants reported that this feature was informative even though they had been 
diagnosed with their cancer for a few months, as there was so much to learn about 
their condition.  
 
I - So going onto the features, what do you think were the most useful features 
on the app?  
P7, Albert (66-75, colorectal cancer( -  I would think the information contained 
in the resources section. 
I – Okay, why do you think that was the most useful for you?  
P7, Albert - Well it was just handy to know, you know what different 
organisations do, how they can help, and just information about cancer in 
general really. So it was all in the same section.  
I - And was that useful to you even at this point [of your cancer]?  
P7, Albert- Yeah I read quite a bit. 
 
I - What do you think were the most useful features of the app?  
P1, Lucy (26-35 years, gynaecological cancer) - Erm the questions I liked and 
the fact you could upload your own questions as well, and the side effects [in 
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the resources feature], you know you have the side effects of chemotherapy 
and radiotherapy already there and …  
I - In the resources section?  
P1, Lucy - Yeah in the quick reference [links to specific topics of information] 
that was good. So you can, you can find them they were there for you.  
I - Yes sort of straight away.  
P1, Lucy – So yeah to have it there as a quick reference so you can just click 
on, you know, I think is brilliant. I mean even now that I'm halfway through [her 
treatment], I'm still looking at side effects of it you know. 
 
Fewer participants reported that they had searched for words in the glossary following 
their consultations and though they reported that it helped to improve their knowledge 
of cancer-related terms. The contacts feature appeared to be the least popular. The 
majority of participants reported that they did not find the contacts feature as useful as 
other features and explained that this was because they already knew their important 
contacts. In contrast, one patient explained that it was useful to have the contact 
details of cancer organisations in one place and storing their clinician details meant 
that they could access them easily in case of an emergency, even when out in the 
community. 
 
I -  The glossary of cancer terms, did you use that?  
P2, Keith (56-65 years, urological cancer) - I did that yeah, that is very very 
helpful. Because you know doctors and nurses tend to use these words 
assuming everybody knows what they mean …and I can understand that but 
obviously people don’t often ... sometimes they don’t know and they are not 
confident enough to ask. So if they can use that to find out what those things 
mean … and following it through that will help a lot of people. 
 
I - And what about least useful features, why were those do you think the ones 
that weren’t so …?  
P1, Lucy (26-35 years, gynaecological cancer) - Erm what I didn’t use was the 
erm, what was it called …? 
I - Was it the contacts section?  
P1, Lucy - The contacts yeah, the groups and, but then I think that’s because of 
where I am in the treatment, I already know those [contacts].  
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P5, Josie (66-75 years, colorectal cancer)- Erm some of the extra support [the 
contacts feature] where it says you could get in touch with people, I found that 
was excellent.  
I -  Okay so you mean where you add the contacts. Did you use that? Do you 
think other patients might use it?  
P5, Josie - I actually put the numbers in.  
I - Oh that’s good erm and why did you save them, why do you think it was 
useful?  
P5, Josie -  If you're not very well sometimes you need to, I don’t keep my 
phonebook with me all the time but if I’d got those phone numbers if I'm out and 
about or if anything happens I've automatically got those numbers that I need to 
get in touch with straight away.  
 
Theme 3: Benefits of and barriers to app use 
Subtheme 3a: Increased question-asking 
Participants reported that the question list feature served as a memory aid as they 
were able to add questions and store them when needed, independent of time and 
location, which prevented them from forgetting important questions. Participants also 
reported that this feature reminded them of the questions that they wanted to ask prior 
to their consultation and for those who used this feature during a consultation, 
participants reported that it prompted them to ask the questions. Participants perceived 
that using the QPL resulted in them asking more questions than they normally would 
during their consultation. Some participants further suggested that the QPL helped to 
improve communication with their clinicians in consultations, as it prompted them to 
actively participate in discussion.   
 
P3, Rachel (36-45 years, breast cancer) - …Like you know, I’d suddenly think 
of something, because you’ve got the phone with you all the time … so I’d 
suddenly think of a question or something and think, “uUh-oh, jot that down”, it’ll 
remind me then when I go and see the specialist.  
I - And did you find that helped …  
P3, Rachel - Yes, yeah.  
I - … you preventing forgetting questions?  
P3, Rachel - That’s right, yeah. Because you do tend to get a bit forgetful when 
you’re in with the … consultant or whatever. You’ve got such a short space of 
time… to, to sort of think of what you want to say… 
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I - What sort of benefits did you get from using the app? Erm, for example, erm 
some of the things patients have said are increase in knowledge, or confidence 
maybe to ask questions, or erm better communication with their doctors and 
nurses.  
P3, Rachel -  Better communications, definitely. I mean because you’ve got the 
questions you want to ask there; you can look at them quickly before you go 
into the room … remember what you, you know …  
I - Okay, that’s good. Erm, so do you think the app, going back to the 
consultation, you said you think it’d improved communication. Erm, how did the 
app make a difference to how you talked to the doctors and nurses?  
P3, Rachel - Well it, it just helped me to, to remember things to ask, really.  
 
I – Okay so you used the app in the consultation with the doctor… 
P2, Keith (56-65 years, urological cancer) – Yes only to refer to the questions 
that I stored in the… 
I – Okay and how did that go? Did you find it useful? 
P2, Keith– Yes, like I said, it’s a good memory aid because you might write 
them down and try to remember them but non of those things are going to 
work. So with the app, you have got them right in there in front of you.  
I – Do you think the app made a difference in how you talked to the doctors and 
nurses? 
P2, Keith - Only in that you have got the information right there in front of you 
so you can… you don’t need to try and think back to remember what you want 
to say, it’s all there for you, so it is a good memory aid definitely.  
 
Subtheme 3b: Increased knowledge  
Some participants perceived an increase in cancer-related knowledge as a result of 
using of the app, particularly from using the resources and glossary features. 
Participants reported that they appreciated that the links included in the resources 
feature were to reputable cancer information websites as this 
reduced the burden of having to search through a huge amount of information on the 
Internet.  
 
P1, Lucy (26-35 years, gynaecological cancer) - …Yeah, yeah but you know all 
the information on there was, like they're trusted sites for a start so it’s not just 
you know typing into Google and God knows what you're going to read, so it 
was nice that it was trusted McMillan and that the Patient, I did use the Patient 
	 192	
one because I had erm a really bad stomach so I used that and put in my 
symptoms. Erm and I had a rash one night and I was like … go through that 
erm, so all that is there and you do gain knowledge from it all. 
 
I – Okay so how did you find using the app in general? 
P2, Keith (56-65 years, urological cancer) -…Very easy to navigate and very 
very informative.  
I - Oh good okay, erm ... so what do you mean informative? Was there anything 
in particular, any particular feature or … ? 
P2, Keith – What I particularly liked was the links to the specific web pages, the 
websites. Because there is loads of information on there particularly about, erm 
... the effects of the various treatments … which I think would be very very 
helpful to a lot of people even though they are given the information at the 
beginning of their treatment… it’s so much information, that it’s got to be able to 
… you can sit in front of a PC and find the websites … but if you are guided 
through to the relevant ones… it’s so much better.  
 
Additionally, some participants suggested that the resources and glossary features 
increased their understanding of their condition by enabling them to understand the 
medical terms used and information provided by clinicians in consultations. One 
participant reported that this increased his confidence in consultations.  
 
I -  Okay. So erm, so you said you used the app leading up to the consultation 
with the doctor, erm do you think the app made a difference in how you talked 
to the doctors and nurses?  
P1, Lucy (26-35 years, gynaecological cancer) - Only in the fact that you're 
more knowledgeable about the wording and things like that so that’s always 
good because it makes you a bit more confident then and you can understand 
what they're saying {…} 
 I -  So what do you mean, so you said you're confident about the wording, do 
you mean you feel confident that you can ask a couple of questions in the right 
way?  
P1, Lucy - Yeah and you're understanding them as well, so.  
 
Subtheme 3c: Reduced anxiety  
Some participants suggested that an increase in cancer-related knowledge reduced 
their anxiety as they were able to develop expectations of their condition with regards 
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to treatment. One patient explained that reading about potential side-effects of 
treatment enabled her to prepare for such effects and provided reassurance that this 
was a normal part of the treatment, which in turn reduced her anxiety.  
 
I - Yeah and how does it help you by reading about the side effects?  
P1, Lucy (26-35 years, gynaecological cancer) - It prepares you mentally and it 
confirms that all you're feeling is normal and other people have felt that way, 
because when you're feeling you know, pretty rundown you do question 
whether it’s just …you know but I know …they say this is part of it, it just puts 
your mind at rest.  
I - Yeah that it’s normal.  
P1, Lucy - Yeah but other people you know, and it is part of the treatment. 
 
In contrast, an avoidant coping approach, and subsequent preferences for information, 
appeared to be a barrier to app use for two participants. These participants reported 
that they did not want to have further information on their condition beyond that 
provided by their clinician, as they felt that this information was sufficient. One 
participant further explained that this approach enabled him to minimise the anxiety 
caused by his illness.  
 
I - What sort of benefits do you think you might get, if you had used this app 
previously, do you think you might have benefited at all?  
P8, Thomas (66-75 years, urological cancer) - No. It’s information, isn’t it?  
I - Yeah.  
P8, Thomas - The, the information I’ve been given is pretty good.  
I - Right, okay, so you feel like you’ve had enough information?  
P8, Thomas - Yeah. I don’t want it to ruin my life… if I was sat at home worrying 
about it all the time … I might have a big file on it and all that. I’m just carrying 
on as normal.  
I - Yeah. Okay, so for you then, you wouldn’t want all these extra bits and bobs 
reminding you about it all the time, so you’ve got the information you need and 
that, that’s enough, is that what you’re saying?  
P8, Thomas - Yeah. I think I’m in very good hands, I’m not worried about it. 
And, I, I’m just going along with the treatment. I’ve not questioned it at all. Erm, 
because I don’t know anything about it, really. But I’m very confident in the 
people who are looking after me. 
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Subtheme 3d: Time since diagnosis  
No participants reported experiencing any disadvantages as a result of using the app, 
however some barriers to app use were highlighted. Some participants reported that 
time since diagnosis was a barrier to the usefulness of the app features. The majority 
of participants felt that the app would be more useful for more recently diagnosed 
patients than themselves, as they had already met most of their information needs by 
gathering information following their diagnosis. Participants suggested presenting the 
app as early as possible to newly diagnosed patients would maximise its benefits.  
 
I - So in general how did you find the app?  
P5, Josie (66-75 years, colorectal cancer) - I would’ve found it much more 
beneficial last year then I had this year, when I was first diagnosed.  
I - Okay and why is that?  
P5, Josie - Because most of the things that I found on the app I’d already 
worked out and had sorted for myself previous. …that would’ve been very 
useful last year.  
I - Okay and do you think that is?  
P5, Josie - Because to be honest when you're diagnosed, number one you 
don’t take in what people tell you. Then you won’t believe what people are 
telling you. And then when you can actually sit down and look at things yourself 
you then begin to take it in a lot better and there are certain things are on there 
then that would’ve been beneficial if I’d been able to say what happens now, 
what is going on. So last year it would’ve been wonderful. 
 
I -Have you got any concerns about the app at all?  
P3, Rachel (36-45 years, breast cancer) - No, I mean erm the sooner they 
[patients] get the app the better though.  
I - Right, okay.  
P3, Rachel - You know, as soon as they, you know, as you’re diagnosed if 
possible, you know, make it available that people know about it. You know, the 
sooner you’ve got the app obviously the easier … it makes it right from day 
one.  
I - Yeah. So do you, do you think patients would get more use out of it as soon 
as they’re diagnosed?  
P3, Rachel - Well I mean they’ll still get a use out of it even if you’re, you’re in 
my stage where I’m you know, later stages but er I’m sure that if, it’s when you 
first get diagnosed is when you’ve got questions.  
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Subtheme 3e: Experience with Smart technology  
A lack of experience with Smart technology and apps appeared to be a barrier to app 
use for some participants. As mentioned previously, three older participants were not 
initially able to locate the app on their home screen of their Smart device in order to 
use it, though two participants later reported that they had located the app and were 
able to use it. However, one participant required a second visit from the candidate in 
order to locate the app and was provided with a second training session. This 
participant had the app for the longest period of time (11 weeks) as he was not using 
the app in consultations but said that he intended to do so. This participant later 
reported that he had hardly used the app throughout the study period and chose not 
use the app during a consultation. Instead, he reported that he would use the app to 
refer to questions but write the questions down. However, this participant anticipated 
that he would use the app in the future if he was able to learn and practice using it.  
 
I - So going back to when I showed you how to use the app, did you feel 
comfortable using it once you'd been shown how to use it?  
P5, Josie (66-75 years, colorectal cancer) - Yes, yes.  
I - And have you got much experience with apps?  
P5, Josie - No I don’t use them very often so.  
I -How did you feel using it sort of on your own running up to the appointment 
was that okay? 
P5, Josie - That was fine.  
I - Did you have any problems?  
P5, Josie  - No, no other than when I couldn't find it.  
I - And then you managed to find it?  
P5, Josie- Yes because erm I actually, like I said when you sit down quietly and 
think things through …  
I - Yeah you have chance to look through and …  
P5, Josie - … then I suddenly found, “Oh right if I go on this one”, so browse it 
and it automatically came up.  
I - Oh good.  
P5, Josie - So it was, it was just where we had hidden it. Well it seemed to have 
got hidden. 
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I - …So you would prefer to use the app and then write, you’d prefer to write the 
questions down on paper? So why do you think you wouldn’t use the actual app 
in a consultation?  
P8, Thomas (66-75 years, urological cancer) - I’m not well used to using this 
…except for making phone calls.  
I - Yeah. Yeah. So you’d prefer to write it down?  
P8, Thomas - Yeah. 
 
Subtheme 3f: Patients’ perceptions of the acceptability of app use in 
consultations 
A further barrier to app use for some participants appeared to be their perceptions of 
the acceptability of using an app in consultations with clinicians. Some participants 
reported that they used the app immediately prior to, instead of during, the consultation 
due to fear of being perceived as rude by their clinician. These participants felt that 
using a Smartphone in a consultation was anti-social and not the norm. One participant 
suggested that they would feel comfortable using an app in a consultation with a nurse 
but not a consultant, which suggests a perceived power imbalance with consultants. 
Participants suggested that they would feel comfortable using the app in a consultation 
in future, if they were to obtain permission and the clinician explicitly approved use of 
the app.  
 
P6, Karen (36-45 years, breast cancer) - …It kind of feels a bit, a bit weird in a 
way because I think sometimes texting and things like that seems quite 
antisocial if you're in an interaction with someone. So I suppose it’s about 
getting that shift of its fine to be looking at your phone and typing whereas 
when I'm making notes really quickly it’s easier to maintain eye contact. 
 
I - So let’s talk about why you didn’t choose to take the app into the 
consultation…  
P3, Rachel (36-45 years, breast cancer) - Well it’s just a little bit rude having a 
phone open in front of the, you know, when the consultations starting I took it in 
with me, the phone … I didn’t actually open the app until … you know, and then 
I’d open it… it depends what and who you’re talking to I think. If it’s just the 
nurses or whatever I’ve always got it open and I’m… doing, doing the blood 
pressure and they’re doing, jotting that down and … 
I - Oh, okay, but you won’t use the app with the doctors?  
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P3, Rachel - The specialist not so much, no, no, it’s a little bit, you know, 
they’re doctors and you feel a little bit intimidated. 
 
7.4.3 App activity data results 
App activity was recorded over a period of approximately four months, from when the 
app was downloaded by the first participant to the day of the interview of the final 
participant.  
 
App sessions and durations 
A total of 415 app sessions were recorded, which might suggest that the app was used 
frequently by participants. However, this number could be artificially inflated due to 
events such as participants exiting and re-entering the app during use or entering the 
app and not using individual features. The average app session duration was 1m 43s 
and participants viewed an average of five pages per session, which suggests 
engagement with the app for a sustained period of time.   
 
Most and least popular app features 
The question list feature appeared to be the most popular feature with 158 page views, 
which was three times that of the other features. The resources and glossary features 
appeared to be of similar popularity, with 42 and 36 page views respectively. The 
contacts feature appeared to be the least popular feature with 29 page views. 
However, it is possible that the page views of the question prompt list reflect 
participants’ flicking back and forth between the six pages of question categories plus 
consultation list pages, whereas all other features have just one page to view.  
 
Question prompt list feature events 
Use of the QPL feature appeared to be high. A total of 57 questions were added from 
the categories of questions to consultation lists, however the data does not indicate 
how many participants created a question list for a consultation or how many 
consultation lists were made. Of the questions added, 42 were added from the pre-set 
categories of questions and 15 were created and added by participants themselves, 
however the data does not indicate how many participants added pre-set questions or 
created their own. Of the pre-set questions selected, 26 were selected from the 
‘treatment’ category, eight were selected from the ‘after your cancer diagnosis’ 
category, five were selected from the ‘support’ category, two were selected from the 
‘remission’ category and one was selected from the ‘family and friends’ category. Of 
the 15 questions that were created and added to consultation lists by participants, five 
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questions were related to treatment, three were related to further tests/investigations, 
two were related to symptoms, two were about diet and lifestyle, one was about the 
cancer diagnosis, one was about finance and one was a duplicate. The majority of 
these questions were cancer-specific questions that were not available on the 
prescribed list of questions, however one question was available but the participant 
worded it differently. One question about travelling during treatment was not on the 
prescribed list of questions and could be added in the future. These results suggest 
that participants only add their own questions if they are not available in the suggested 
categories of questions.  
 
Resources feature events 
Links to external cancer information websites in the resources feature were accessed a 
total of 23 times. Links to the home pages of cancer information websites were 
accessed ten times and links to specific topics of information, such as ‘information on 
chemotherapy’, were accessed 13 times. Of the links to the home pages of cancer 
information websites, www.patient.info and www.macmillan.org.uk were accessed four 
times each, and www.tenovuscancercare.org.uk and the NHS website were accessed 
once each. Of the links to individual topics of information, links for information on 
chemotherapy or radiotherapy side effects were accessed six times, links for 
information on clinical trials were accessed four times and links for information on 
finances were accessed three times. However, the data does not indicate how many 
participants accessed links.  
  
Glossary feature events 
Searches performed within the glossary appeared to be very low. Four cancer-related 
terms were searched for in the glossary by inputting the text in the search bar, however 
the data does not indicate how many participants searched for terms in this way. Three 
out of four of these terms were cancer-specific terms and were not available in the 
glossary. It was not possible for the app to record manual searches by scrolling 
downwards through the glossary.  
 
Contacts feature events 
Only one participant added and saved a contact within the app. It was not possible for 
the app to record participants’ use of the contact numbers listed.   
 
7.3.5 Validation of qualitative findings 
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In qualitative interviews, participants’ suggested that their preferred app feature was 
the QPL. App activity data supports participants’ reports as the QPL feature displayed 
the highest number of page views and a high number of events. However, the number 
of page views may have been artificially inflated due to the number of pages within the 
feature to view, as suggested above, and it is unclear how many participants used the 
QPL feature. Second to the QPL feature, qualitative findings suggested that the 
resources and glossary features were of similar popularity, with slightly fewer 
participants reporting that they had found the glossary useful. App activity data 
supports participants’ reports as the resources and glossary features received a similar 
number of page views, with the glossary feature receiving slightly less views, both of 
which were less than the page views of the QPL. Participants reported that they found 
the links to specific topics of information to be particularly useful, which is supported by 
a slightly higher number of links accessed compared to links to the main homepage of 
websites. Some participants reported that they had searched for words in the glossary 
following their consultations, which is supported by activity data that showed four terms 
were searched for. Qualitative findings suggested that the contacts feature was the 
least popular feature, which is supported by app activity data that showed only one 
contact was added to this feature.  
 
7.5. Discussion 
This chapter described a field testing study of the ‘Ask Us’ cancer app, which is the first 
app developed to specifically enable patients (and their relatives) to meet their full 
range of information needs in non-inpatient settings. The aim of this study was to 
explore the acceptability and feasibility of the app in real life settings, which was 
determined by exploration of patients’ views and opinions after using the app prior to, 
and during, a consultation with their clinician. The acceptability of this type of 
intervention, including their relatives’ opinions on the app, their use of the app, the 
most and least useful features, and the benefits and disadvantages of, and barriers to, 
this type of intervention were explored. A secondary aim of this study was to guide 
further development of the app content, where needed. App activity data was used to 
provide further insight into patients’ use of app features and to compare with patients’ 
perceptions. Findings indicated that the majority of patients found the app to be 
acceptable and most found it easy to use, however there was variation in patients’ 
perceptions of the acceptability of using an app during a consultation with their clinician 
and some older patients had initial difficulty learning to use the app. The QPL was 
perceived to be the most useful app feature, followed by the resources and glossary 
features, and the contacts feature was perceived as the least popular feature. App 
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activity data appeared to corroborate patients’ perceptions of app use. Patients 
reported several benefits of using the app, including increased question-asking in 
consultations, increased knowledge on their condition and reduced anxiety. 
Nonetheless, the app generally appeared to be a feasible intervention to help this 
sample of patients to meet their information needs. The identification of some of the 
barriers to use of the app in real life settings is useful for the future development of the 
app, as this information can be used to circumvent or minimise these issues prior to 
implementation. Finally, there were few minor suggestions for an improved version of 
the app.  
 
Findings from this study suggested that the ‘Ask Us’ cancer app was an acceptable 
intervention to help a variety of patients to meet their information needs in non-
inpatient settings, including those of differing ages, genders and cancer types. Most 
patients found the app easy to use, regardless of the device type, and only one patient 
experienced a minor technical issue that could be amended during further 
development of the app. However, the sample consisted of patients with higher levels 
of education compared to the general population. As described in Chapter 6, section 
6.6.1, individuals with higher levels of education may have higher levels of health 
literacy and eHealth literacy, compared to their counterparts (Kontos et al., 2014; Neter 
& Brainin, 2012). This means that the present sample may have been more familiar 
with, and engaged in, using this type of technology for their health, leading to inflated 
findings of ease of use and perceived usefulness. 
 
Three older patients had initial difficulty when first using the app, however a novel 
finding of this study is that two of these participants quickly learned to use the app 
without further assistance. These preliminary findings are encouraging as they suggest 
that an app could be a useful platform to deliver interventions to all types of cancer 
patients, including those who lack experience with technology, such as older patients. 
In support of this, participants anticipated that patients who have less experience with 
apps would be able to learn to use the app due to its simple design and navigation. 
This finding is consistent with previous studies that have found Smart devices to be an 
acceptable platform through which to deliver interventions remotely to a variety of 
patients with cancer (Somers et al., 2015; Stinson et al., 2013; Sundberg et al., 2015; 
Yap et al., 2013).  
 
Overall, patients found at least some of the features to be useful for themselves during 
the study period. The QPL feature appeared to help patients to prepare for their 
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consultations, the resources feature enabled patients to access reliable information 
that they needed outside of consultations, and the glossary helped patients to learn the 
definition of new cancer terms following consultations. The contacts feature was 
perceived to be the least useful feature due to the fact that the majority of patients in 
the present study were at least three months post diagnosis and already knew their 
important contacts. In contrast, patients still found the other features useful as they still 
had regular consultations and were still learning about their illness and the related 
cancer terms. Time since diagnosis was explicitly reported as a barrier to app use by 
some patients in the current study and therefore suggested presenting the app to 
patients as soon as possible in order to maximise the benefits of the app. This is 
supported by a previous study of patients’ use of mobile interventions for patients with 
cancer found the intervention was more useful for those who had not received 
chemotherapy before (Yap et al., 2013). It also well established that patients’ 
information needs are highest following diagnosis (Mistry et al., 2010). Nonetheless, 
the present study found that the app was generally perceived as useful and easy to 
use, which are positive preliminary indicators of the uptake of the app in practice 
(Davis, 1989).    
 
This study was not able to gain insight into relatives’ opinions on the app as most 
patients reported that they had not used the app with their partner, for various reasons. 
This is likely due to the short period of time that some patients had to use the app, as 
well as the fact that some patients reported that time since diagnosis was a barrier to 
their own app use, which would also likely be a barrier for relatives.  
 
Under half of participants used the QPL app feature during a consultation, however 
those that did reported that they felt comfortable using the app during their 
consultation, did not find it distracting and perceived that their clinicians responded 
positively to them using the app. QPLs are intended to be used and referred to during 
consultations to prevent patients from relying on their memory to ask questions 
(Brandes et al., 2015; Dimoska et al., 2008), and so it is encouraging that patients had 
a positive experience. Additionally, a positive response to the app from clinicians is key 
to the successful uptake and implementation of the app (Murray et al., 2016). However, 
the present study identified three barriers to use of the app in practice. Firstly, fear of 
being perceived as rude by clinicians and use of the app distracting from non-verbal 
communication in consultations prevented some patients from using the app during 
their consultation. The finding that some patients have negative perceptions of the use 
of Smart devices in consultations is novel, however previous studies have similarly 
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reported that some clinicians, and the general population, may perceive the use of a 
Smartphone by clinicians in clinical settings to be unprofessional due to the association 
of mobile technology with social contact (Koehler et al., 2013; Koehler et al., 2012). 
Fortunately, patients’ negative perceptions of app use in consultations is likely to be a 
temporary barrier as these perceptions are anticipated to diminish over time as use of 
Smart devices increases (Koehler et al., 2013). Alternatively, patients in the present 
study suggested that they would feel comfortable using an app in consultations if they 
were to obtain the clinicians’ permission.  
 
Lack of experience with Smart technology also proved to be an initial barrier for some 
patients, one of which required a second training session. This finding is unsurprising 
as studies have suggested that older people might need more time to learn due to 
being more error-prone as a result of sensory, motor and cognitive changes (Conci, 
Pianesi & Zancanaro, 2009). Though the brief training session provided for patients 
prior to app use in the present study appeared to be sufficient, some older adults will 
likely need further on-going support while they become familiar with the app. This could 
be provided in the form of manual instructions and a task list to keep costs down 
(Conci et al., 2009; Tang, Leung, Haddad & McGrenere, 2013). Alternatively, relatives 
of patients may use the app on behalf of patients who are unable to use the app 
(McCall et al., 2008). Finally, a further novel finding is that a minority of patients 
appeared to have an ‘avoidant’ coping approach and did not perceive the app to be of 
benefit to them as they did not wish to have further information on their condition, 
beyond that provided by their clinician. It appears that this was an attempt to minimise 
anxiety and so an app that is seen to provide information may be perceived as a threat 
to this type of patient. This finding can be explained by theories of coping with a 
chronic illness, such as the CSM of health and illness (Leventhal et al., 1984) or crisis 
theory (Moos & Schaefer, 1984). A previous qualitative interview study with patients 
with cancer supports these findings, as it reported how some patients avoid too 
detailed or ‘unsafe’ information in order to maintain hope and as normal a life as 
possible (Leydon et al., 2000).  
 
Importantly, no patients reported experiencing any negative consequences as a result 
of using the ‘Ask Us’ cancer app. This finding, along with feasibility studies and RCTs 
of other mobile interventions for cancer patients reported in Chapter 2, is a preliminary 
indictor of the safety of this type of app. Furthermore, several perceived benefits of the 
app were identified. Due to the nature of this study, it is unclear which components of 
the intervention are responsible for these perceived benefits, however findings provide 
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preliminary evidence for the QPL, resources and glossary features. The finding that 
some patients perceived an increase in question-asking and/or knowledge of cancer-
related information may be indicative of increased levels of activation and patients 
taking a more active role in their care (Hibbard et al., 2004). It is possible that the 
features included in the app are working to increase patients’ knowledge of their 
condition, their skills and confidence in order to participate more effectively in their 
care. Additionally, the finding that the app may have reduced some patients’ anxiety 
could be explained by psychological theories of coping with a chronic illness, such as 
the CSM (Leventhal et al., 1984), which suggests information-gathering may help to 
construct adaptive illness cognitions to promote better adjustment to the illness.  
 
Few app modifications were suggested by patients in the present study, which might 
indicate patients’ overall satisfaction with the app design and content. It was thought 
that navigation of the app could be made easier by including a ‘Back’ button to exit 
features quickly and the creation of a separate feature for relatives to make it easier to 
access related information was suggested. Some patients suggested additional app 
features that they thought would be useful for future patients, however these features 
had been previously suggested by patients, relatives or clinicians in Chapters 4-6, and 
were either unpopular or were excluded by the APEASE criteria.  
 
App activity data appeared to support patients’ perceptions on use of the app. Data 
suggested that patients engaged frequently in the app, for a sustained period of time 
and the number of page views and feature events support patients’ perceptions on 
their engagement the app and preferences for features. App activity data also 
highlighted that questions related to treatment and links to information on treatment-
related side effects were popular with patients. This finding provides further support for 
presentation of the app immediately following a patients’ diagnosis and prior to the 
start of treatment. However, app activity data findings should be interpreted with 
caution. It is possible that the number of app sessions was affected by non-engaged 
activity (i.e. entering and exiting the app without engaging) and the number of 
participants that used each feature, and the total use of each feature could not be 
determined.   
 
7.5.1 Study strengths and limitations 
A strength of this study is that it recruited a varied sample of patients, with several 
types of common cancers, different types of treatment (or remission), varied times 
since diagnosis and a mix of ages and genders. However, this study has several 
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limitations to consider. Firstly, the sample size was small, however analysis of data 
indicated that similar views were being expressed by the majority of participants and a 
decision was made to halt data collection. Secondly, the study had a low response 
rate, information on the key characteristics of those who declined to participate in the 
study was not collected and one participant did not complete the study. Those that 
declined to participate or did not complete the study may have had less favourable 
perceptions of an app than those who chose not to, or could not, participate. For 
example, they may have had limited experience with apps and may not have found the 
app as easy to use as those included in the present sample. Thirdly, participants had 
to own or have access to a Smart device to participate in the study. Individuals who 
already own Smart devices are likely to be more familiar with them than those who do 
not own such technology. The positive findings of the present study may therefore 
have been artificially inflated by recruiting a sample of patients who already owned a 
Smart device. Similarly, the participants in this sample mostly had high levels of 
education, which further increases the possibility that findings of the acceptability and 
feasibility of the app were inflated. Additionally, the sample included were White 
Caucasian. Further testing of the app is required with a sample that is more 
representative of the population, including patients with lower levels of education, 
those who do not own their own Smart device, and those of black and minority ethnic 
groups in order to support the present findings.   
 
It is also possible that the participants’ reported views may have been influenced by 
their desire to be polite and supportive of the candidates’ PhD (a form of social 
desirability bias), however prior to beginning the interviews the candidate explained 
that both positive and negative opinions would help in the future development of the 
app. Similarly, participants were aware that their app activity was being recorded. This 
data may have been subject to the Hawthorne effect, where participants alter their 
behaviour due to their awareness of being ‘observed’ (Merrett, 2006). However, steps 
were taken to minimise this potential bias. At the start of this study, participants were 
instructed to use the app as and when they wish and that there were no obligations for 
them to use the app in any particular way.  
 
A further limitation of this study is that participants used the app for different periods of 
time prior to their upcoming consultation date, which may have affected their opinions 
and experiences of the app. For example, some patients may not have used the app 
for long enough in order to experience potential benefits. Similarly, only one patient in 
the current study had been recently diagnosed with cancer within the last three 
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months, all other patients are likely to have met most of their information needs after 
three months which would limit the usefulness of the app for these patients. Finally, 
this study was unable to explore relatives’ opinions on the app through patients.  
 
7.5.2 Future research  
Following from this field testing study, the MRC framework for the development of 
complex interventions encourages a feasibility study, followed by a pilot evaluation 
(Craig et al., 2008). A feasibility study would look to explore issues additional to the 
acceptability and feasibility of the app, including adherence, delivery, recruitment and 
retention (Craig et al., 2008). Outcome variables and suitable measures for a pilot 
evaluation would then be selected from the findings of this study. Ideally, a pilot 
evaluation would include randomisation and a control arm to allow assessment of the 
size of the effect. This study would provide a basis for calculating the sample sizes 
required for a definitive, controlled evaluation of the app. Given the limitations of the 
sample in the present study, further research should include a sample of patients that 
better reflect the general population, including those with lower levels of education, 
those who do not own Smart technology and patients from black and ethnic minority 
groups. Additionally, a future sample of patients should include more recently 
diagnosed patients in order to further explore the full range of potential benefits of this 
type of app. Although this study has reported the benefits experienced by patients and 
the most and least popular app features, further research is needed to determine the 
active components of the app (Yardley et al., 2015). Additionally, the current study did 
not include relatives of patients, therefore a future study would explore the usefulness 
and benefits of the app for this group. Finally, future studies may seek to determine 
which app features might be more useful for patients who are further along in their 
cancer journey.  
 
7.5.3 Implications  
This study presents some preliminary evidence to suggest that the ‘Ask Us’ cancer app 
may be a useful, acceptable and feasible intervention to support patients with cancer of 
various ages, gender and cancer types, in non-inpatient settings, though these findings 
are limited to this sample. It is likely that some older patients with a lack of experience 
with Smart technology will require on-going support when first learning to use an app.  
 
Patients’ perceptions of the usefulness of the app features, suggestions for 
improvement of the app, and the findings from the analysis of app activity data can be 
used to further to optimise the usefulness, acceptability and feasibility of the app prior 
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to implementation (Yardley et al., 2015). Additionally, app activity data highlighted 
patients’ patterns of use the app features. This information can be used to improve our 
understanding of how patients engage with and use this type of app.  
 
The perceived benefits of the app reported by patients in this study suggest that the 
app may be helping patients to meet their information needs by facilitating information 
exchange in consultations (i.e. increased question-asking and increased understanding 
of information provided in consultations) and information-gathering outside of 
consultations (i.e. increased cancer-related knowledge). The present study provides 
preliminary evidence that suggests that the app achieved some of the intervention 
objectives set out in Chapter 6. Furthermore, this study provides some evidence to 
suggest that the app may have increased patients’ levels of activation (Hibbard et al., 
2004) and/or improved their psychological coping with their illness (Leventhal et al., 
1984; Moos & Schaefer et al., 2984). This information may be used to explore of the 
active components and mechanisms of the app and to design a full feasibility and then 
pilot evaluation (Yardley et al., 2015).  
 
Importantly, this study did not indicate that patients experienced any negative 
consequences as a result of using the app, which contrasts to patients’, relatives’ and 
clinicians’ anticipations described in Chapters 4 and 5, that the app might lead to 
increased anxiety and poorer communication in consultations. The present study also 
identified some barriers to app use that were experienced in a real life setting. Time 
since diagnosis and patients’ perceptions of the acceptability of app use in 
consultations were not initially anticipated to be barriers by patients, their relatives and 
clinicians in Chapters 4 and 5, which highlights the usefulness of conducting a field 
testing study. This information can can be considered prior to implementation in order 
to further optimise the usefulness and feasibility of the app (Craig et al., 2008). Finally, 
this study adds to the growing body of evidence on the potential acceptability, 
feasibility and benefits of interventions for patients with cancer delivered remotely via 
mobile technology.  
 
7.5.4 Conclusion  
This study presents some preliminary evidence to suggest that an app that enables 
cancer patients to meet their information needs might be an acceptable and feasible 
intervention for the majority of patients with cancer. The majority of patients perceived 
the app to be useful, easy to use and reported that clinicians responded positively to 
app use in consultations. Findings suggested that the preferred features of the app, 
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including the QPL, resources and glossary app features, have the potential to enable 
patients to meet their information needs by facilitating question-asking in consultations 
with clinicians and information-gathering outside of consultations. App activity data 
appeared to corroborate patients’ preferences. Benefits including increased question-
asking, increased cancer-related knowledge and reduced anxiety were reported as a 
result of using the app, though further research with a larger sample of very recently 
diagnosed patients is required to establish the full range of potential benefits. 
Importantly, no negative consequences of using the app were reported and minimal 
problems were experienced during the study period. Some barriers to app use were 
identified, though these barriers can be minimised if taken into consideration prior to 
future implementation of the app. However, several limitations of the study, including 
the higher levels of education of the sample, requirement to own a Smart device to 
participate and low response rate to the study, may have artificially inflated findings.  
Further field testing with a sample that better reflects the general population is required 
to support the present findings.
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Chapter 8 
 General discussion 
 
8.1 Chapter overview 
This chapter presents an overview and critical reflection of the PhD findings and a 
discussion of how findings from each study were used to develop an app intervention 
to help patients and their relatives to meet their information needs. Findings are 
discussed in relation to theory and existing knowledge, and the novel contributions of 
this thesis are highlighted. The strengths and limitations of the methodology used 
throughout the PhD are discussed and the implications of findings for future 
development of the app and research are outlined.    
 
8.2 Thesis findings and novel contributions 
This PhD aimed to: (1) understand the needs and preferences of patients with cancer 
regarding an app to help them to meet their information needs in non-inpatient settings, 
and (2) develop an app intervention based on identified needs and preferences, which 
may also be used by relatives. Based on existing literature, it was hypothesised that an 
app would help patients with cancer to meet their information needs by facilitating 
information-gathering and understanding during and between consultations with 
clinicians. There were six objectives of this PhD:  
 
(1) Identify how mobile devices have previously been used to help patients with 
cancer to meet their information needs in non-inpatient settings. 
(2) Identify potentially relevant theory related to the impact and self-management 
of cancer. 
(3) Explore patients’ and relatives’ needs and preferences regarding an app to help 
them to meet their information needs and the reasons for these perceptions. 
(4) Explore cancer clinicians’ opinions on the value of an app for patients with 
cancer and their relatives, their preferences of app features and reasons for 
these perceptions. 
(5) Design an app intervention based on the identified needs and preferences of 
patients and their relatives and opinions of clinicians. 
(6) Conduct a field test of the app with patients in the community to assess its 
acceptability and feasibility in practice.  
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The MRC framework for the design of complex interventions in healthcare was used as 
an over-arching framework to guide the work presented in this thesis (Craig et al., 
2008) (Figure 2), specifically, phases one, ‘development’ and two ‘feasibility and 
piloting’ of the framework. The findings and novel contributions of each chapter of this 
thesis are discussed below and presented in Table 8.  
 
Figure 2 (from Chapter 1): MRC framework phases and the aims and objectives of 
this PhD. 
 
8.2.1 A systematic review of existing mobile interventions for patients with 
cancer 
Previous reviews have been conducted to explore the use of mobile interventions for 
cancer, including from cancer prevention to survivorship (e.g. Bender et al., 2013; 
Davis & Oakley-Girvan, 2015; Davoodi et al., 2016), however the systematic review 
conducted for this thesis was the first to identify how mobile devices have been 
specifically used to help patients with cancer to meet their information needs in non-
inpatient settings. This review made several novel contributions to the wider cancer 
intervention field. Firstly, this review found that mobile devices appeared to be an 
acceptable platform to deliver interventions to remotely to a range of patients with 
cancer, including a variety of ages, genders, nationalities and familiarity with 
technology. Secondly, the potential benefits of this type of intervention were 
highlighted, including improve symptom management, patient empowerment, reduced 
anxiety, improve patient-clinician communication and increased health-related quality 
of life. In contrast, the review pointed out one study that reported the information 
intervention appeared to have increased some patients’ anxiety by drawing attention to 
negative aspects of their condition (Foley et al., 2016), which drew attention to the 
literature on monitoring and blunting coping styles (Miller, 1995) and the goodness-of-
fit hypothesis (Christensen et al., 1994; Park et al., 2001).  
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A fourth novel finding of this review is that it identified how so far, the majority of mobile 
interventions have been designed to enable remote surveillance of patients with cancer 
in the form of symptom-monitoring interventions. This type of intervention has sought 
only to increase patients’ knowledge of their treatment side-effects and so highlighted a 
a gap for an app intervention that enables patients to meet their full range of 
information needs (i.e. any cancer-related information) in non in-patient settings.  
 
Finally, this review identified that the majority of intervention studies had failed to report 
the race and ethnicity of participants, and those that did, failed to explore the effects of 
the interventions on these groups. As the UK is an expanding multi-cultural society, it is 
important that intervention developers explore the acceptability and perceived 
usefulness of interventions among minority groups, as they may have different 
experiences of cancer, and subsequently, needs and preferences for interventions 
(Matthews et al., 2002). 
 
8.2.2 Models, theories and approaches relevant to patients’ experiences of 
cancer 
A review of relevant theory related to the impact and coping with cancer was 
conducted for this thesis. A selection of health behavior theories, models and 
approaches were identified as applicable to the context of the development of a novel 
app intervention to help patients with cancer to meet their information needs, including 
the Common Sense Model (CSM) of illness self-regulation (Leventhal et al., 1984), 
crisis theory (Moos & Schaefer, 1984), the theory of cognitive adaptation (Taylor et al., 
1983), self-efficacy theory (Bandura, 1996) and the concepts of health literacy (Kindig 
et al., 2004) and patient activation (Hibbard et al., 2004). It was clear that there were 
common constructs that permeated these theories, such as appraisal and self-efficacy, 
and that they shared a focus on the empowerment of the patient and the potential role 
of mobile interventions in enabling patients to take a more active role in their care. 
However, this review outlined how there appeared to be an inherent assumption within 
this body of literature that knowledge would lead to behavior change, ignoring the 
‘knowledge-behaviour’ gap that has been widely noted in research studies (Sligo & 
Jameson, 2000). Nevertheless, each of these theories useful provided insight into the 
many constructs required to effect behaviour change, including knowledge, skills, 
confidence and motivation. The framework of patient activation incorporated each of 
these concepts and is therefore likely to be the most useful for the future development 
of an app that aims to activate patients in their care (Hibbard et al., 2004).  
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The point of ‘goodness-of-fit’ in relation to knowledge was returned to in this chapter. 
The CSM (Leventhal et al., 1984) and crisis theory (Moos & Schaefer, 1984) and 
supporting literature suggested that ‘approach’ or ‘active’ coping leads to improved 
psychological adjustment for patients with cancer. However, in practice, a body of 
literature has shown how a minority of patients with cancer do not benefit from 
obtaining illness-related information (Folkman & Lazarus, 1980; Lazarus & Folkman, 
1984; Miller, 1996). Research has since presented the conclusion that patients tend to 
have better physical, psychological and behavioural outcomes when the information 
they receive about their condition is tailored to their particular coping style (Miller, 
1995). It is important that intervention developers, and cancer clinicians, are aware of 
this goodness-of-fit and do not prescribe the use of information interventions for those 
who may suffer consequences as a result of this type of intervention, such as 
increased anxiety (Christensen et al., 1994; Park et al., 2001). Finally, this review of 
relevant theory identified the potential outcomes of an app that facilitates patients’ 
information-gathering, for those patients who prefer an active coping style, including 
improved psychological adjustment by enabling the development of adaptive illness 
cognitions and suitable coping strategies, and increasing patients’ knowledge, skills 
and confidence to participate in their care (i.e. activation), which may ultimately lead to 
better health outcomes.  
 
8.2.3 Patients’ and relatives’ needs and preferences regarding an app for cancer 
The systematic review conducted for Chapter 2 included studies of adolescent 
patients, however the interventions for this group were gamified apps (e.g. Stinson et 
al., 2013). It was therefore anticipated that this population might have different needs 
and preferences regarding an app and so a decision was made to develop an 
intervention for adult patients with cancer only. A qualitative interview study was 
conducted to explore patients’ and relatives’ needs and preferences regarding an app 
to help them to meet their information needs. This study made several contributions to 
the wider cancer intervention field. Firstly, this study identified the context of patients’ 
and relatives’ needs and preferences regarding an app for cancer. Findings revealed 
that, despite advances in understanding of doctor-patient communication, barriers to 
information exchange and understanding during and between consultations with 
cancer clinicians still exist for patients and their families today, mirroring previous 
literature on doctor-patient communication in consultations (Ford, Fallowfield, & Lewis, 
1996; NHS, 1993; Chapman et al., 2003; Shea–Budgell et al., 2014; Slort et al., 2011). 
These barriers created the need for four broad types of app features, including features 
that supported patients’ self-management of their condition, facilitated information 
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exchange in consultations with clinicians and increased access to support for both 
patients and their relatives. These findings are of particular value to the wider cancer 
intervention field as they describe a range of patients’ (and relatives’) needs, and the 
underlying context, which could guide researchers to design interventions that are of 
more value to patients, compared to interventions that are designed using a theory-
driven, deductive approach without direct involvement of its target users.   
 
Secondly, this study identified that most patients and relatives anticipated an app to be 
an acceptable platform through which to deliver an intervention, which provided 
preliminary evidence for the potential uptake of an app for cancer upon 
implementation. However, several limitations of this sample, such as the low response 
rate, high numbers of Smart technology owners and a majority with higher educational 
levels, meant that the positive findings on the acceptability and potential usefulness of 
the app should be interpreted with caution. It is possible that these limitations 
introduced bias to findings and artificially inflated the findings. Additionally, the sample 
used in this study was not representative of the general cancer patient population; the 
perceptions of many subgroups of patients with cancer are still unknown. For example, 
a limitation of this sample was that all patients were White Caucasian; patients of black 
and ethnic minorities may be less likely to find such an intervention acceptable 
depending on their beliefs about cancer and may consequently differ in their needs and 
preferences regarding an app (Matthews et al., 2002). Similarly, adolescent patients, 
patients with lung cancer, rare cancers and those with less than 12 months life 
expectancy were not included in this sample due their potentially different needs and 
preferences regarding an app. Future studies will be required to explore the 
perceptions of subgroups of the cancer population in order to provide a more realistic 
indictor of the uptake of an app intervention for cancer that enables patients to meet 
their information needs. Notwithstanding these limitations, the favourable views of 
patients and relatives are consistent with several studies on patients’ perceptions and 
expectations for other types of mobile interventions for other chronic conditions 
(Bostock et al., 2009; Pinnock et al., 2006; Seto et al., 2010).  
 
Thirdly, this study highlighted the positive perceptions of relatives on an app for 
patients and caregivers. However, the sample size for relatives was small and all 
chose to participate in joint interviews with patients, which may have led to participants 
engaging in protective buffering, where they withold information so as not to burden or 
upset one another (Hagedoorn et al., 2000; Kuijer et al., 2000). These limitations mean 
that it is possible that the unique experience of relatives has been missed and so a 
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further study of individual interviews with relatives is required to support the these 
findings (Kendall et al., 2009). Nevertheless, the fact that all relatives of patients with 
cancer chose to participate in joint interviews when given the choice is of value to the 
wider cancer intervention field. Researchers are advised to conduct a number of 
individual interviews with relatives who are not offered a joint interview, as well as 
dyadic interviews, in order to compared findings.  
 
Fourthly, this study identified the potential benefits of this type of intervention for 
patients with cancer and their relatives, which included a more informed patient, 
increased quality of life, reduced anxiety, a sense of empowerment and more 
convenience. Potential disadvantages were also identified and included increased 
anxiety and poorer communication in consultations. Finally, several potential barriers to 
app use were anticipated by patients and relatives and included patients’ age and 
experience with Smart technology, access to Smart devices, the perceived reliability 
and security of information, and an avoidant coping approach. Previous studies of 
patients’ anticipations of mobile interventions for a range of other chronic conditions, 
such as asthma and heart failure, have identified patients’ age (and prior experience 
with Smart technology), increased anxiety and access to Smart technology as 
concerns (Bostock et al., 2009; Pinnock et al., 2006; Seto et al., 2010). However, an 
avoidant coping approach may be a potential barrier that is specific to the context of 
cancer due to the life-threatening nature of the disease. Concerns about the reliability 
and security of information on an app also appeared to be specific an intervention that 
aims to meet patients’ information needs. However, although these findings provided 
an insight into the potential outcomes of this type of intervention, research has shown 
that dyadic interventions, which may be used jointly by the patient and their caregiver, 
may produce different effects on patients and their caregivers compared to individual 
interventions, particularly for the caregivers who participate in patient-focused 
interventions (Northouse et al., 2010). Future studies of this type of intervention should 
therefore consider testing the effects of the app on patients and their caregivers 
separately. 
 
Finally, although not a novel finding, this study confirmed previous findings on the role 
of information-seeking for patients with cancer (Ranchor et al., 2010; Hinds et al.,1995) 
and theories of coping with a chronic illness (Leventhal, et al., 1984; Moos & Schaefer, 
1984) as it reported how information-gathering was used as an adaptive coping 
strategy by the vast majority of patients and their relatives. Furthermore, this study 
reported how a minority of patients appeared to adopt avoidant coping strategies 
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where they preferred a minimum amount of information, from their clinician only, and 
did not use the Internet in order to avoid threatening information, which supports the 
literature on the goodness-of-fit of opposing coping strategies, such as monitoring and 
blunting (Christensen et al., 1994; Miller, 1995; Park et al., 2001). Based on these 
findings, it was hypothesised that this subgroup of patients would be unlikely to benefit 
from using an app intervention that facilitates information-gathering (Folkman & 
Lazarus, 1980; Lazarus & Folkman, 1984; Miller, 1996). 
 
8.2.4. Clinicians’ views and opinions of an app for patients with cancer and their 
relatives 
A similar qualitative interview study was conducted to explore patients’ and relatives’ 
needs and preferences regarding an app from the perspective of cancer clinicians, as 
second to patients themselves, clinicians know what is best for the patient. This study 
also made several contributions to the wider cancer intervention field. Firstly, this study 
identified that clinicians’ views on the barriers to information exchange and 
understanding for patients during and between consultations were consistent with 
patients’ and relatives’ perceptions. As a result of their awareness of the 
communication issues in cancer consultations, this study reported how clinicians 
suggested the same four types of app features as patients and their relatives and 
anticipated this type of app to be useful. Although previous studies that have 
demonstrated that some clinicians are aware of some of these issues (Légaré et al., 
2008; Slort et al., 2011), this is the first study that has demonstrated full agreement 
between patients, their relatives and clinicians about the communication issues faced 
in today’s cancer consultations. These findings are useful for the wider cancer 
intervention field as they may be used to guide efforts in developing new interventions 
to facilitate doctor-patient communication in cancer consultations.  
 
Secondly, this study identified that clinicians were supportive of the development of an 
app for cancer care and did not anticipate that they would need additional training for 
implementation of an app. This finding is consistent with previous studies that reported 
clinicians’ positive perceptions and expectations for new technology in healthcare, 
including other types of mobile interventions for chronic conditions (Bostock et al., 
2009; Pinnock et al., 2006; Seto et al., 2010).  
 
Thirdly, this study highlighted the concerns of some clinicians regarding an app 
intervention; some clinicians were concerned that an app used in consultations could 
distract patients and hinder communication and others anticipated that some older 
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clinicians might resist this new technology. Relevant theories were used to explain 
these findings, including the Technology Acceptance Model (TAM) (Davis, 1989; 
Venkatesh & Bala, 2008), the diffusion of innovation theory (Rogers, 2003) and models 
of the doctor-patient relationship, including paternalism and the shift to patient-
centered care (Hellin, 2002; Kaba & Sooriakumaran, 2007). The present findings 
suggest that currently, there is a critical mass of clinicians that would find app use by 
patients in consultations to be acceptable, and over time, the remaining clinicians will 
become ‘late adopters’ and ‘laggards’, as they were not opposed to the app (Rogers, 
2003). However, an app might not be perceived as useful by a minority of clinicians 
who adopt a paternalistic approach with their patients as this type of intervention acts 
to facilitate patient-centered care by empowering the patient, causing a power shift.   
 
Finally, this study identified the potential outcomes of an app that enables patients to 
meet their information needs, anticipated by clinicians. The anticipated benefits of this 
type of intervention were consistent with patients’ and relatives’ views, however 
clinicians also anticipated that there may be improved communication between 
patients and their clinicians, as well as possible benefits for clinicians themselves, as a 
result of the app. These findings demonstrate the usefulness of multi-perspective 
interviews to the wider cancer intervention field, as different groups of key stakeholders 
may foresee potential outcomes that others may not have anticipated. Another 
example of this benefit of multi-perspective interviews is that clinicians appeared to be 
more skeptical of the uptake of the app compared to patients and relatives. This may 
be due to the fact that clinicians consult a wide range of patients, such as patients with 
an avoidant coping approach and older patients who are unfamiliar with technology, 
who may therefore have less favourable perceptions of an app, whereas patients and 
relatives included in the studies in this thesis were mostly technology owners and had 
an active coping approach. Clinicians also anticipated the same types of potential 
barriers and disadvantages to this type of app as patients and relatives, however 
clinicians additionally suggested that this type of intervention might increase clinicians’ 
workloads. Previous studies of clinicians’ anticipations of mobile interventions for a 
range of other chronic conditions have identified patients’ age, access to Smart 
technology and increased workload as some of their concerns (Bostock et al., 2009; 
Pinnock et al., 2006; Seto et al., 2010).  
 
8.2.5 The design and user-testing of an app for patients with cancer and their 
relatives 
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The findings of Chapters 2-5 motivated and justified the design of an app intervention 
for patients with cancer and their relatives. Chapter 6 reported on the systematic 
process that was used to create the ‘Ask Us’ cancer app, which consisted of an 
iterative process and several stages, including development of the intervention 
objectives, selection and development of app features and content, design of the app 
interface and a user-testing discussion group with a sample of patients and their 
relatives to inform the final version of the app. The ‘Ask Us’ app consisted of a QPL, a 
glossary of cancer terms, a resources feature and a contacts feature. Although there 
are several similar apps for patients with cancer currently available, such as the Pocket 
Care Cancer Guide or Macmillan’s ‘My Organiser’, the ‘Ask Us’ cancer app has several 
unique advantages. Firstly, the app provides patients with fast and easy access to a 
unique combination of cancer-related tools and services, which were perceived to be of 
great value by patients, relatives and clinicians. Secondly, these useful features can be 
accessed via one platform and are available to use without access to wifi by taking 
advantage of the benefits of Smart technology. Findings from the discussion group 
showed that patients and their relatives perceived the app to be useful and easy to use 
and only minor modifications were made following the discussion group, which created 
the final version of the app. However, limitations of the methodology of the user-testing 
study means that these findings may have been artificially inflated. For example, the 
sample was more highly educated compared to the general population. Education 
level, a proxy of socioeconomic status, has been shown by some studies to be 
predictive of the use of web-based technologies across the health care and health 
information-seeking domains (Kontos, Blake, Chou & Prestin, 2014; Neter & Brainin, 
2012). The current sample may therefore have perceived the app to be more useful 
and easier to use compared to patients with lower education levels. More in depth user 
testing with patients of a range of education levels is required to add weight to the 
findings of this study.  
 
8.2.6 The acceptability and use of the ‘Ask Us’ cancer app in community settings  
Following ‘in-house’ user-testing, a mixed-methods field testing study was conducted 
to test the app in real life settings. This study provided several contributions to existing 
knowledge on the implementation of an app intervention into routine cancer care. 
Findings of this study suggested that overall, patients found the app to be an 
acceptable platform through which to receive an intervention, however several barriers 
were identified that would need consideration prior to future implementation of the app. 
Firstly, although most patients found it easy to use, some older patients with a lack of 
experience with Smart technology had initial difficulty when learning to use the app and 
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one patient appeared dis-interested in the app throughout the entire study period. This 
finding generally contrasts with previous studies, which have claimed this type of 
intervention to be acceptable for a wide range of patients, including different ages and 
patients who were receiving palliative care (McCall et al., 2008; Somers et al., 2015; 
Stinson et al., 2013; Sundberg et al., 2015; Yap et al., 2013). These studies may have 
failed to report the initial difficulties of older patients when learning to use the 
intervention, if they eventually used it successfully. The present field testing study 
highlights the fact that some older patients might need more time to learn to use the 
app compared to younger patients who are more familiar with this technology, which is 
expected due to them being more likely to be error-prone as a result of sensory, motor 
and cognitive changes (Conci et al., 2009).  
 
Secondly, this study revealed how some patients were concerned about the 
acceptability of using an app during a consultation with their clinician and wanted 
permission from the clinician to use the device. It is possible that finding indicates 
patients’ perceptions of a paternalistic relationship with their clinician, however as 
anticipated by the diffusion of innovation theory (Rogers, 2003), it is likely that this will 
be a temporary issue until the widespread adoption of Smart technology in health care 
becomes common place (Koehler et al., 2013). Importantly, this barrier was not initially 
anticipated by patients, their relatives or clinicians in early qualitative interviews, which 
highlights the usefulness of testing the app in the context in which it will be used 
(Yardley et al., 2015). In contrast, this study confirmed the previous expectations of 
patients, relatives and clinicians in qualitative interviews that a minority of patients who 
appeared to have an avoidant coping approach did not perceive the app to be of 
benefit to them as they did not wish to have further information on their condition. 
Importantly however, this study found that there were no perceived disadvantages for 
any patient as a result of having access to the app, which is a preliminary indicator of 
its safety.  
 
Thirdly, this study identified some of the outcomes of this type of intervention in 
practice. Several perceived benefits of using the app were reported by patients, 
including increased question-asking in consultations, increased knowledge on their 
condition and reduced anxiety. These findings might suggest that the app is helping 
patients to meet their information needs by facilitating information exchange in 
consultations (i.e. increased question asking and increased understanding of 
information provided in consultations) and information-gathering outside of 
consultations (i.e. increased cancer-related knowledge), as outlined in the intervention 
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objectives. These findings suggest that the app could be increasing patients’ levels of 
activation (Hibbard et al., 2004), as well as improving psychological coping with their 
condition (Leventhal et al., 1984, Moos & Schaefer, 1984). Overall, the app appeared 
to be an acceptable and feasible intervention in real life settings, however these 
findings were restricted to particular subgroups of patients. The sample included 
included Smart-technology owners, most of whom had higher educational levels 
compared to the general population. It is possible that patients included in this study 
found the app more acceptable, easier to use and more useful compared to their 
counterparts and so further field testing with a sample of patients with lower education 
levels is required to add weight to present findings (Kontos et al., 2014).  
 
Nevertheless, this study identified patients’ preferences for the selected app features 
and patterns of app use. The QPL feature was identified as the most popular app 
feature, followed by the resources and glossary features, and the contacts feature was 
identified as the least popular. Most patients suggested that the app features would 
have been more useful if presented early after their diagnosis as they felt their 
information needs were greatest at this point. For example, it was anticipated that the 
glossary feature will be useful when patients are attending consultations, which is 
mostly between diagnosis and during treatment, and the contacts feature will mostly be 
useful at diagnosis, when patients are first meeting their team of clinicians. However, 
the QPL and resources features were suggested to be useful even for patients who 
had been diagnosed with their cancer for a few months due to the need for new 
information as their disease or treatment progressed. Figure 9 illustrates the potential 
usefulness of each feature throughout around diagnosis, treatment and remission, 
based on these findings reported in this study. Finally, app activity data appeared to 
corroborate patients’ perceptions of app use and suggested that patients engaged in 
the app frequently, and for a sustained period of time. 
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Figure 9: Perceived usefulness of app features throughout the stages of cancer. 
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Table 8: Novel contributions of this thesis.  
Chapter Study 
design Primary aims Contribution to research 
2 Systematic 
review 
Identify how mobile 
devices have previously 
been used to help 
patients with cancer to 
meet their information 
needs in non-inpatient 
settings. 
• Most interventions were symptom-monitoring interventions which sought only 
to increase patients’ knowledge of their treatment side-effects. The review 
highlighted a gap for an app intervention that aimed to enable patients and 
their relatives to meet their full range of information needs in non in-patient 
settings. 
• Mobile devices appeared to be acceptable platform to deliver interventions 
remotely to a range of patients with cancer and potential benefits of this type of 
intervention included improve symptom management, patient empowerment, 
reduced anxiety, improve patient-clinician communication and increased 
health-related quality of life. 
• One study highlighted how information interventions are unlikely be suitable for 
all patients and might increase anxiety for those who adopt an 
avoidant/blunting coping style. 
• Most studies failed to report race/ethnicity and so it is possible that unique 
experiences of minority groups were missed.  
 
3 Scoping 
review  
Review of theory relevant 
to the impact and self-
management of cancer. 
• The CSM, crisis theory, theory of cognitive adaptation, self-efficacy theory and 
the concepts of health literacy and patient activation were identified as relevant 
theories for the development of an intervention to help patients with cancer to 
meet their information needs.  
• This chapter also discussed the limitations of knowledge in this context and 
how the usefulness of an information intervention depends of the ‘goodness-of-
fit’ between the demands of the situation and selected coping style.  
4 Qualitative 
interview 
study 
Establish patients’ (and 
relatives’) needs and 
preferences for an app 
and the underlying 
psychosocial context.  
• This study identified the underlying context of patients’ and relatives’ needs 
and preferences regarding an app; barriers to information exchange and 
understanding during and between consultations appeared to lead to unmet 
information needs.  
• Patients and relatives desired four types of app features, including features 
that: (i) supported patients’ self-management of their condition, (ii) facilitated 
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information exchange in consultations with clinicians, (iii) increased access to 
patient support, and (iv) increased access to support for relatives.  
• Patients and their relatives reported positive views on the potential usefulness 
and acceptability of this type of intervention. 
• Potential outcomes of this intervention were identified. Perceived benefits of 
this type of intervention included a more informed patient, increased quality of 
life, reduced anxiety and a sense of empowerment. Potential disadvantages of 
this type of app included increased anxiety and poorer communication, and 
anticipated barriers to app use in practice included patients’ age and 
experience with Smart technology, access to Smart devices, the perceived 
reliability and security of information, and an avoidant coping approach.  
 
5 Qualitative 
interview 
study 
Establish clinicians’ 
perspectives regarding 
an app for patients and 
relatives. 
  
• This study identified that clinicians’ views were consistent with those of patients 
and relatives on the barriers to information exchange and understanding during 
consultations.  
• Clinicians supported the development of an app that aims to help patients with 
cancer and their relatives to meet their information needs and suggested the 
same four types of app features as patients and relatives. 
• Clinicians did not anticipate that they would need additional training for the 
implementation of the app. 
• Clinicians’ views of the perceived benefits, possible disadvantages, and 
barriers to this type of intervention were largely consistent with those of 
patients and relatives’, although clinicians were also concerned about an 
increase in workload. 
6 App 
development  
Describe the systematic 
development of an app 
and assess its usability 
in-house 
• Patients and their relatives perceived the app to be acceptable, useful and 
easy to use during a user-testing discussion group. 
7 Mixed-
methods 
field testing 
study 
Assess the acceptability 
and feasibility of the app 
in a real life setting and 
understand whether it 
• Most patients perceived the app to be acceptable, though some older patients 
had initial difficulties when first learning to use an app. 
• The QPL feature appeared to be the most popular app feature and the 
contacts feature was least popular. App activity data appeared to corroborate 
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would be useful to 
patients in practice. 
patients’ perceptions of app use and suggested that patients engaged in the 
app frequently and for a sustained period of time. 
• Perceived benefits of using the app included increased question-asking in 
consultations, increased knowledge on their condition and reduced anxiety, 
which might indicate increasing levels of patient activation.  
• There were no reports of any disadvantages as a result of using the app, 
however time since diagnosis, experience with Smart technology, perceptions 
of the acceptability of app use in consultations and an avoidant coping 
approach were perceived by some as barriers to app use. 
• Overall, the app appeared to be feasible in practice for particular groups of 
patients, such as those who are familiar with technology and an 
active/monitoring coping style.  
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8.3 Theoretical underpinning 
In Chapter 3, several models, theories and approaches relevant to the impact and self-
management of cancer were identified as potentially useful for the development of an 
app intervention to help patients and their relatives to meet their information needs. 
Broadly, the CSM (Leventhal et al., 1984), crisis theory (Moos & Schaefer, 1984), and 
theory of cognitive adaptation (Taylor, 1983) provided insight into patients’ responses 
to a cancer diagnosis, its impact, and the process of psychological coping. Self-efficacy 
theory (Bandura, 1996), health literacy (Kindig et al., 2004) and patient activation 
(Hibbard et al., 2004) provided insight into the determinants of patients’ engagement 
with their care and self-management of their condition. However, it was apparent that 
similar elements permeate the models, theories and approaches (e.g. appraisal, 
coping responses, self-management behaviours). Additionally, the term ‘self-
management’ has come to be used in the literature as one that encompasses both 
patients’ coping with, and adjustment to, cancer and self-management of the disease. 
As such, it was anticipated that each of these models and theories could be useful for 
providing insight into patients’ and relatives’ experiences of cancer and inform the 
development of an app intervention.  
 
Findings from the qualitative study with patients and relatives reported in Chapter 4 
suggested that theories of coping with cancer, such as the CSM, crisis theory and 
theory of cognitive adaptation, were useful in understanding their needs and 
preferences regarding an app, and the underlying psychosocial context. These 
theories, particularly the CSM and crisis theory, were useful to explain the initial impact 
of a cancer diagnosis (i.e. perceived loss of control) and patients’ and relatives’ use of 
information-gathering as a coping mechanism. Approaches relating more to the self-
management of cancer, particularly patient activation, were a useful framework to 
provide further insight into the barriers of information exchange and understanding in 
consultations and identification of information sources outside of consultations. For 
example, it was apparent that many participants lacked the skills (i.e. unable to identify 
reliable information on the Internet), knowledge (i.e. limited understanding of cancer 
upon first diagnosis, clinicians’ use of medical terminology in consultations) and 
confidence (i.e. lack of confidence to ask questions in consultations) to self-manage 
their condition. This selection of models, theories and approaches also provided insight 
into patients’ and relatives’ suggestions for app features. For example, suggestion of 
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features such as question prompt list and a glossary of cancer terms might suggest 
that patients were attempting to increase their knowledge, skills and confidence to 
enable them to self-manage their condition more effectively. Similarly, suggestion of 
features such as connecting with other patients might suggest that patients would use 
this feature as an emotion-focused coping strategy or a mechanism of self-
enhancement to increase their self-esteem.   
 
The CSM and crisis theory were considered particularly useful during development of 
the app due to their frameworks of coping strategies. Features that could be used as 
adaptive coping strategies to promote better psychological adjustment were selected 
for inclusion in an app. For example, use of the resources feature could be considered 
a problem-focused strategy as patients can use this feature to actively gather 
information to answer questions, when needed. Similarly, links to local support groups 
provide an opportunity for patients to adopt an emotion-focused strategy, such as 
venting their emotions to other patients. The patient activation framework was also 
considered particularly useful during app development and was used to guide the 
selection of features that would help to increase patients’ knowledge (e.g. QPL, 
glossary of cancer terms, resources feature, contacts feature), skills (e.g. resources 
feature, QPL), and confidence (e.g. QPL, glossary of cancer terms, contacts feature) to 
self-manage their condition in non-inpatient settings. It was therefore hypothesised that 
an app that facilitates patients’ information-gathering could promote better 
psychological adjustment to cancer by enabling them to develop adaptive illness 
cognitions and adopt problem-focused coping strategies. Furthermore, an app that 
aims to increase patients’ knowledge of their condition and their skills and confidence 
to participate in their care could increase patients’ levels of activation and lead to better 
health outcomes. However, as discussed in Chapter 3, based on the goodness-of-fit 
hypothesis (Park et al., 2001), it is anticipated that the intervention will be suitable only 
for those patients with an active/monitoring coping style. Patients with an 
avoidant/blunting coping style are unlikely to use, nor benefit, from this type of 
intervention.  
 
Findings from the field testing study of the app provided further insight into the theories 
that may be most relevant to this type of intervention. Reported benefits experienced 
by patients, including increased knowledge and question-asking in consultations might 
suggest that the app increased patients’ levels of activation and so the patient 
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activation framework might be useful for this aspect (Hibbart et al., 2004). Furthermore, 
some patients reported that they experienced reduced anxiety as a result of using the 
app. This finding might indicate that the app was useful for psychological coping with 
the condition, as anticipated by the CSM (Leventhal et al., 1984) and crisis theory 
(Moos & Schaefer, 1984). However, as the development of the app for this PhD project 
was largely exploratory, these studies cannot yet confidently determine the most or 
least useful theories. Additionally, as the app is a multi-feature, complex intervention, it 
is likely that elements of each of these models, theories and approaches discussed 
throughout this thesis will be relevant for its future development and evaluation.  
 
8.4 Study methodology strengths and limitations 
8.4.1 Systematic review 
A systematic review method was used in this thesis to identify studies of existing 
mobile interventions that aimed to help patients with cancer to meet their information 
needs in non-inpatient settings. Systematic reviews are regarded as the highest level 
of evidence due to the efforts taken to reduce potential bias and the transparency of 
the methods used. The aim of this review was to assess data on the effects and 
feasibility of this type of intervention, provided by empirical studies, and conduct a 
formal assessment of the quality of the methodologies used. In contrast, scoping 
review methodology allows for the inclusion of grey literature and interventions of lower 
quality. Although grey literature may include useful studies that were subject to 
publication bias, these studies are not peer-reviewed. Additionally, double coding at 
each stage of the search, study selection and data extraction is not compulsory for 
scoping review methodology and so allows for potential bias at each stage. 
Additionally, this methodology does not include a formal assessment of included 
studies and so has the potential for conclusions to be drawn on methodological flawed 
evidence or untrustworthy studies. Some systematic reviews extend the search to 
include grey literature to be as inclusive as possible, however the aim of this review 
was to assess data on the effects and feasibility of this type of intervention, provided by 
empirical studies. Prior to the search, it was therefore decided that grey literature 
would not be searched as these studies are not peer-reviewed and are unlikely to 
contain empirical data. Finally, due to the small number of studies and lack of suitable 
data, a meta-analysis was not conducted for this review.  
 
8.4.2 Qualitative methods 
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Qualitative methods were selected for this thesis to enable an in-depth exploration of 
the psychosocial context of patients’ and relatives’ needs and preferences regarding 
an app intervention to meet their information needs, as well as clinicians’ views on the 
value of such an app. Face-to-face interviews were used to facilitate a personal 
response to these topics in order to provide a deep understanding of an individuals’ 
experiences and views. This method was considered suitable for exploration of a 
sensitive subject, such as cancer. Furthermore, semi-structured interviews enabled the 
investigation of pre-determined topics but also allowed the candidate the freedom to 
deviate from the topic guide to further explore any interesting issues raised by the 
participants.  
 
Although qualitative, semi-structured interviews were most suitable for these studies, 
there are limitations to consider. Firstly, qualitative methodology is criticised for its lack 
of generalisability. As qualitative methods provide in depth understandings of 
individuals on a case-by-case basis, findings may not be generalisable to the general 
population. For example, patients included studies in this thesis were those that had 
one of the most common types of cancers, including colorectal, urological, breast and 
gynaecological cancers. As these cancers are more common, there are more support 
services available for these cancer types. Additionally, more common cancers tend to 
be diagnosed sooner and have better treatment outcomes compared to rarer cancers, 
such as pancreatic cancer, which tend to be diagnosed later and have poorer 
prognoses. Patients with other cancers may therefore have different needs and 
preferences for an app compared to those included in this qualitative study.  
 
Secondly, qualitative methods are criticised for the potential influence of researcher 
bias on the analysis and interpretation of findings. It is argued that qualitative research 
is so personal to the researcher (e.g. their epistemology, values, experiences) that they 
may select, analyse and interpret data in ways that favour their own view. The third 
criticism of qualitative research is therefore the potential lack of reproducibility, as one 
research might produce different findings to another. However, practicing reflexivity 
throughout the data collection, analysis and interpretation of research enabled the 
candidate to minimise this potential bias. Additionally, double coding was conducted 
during data analysis of the qualitative studies included in this thesis.  
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Measures were also taken to prevent any social desirability bias affecting the findings. 
Prior to interviews, I explained to participants that there were no ‘right’ or ‘wrong’ 
answers to questions and that both positive and negative opinions were useful to 
inform the development of an app for patients and their families. I explained the 
importance of their honesty in developing an app that would be useful to future patients 
and their families. Additionally, I assured participants that all data would be 
anonymised and could not be linked back to them in any way, which was particularly 
important for patients and relatives when discussing the care provided by their 
clinicians. 
 
I was also aware of how I may be perceived by participants (patients and their 
relatives), as a doctoral researcher from a reputable university. In order to reduce any 
potential influences of my own social standing during interviews, I made efforts to build 
rapport with participants and dressed appropriately to make them feel comfortable. I 
have never received a diagnosis of and lived with cancer which this means that I may 
never fully understand the impact of this disease and the needs and views of patients 
and their relatives that participated in the studies.  
 
Other methods that could have been used in place of the qualitative studies include 
focus groups or observations. However, a focus group would have precluded any in-
depth exploration of patients’ and relatives’ psychosocial context, which was required 
in order to understand their needs and preferences regarding an app and the type of 
app that would be most useful to them. Additionally, patients and relatives may feel 
self-conscious talking about such personal issues in a focus group, and providing 
information on their information technology skills or issues. Observations of patients’ 
and their relatives may have provided further insight into living with cancer on a daily 
basis and the different ways in which an app could help to support them. This method 
circumvents the self-report bias that is a potential risk with face-to-face interviews. 
However, semi-structured interviews allowed the exploration of large breadth and 
depth of information in a short space of time and this method was considered most 
suitable for the aims and objectives of this thesis.  
 
Finally, joint interviews with patients and relatives may have precluded exploration of 
the unique experiences of relatives. Firstly, it is difficult to get a full account from each 
participant in a joint interview and secondly, relatives may have engaged protective 
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buffering, where they censor information so as not to burden or upset the patient 
(Hagedoorn et al., 2000; Kuijer et al., 2000). Similarly, patients may have withheld 
relevant information to protect their relatives.  
 
8.4.3 Frameworks and approaches to guide the development of an app 
The MRC framework (Craig et al., 2008) for the development of complex interventions 
in healthcare was considered suitable to use as an overarching framework to guide the 
early phase, exploratory work conducted for this thesis. This framework advocates a 
systematic, phased approach that enabled the candidate to develop the evidence base 
for the intervention, as well as evidence for the use of theories, intervention processes 
and outcomes. The advantage of using such an approach is that development of an 
intervention is guided by evidence and tailored according to findings, which enables 
the creation of an intervention that is useful and engaging for its users, as well as 
acceptable and feasible.  
 
However, the MRC framework is not without its limitations. Firstly, it has been criticised 
for being too closely tied with the development of pharmacological interventions, for 
which significant resources are provided. In contrast, public health interventions and/or 
those that do not involve the generation of intellectual property do not often have the 
resources to follow the rigorous development and evaluation process of the MRC 
framework, which ultimately ends in a full RCT (Lakshman et al., 2014). Secondly, 
although the RCT is held as the gold standard method for evaluation, this method is 
not always practical or appropriate for complex interventions in healthcare (De Silva et 
al., 2014). For example, as described below in section 8.3.5, researchers have argued 
that the timeline of an RCT is incompatible with web- and mobile-based interventions 
as technology rapidly advances (Mohr, Cheung, Schueller, Brown & Duan, 2013). 
Furthermore, the RCT is limited to identifying the efficacy of an intervention, that is 
whether an intervention ‘works’, and is usually conducted in closed systems where the 
intervention is typically isolated from other extraneous influences. However, the effects 
of interventions can be very dependent upon factors such participant characteristics, 
setting, and the way in which it is implemented. Trial methodology does not account for 
the translation of interventions into practice where they are delivered in open systems, 
and is not sufficient to understand what works, for whom and under what 
circumstances (Bonell, Fletcher, Morton, Lorenc & Moore, 2012; Pawson and Tilley, 
1997; Sayer 2000). Researchers have therefore argued that the MRC framework does 
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not sufficiently account for the role context in shaping implementation and causal 
processes (Bonell et al., 2012; De Silva et al., 2014). However, new MRC guidance 
has endorsed the integration process evaluation within RCTs of complex interventions, 
with the use of qualitative data collection and analysis focused that is focused on the 
interactions between mechanisms, context and outcomes, termed ‘realist RCTs’ 
(Moore et al., 2015). Thirdly, researchers have argued that greater attention is required 
to early phase piloting and development work for behavior change interventions, 
including the involvement of key stakeholders, than is advocated in the MRC 
framework (Yardley et al., 2015). For this reason, the person-based approach (Yardley 
et al., 2015) was selected to complement the MRC framework to guide the work in this 
thesis as this approach highlights the importance of understanding and 
accommodating the perspective of the people who will use the intervention and the 
context of the intervention in which it will be delivered (e.g. consultations with 
clinicians). Similarly, the field of psychology has accumulated psychological principles 
that can be used to change determinants of behaviour, such as knowledge, attitudes, 
subjective norms and self-efficacy (Sheeran, Gollwitzer, & Bargh, 2013). These 
principles have been codified into taxonomies to facilitate coding and description of 
behaviour change interventions, such as Abraham and Michie’s Behaviour Change 
Technique (BCT) taxonomy (Abraham & Michie, 2008). However, the codification of 
principles into a taxonomy suffers from the same limitation as the MRC framework; it 
does not acknowledge the fact that methods of behavior change are only effective 
under specific conditions (Schaalma & Kok, 2009). Researchers have highlighted the 
need for more systematic evidence regarding context, i.e. about which methods work 
in relation under which conditions (Peters, De Bruin & Crutzen, 2015). 
 
Due to the growing number of mobile interventions for being developed for healthcare,  
researchers have also designed specific frameworks to guide development and 
evaluation of this particular type of intervention. The advantages of using a more 
specific framework for mobile interventions includes increasing the rigor of such 
studies and facilitating the translation of literature into replicable and evidence-based 
mobile interventions that can be systematically evaluated, used and adapted to health 
care settings. The Chronic Disease mHealth App Intervention Design Framework 
(Wilhide III et al., 2016), the Technology Acceptance Model (Davis, 1989), the Health 
IT Usability Evaluation Model (Health-ITUEM) (Brown et al., 2013), and the People At 
the Centre of Mobile Application Development (PACMAD) model (Harrison et al., 2013) 
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were selected to guide the design of the app and testing of its usability. For example, 
an ‘in house’ user-testing discussion group, followed by a field testing study where the 
app is used in real life settings, were considered the most appropriate methods to test 
the acceptability and feasibility of the intervention at this early point in app 
development. As described by the MRC framework (Craig et al., 2008), intervention 
development is an iterative process and so several user testing sessions will likely be 
required over time as improved versions of the app evolve. A more in-depth and 
resource-intensive user-testing study, such as a think aloud study, would be a suitable 
method further down the line when there is more certainty of the core features of the 
app as this type of study is more resource-intensive. 
 
8.4.4 App design and user-testing 
A common-sense process was used to collate and synthesis the evidence on 
suggested app features. Following synthesis of findings from Chapters 4 and 5, a 
digital software team was also consulted on the types of app features that would be 
feasible to build and include in an app and the APPEASE criteria (Michie et al., 2014) 
was considered a suitable method to screen potential app features for inclusion. 
Additionally, discussions with the supervisory team on the selection process helped to 
reduce the potential influence of researcher bias on the interpretation of findings.  
 
A discussion group was conducted to user-test the app, with the aim of ironing out any 
issues and to optimise the app prior to field testing. Research has shown that user-
testing with just five participants can reveal up to 85% of usability issues (Nielsen, 
1993; Nielsen & Landauer, 2000) and a discussion group offers the benefits of 
prompting participants to think about issues that they may not have thought about 
individually and providing participants with the opportunity to build upon one another’s 
opinions (Kitzinger, 1995). As a result, this method enables a consensus to be reached 
on suggested app modifications, much like a focus group (Kitzinger, 1995). For these 
reasons, a discussion group with 5-6 participants was considered a suitable method to 
conduct user-testing of the app to identify any issues at this early stage in app 
development. However, the usefulness of this method hinges upon recruitment of a 
suitable sample. The present sample suffered from several limitations, such as higher 
educational levels and previous participation for research in this thesis, which may 
have reduced the validity of the findings.  
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8.4.5 Mixed-methods field testing  
A mixed-methods field testing study, including semi-structured qualitative interviews 
and recording of app activity data, was considered an appropriate method to explore 
patients’ experiences of using the app in practice. As described in section 8.4.2, face-
to-face interviews were used to facilitate a deep understanding of individuals’ 
experiences and views on using the app running up to and during a consultation with 
their clinician. Semi-structured interviews enabled the investigation of pre-determined 
topics of app use but also allowed the candidate the freedom to deviate from the topic 
guide to explore any interesting issues raised by the participants. Recording of app 
activity data was considered a useful addition to semi-structured interviews as this 
method provided further insight into patients’ actual use of the app, including patterns 
of app use and the way patients engaged in the app. This mixed-methods approach 
offered the advantage of comparing the data sets and validating or highlighting the 
differences between recorded app activity data and patients’ explicit perceptions of the 
app. However, there were limitations to this approach.  
 
Firstly, conducting face-to-face interviews with participants on their opinions on the 
acceptability and feasibility of the app has the potential to introduce social desirability 
bias. Participants may have responded favourably to interview questions in order to 
please the interviewer. Steps were taken in order to limit this possible bias. Prior to the 
start of this study, the candidate explained to participants that all opinions on the app, 
both positive and negative, were essential in order to develop the most useful app for 
future patients.  
 
Secondly, although semi-structured interviews provided in depth information on a 
range of pre-determined topics of interest, not all topics were explored equally with 
participants. For example, some participants had much to say about some app 
features but little to say about others. The addition of a questionnaire for this study may 
have be useful as it would ensure a breadth of information was collected on all topics, 
whereas interviews provided in-depth information on certain topics.  
 
Thirdly, participants were aware that their app activity was being recorded. This data 
may have been subject to the Hawthorne effect, where participants alter their 
behaviour due to their awareness of being ‘observed’ (Merrett, 2006). Participants in 
the current study may have used the app differently to what they may do in ‘real life’ as 
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they knew the candidate would be able to see their app activity data. However, steps 
were taken to minimise this potential bias. At the start of this study, participants were 
instructed to use the app as and when they wish and that there were no obligations for 
them to use the app in any particular way.  
 
A further limitation is that relatives and clinicians were not included in this field testing 
study and it is important to assess the acceptability and feasibility of an intervention 
with its key users. However, it is possible that this type of dyadic intervention will have 
a different effect on patients and relatives due to protective buffering and so it is 
important to test the intervention with each group separately, as well as jointly (Kuijer 
et al., 2000).  
 
8.5 Strengths and limitations of sampling methods 
Maximum variation sampling, a type of purposeful sampling strategy in which cases 
are selected on the basis of the study populations’ characteristics and on the study 
objectives was considered appropriate as this method allows for divergent views to 
emerge (Patton, 2002). The studies aimed to recruit patients of different cancer types, 
treatment types, time since diagnosis, ages, and genders. It was important to gather 
opinions from a range of patients in order to determine the type of app that would be 
most useful. However, most patients (and relatives) included in this study had higher 
education levels and were owners of Smart technology and these factors may have 
artificially inflated findings of the acceptability and perceived usefulness of the app. A 
more representative sample of the cancer patient population is therefore required to 
support the findings of the studies included in this thesis. Additionally, patients 
recruited from the clinical trials unit at Velindre Hospital are more likely to be already 
participating in research and so may have more favourable opinions towards any 
interventions compared to patients recruited from the cancer clinics at Velindre and 
University Hospital Wales.  
 
Opportunistic recruitment methods involving snowball sampling via patients were used 
to invite relatives to participate in the interview study. This method was considered 
useful for engaging participants who may otherwise not have been included in the 
study. Some relatives also volunteered to participate in interviews at the time of 
interviewing the patient. However, these sampling methods may have lead to 
recruitment of relatives who had more favourable opinions of Smart technology, which 
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may have artificially inflated the perceived acceptability of an app intervention for 
patients’ caregivers, and may also have led relatives to believe that they were there to 
validate the patients’ experiences. As a result, the unique experiences of relatives may 
have been missed.  
 
Maximum variation sampling was used to recruit clinicians for this thesis, however 
opportunistic methods, involving snowball sampling via clinicians, were later used to 
increase the response rate (Patton, 2002). Again, it is possible that clinicians that 
participated in the study had an interest in, and more favourable opinions of, Smart 
technology.  
 
Maximum variation sampling was also used in the user-testing discussion group, 
however, as these participants had already taken part in research for this thesis, they 
may have had a vested interest in the app and therefore more favourable opinions than 
those who declined to participate. Additionally, the monetary incentive may have 
introduced bias as participants may have felt obligated to give positive feedback on the 
app. However, as in the qualitative studies, the candidate outlined the importance of 
honest feedback and the usefulness of a range of opinions.    
 
A new sample of patients were recruited for the field testing study in this thesis. This 
prevented the possible bias that may have been introduced by using patients that had 
participated in the qualitative interview study. Initially, maximum variation sampling was 
used in order to gather a range of opinions of the use of the app in practice (Patton, 
2002). However, the response rate was particularly low for this study and so this led to 
the use of convenience sampling. Those included in the study may have had more 
favourable opinions of Smart technology than those who declined, however nurses that 
were helping with recruitment informed the candidate that many patients at the CTU 
where they were recruited were poorly from participation in a clinical trial. The low 
response rate might also reflect patients’ concerns about what is being asked of them 
(i.e. to learn something new) and or the burden it might place on them while they are 
undergoing treatment for cancer (i.e. having two visits from a researcher and having to 
use an app). It is possible that the studies have included participants who are more 
well and able to use an app during their cancer than those who declined to participate, 
and therefore inflated the feasibility of this type of intervention for patients with cancer 
in practice.  
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8.6 Recommendations for further evaluation 
This section will outline the future for the intervention, including suggestions for 
feasibility and pilot testing, evaluation, and consideration of future implementation, as 
outlined by the MRC framework (Craig et al., 2008). The role of the intervention in 
relation to current policy initiatives will also be discussed.  
 
8.6.1 App refinements and intervention mapping 
Findings from the field testing study indicated some possible changes that could be 
implemented in order to improve the app prior to further testing. Additionally, the 
‘person-based’ approach encourages researchers to carry out intervention mapping of 
behavioural determinants and behaviour change techniques (Yardley et al., 2015). The 
relevant theories outlined in this thesis could be used to map the behaviour 
determinants of the intervention and the behaviour change taxonomy could be used to 
code the specific behaviour change techniques embedded within the app (Abraham & 
Michie, 2008). At this stage, the person-based approach also suggests creating a logic 
model describing the hypothesised mechanisms of action of intervention (Yardley et 
al., 2015). However, as discussed in section 8.4.3, this process should consider the 
context in which the app will be used in relation to its causal mechanisms, in order to 
overcome the constraints of overly prescriptive frameworks and taxonomies.      
 
8.6.2 Feasibility testing 
Preliminary findings from a field testing study suggested that the ‘Ask-Us app’ is 
acceptable, however, further testing is required prior to pilot testing. Firstly, although 
the MRC framework suggests that a feasibility study need not be a scale model of a 
future evaluation, it should estimate the sample size required for a larger study and 
assess appropriate methods for recruitment (Craig et al., 2008). This would include 
estimates of the number and type of patients that would be eligible for the intervention 
and the willingness of clinicians to help identify eligible participants, as well as the 
response rate of the recruitment methods. Additionally, the study would be conducted 
across multiple sites to assess the feasibility in several locations.  
 
Secondly, it is important to test the acceptability and feasibility of the intervention with 
samples of its key users. The ‘Ask Us’ app has been developed to be be used by both 
patients and relatives, therefore a feasibility study would recruit a sample of relatives to 
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use the app. It would be prudent to recruit dyads but also patients and relatives who 
plan to use the intervention individually in order to explore whether the intervention 
produces different effects on dyads compared to individuals. This study should also 
explore the perspectives of clinicians, particularly on the acceptability and feasibility of 
patients using the app during their consultations, as it is important to gain an 
understanding of the context in which the app is used and the potential influences on 
the intervention (Murray et al., 2016; Yardley et al., 2015). Clinicians’ support is key to 
the successful implementation due to their role in encouraging patients’ use of the app, 
particularly during consultations.  
 
Thirdly, a feasibility study should assess the acceptability and suitability of the methods 
used. As suggested previously, it would be beneficial to used a mixed-methods 
approach that includes semi-structured interviews for in-depth assessment, a 
questionnaire to ensure breadth of information and app activity data to provide further 
insight into app use and compare this data to patients’ explicit perceptions. For 
example, comprehension and usefulness of questions asked in qualitative interviews 
could be explored by conducting separate focus groups with samples of patients and 
relatives on the interview topic guide. Similarly, patterns of missing data or multiple 
responses on the questionnaire could be observed and explored with participants upon 
completion. Amendments of these methods could then be made accordingly. Finally, a 
feasibility study should record the time taken to recruit participants and the time 
required for older patients to learn to use the app, in order to estimate the time scale 
required for a larger pilot study. 
 
Upon completion of feasibility testing, potential changes to improve the app that may 
have come to light during the study may be discussed with the project team. This 
allows for a more refined version of the app to be used during pilot testing. Additionally, 
barriers that were identified during the feasibility study may be considered and ways to 
circumvent or minimise these barriers can be implemented. If the feasibility study 
provides more evidence for the perceived usefulness of the app features, a think aloud 
study, where users use the app and talk through the process with a researcher, could 
be used to elicit and observe user reactions to each intervention element (i.e. app 
feature) (Yardley et al., 2015). This study would enable the iterative modification of the 
app in order to optimise its acceptability and feasibility prior to a pilot evaluation. 
Specific frameworks for evaluating the usability of mobile interventions in healthcare 
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may be used to guide the think aloud study. These frameworks might include the 
Health-ITUEM (Brown et al., 2013) and the PACMAD model (Harrison et al, 2013). 
 
8.6.2 Pilot testing 
Following completion of feasibility testing, the MRC framework encourages pilot testing 
of the intervention across multiple sites (Craig et al., 2008). A pilot study is designed to 
replicate a larger controlled trial on a smaller scale and is conducted to ensure that 
methods and study procedures run as intended, such as recruitment of participants, 
intervention implementation, and completion of baseline and follow up measures. A 
pilot study should also be randomised to allow assessment of the size of the 
intervention effects. This will enable the calculation of the sample size required for the 
main, larger controlled trial. Importantly, outcome measures for the main trial will be 
piloted during this study to provide preliminary insights into the intervention effects. 
Patients and their relatives would be randomised to one of two arms: an intervention 
arm where patients and relatives would receive the app following a diagnosis of 
cancer, and a control arm, where no intervention is received. In the intervention arm, 
patients and relatives would use the app running up to, and during, a consultation with 
their clinician, which would be audio-recorded. Again, it is important that dyads and 
individuals are recruited to the study to explore whether the intervention has different 
effects on each group. App activity data would be recorded by Google Analytics. The 
primary outcome would be levels of activation, with levels of anxiety as a secondary 
outcome (and proxy measure of psychological coping). Measures could include the 
State-Trait Anxiety Inventory form, a valid and reliable self-report measure of anxiety 
levels that has previously been used in mobile interventions for patients with cancer 
(Spielberger, 1983), and the Patient Activation Measure (PAM) questionnaire (Hibbard 
et al., 2004), which is the most commonly used measure, which has been found to be 
a scientifically valid and reliable tool to measure patient activation. The potential 
effectiveness of the app to improve patients’ levels of activation and anxiety will be 
determined by analysing the differences between pre- and post-intervention PAM and 
anxiety scores. Audio-recordings of consultations would be transcribed verbatim and 
analysed using thematic content analysis. A subset of consultations would be further 
analysed with in-depth discourse analysis to gain an understanding of how changes in 
patient-clinician communication occur. App activity data, in combination with anxiety 
scores, PAM scores and audio-recordings, will help to determine the probable active 
components of the intervention.  
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8.6.3 Controlled evaluation  
A larger, controlled evaluation could then be considered if pilot testing indicated that 
the intervention, study methods and procedures were acceptable and feasible. The 
MRC framework suggests the evaluation is in the form an RCT including the measures 
used in the pilot study, however completion of RCT can require years to validate the 
intervention, by which time technology may have advanced and cancer care and 
patients’ requirements for an app may have changed. Researchers have argued that 
the timeline of an RCT is therefore incompatible with web- and mobile-based 
interventions (Mohr et al., 2013). A methodologic framework, Continuous Evaluation of 
Evolving Behavioral Intervention Technologies (CEEBIT), has been developed as an 
alternative method to support the evaluation of web- and mobile-based interventions 
(Mohr et al., 2013). The CEEBIT methodology works by taking advantage of the ability 
of mobile interventions to collect and transmit outcome and use data in real-time, 
thereby enabling the evaluation of multiple interventions or evolving versions of the 
same intervention provided by one deployment system (e.g., a clinical care 
organisation or commercial marketplace). By using real-time data, this method enables 
the identification and elimination of interventions, or older versions of a single 
intervention, that demonstrate poorer outcomes, and the entering of new interventions, 
or updated versions of a single intervention, at any time. This process facilitates the 
continuing evolution of a digital intervention, thereby providing patients with continually 
improving care. Irrespective of choice of method, a controlled evaluation would involve 
multiple national sites (e.g. Wales and England), and ideally international sites, in order 
to assess the generalisability of the findings. If the intervention is found to be effective, 
intervention implementation could be then considered.  
 
8.7 Intervention implementation: consideration and challenges 
8.7.1 Encouraging the adoption of the ‘Ask Us’ cancer app 
The findings of the field testing study conducted for this PhD thesis highlighted the 
potential barriers to the successful implementation of the app in practice, including time 
since diagnosis, experience with Smart technology, patients’ perceptions of the 
acceptability of app use in consultations and an avoidant coping approach. These 
findings highlighted the importance of presenting the app to patients at the earliest 
opportunity following diagnosis, in order for them to maximise the benefits of the 
intervention. Patients may be provided with information leaflets, booklets or websites 
	 238	
by the consultant or cancer nurse specialist when diagnosed in a consultation. A leaflet 
about the ‘Ask Us’ app and the benefits of using it could be created and presented to 
patients and relatives during this consultation. Alternatively, the ‘Ask Us’ app could be 
made publically available to download from the Tenovus Cancer Care website.   
 
The field testing study also highlighted that some patients, most likely older patients, 
will lack knowledge and experience with Smart technology and so may require training 
in how to use the app. An in-app tutorial of how to use the app would be an 
inexpensive way to provide this training. However, older individuals might need more 
extensive training and time to learn to use the app. This could be provided in the form 
of manual instructions and a task list to keep costs down (Conci et al, 2009; Tang et 
al., 2013). Indeed, a previous study of older adults learning to use Smart technology 
found that they preferred to learn by trial and error (with on screen instructions) or by 
paper manual (Tang et al., 2013), both of which are cheap to implement. Alternatively, 
relatives of patients may use the app on behalf of patients who are unable to use the 
app (McCall et al., 2008). Similarly, for the minority of individuals that might not own a 
Smart device, they may access the app by using it on a relatives’ device.  
 
A further potential barrier to implementation of the app in practice is patients’ 
perceptions of the acceptability of using an app during consultations with clinicians. 
The QPL feature of the app is intended to be used to prompt patients to ask questions 
during consultations. Findings from the field testing study in this thesis suggested that 
it would be useful to make clinicians aware of the app and its purpose so that they 
might encourage its use if patients present it at consultations. Patients in the field 
testing study suggested that they would feel comfortable using the app if their clinician 
approved of it and gave their permission. An information leaflet could be created and 
distributed to clinicians detailing the purpose of the app.  
 
Some individuals might not be able to, or want to use, this type of technology due to 
being too poorly, or having preference of traditional methods of information-gathering 
or an avoidant coping approach (Leydon et al., 2000). However, relatives might use the 
app on the patients’ behalf if they are too poorly to use it themselves. Additionally, this 
app was developed as a tool for those patients who want, and will benefit from, 
information on their condition. It is intended to supplement existing information 
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resources and interventions and to encourage patients to retrieve accurate and reliable 
information from their clinicians.  
 
Finally, long-term maintenance of the app must be considered prior to wide scale 
implementation. It is anticipated that the app would be publically available to download 
from the Tenovus Cancer Care website and maintained by their information technology 
services. Additionally, the NHS has recently launched a website called the Digital Apps 
Library, which contains trusted apps that patients can use for their health and care 
(https://apps.beta.nhs.uk) (see section 8.7.2). Currently, there is only one app for 
cancer patients listed, the ‘OWise Breast Cancer App’, which enables patients to track 
their treatment and wellbeing. To be listed on this website, an app must be available in 
either Apple, Google or Microsoft App Stores as the library does not host apps, it only 
provides links to the stores. Additionally, an app must be approved by the NHS 
following submission of sufficient evidence of its effectiveness, safety and usability (i.e. 
a controlled trial) (more information can be found here https://apps.beta.nhs.uk/about-
us/). 
 
8.7.2 Policy considerations 
The development of an app that enables patients and their relatives to meet their 
information needs in non-inpatient settings follows the objectives set out by  
the UK Government and National Health Service plans, such as the National Cancer 
Strategy and Cancer Delivery Plan, which highlighted information provision as one of 
their key priorities (DOH, 2011; 2013; Welsh Government, 2016). Additionally, the 
development of an app that may be useful for relatives, as well as patients, supports 
the objectives of recent cancer policies, the NHS and cancer organisations, which 
encourage the development of interventions that consider and support patients’ 
families (DOH, 2011; 2013; Welsh Government, 2016).  
 
The UK government has encouraged the integration of mobile interventions into 
traditional healthcare services since the early 2000’s (DoH, 2006; Liddell et al., 2008). 
However, key reviews over the last few years, such as NHS Five Year Forward (NHS 
England, 2014) and the Wachter review (Wachter, 2016), have highlighted the 
importance of, and urgent push for, digitisation in the NHS, in order for it to continue to 
provide a high level of healthcare at an affordable cost. In 2016, Jeremy Hunt stated 
that more than £4 billion had been set aside to support digital and technology projects 
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in the NHS, including £1.8 billion to meet the ambition of a paperless NHS (Honeyman, 
Dunn & McKenna, 2016). 
 
The Next Steps on the NHS Five Year Forward View report (NHS, 2017) outlines the 
commitment of the organisation to support the implementation of healthcare apps that 
enable patients to manage their health remotely. In April 2017, the NHS launched two 
new digital platforms, NHS Digital Apps Library for patients and clinicians and a ‘mobile 
health space’ for app developers on www.developer.nhs.uk. The apps have been 
designed and tested to support the self-management and prevention of health related 
conditions. The NHS Apps Library have created a Digital Assessment Questionnaire 
and review process that enables app developers to provide information and evidence 
for the safety and effectiveness of the apps. This process is currently being tested. 
Once an app assessment has been completed, it will go through a pre-assessment 
process at NHS Digital to determine if the app is suitable. If it qualifies, the developer 
will be invited to take part in the self-assessment by answering the digital assessment 
questions. This will then be reviewed by subject matter experts, who are specialists in 
various fields (e.g. clinical safety, data security). If an app successfully satisfies the 
assessment criteria, it will go through a process that will lead to publication on the NHS 
Apps Library.  
 
8.8 Conclusion  
The body of work completed for this PhD thesis identified patients’ (and their relatives’) 
needs and preferences regarding an app to help them to meet their information needs, 
and the psychosocial context that underpinned these perceptions. This thesis also 
provided insight into clinicians’ perceptions of the value of an app for patients and their 
relatives and the type of app that they anticipated to be useful. The ‘Ask Us’ cancer up 
was created on the basis of these findings and was found to be an acceptable platform 
to deliver interventions to patients in non-inpatient settings, although further exploration 
is required with a sample that is more representative of the general cancer patient 
population to add weight to these findings. This type of intervention has the potential to 
provide a range of benefits to a variety of patients and preliminary findings did not 
indicate any disadvantages of app use. Potential barriers that were identified were 
mostly considered temporary, due to the rapid diffusion of new technology in the 
general population and healthcare, and can be considered and minimised prior to 
implementation. There is potential for this intervention to be listed on the NHS Digital 
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Apps Library to provide patients and relatives with free access to the app. The work 
conducted for this PhD project, and the creation of the ‘Ask Us’ cancer app, support 
the recent policies and objectives set out by the government and NHS in the UK to 
enable patients and their families to take a more active role in their care and to harness 
the power of health information technology in order to do so.  
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